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Abstract 
In this chapter the evolution of monodentate P-ligands in asymmetric catalysis is shortly traced from its 
beginning to the advent of combinatorial and supramolecular approaches used in homogeneous transition 
metal catalysis.  
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1.1 GENERAL INTRODUCTION 
 
Since van’t Hoff  and Le Bel introduced 135 years ago the tetrahedral model of the carbon 
atom to explain the optical activity of organic molecules and provide a structural basis for molecular 
stereochemistry, scientists have been fascinated by the challenge to achieve absolute stereocontrol in 
chemical transformations starting from achiral compounds. Chirality has been denoted as “signature of 
life”, and it is not unexpected that questions on the origin, control and amplification of homochirality 
are intimately associated with chemical evolution and the origin of life. 
In spite of the incredible importance, asymmetric catalysis has not been considered as a 
fundamental research area until 1968. In fact, besides enzymatic processes, only few examples of 
enantioselective catalytic reactions were known at that time, and in view of the generally low 
enantiomeric excesses, many chemists doubted that synthetic chiral catalysts would ever play an 
important role in asymmetric synthesis. Shortly after, the situation changed dramatically as spectacular 
progress was made in the rhodium-catalyzed hydrogenation of olefins (Knowles, Noyori, Horner, 
Kagan), culminating in the famous Monsanto process for L-DOPA, and in the selective epoxidation 
and dihydroxilation of olefins (Sharpless). Since then, asymmetric catalysis based on chiral catalysts 
which are metal complexes containing chiral organic ligands has undergone explosive growth. 
Without any doubts, transition metal-mediated asymmetric hydrogenation is one of the most 
important process and a well-established and efficient methodology for the catalytic reduction of many 
prochiral substrates such as alkenes, imines and ketones. There have been several significant 
breakthroughs in the field and now a myriad of chiral Ru-, Rh- and Ir-coordination compounds 
(mostly phosphorus-containing derivatives) capable of mediating this transformation with very high 
enantioselectivities are known. The development of commercial processes has rendered this 
transformation highly desiderasble to both academia and industry. 
During these decades, research efforts have been directed towards the development of chiral 
ligands with attractive industrial profiles, which means that they should induce high stereoselectivities, 
be easily prepared and not be covered by current patents. Combinatorial and high-throughput synthetic 
strategies have led to the development of a number of highly efficient monodentate and bidentate 
phosphorus and nitrogen-containing ligands for many different asymmetric reactions (e.g. 
hydrogenation, hydroformylation, allylic alkylation and conjugate addition) that utilise either standard 
covalent chemistry or supramolecular interactions. 
 
The formation of bidentate ligands by non-covalent interactions, so called supramolecular, is 
now a cutting-edge strategy for the combinatorial search of new selective catalysts and the object of 
the scientific interest of several important research groups worldwide.1  
Our research group has a long-standing interest in the search for combinatorial/high-
throughput approaches to enantioselective catalysis,2 and for this reason it has followed the recent 
evolution in P-ligand design with high interest, providing significant contributions in this field.3 In 
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particular supramolecular bidentate ligands have been recently the object of our attention because they 
merge the advantages of monodentate ligands (i.e. easy and fast preparation, possibility of a 
combinatorial screening of ligand combinations) with those of their bidentate counterparts (i.e. rigidity 
and preorganisation). In particular, our goal is to achieve the self-assembly exploiting non-covalent 
interactions such as coordinative interactions and hydrogen bondings. 
Moreover, the present work of thesis accounts for our early efforts in a new and virtually 
unexplored direction: pursuing the selective assembly of two different ligands around a metal centre 
exploiting the intrinsic thermodynamic preference of the system in favour of the heterocomplex. 
Significant results in this sense were obtained combining ligands having complementary electronic 
properties in the presence of a metal source, as it will be discussed below. The resulting complexes 
were exploited for the catalysis of reactions promoted by rhodium and palladium, where the role 
played by the heteroleptic complex emerged clearly. 
 
Before describing the guidelines and the results of these projects, it can be helpful showing 
briefly the role of monodentate P-ligands in different transition-metal catalyzed reactions (Chapter 1).  
Particular interest was made to asymmetric 1,4 conjugate addition, allylic substitution and 
homogeneous asymmetric hydrogenation of olefins.4 as powerful transformations for industrial 
applications. The latter transformation is arguably one of the most intensely studied topic in 
organometallic chemistry and it exemplifies well the evolution of phosphorus ligand design that has 
led to self-assembled bidentate ligands. 
In Chapter 2 a new approach to the selective formation of heterocomplexes combining pi-
acceptor phosphite ligands with σ-donor phosphinamines is presented. 31P NMR studies are described 
which show preferential formation phosphite /C1-symmetric aminophosphine heterocomplex (70 –
100% selectivity). The results of the screening of ligand combinations in several kinds of different 
reactions are discussed. 
In Chapter 3 the synthesis of supramolecular monodentate P-ligands through coordinative 
bonding was investigated taking advantages of a cobalt(III)-salen complex as template. The screening 
of these P-ligands was studied in several enantioselective catalytic applications, showing good activity 
and moderate enantioselectivity in several palladium-catalyzed asymmetric reactions. 
In Chapter 4 the synthesis of a library of novel chiral supramolecular ligands containing a 
phthalamide moiety capable of hydrogen bonding interactions was reported. The new ligands, named 
PhthalaPhos, are easy to prepare from inexpensive starting materials, and displayed an excellent level 
of enantioselectivity in the hydrogenation of benchmark olefins (methyl 2-acetamidoacrylate and 
acetamidostyrene) as well as of more challenging, industrially relevant substrates. In two reported 
cases, namely the cyclic enamide N-(3,4-dihydronaphthalen-1-yl)acetamide and β2-dehydro 
aminoester (E)-methyl 2-(acetamidomethyl)-3-phenylacrylate, our ligands rival or even outperform the 
best results obtained with known ligands. The pre-catalytic Rh complex of one of these ligands was 
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fully characterized by NMR, IR and MS spectroscopy. These studies show that a supramolecular 
bidentate ligand is formed in the Rh complex by ligand self-association through a pair of interligand 
hydrogen bonds. 
 
 
1.2 MONODENTATE P-LIGANDS IN ENANTIOSELECTIVE 
CATALYSIS 
 
In this chapter a brief overview of the most important asymmetric applications of monodentate 
P-ligands was discussed. Particular interest was made to asymmetric 1,4 conjugate addition, allylic 
substitution and hydrogenation as powerful transformation for industrial applications. 
 
1.2.1 Asymmetric 1,4 conjugate addition 
 
The copper catalyzed conjugate addition of diethylzinc to cyclohexenone (Scheme 1.1), as a 
benchmark reaction for monodentate phosphorus ligands was first reported by Alexakis in 1993 
making use of phosphoramidite ligands (Scheme 1.2).5 
 
Scheme 1.1 1,4-Conjugate addition of diethylzinc to cyclohexenone 
 
Subsequently, the activity of Cu(OTf)2 in the presence of chiral monophosphites and phosphoramidites 
derived from TADDOL was reported by Alexakis. 6 Altough biphenylphosphite ligands bearing a 
stereoidal third phosphorus substituent showed some catalytic activity but moderate 
enantioselectivity,7 the best efficiencies were obtained with phosphoramidites derived from BINOL 
either with an achiral amino group8 or a chiral one as in 1-3.9 Different phosphoramidite ligands 4 
prepared from biphenol and optically active amine were also shown to be very efficient for the 
enantioselective conjugate addition of dialkylzinc derivatives to cyclic and acyclic enones.10 Sterically 
demanding phosphoramidites derived from partially hydrogenated atropoisomeric H8-BINOL provide 
an efficient enantioselective conjugate addition of diethylzinc to cyclohexenone.11 Phosphoramidites 
built on spiranic diol have also shown excellent efficiencies in the conjugate addition of diethyl zinc to 
cyclohexenone leading to over 98% ee (ligands 5).12 A P-H phosphonite ligand based on biphenyl-
2,2’-bisfenchol as diol showed good enantioselectivity in the enantioselective copper-catalyzed 
reaction.13 Not only zinc derivatives but also trialkylalumnium derivatives lead to very good levels of 
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enantioslectivity upon addition to conjugate enones14 and nitroalkenes15 in the presence of biphenol 
phosphoramidite ligands associated to a copper precursor. 
Scheme 1.2 Examples of performing monodentate P-ligands in the asymmetric conjugate additions 
 
Besides enones, other Michael acceptors such as nitroolefins have been alkylated with Et2Zn 
under copper catalysis conditions in the presence of phosphites, phosphonites and phosphoramidites 
derived from TADDOL and BINOL,16 and biphenol.17 
α-β Unsaturated imines have also been used to prepare enamine derivatives with excellent 
enantioslectivities upon addition of Et2Zn in the presence of a copper salt and phosphoramidite 
ligands.18 Conjugate addition of alkyl-zinc or –aluminium reagents to alkylidene malonate derivatives 
has been carried out with phosphonites and phosphoramidites with satisfactory to excellent 
enantiometric excesses.19 
The addition of aryl and vinyl groups to cyclohexenone, which is not always possible from 
zinc reagents, has been efficiently performed with aryl and vinyl boron derivaties by using rhodium 
catalysts associated to phosphoramidite ligands. Thus, >98% ee was obtained from PhB(OH)2 or 
PhBF3K in the presence of selected phosphoramidite ligands.20 
1.2.2 Asymmetric Allylic Substitution 
 
Metal-catalyzed asymmetric allylic substitution has been extensively investigated. Among all 
chiral ligands designed and reported for the benchmark allylic alkylation with 1,3 diphenyl propenyl 
acetate, some chiral monodentate phosphites, phosphoramidites, monoaminophosphonites and 
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diaminophosphonites have been used. Thus, malonate has been successfully allylated in 95% ee with 
ligand 6 (Scheme 1.3),21 and in 70% ee with 1.22 
 
Scheme 1.3 Pd-catalyzed asymmetric alkylation 
 
Amines have also been used as nuclephile in high ee with ligand 8 (87-95% ee) and with 6.23 
The reaction of cis-1,4-dibenzoyloxy-2-cyclohexene with a malonate using chiral monodentate 
phosphoramidite ligand 9 or with α-methoxycarbonylacetamide derivative using ligand 10 or 11 
yielded the desymmetrized cyclohexene with high enantioselectivity. The former reaction opened a 
highly efficient short total synthesis of (+)-γ-lycorane (Scheme 1.4).24 
 
Scheme 1.4 Total Synthesis of (+)-γ-lycorane. 
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Reactions with non-symmetric allylic carbamates, acetates or phosphates with a wide range of 
nucleophiles (malonates, alkyl or aryl-amines, aliphatic alcohols or phenol derivatives), in the 
presence of iridium complexes bearing chiral phosphite, or phosphoramidite ligands, afforded the 
branched isomers with high region- and enantioselectivities (Scheme 1.5).  
 
Scheme 1.5 Asymmetric Ir-catalyzed alkylation 
 
Phosphite 12 allowed the addition of malonate25 or glycinate26 in high yields, good 
regioselectivities and high level of enantioselectivities. Phosphoramidites have been used more 
frequently and have led to high region- and enantioselectivities for the allylation of malonates (with 
ligand 127 and 1328), nitroethane or ethyl α-nitroacetate (with ligand 1329), amines (with ligands 1,30 
13’,31 14,32 1533), alcohols (with 1 and 1434) and potassium silanoate (with 135) (Scheme 1.6). 
Scheme 1.6 Ligands used for asymmetric Ir-catalyzed alkylation 
 
Branched enones can be produced by reaction of trimethylsilylenol ethers with allylic 
carbonates in the presence of a catalytic amount of [Ir(COD)Cl]2 and the phosphoramidite ligand 1 in 
high enantiomeric excesses (91-96%) and regioselectivities (87/13-99/1) (Scheme 1.7).36 
 
Scheme 1.7 Ir-catalyzed reaction of trimethylsilylenol ethers with allylic carbonates 
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Copper-catalyzed coupling reaction of substituted allylic substrates with Grignard or 
dialkylzinc reagents in the presence of chiral phosphoramidite 16 or 18,37 or phosphite 17 or 19,38 
afforded the related terminal olefins with good regioselectivities and enantioselectivities (Scheme 1.8). 
Scheme 1.8 Copper-catalyzed coupling reaction of substituted allylic substrates with Grignard or dialkylzinc 
reagents (TC = tiophene-2-carboxylate). 
 
Kinetic resolution of allylic epoxides with dialkylzinc species in the presence of chiral copper-
phosphoramidite catalysts was reported by Pineschi et al. (Scheme 1.9).39 Allylic and homoallylic  
alcohols were isolated with good to excellent enantioselectivities. The regioselectivity of the reaction 
depends on the absolute configuration of the chiral catalyst. 
 
 
Scheme 1.9 Products of kinetic resolution with dialkyl zinc in dependence on the reaction mechanism 
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Extension of this reaction to 2-alkenyl aziridines was also examined (Schiral 1.10).40 Chiral 
copper-phosphoramidite complexes were shown to be very efficent for the ring-opening reaction. The 
dialkylzinc addition was anti-stereoselective and allylic amines were isolated with good 
enantioselectivities (up to 83% ee). 
 
Scheme 1.10 Cu-catalyzed opening of 2-alkenyl aziridines with dialkyl zinc 
 
Highly region-, diastereo and enantioslective desymmetrization of five-, six-, and seven-
membered meso cyclic allylic diethyl-phosphates with organozinc compounds was described by 
Piarulli and Gennari.41 Good to excellent enantioselectivities were observed with phosphoramidites 1 
or 2. Selectivities (de and ee) were highly dependent on the size of the ring (Scheme 1.11). 
Scheme 1.11 Desymmetrization of cyclic meso allylic diethyl-phosphates with organozinc compounds 
 
Enantioselective ring opening of oxabicyclic alkenes with Grignard reagents in the presence of 
copper and spirophosphoramidite was disclosed by Zhou et al. (Scheme 1.12).42 The corresponding 
alcohols were obtained in excellent diastereoselectivities and in moderate to good enantiomeric 
excesses. 
Scheme 1.12 Enantioselective ring opening of oxabicyclic alkenes with Grignard reagents 
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Regio- and enatioselective asymmetric ring opening of 1,3-cyclopentadiene-heterodienophile 
cycloadducts with trialkylaluminium species and copper-phosphoramidite 1” was reported by Pineschi 
et al. (Scheme 1.13).43 1,2-disubstituted cyclopentenes were prepared in up to 86% ee. Alexakis et al.44 
have pointed out that extreme care was required in this reaction as BINOL- or biphenol based 
phosphoramidites could react with trimethylaluminium in non-coordinating solvents (toluene, 
dichloromethane) to give dimethylaminophosphines. These phosphines can act as ligands in the 
nucleophilic ring opening of bicyclic hydrazines and then modify the selectivities. 
Scheme 1.13 Regio- and enantioselective asymmetric ring opening of 1,3-cyclopentadiene-heterodienophile 
cycloadducts with trialkylaluminium 
 
1.2.3  Rhodium catalyzed asymmetric hydrogenation45 
 
The first asymmetric olefin hydrogenation was achieved, with up to 15% e.e., by Knowles46a 
and Horner46b in 1968 using a rhodium complex bearing two chiral monodentate phosphines. Although 
Knowles could later obtain significantly higher levels of enantioselectivity in the hydrogenation of α-
dehydroaminoacids using PAMP and CAMP ligands (Scheme 1.14),47 an even more impressive 
breakthrough was made in the same period by Kagan.48 He reported the first bis-phosphine ligand, 
DIOP, for Rh-catalyzed asymmetric hydrogenation. The successful application of DIOP resulted in 
several significant directions for ligand design in asymmetric hydrogenation. Chelating bis-phosphines 
could lead to superior enantioselectivity compared to monodentate phosphines. Additionally, C2 
symmetry was an important structural feature for developing new efficient chiral ligands. Kagan’s 
seminal work immediately led to the rapid development of chiral bis-phosphorus ligands. Knowles 
later reported a C2-symmetric chelating bis-phosphine ligand, DIPAMP,49 which, due to its high 
catalytic efficiency in Rh-catalyzed asymmetric hydrogenation of dehydroaminoacids, was quickly 
employed in the industrial production of L-DOPA,50a [(S)-3,4-dihydroxyphenylalanine, wich had 
proved useful in the treatment of Parkinson's disease]. The success of practical synthesis of L-DOPA 
via asymmetric hydrogenation represented a milestone work, for which Knowles was awarded the 
Nobel Prize in 2001.50b 
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Following the significant contributions by Knowles and Kagan came the development of thousands of 
chiral phosphorus ligands for asymmetric hydrogenation over the 1980s and 1990s, the overwhelming 
majority of which were C2 or C1-symmetric bidentate P,P-ligands. Among these, Noyori’s BINAP 
must be mentioned (Scheme 1.14),51 whose ruthenium complexes efficiently catalyze the 
enantioselective reduction of olefins and ketones. For having developed this very important catalytic 
system, Noyori received the Nobel Prize in 2001.51f 
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Scheme 1.14 The first most important asymmetric olefin hydrogenation reactions using phosphorus ligands 
 
In the context of such “explosion” of the interest in P,P-bidentate ligands for asymmetric 
hydrogenation, despite having been the first enantioselective systems, monodentate P-ligands were 
somehow “neglected”, as far as asymmetric hydrogenation is concerned: for some thirty years the 
rigidity typical of bidentate systems was deemed a possible indispensable requirement for the 
stereochemical information of the ligand to be efficiently transferred to the hydrogenation product. 
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The widely accepted dominance of the bidentate diphosphorus ligands was questioned for the first 
time in 1999, when Guillen and Fiaud reported a rhodium complex of 1,2,5-triphenylphospholane 20 
(Scheme 1.15), a monodentate species of the DuPHOS-type. The Rh-complex of 20 could reduce 
methyl 3-phenyl-2-acetamidopropenoate with 82% e.e..52 Orpen, Pringle, and co-workers attained the 
hydrogenation of methyl 2-acetamidoacrylate in 92% e.e. with the asymmetric monophosphonite 21 
and thus demonstrated that a higher enantioselectivity with respect to comparable C2-symmetric 
diphosphonite analogues was possible (Scheme 1.15).53 Reetz and Sell showed in response that 
through the exchange of the t-butyl group for an ethyl group (22) the enantioselectivity can be further 
increased.54 Dimethyl itaconate was also hydrogenated with the same catalyst with a respectable 90% 
e.e.. However, in spite of this, a related diphosphonite ligand delivered >99% e.e.. The old rule 
considering chelating diphosphorus ligands as superior still appeared to hold. A comparison between 
the performances of the monodentate ligands just described is set in Scheme 1.15. 
 
Scheme 1.15 Rh-catalyzed hydrogenation of pro-chiral olefins 
 
A clear tie in regard to performance, with enantioselectivities that could not be topped, was achieved 
with the use of monodentate binaphthol phosphites and phosphoramidites. In 2000 Reetz and Mehler 
prepared the monophosphite 23.55 The corresponding catalyst induces >99% e.e. in the hydrogenation 
of dimethyl itaconate. Particularly noteworthy is the high substrate: rhodium ratio of up to 5000:1, 
which still guarantees complete conversion in 20 h under atmospheric pressure. Surprisingly, the 
configuration of the stereogenic carbon atom of the benzyl ether does not play any kind of role, and 
the enantioselectivity of this type of ligand is dominated by the chiral binaphthyl unit. 
Phosphoramidites, a ligand class that had only recently been introduced into asymmetric 
hydrogenation in the form of hybrid chelate ligands,56 showed able to induce excellent 
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enantioselectivity as monodentate ligands. De Vries, Feringa, and co-workers could reduce standard 
substrates in > 94% e.e. with a rhodium complex based upon the binaphthol phosphoramidite 24 
(MonoPhos), once the reaction conditions had been optimized.57 
It should be noted that all of these early examples of highly enantioselective monodentate 
ligands were phosphorus derivatives of binaphthol. Based on the crystal structure of a Pt(II) complex 
with monophosphonite ligands, Orpen and Pringle proposed a plausible explanation that later was to 
be helpful in the development of other selective mono-phosphorus ligands.58 Through the cis 
coordination both the sterically demanding monophosphonite ligands take up an exceptionally stable 
configuration around the metal centre, and the rotation about the P-O bond is reduced. In this 
conformation the two biaryl fragments point out of the plane of the projection in what is described as 
edge-on arrangement. In a virtual coordination system two diagonally opposing squares are occupied 
(Scheme 1.16 A). The squares at the top left and bottom right are not effectively occupied, because of 
the planar arrangement of the two phenyl groups in the plane of the projection (face-on). From 
investigations with chelating diphosphorus ligand complexes it was known that such an alternating 
edge/face arrangement59 can support the diastereo-differentiating coordination of a pro-chiral substrate 
through the minimization of repulsive interactions.60 In contrast, by the cis coordination of the 
diphosphonite ligands the stabilized rotamer is that in which the biaryl units are in the face-on 
orientation; none of the squares is favoured (Scheme 1.16 B). Thus the chances of diastereomeric 
recognition of the pro-chiral substrate are greatly reduced. 
 
 
Scheme 1.16 Quadrant diagrams for (a) monophosphonite and (b) diphosphonite ligands 
 
On the basis of this general model and supported by first semi-empirical calculations from de 
Vries and Feringa61 it became clear that, for the mechanism of chiral transfer in asymmetric 
hydrogenation, mono- and diphosphorus ligands do not necessarily fundamentally differ. By year 2000 
it was understood that the requirement originally laid down by Kagan, that the catalyst must be 
conformationally rigid, is clearly also achievable with two appropriate monodentate monophosphorus 
ligands.62 
Not surprisingly, however, no single ligand proved “universal”, because there cannot be such 
a thing as a general catalyst. When encountering cases in which enantioselectivity is insufficient, a 
“traditional” combinatorial approach would suggest to prepare and screen further, structurally 
modified derivatives. This is what was done exploiting the high modularity of the simple ligands 
discussed above: in the case of BINOL phosphites, for example, the substitution of naphthyl rings and 
the alkoxy moiety were modified in turn, which led to the preparation of a large number of catalysts.63 
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In a similar way, a large number of monodentate phosphoramidites, 64,65b were prepared and tested as 
ligands for the Rh- and Ir-catalyzed reactions such as, respectively: (i) the asymmetric hydrogenation 
of α- and β-dehydroaminoacid derivatives and dimethyl itaconate;65a (ii) the asymmetric 
hydrogenation of ketoimines,64s,z and hydrogenation of quinoaxilines.64t Several monodentate 
phosphinites,66a-b,e and aminophosphinites,66c phosphines66d and phospholane66f were reported as well. 
Some of the best-performing ligands are shown in Scheme 1.17. 
 
 
Scheme 1.17 Example of some of the best-performing ligands 
 
The concept itself of utilizing libraries of modular ligands for asymmetric transition-metal 
catalysis was not new, having also been developed by Burgess,67 Gilbertson,68 Kobayashi,69 
Waldmann,70 Berkessel,71 Schmalz,72 Ding,73 and others.74 
 
1.3 Combinatorial homogeneous transition-metal catalysis using mixtures 
of ligands 
 
1.3.1 Combinatorial catalysis “General Concept” 
 
The development of new catalysts is a challenging task. In many cases the correlation between 
their features (structural, electronic) and their performance (activity, selectivity, lifetime) is not easily 
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established. Therefore an iterative process of design, synthesis and testing is usually followed to 
improve catalyst performance. Combinatorial chemistry and “high-speed screening” technology can 
accelerate this process considerably, allowing for the simultaneous evaluation of a large number of 
candidates (Scheme 1.18).  
In most general terms, the key-idea of combinatorial methods is to synthesize and screen large 
libraries of chemical entities as fast as possible using special techniques, rather than performing the 
task sequentially in a traditional and thus time-consuming manner. 
 
 
Scheme 1.18 Comparison between classic and combinatorial methods 
 
When performing a synthetic combinatorial chemistry experiment, two basically different strategies 
may be followed to create a library of compounds: split-and-mix (also termed split and pool) method 
developed by Furka75b and parallel synthesis employing appropriate laboratory equipment. 
Solution or solid phase parallel methods are not new, and nowadays this approach is used routinely.75 
The important issue of automated solution-phase synthesis in an integrated system has been 
reviewed.75d Parallel screening of catalysts and biocatalysts is also practiced widely,76 made possible 
by modern automation and robotics. Miniaturized equipment such as microreactors77 or micro-fluidic 
chips (lab-on-a-chip)78 may in the future allow for small-scale reactions and analyses within a single 
device in a high-throughput manner.  
The term “combinatorial homogeneous catalysis” is not well defined. Most often, it simply 
means parallel synthesis and rapid evaluation of a large number of soluble catalysts. This includes not 
only the synthesis and testing of structurally different ligands/catalysts, but also the study of the 
influence of temperature, pressure, solvent, and additives. Multiple substrate screening as introduced 
by Kagan and Satyanarayana79b and ourselves79a is another practical facet of combinatorial 
homogeneous catalysis. 
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1.3.2 Combinatorial transition metal catalysis using ligand mixtures – 
“The concept” 
 
The synthetic and mechanistic work described above inspired Reetz and co-workers to 
propose a new method in combinatorial homogeneous transition-metal catalysis: the use of mixtures of 
monodentate ligands. 
The idea of mixtures may sound counterintuitive because chemists traditionally aim for single 
well-defined homogeneous catalysts. However, as first demonstrated in 2002/2003,80,81 the concept is 
viable if applied properly.  
The methodology is relevant whenever at least two monodentate ligands L are coordinated to 
the metal M of the active catalyst [MLn] in the transition state of a reaction.80,81 Thus its applicability 
goes beyond the field of asymmetric hydrogenation, as it will be discussed below. The simplest case 
involves a mixture of two such ligands La and Lb, in which three different catalysts exist in equilibrium 
with one another, namely the two homocomplexes [MLaLa] and [MLbLb] and the corresponding 
heterocomplex [MLaLb] (Scheme 1.19). If the ratio of components M, La, and Lb is chosen to be 1:1:1, 
then the ratio of [MLaLa]/[MLbLb]/[MLaLb] is not necessarily statistical (1:1:2). Rather, under 
thermodynamic conditions very different ratios are likely to result. The ideal case would constitute an 
equilibrium completely in favour of the heterocomplex [MLaLb], because then only a single well-
defined catalyst would exist in the reaction flask. If ligand exchange is fast and reversible (which is the 
general case), the position of the equilibrium can be influenced by adjusting the amounts of the ligands 
La and Lb relative to each other and relative to the metal. Even if a mixture of catalysts exists the 
concept is valid, provided the heterocombination is more reactive and more selective than either of the 
two homocombinations. 
 
 
Scheme 1.19 The concept of using mixtures of chiral monodentate ligands 
 
This applies to every kind of selectivity, including enantio-, diastereo-, and regioselectivity. If such 
selectivities are not relevant in a given reaction, this approach may still be of interest, namely when 
attempting to increase the rate of a reaction. The concept featured in Scheme 1.19 is related but 
certainly not identical to the idea of dynamic combinatorial chemistry as developed by Sanders et al.82a 
and Lehn.82b 
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Since the catalytic profiles of homocomplexes [MLaLa] and [MLbLb] are already difficult to 
predict by theory, anticipating the catalytic properties of the respective heterocomplex [MLaLb] is even 
more challenging. Therefore, in order to identify the optimal heterocombination from a library of 
ligands, an empirical combinatorial protocol is necessary.80 As time goes on and more experience 
accumulates, trends and hopefully theoretical models will emerge, which will aid the practicing 
chemist in new situations. 
As the size of a library of n monodentate ligands increases, so does catalyst diversity as a 
consequence of mixing (Table 1.1). For example, once 20 different ligands have been prepared, not 
only are 20 different catalyst systems accessible according to traditional thinking, but also 190 
additional catalysts in the form of the respective heterocombinations. Upon expanding the size of a 
library of monodentate ligands to 50, 100, or 200, the calculated number of heterocombinations 
increases drastically to 1225, 4950, and 19900, respectively. Thus, an explosion of catalyst diversity is 
possible without the need to synthesize any new ligands. Not all of the theoretically possible 
combinations may be meaningful in a given case, and these can be eliminated from further 
consideration on chemical grounds, thereby reducing the screening effort. 
 
Table 1.1 Mixtures of monodentate ligands generate high catalyst diversity without the need to prepare new 
ligands 
Number of 
ligands (n) Number of binary heterocombinations 2
)1( −×
=
nn
 
20 190 
50 1225 
100 4950 
150 11175 
200 19900 
500 124750 
 
Thus far only monodentate P-ligands have been tested in mixtures, although in principle 
monodentate C, N, O, or S-ligands can also be considered. Rapid ligand exchange is necessary, which 
may not always be the case. It should be noted how the mechanistic dividing line between the concept 
just described and the traditional use of additives or activators may not be sharp in some cases.83 
In the studies reported so far, only very small ligand libraries were constructed, which means 
that the full potential of the mixture concept has not been exploited. Nevertheless, significant results 
have accumulated. 
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1.3.3 Combinatorial transition metal catalysis using mixtures of chiral 
ligands 
 
The seminal study by Reetz et al.80 is shortly outlined below, because it effectively shows the 
potentialities of this methodology. 
Rh-catalyzed olefin hydrogenation was performed using a relatively small library of eight 
BINOL-derived phosphites 33a–h, five phosphonites 34a–e, and the chloride 35 as the monodentate 
ligands (Scheme 1.20).80 The pro-chiral olefins which were considered for asymmetric hydrogenation 
were N-acetamido acrylates, N-acyl enamines and dimethyl itaconate. Rh(cod)2BF4 was treated with 
two equivalents of monodentate ligands (2.0 eq of one ligand or, alternatively, 1 eq of two different 
ligands) with formation of the precatalysts Rh(cod)L2BF4. The library of 14 ligands under 
consideration allows for 91 heterocombinations, but only 31 were actually tested. 
 
 
Scheme 1.20 Monodentate phosphorus ligands for Rh-catalyzed assymetric hydrogenation of pro-chiral olefins 
 
This means that a mere 30% of chemical space was explored. In the hydrogenation of methyl 
2-acetamidoacrylate (Scheme 1.21 A) several hits were identified, revealing moderately positive 
effects in several cases. An effect is defined as positive if the heterocombination results in an 
enantioselectivity which is higher than that of the best respective homocombination. 
 
Scheme 1.21 Rh-catalyzed hydrogenation of (a) methyl 2-acetamidoacrylate and (b) N-(1-phenylvinyl)acetamide 
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One of the notable hits is the combination (R)-33a/(R)-33f, leading to 84.6% (S) ee, compared 
to the respective homocombinations (R)-33a and (R)-33f, which result in e.e. values of only 76.6% (S) 
and 32.4% (S), respectively. The best catalyst in the whole library of homo-and heterocombinations is 
the heterocombination comprising (R)-34a/(R)-34c, which leads to 97.9% (S) ee. The respective 
homocombinations result in markedly lower e.e. values of 91.8% (S) and 92.0% (S), respectively. This 
initial set of experiments indicates that the combination of a sterically small ligand and a bulky ligand 
constitutes the mixture of choice. This observation was made in numerous subsequent cases as well, 
although exceptions exist. 
In the Rh-catalyzed asymmetric hydrogenation of N-acyl enamines (Scheme 1.21 B), the 
combinatorial search was confined to the use of the mini-library 34a–e and 35. The positive effect of 
mixing ligands proved to be much more dramatic than in the case of the other substrates. Upon 
performing a total of only 30 hydrogenation experiments, several highly selective combinations were 
discovered. For example, the best catalyst for the hydrogenation of α-acetamido styrene is again the 
“small/large” heterocombination (R)-34a/(R)-34d (96.1% e.e. for enantiomer S). This positive effect 
needs to be compared to the performance of the respective homocombinations: (R)-34a/(R)-34a 
(75.6% e.e. for enantiomer S) and (R)-34d/(R)-34d (13.2% e.e. for enantiomer S). 
All of these experiments were performed using a Rh/La/Lb ratio of 1:1:1. To explore the 
possible effect of varying the ratio of the two phosphonites 34a/34d while maintaining the original 
ratio of metal to total amount of ligand (Rh/L = 1:2), additional hydrogenations were carried out 
employing N-(1-phenylvinyl)acetamide (Scheme 1.21 B). Upon raising the relative amount of the 
bulky t-butyl phosphonite (34a/34d = 1:3), the enantiomeric excess increased to 97.4% (S). When 
doing the opposite (34a/34d = 3:1), the e.e. value decreased to 85.0% (S). Thus, this early study 
demonstrated that a variation of the ligand ratio in a heterocombination constitutes a further tool for 
catalyst optimization. Furthermore, it should be noted that in this particular case the bulkier of the two 
ligands dominates when attempting to increase enantioselectivity beyond the e.e. value obtained with 
the “usual” 1:1 ratio of ligands La and Lb. 
These and other results of this early study demonstrated that the enhancement of 
enantioselectivity and reaction rate as a result of mixing two chiral monodentate ligands was not just a 
fortuitous event observed in a single case, but that a new principle in combinatorial asymmetric 
catalysis had emerged. 
Immediately following the initial report from Reetz et al.,80a a note by de Vries, Feringa, et al. 
appeared,84 describing the benefits of mixing certain BINOL-derived phosphoramidites in the Rh-
catalyzed hydrogenation of β-(acylamino)acrylates with formation of the β-amino acid derivatives. 
Later on, again Reetz reported that the stereoselectivity of the same reaction could be improved using 
appropriate mixtures of phosphites and phosphonites.85 
As stated above, the principle of mixing monodentate ligands in transition metal-catalyzed 
reactions is not restricted to asymmetric hydrogenation. It was also applied by Feringa and co-workers 
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to the asymmetric Rh-catalyzed conjugate addition of aryl boronic acids (Scheme 1.22),86 a 
synthetically useful reaction type originally developed by Miyaura, Hayashi et al.87 and applied by 
others.88 Only three monodentate P-ligands were tested in this study, and the effect of mixing was 
remarkable, although the results had little practical utility (up to 47% e.e. in reaction A, up to 77% e.e. 
in reaction B, Scheme 1.22). Interestingly, in several cases the heterocombination of two ligands 
having opposite stereochemical preferences proved more enantioselective than the corresponding 
homocombinations. 
 
 
Scheme 1.22 Rh-catalyzed conjugate addition of aryl boronic acids 
 
Also our research group provided a significant contribution in this field of organometallic 
catalysis: extending the concept of mixing monodentate compounds, Gennari and Piarulli et al. 
exploited the dynamic behaviour of ligands composed of fluxional “axially chiral”  tropos moieties 
(i.e. having a stereogenic axis free to rotate) and a covalently attached configurationally stable entity 
in Rh-catalyzed olefin hydrogenation (Scheme 1.23).89 If two different ligands of this kind are used in 
a mixture, an intriguing situation arises. 
 
Scheme 1.23 Chiral phosphorus ligands based on a chiral P-bound alcohol or secondary amine and a flexible 
(tropos) P-bound biphenol unit 
 
When employing a “single” ligand, two diastereomeric homocomplexes [MLaLa] and [MLa’La’] as well 
as the heterocomplexes [MLaLa’] are possible. Consequently, three diastereomers are actually involved 
in the mixture, that are likely to have different catalytic profiles in terms of activity and 
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enantioselectivity. Moreover, the ratio of the three species is not expected to be statistical (1:1:2). In 
the case of two different ligands La and Lb of this kind, up to 10 different species may be formed: 
[MLaLa], [MLaLa’], [MLa’La’], [MLbLb], [MLbLb’], [MLb’Lb’], [MLaLb], [MLaLb’], [MLa’Lb] and 
[MLa’Lb’].81 Intriguing observations  
 
 
Scheme 1.24 Libraryof 20 ligands, 11 phosphites [P(O)2O 36–46] and 8 phosphoramidites [P(O)2N 47–54] 
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were made in a study employing such compounds as 36-54 as ligands in the Rh-catalyzed 
hydrogenation of methyl 2-acetamidoacrylate. A total of 85 reactions were performed, which means 
that only a portion of the total chemical space was actually explored. No homocombination of the 
ligands 36-54 performs well (e.e.’s range from 0 to 55%). When ligand heterocombinations were used, 
certain phosphite/phosphoramidite combinations proved to be optimal. The best hit is 39/48, which 
leads to an e.e. value of 87% compared to 53% e.e. and 52% e.e. for the respective homocombinations. 
It is also clear that 39/48 constitutes the matched system, because 39/47 provides an e.e. value of only 
35%. Similar results were observed when hydrogenating other substrates such as enamides and 
dimethyl itaconate. From a practical point of view the asymmetric hydrogenation of methyl 2-
acetamidoacrylate is best performed classically by using a single ligand; for example, the best 
phosphite ligand for hydrogenation of methyl 2-acetamidoacrylate is picked as a result of testing a 
library of derivatives differing in the nature of the RO- group at phosphorus. This is true in this 
particular example, but it may not be so in all cases. The importance of the present study lies in the 
proof of principle and in the mechanistic lessons learned therein. Extensive kinetic investigations were 
included, which led to a useful mathematical model. The same library was utilized in Rh-catalyzed 
Miyaura–Hayashi reactions,87 for example the one shown in Scheme 1.22 B.90 Enantioselectivities of 
up to 95% e.e. were observed when using the heterocombination 41/54, compared to only 70% e.e. 
and 36% e.e. for the respective homocombinations.  
In another study by Reetz et al. it was shown that structurally very different types of chiral 
monodentate P-ligands can also be used successfully in mixtures.91 These include ephedrine and 
pseudo-ephedrine-derived oxazaphospholidines such as 55 and 56 (Scheme 1.25), known types of 
compounds that had previously been used by Alexakis et al. as single ligands in Cu-mediated 
conjugate additions and other reactions.92 In the study regarding mixtures, the small library of six 
ligands shown in Scheme 1.25 was extended to include the C2-symmetric phosphites 57 and 58 (R,R 
and S,S configuration, respectively).91 The performance of these ligands as homocombinations in the 
Rh-catalyzed hydrogenation of such substrates as dimethyl itaconate proved to be poor (0–56% e.e.).91 
Some improvements were observed through pair wise mixing. However, the best hit constitutes a 
mixture in which one of the components is a BINOL-derived monophosphonite, as in (R)-34d/56b, 
which gives rise to an e.e. value of 89% (R). These results are all the more remarkable because one of 
the respective homocombinations induces the opposite sense of enantioselectivity. The diastereomeric 
heterocombination (S)-34d/56b results in considerably lower enantioselectivity (52% e.e. for the S 
enantiomer), which means that this is the mismatched case. 
Chemical modification of BINOL leads to added structural diversity in the respective P-
ligands, although this is accomplished at the cost of additional synthetic efforts. If only one naphthyl 
moiety in BINOL is modified, C2 symmetry no longer holds, which means that the P atoms in the 
respective phosphites, phosphonites, or phosphoramidites turn into stereogenic centres (PR or PS). This 
gives rise to two diastereoisomers.  
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Scheme 1.25 Ephedrine and pseudo-ephedrine-derived oxazaphospholidines 55-56 and the C2-symmetric 
phosphite ligands 57-58 
 
Reetz and co-workers prepared such compounds (Scheme 1.26), for example 59–61, in the 
hope that the stereogenic units positioned closer to the Rh centre would exert special effects.93 
 
 
Scheme 1.26 Diastereomeric phosphoramidite 59-60 and phosphite 61 ligands with stereogenic phosphorus 
centers 
 
The single ligands as homocombinations proved to be quite effective in olefin hydrogenation 
reactions, as in the reduction of methyl 2-acetamidoacrylate with e.e. values in the range 97% to 
greater than 99%. In some cases an unusual effect was observed, namely that a mixture of two 
diastereomers differing only in the absolute configuration at phosphorus is more effective than either 
of the two respective homocombinations. The interesting area of ligands having stereogenic centres at 
phosphorus94 has not been explored systematically in the present context. 
 
1.3.4 Combinatorial transition metal catalysis using mixtures comprising a 
chiral and an achiral P-ligand 
 
Early on, Reetz et al. also contemplated the use of mixtures of chiral and achiral ligands in 
Rh-catalyzed hydrogenation (Scheme 1.27).80b-d This proposal seems counterintuitive, because one of 
the homocombinations in the mixture is achiral, necessarily leading to a racemic product. However, as 
before, the heterocombination may define the outcome of the reaction if it is more reactive and more 
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enantioselective than the homocombinations. Since vast numbers of achiral P-ligands are available at 
low cost, high structural diversity regarding the heterocombination is readily accessible. 
 
 
Scheme 1.27 The concept of using mixtures of monodentate chiral and achiral ligands in transition-metal-
catalyzed asymmetric reactions 
 
Initially representatives of the three BINOL-derived types of P-ligands such as phosphites 33, 
phosphonites 34 (Scheme 1.20) and phosphoramidites 62 (Scheme 1.28) were each tested in mixtures 
with different achiral monodentate P-ligands such as 63 or 64 (Scheme 1.28) and one fluxional 
(tropos) phosphite 66 (Scheme 1.29), in hydrogenation of methyl 2-acetamidoacrylate serving as the 
model reaction.80d 
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c: R = CH(CH3)2
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Scheme 1.28 Phosphoramidite 62, achiral phosphine 63-65 ligands 
 
In most cases enantioselectivity decreased, which may not be surprising. However, in several instances 
the sense of enantioselectivity was reversed upon using an achiral ligand as one of the components, 
especially when employing mixtures of 33 and tris(2-naphthyl)phosphine (63) or the phosphinine 64, 
respectively. For example, the homocombination (R)-34a/(R)-34a is a respectable ligand system in the 
hydrogenation of methyl 2-acetamidoacrylate (92% e.e. for enantiomer S), whereas the 
heterocombination (R)-34a/64 induces reversal of the enantioselectivity (58% e.e. for enantiomer 
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R).80d Energetically, such a switch is dramatic (∆∆G‡ = 2.6 kcal mol-1), which means that the mixing 
effect is pronounced. Of course, to get a product with opposite absolute configuration, it is best to use 
the enantiomeric form of the BINOL-derived ligands (S)-33 or (S)-34, which provide much higher e.e. 
values. Nevertheless, the results are of theoretical interest, and they also set the stage for further 
research using other mixtures of chiral and achiral monodentate ligands.80 b,c 
Upon applying the mixture concept to chiral and achiral monodentate P-ligands more 
systematically, remarkable observations were made.80b,c In this study β-N-acylamino acrylates were 
used as model substrates, with phosphite 33a and phosphonite 34d serving as the chiral P-ligands. In 
addition to the achiral P-ligands 65, fluxional diphenol-derived (tropos) phosphites 66 (Scheme 1.29) 
were also employed. A relatively short combinatorial search was made in the study of the Rh-
catalyzed asymmetric hydrogenation of Z-3-acetamido-2-butenoate.80c It can be seen that pronounced 
effects result when using the t-butyl phosphonite 34d as the chiral ligand in combination with achiral 
ligands. The homocombination 34d leads to an e.e. value of only 45%. Upon employing a 1:1 mixture 
of 34d and trimethyl phosphite (65d) or triphenyl phosphite (65g), the e.e. value climbs to 84 and 
88%, respectively. When using the configurationally fluxional phosphites 66 in combination with 34d, 
even higher enantioselectivities are observed. Accordingly, 34d/66a, 34d/66b, and 34d/66d lead to 
e.e. values of 98, 98, and 94%, respectively. In contrast, the sterically demanding fluxional phosphite 
66c in combination with the bulky phosphonite 34d results in an almost racemic product. This result is 
reminiscent of the behaviour of two bulky chiral P-ligands, whose combination generally leads to low 
levels of enantioselectivity. Similar effects were observed when hydrogenating other β-acylamino 
acrylates and dimethyl itaconate. For example, when hydrogenating dimethyl itaconate ligand 34d 
alone results in an e.e. value of 77%, whereas the use of 34d/65g or 34d/66a boosts enantioselectivity 
to 94% e.e. in both cases.80c 
 
 
Scheme 1.29 Fluxional diphenolderived (tropos) phosphites  
 
Subsequent to these studies, Feringa, de Vries, et al. applied the idea of using a mixture of a 
chiral and an achiral monodentate P-ligand in the hydrogenation of α,β-unsaturated acids of the type 
shown in Scheme 1.30, leading to the corresponding chiral dihydrocinnamic acid derivatives.95 
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Scheme 1.30 The Rh-catalyzed hydrogenation of α,β-unsaturated acids 
 
These are key intermediates in the synthesis of a number of bioactive compounds such as 
renin inhibitors, γ-secretase inhibitors, enkephalinase inhibitors, endothelin receptor antagonists, and 
opioid antagonists. A variety of different BINOL-derived phosphoramidites 62 with various achiral 
and chiral R groups in the amino group were first tested in respective mixtures with 
triphenylphosphine (65c) using substrate a (Scheme 1.30). Unfortunately, improvements in 
enantioselectivity were meagre. In contrast, ortho-dimethyl derivatives 67 led to notable positive 
effects when used in mixtures with triphenylphosphine (65c). For example, ligand 67d failed 
completely when used alone, and this homocombination resulted in racemic product in a slow 
reaction. In contrast, upon using the heterocombination 65c/67d, a fast and quantitative reaction was 
found to occur with 85% e.e. Upon tuning the achiral phosphine, further improvements proved to be 
possible, as in the heterocombination comprising tris(xylyl)phosphine and 67d, leading to 92% e.e. 
 
Scheme 1.31 3,3’-dimethyl substituted  BINOL-derived phosphormidite ligands 
 
In other cases involving industrially relevant substrates such as b (Scheme 1.30), even higher e.e. 
values were achieved. Similar developments were subsequently reported for other types of substrates 
such as N-formyl dehydroaminoacid esters96a and 2-(acetylaminomethyl)-3-aryl acrylic acid esters.96 
 
In a more recent study Reetz et al. reported once more the remarkable effect that the process 
of mixing chiral and achiral monodentate P-ligands can induce, specifically in the Ir-catalyzed 
asymmetric hydrogenation of pro-chiral ketimines.97 In this attempt the cheap phosphorous acid 
diester 68 was utilized as the chiral component together with various achiral monodentate P-ligands. 
Phosphorous acid diesters are known to exist in an equilibrium PV-PIII, the penta-valent form PV being 
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favoured as in 68B (Scheme 1.32). However, it is well known that transition metals bind to the P atom 
in the three-valent form, as shown by crystal structures and spectroscopic data.98 Several ketimines 
were subjected to Ir-catalyzed hydrogenation with formation of the corresponding chiral amines. The 
results show that the chiral ligand 68 alone is a poor ligand (7–36% e.e.), whereas the 
heterocombination with achiral triphenylphosphine 65c/68 leads to e.e. values of 88–92%. 
 
 
Scheme 1.32 Iridium-catalyzed hydrogenation of ketimines 
 
1.3.5 Controlling the diastereo- and regioselectivity 
 
The combinatorial concept of applying mixtures of monodentate P-ligands was also extended 
to include the control of diastereoselectivity.99 Diastereoselective reactions where the stereochemical 
information existing on the substrate influences the creation of new stereogenic unit(s) (“1,n-
asymmetric induction”)100 were studied using a library of 21 mostly achiral monodentate P-ligands. 
For example, in the case of the hydrogenation of chiral allylic alcohols (Scheme 1.33 A) 150 reactions 
were performed (although a total of 210 different heterocombinations are possible), which led to the 
identification of 15–20 positive hits. These are the heterocombinations which display a higher 
diastereoselectivity than either of the two respective homocombinations alone. Some of the hits 
resulted in extremely high diastereoselectivities (anti/syn ratio up to 27:1, using combination of the 
phosphines 64/69). 
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Scheme 1.33 (a) hydrogenation of chiral allylic alcohols; (b) hydroformylation of olefins. 
 
In principle, any parameter of a catalytic profile can be influenced by using mixtures of monodentate 
ligands. It was thus attempted to influence the regioselectivity of transition-metal-catalyzed reactions 
by applying this type of combinatorial catalysis. The Rh-catalyzed hydroformylation of olefins was 
chosen as a first target.101,102 Many different achiral monodentate P-ligands are potential candidates for 
such an endeavour, but the combinatorial search was confined to a small library of 14 simple 
phosphine and phosphite ligands. t-butyl metacrylate (Scheme 1.33 B) was chosen as the model olefin 
with formation of the branched product with a quaternary C atom and the linear regioisomer. As 
expected, the most common P-ligands favour the linear product. Thus, it was a challenge to find a 
catalyst system which leads to a strong preference for the branched aldehyde. It was found that 12 
heterocombinations induce the preferential formation of the branched product, despite the fact that the 
respective homocombinations all display opposite regioselectivity favouring the linear isomer. The 
best catalyst system, obtained by combination of the phosphinine 64 and triphenylphosphine 65c, led 
to a 8.4:1 b/l ratio, while the corresponding homocombinations induce ratios of 0.76:1 and 0.72:1, 
respectively. This system was then optimized by tuning the reaction conditions (80 bar CO/H2 = 1:1; 
40 °C, 30 h, substrate/Rh= 50:1, La/Lb=1:1; Rh/total ligands = 1:2.4; toluene as solvent). As a result, 
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the regioselectivity climbed to 20:1, which means 95% regioselectivity in favour of the branched 
product. 
 
1.4 SUPRA MOLECULAR BIDENTATE P,P –LIGANDS 
 
1.4.1 Basic principle 
 
As reported in section 1.3.2, when two ligands La and Lb are added to a metal source, the 
two homocomplexes [MLaLa] and [MLbLb] compete with the heterocomplex [MLaLb] for acting as 
the catalyst. As a consequence, when the heterocomplex is the most selective species, the 
homocomplexes lower the overall selectivity of the process, unless the catalytic activity of the 
heterocomplex is exceedingly higher. The relative amounts of hetero- and homocomplexes were 
studied by NMR spectroscopy and it was found that, under thermodynamic control (fast and 
reversible ligand exchange), the heterocomplex/homocomplexes ratios often exceed the statistical 
value (2:1:1).80,103 It was also reported that the amount of heterocomplex can be enhanced by 
carefully tuning the La/Lb ratio, with consequent optimisation of the overall selectivity of the 
catalytic transformation.104 Nevertheless, non-covalent interactions soon appeared as a clever way 
to achieve the exclusive formation of the heteroleptic complexes from mixtures of monodentate 
ligands. To this end, supramolecular ligands capable of complementary interactions (Scheme 1.34 
A) are required, so that attractive interactions take place only between different ligands.105  
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Scheme 1.33 Schematic representation of supramolecular bidentate ligands formed by complementary (A) and 
non-complementary interactions (B).. 
Introduction 
 
31
The heterocomplexes formed in this way are expected to have reduced degrees of freedom106 
compared to the complexes of normal monodentate ligands, and thus supramolecular ligands 
somehow resemble traditional bidentate ligands. According to this analogy, they are often referred 
to as supramolecular bidentate ligands or self-assembled ligands, thanks to their ability to 
spontaneously form bidentate systems in solution. These terms also apply to those supramolecular 
ligands that are only capable of non-complementary interactions (Scheme 1.34 B):105 indeed these 
systems are still capable of forming rigid and conformationally restricted complexes, although 
they cannot selectively form heterocomplexes when used in a mixture, which quite reduces their 
"combinatorial appeal". Using non-covalent interactions, ligands can be linked to other molecules 
for different purposes than forming supramolecular bidentate ligands,107 and these applications are 
not discussed in the present review. 
In this section, supramolecular bidentate ligands are classified on the basis of the non-
covalent interactions they rely on, hydrogen bonding and coordinative bonding being by far the 
most widely exploited. 
 
1.4.2 Self-assembly through hydrogen-bonding interactions 
 
1.4.2.1 Secondary phosphine oxides 
 
Secondary phosphine oxides (SPOs) form an unusual class of ligands,108a that are stable and 
inert to water. This is due to the tautomerization equilibrium that is in favour of the stable oxide, but in 
1968 it was found that the equilibrium can be shifted by the addition of a metal precursor (Scheme 
1.35)108b and in 1975 the formation of platinum complexes based on SPOs were reported.109 
 
Scheme 1.35 Tautomeric forms of SPOs: SPOs exist in equilibrium between pentavalent (phosphine oxide form) 
and trivalent (phosphinite form) tautomeric structures. Although at room temperature the phosphine oxide form 
is the more stable one, it is the phosphonite form that coordinates to the transition metal 
 
Although they were not specifically designed as supramolecular ligands, this class of compounds 
represent the first example of ligands that form a bidentate ligand via a hydrogen bond. In this 
particular case between the phosphine oxide and the alcohol, as was later confirmed by X-ray 
analysis.110 In 1986 it was reported that these platinum complexes are active in the hydroformylation 
and hydrogenation reaction and that the ligands were operating as bidentate ligands.111 Much later it 
was found that the class of ligands can be used for a variety of reactions such palladium-catalyzed 
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cross coupling reactions,112 platinum catalyzed nitrile hydrolysis and iridium catalyzed hydrogenation. 
In most examples, however, the ligands were employed as monodentate ligands rather than 
supramolecular bidentate ligands. In some of the reactions the ligands might rearrange into the 
supramolecular bidentate, but in many reports where the ligands were added in situ and the ligation 
was not investigated in detail. Various chiral SPOs have been prepared by the groups of Feringa and 
de Vries, which provide fascinating new opportunities to this field.113 
 
1.4.2.2 Systems relying on hydrogen bonding between polar heterocycles 
 
The first example of self-assembled bidentate ligand was reported by Breit and Seiche in 2003.114 As a 
platform for hydrogen bonding, the tautomer system 2-pyridone (70B)/2-hydroxypyridine (70A), 
firstly prepared and employed in different context by Nakamura et al.,115 was employed. The parent 
system (Do = H) is known to dimerize in aprotic solvents to form predominantly the symmetrical 
pyridone dimer 71 (Scheme 1.36).116 However, if Do is a donor atom capable of binding to a metal 
centre (e.g. PPh2), the equilibrium can be shifted towards the mixed hydroxypyridine/pyridone dimer 
72. This intermediate may be stabilized by the chelation effect exhibited through coordinative binding 
to the metal centre (Scheme 1.36). In fact reaction of 2 equiv of 6-diphenylphosphanyl-2-pyridone 
(70a, Do = PPh2, Scheme 1.37) with Pt(cod)Cl2 furnished quantitatively cis-PtCl2(70a)2, which 
showed the expected hydrogen-bonding network both in solution and in the solid state. 
 
 
Scheme 1.36 The Breit system for the self-assembly of a monodentate P-ligand114a 
 
A rhodium catalyst derived from ligand 70a displayed the typical behaviour of a bidentate 
ligand in the hydroformylation of terminal alkenes.114 Thus, excellent regioselectivity in favour of the 
linear aldehyde was noted for hydroformylation of a range of functionalized terminal alkenes (Scheme 
1.38). Among them, even those with functional groups capable of hydrogen bonding were tolerated. 
However, the hydrogen-bonding network in the ligands and thus the chelating binding mode can be 
disrupted by employing either temperatures above 110 °C or protic solvents such as methanol and 
acetic acid; low regioselectivity results were obtained in this case. 
Recently, Börner, Breit et al. reported the synthesis of several derivatives 70 bearing a chiral 
phosphine group (Scheme 1.37).117 
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Scheme 1.37 The enantioselective Rh-catalyzed hydrogenation of pro-chiral olefins with self-assembled 
rhodium complexes 
 
 
Scheme 1.38 Rh-catalyzed hydroformylation of functionalized terminal alkenes 
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The new ligands were shown by 31P-NMR to be able to self assemble in the presence of a rhodium 
source in a similar way to 70a. The corresponding self-assembled rhodium complexes were employed 
for catalyzing the enantioselective hydrogenation of pro-chiral olefins such as methyl 2-
acetamidoacrylate (up to 91% e.e.), methyl Z-2-acetamidocinnamate (up to 94% e.e.) and dimethyl 
itaconate (up to 99% e.e.). Remarkably, all the self-assembling ligands 70 performed better than the 
corresponding O-t-Bu-protected hydroxypyridine-derivatives 71 (unable to self-assemble), thus 
demonstrating once again the efficiency of this strategy. It should be noted that, although ligands 70 
behave undoubtedly as a supramolecular bidentate ligands, the systems 70 / [Rh] are actually 
homocomplexes, since the two tautomers –the hydroxypyridine 70A and the pyridone 70B– 
equilibrate rapidly, the complementarity of their interaction cannot be exploited to achieve a selective 
formation of the heterocomplex. Mixing two pyridone ligands with different donor sites would result 
in mixtures of heterodimeric and homodimeric catalysts. Thus this first example of supramolecular 
bidentate catalyst is not suitable for achieving a selective formation of the heterocomplex. 
The heterodimeric structure would require the self-assembly of two (non-interconverting) 
complementary species through hydrogen bonding –a principle employed by nature in DNA base 
pairing. Thus an A-T base-pair model relying on the aminopyridine 73/isoquinolone 74 platform was 
selected to serve for specific heterodimeric ligand assembly (Scheme 1.39).118a 
 
 
Scheme 1.39 Self-assembly through hydrogen bonding of the adenine/thymine systems 
 
When phosphine ligands based on this platform were mixed in the presence of a Pt(II) salt, the 
heterodimeric complex (75) formed exclusively. An X-ray structure of 75 (Dox = Doy = PPh2) shows 
the expected hydrogen bonding network reminiscent of the Watson–Crick base pairing of A and T in 
DNA. NMR studies provided support that a similar structural situation occurs also in solution. The 
first 4 × 4 self-assembled ligand library based on hydrogen bonding was generated and explored for 
regioselective hydroformylation of terminal alkenes (Scheme 1.40). In this study a catalyst was 
identified ([Rh][76d][77d]) that operated with outstanding activity (TOF = 8643 h-1) and 
regioselectivity (n / i = 96:4).118a Also other heterocyclic platforms analogous to the A-T base pair 
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were subsequently screened,118b and it was found that thiazole 78 could interact with isoquinolone 77 
so strongly that their interaction was unaffected even by protic solvents such as methanol. 
 
 
Scheme 1.40 Regioselective hydroformylation of 1-octene using 4 × 4 self-assembled ligand library based on 
hydrogen bonding 
 
Subsequently, the same concept was applied in the enantioselective Rh-catalyzed olefin 
hydrogenation.119 In this case the two substituents at the P atom bound to the heterocycles are either 
two different aryl groups (so that P is stereogenic) or the BINOL moieties, leading to the respective 
phosphonites 80 and 81 (Scheme 1.41), which dimerize spontaneously. 
 
 
Scheme 1.41 Self-assembled chiral phosphine and phosphonite ligand library for Rh-catalyzed olefin 
hydrogenation 
 
The respective Rh-complexes obtained by their heterocombinations lead to high enantioselectivity 
(>90% e.e.) in the hydrogenation of dehydroamino acid esters (methyl 2-acetamidoacrylate and methyl 
α-acetylamino cinnamate) and dimethyl itaconate (Scheme 1.42). 
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Scheme 1.42 Rh-catalyzed hydrogenation of (a) methyl 2-acetamidoacrylate, (b) α-acetylamino cinnamate and 
(c) dimethyl itaconate 
 
It was also shown that one of the partners can harbour a diphenylphosphanyl moiety. This corresponds 
to the use of a mixture of an achiral and chiral monodentate P-ligands mentioned in Paragraph 1.3.4. 
Recently, Breit and co-workers took advantages of the geometric properties (bite angles close to 105°) 
and electronic features (electron poor) of these supramolecular catalysts  displaying excellent 
reactivity and selectivity also in the nickel-catalyzed hydrocyanation of akenes.120 
Heterocombinations of achiral ligands of the 76 / 77 type were subsequently screened in the Ru-
catalyzed hydration of alkynes,121 with the aim of maximizing the amount of anti-Markovnikov 
aldehyde product (Scheme 1.43 A).122 
 
 
Scheme 1.43 The Ru-catalyzed hydration of alkynes and nitriles  
 
With the best heterocombination, up to > 99:1 selectivities were obtained in favour of the anti-
Markovnikov product. 
Another application found by the Breit group for their achiral ligands 76 / 77 is the Ru-catalyzed 
hydration of nitriles (Scheme 1.43 B).123,124 
On the base of hydrogen bonding between polar heterocycles such as 2,6-diaminopyridine and 
barbituric acid-derived phosphines, Jun et al. developed recyclable catalysts for Rh-catalyzed 
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hydroacylation of olefins,125 which however do not form supramolecular bidentate ligands and thus 
will not be discussed here. 
 
1.4.2.3 Self-assembly through hydrogen bonding between peptides 
 
Very recently the group of Prof. Breit developed also another family of supramolecular 
bidentate ligands126 that mimic the well known PhanePhos ligand.127 After an inspection of molecular 
models, meta-carboxypeptidyl-substituted triarylphosphines 82 (Do = PPh2 in Scheme 1.44) or 
phosphites 83 (Do = OP(OAr)2) turned out to be suitable candidates to provide a PhanePhos-like 
structure. An inter-ligand helical hydrogen-bonding network, as indicated in Scheme 1.45, could be 
expected. This in turn might induce a planar chiral pi-stacking arrangement of the two meta-substituted 
arene rings which resembles the planar stereogenic element found in PhanePhos. 
The coordination properties of ligands 82 and 83 were investigated in the presence of cis-Pt(cod)Cl2 or 
Rh(cod)2BF4. All of the homocombinations except 83, formed the corresponding self-assembled 
ligand complex. The complexes were studied by X-ray analysis. The cis-coordinated phosphine 
ligands are linked by pairs of interligand N–H. . .O=C hydrogen bonds of the peptidyl side chain, which 
adopt a helical conformation. 
 
 
Scheme 1.44 (a) Schematic representation of “SupraPhanePhos”; (b) peptidyl phosphines 82 and peptidyl 
phosphites 83 
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Interestingly, the meta-substituted arene rings of the two neighbouring phosphine ligands 82 adopt a 
PhanePhos-type conformation. This pi–pi interaction (~ 3.30 Å) is also expected to additionally 
contribute to the stabilization of the supramolecular metal-induced ligand assembly.128 Additionally, a 
hydrogen-bonding intermolecular network is formed between the homodimeric complexes in the 
crystalline state. NMR studies indicated that a similar geometry is prevalent in solution in aprotic 
solvents such as CDCl3 as well. The homocombinations of ligands 82 and 83, in the presence of 
Rh(cod)2BF4, were tested in the hydrogenation reactions shown in Scheme 1.44: the best combinations 
(involving ligands 83) gave enantioselectivity levels comparable with those of PhanePhos ligands (up 
to 99% e.e.). 
It should be noted how this new approach does not allow, in its first version, to selectively prepare 
heterocombinations of ligands, because the hydrogen-bond interaction utilized lacks the 
complementarity required for this task: combining different ligands in the presence of a metal source 
would result in a mixture of homo- and heterocomplexes. 
Shortly after the first communication, however, Breit et al. addressed the issue of exploiting 
self-assembly based on peptidic structures as a new platform to generate heterodimeric complexes 
selectively,129 which enabled a new combinatorial approach to novel chelation-emulating ligand 
libraries for metal complex catalysis. 
Thus, as a peptidyl ligand complementary to the C-linked peptide-based P-ligand LC, a N-
linked peptidic system such as LN was chosen (Scheme 1.45, right-hand side). Molecular modelling 
suggested that complementary hydrogen bonding between the amide functions of both systems might 
occur and induce the formation of an antiparallel β-sheet structure. Indeed, mixing of C-linked 
phosphane-functionalized peptidyl ligands (LC) with the complementary N-linked phosphane-
functionalized peptidyl counterparts (LN) in the presence of platinum(II) and rhodium(I) transition-
metal salts led to the selective formation of heterobidentate complexes [MX2-(LC·LN)]. Detailed 
conformational analysis in solution, theoretical investigations, and X-ray studies showed the formation 
of a two-stranded, antiparallel, β-sheet structure. The factors that influence the equilibria between 
heterodimeric complexes and homodimeric complexes were studied in detail, which provided insights 
into the importance of individual non-covalent interactions. Furthermore, the antiparallel, β-sheet, self-
assembly template system has served as basis for the generation of a heterobidentate ligand library, 
which has been explored in linear-selective asymmetric hydroformylation of styrene (Scheme 1.46). 
From these experiments it became evident that the β-sheet self-assembly template does not only cause 
the selective formation of heterobidentate ligand arrangements, but although in a remote position 
relative to the catalytically active centre can induce a moderate enantioselectivity (up to 38%) in the 
course of a catalytic reaction.129 
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Scheme 1.45 Expanding the concept of self-assembly of monodentate ligands through formation of secondary 
structures: two complementary metal binding sites with two otherwise flexible appended peptide chains are 
directed to form a conformationally stable folded β-sheet upon coordination of a metal ion 
 
Scheme 1.46 Rh-catalyzed assymetric hydroformylation of styrene 
 
1.4.2.4 Systems exploiting the hydrogen bonding properties of urea derivatives 
 
Love and co-workers described the formation of transition metal complexes (namely with 
palladium and rhodium) containing the urea–phosphine ligand (86)(R = Ph, Scheme 1.47). When 
PdCl2(CH3CN)2 was used as a palladium source, a 1:3 mixture of cis/trans complexes (measured by 
NMR) was obtained, which was assumed to have a polymeric nature with intermolecular hydrogen 
bonding due to its insolubility in commonly used solvents. 130 Alternatively, when Pd(cod)(CH3)Cl 
was reacted with 86 (R = CH2CO2Et), as reported independently by Reek and co-workers, 131 only the 
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formation of the trans  complex 87 was observed (Scheme 1.47 A). In this case, the formation of the 
intramolecularly hydrogen bonded species was assumed on the basis of its solubility and spectroscopic 
properties. Interestingly, on addition of nBu4NCl (Scheme 1.47 B), the formation of an anionic 
complex 88 incorporating the chloride anion intramolecularly bonded between the two urea units, was 
observed in both works.130,  
 
Scheme 1.47 The urea-based phosphine ligand complexes formation via (a) self-association or (b) anion-
templation  
 
Later on, Reek and co-workers developed a new class of chiral urea-functionalised phosphite (89), 
called UREAphos (Scheme 1.48), which are capable of self-assembling in the presence of a rhodium 
source to give the supramolecular homocomplexes, as suggested by NMR studies. Rhodium 
complexes of UREAphos ligands were screened in the enantioselective hydrogenation of both 
benchmark substrates (up to 96% e.e. with dimethyl itaconate and up to 94% e.e. with methyl 2-
acetamido acrylate) and challenging, industrially relevant olefins such as enamide A (up to 76%, 
scheme 1.48).131b 
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Scheme 1.48 Rh-catalyzed asymmetric hydrogenation of N-(3,4-dihydro-2-naphthalenyl)-acetamide 
 
1.4.2.5 Pseudo-rotaxanes held together by the interaction between a secondary 
ammonium salt and a crown ether 
 
Nishibayashi et al.132 and Fan et al.133 independently reported new self-assembled ligands 
formed by reaction between a secondary ammonium salt and a crown ether of the proper size each 
bearing a phosphorus donor atom (a phosphine and a BINOL-phosphite, respectively). These 
supramolecular bidentate ligands possess a stereogenic plane and thus exist as mixtures of 
diastereoisomers (only one diastereomer for ligand is displayed in Scheme 1.49), but when a rhodium 
source is added a single species (whose stereochemistry has not been clarified yet) is apparently 
formed. Several ammonium salts and crown ether macrocycles were prepared and screened as ligands 
for rhodium in hydrogenation reactions of α-dehydroaminoacids. With the best axle-macrocycle 
heterocombinations (90 for Nishibayashi and 91 for Fan, Scheme 1.49) fair to good levels of 
stereoselectivity were obtained: 90 to 96% e.e. with Nishibayashi’s system and 70-84% e.e. with Fan’s 
system. 
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Scheme 1.49 Rh-catalyzed asymmetric hydrogenation of pro-chiral olefins with supramolecular chiral 
phosphorous ligands based on a pseudorotaxane complex  
 
1.4.2.6 Other systems 
 
In 2006 Ding and co-workers reported that phosphoramidites 92 (Scheme 1.50), derived from 
primary amines (i.e. having a N-H able to act as a hydrogen bond donor), in the presence of a rhodium 
source in solution, form the corresponding hydrogen-bonded mono-complexes, as it was demonstrated 
with NMR experiments and DFT calculations.134 The new ligands were screened in the hydrogenation 
of (Z)-methyl α-(acetoxy)acrylates and (E)-β-(aryl)itaconates, where the 92 complexes resulted highly 
stereoselective. On the contrary the complex 93, unable to form hydrogen bonds, turned out to be 
catalytically not active. Thus the rigidity conferred to the complex by the presence of the hydrogen 
bonds here has a dramatic effect on the outcome of the reaction. It should be remarked that this self-
assembled system is not suitable for the selective formation of heterocomplexes, because it exploits an 
interaction which is not complementary: mixing different ligands would certainly result in a mixture of 
hetero- and homocomplexes. 
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Scheme 1.50 Rh(I)-catalyzed asymmetric hydrogenation of (Z)-methyl α-(acetoxy)acrylates and (E)-β-aryl 
itaconate derivatives with DpenPhos ligands 
 
Reek et al. have recently reported that ligands of the families 94 and 95 are able to self-
assemble forming the corresponding heterocomplexes as shown in Scheme 1.51:135 compound 94 
exists in solution at room temperature as a mixture of tautomers a and b. On addition of 
Rh(acac)(CO)2, compound 94 forms the corresponding “homocomplex”. In this complex, the P-
ligands feature a trans disposition and are held together by the hydrogen bond between the 
sulfonamidic proton of a and one of the oxygens of b. In the presence of a similar ligand existing as a 
single tautomer (95, probably because of the different basicity of the phosphorus atom), however, 94 
forms the hydrogen-bonded heterocomplex with complete selectivity. The homo- and 
heterocomplexes of ligands 94 and 95 proved able to catalyze the hydrogenation reactions only after 
protonation with HBF4•OMe2, which facilitates the dissociation of the sulfonamidic oxygens necessary 
for the catalytic cycle to take place. In the hydrogenation of methyl 2-acetamidoacrylate the 
heterocomplex 94 / 95 proved slightly less stereoselective than the homocomplex of 95 (91% vs. 96% 
e.e.), and this means that in this case the presence an achiral ligand has a negative effect on the level of 
stereocontrol.135 Even if there is no improvement of the catalyst performance when the heterocomplex 
is used, the way for a new type of self assembly through hydrogen bonding is open, and further results 
will probably come. 
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Scheme 1.51 Selective formation of heterocomplex and a control experiment 
 
Very recently Reek et al. proposed a new class of supramolecular bidentate ligands held 
together by hydrogen bonding between a primary amine-derived chiral phosphoramidite (96) and an 
achiral phosphine bearing an urea group (96).136 The level of selectivity in the formation of the 
supramolecular heteroleptic complex was determined by 31P-NMR spectroscopy. It is important to 
note that hydrogen bonding is not the only responsible for the selective formation of the heteroleptic 
complex: the phosphoramidite-phosphine rhodium heterocomplexes themselves are shown to be 
thermodynamically favoured due to the complementary electronic properties of the two classes of 
ligands (σ-donor phosphines and pi-acceptor phosphoramidites). The heterocomplexes are formed with 
a high level of selectivity (70-97%) even in the absence of functional groups capable of hydrogen 
bonding, which plays the role of improving the selectivity up to > 99%., and turned out to promote the 
asymmetric hydrogenation of several derivatives of methyl 2-hydroxymethylacrylate with very good 
enantioselectivity (up to > 99% e.e). 
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Scheme 1.52 Chiral phosphoramidite LEUPhos and achiral aromatic phosphine ligands used the asymmetric 
hydrogenation of methyl 2-hydroxymethylacrylate 
 
Remarkably, as in other cases when a chiral and an achiral ligand are mixed, the streochemical 
preference of the heterocomplex is opposite to that of the chiral ligand homocomplex. 
 
1.4.3 Self-assembly through coordinative bonding 
 
1.4.3.1 Three-component systems based on the use of a template 
 
In 2003 Reek, van Leeuwen and co-workers reported the first example of supramolecular 
bidentate ligand based on coordinative bonding.137a In general terms, this new strategy involves a 
metal-containing template which binds and thus positions two monodentate ligands having an 
additional donor site (Do in Scheme 1.53). Subsequent chelation to a catalytically active transition 
metal M generates the catalyst or precatalyst (Scheme 1.53).  
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Scheme 1.53 Schematic representation of a self-assembled chelating ligand 
 
The template is often a bis{Zn(porphyrin)} complex such as 99 (Scheme 1.54), which binds the 
additional donor site (usually a pyridine moiety) bearing the P-ligand.  
The latter can be either chiral or achiral depending on the application of the supramolecular ligand. In 
the first report on this strategy for self-assembly,137a the application of both chiral and achiral systems 
as ligands for Rh-catalyzed hydroformylation was described: compared to the corresponding 
monodentate ligands 100a and 100b, the supramolecular ligands 101 behave much more similarly to 
“classic” covalent bidentate ligands, giving higher l / b ratios (up to 94:6) in the hydroformylation of 
1-octene  and better e.e.’s (up to 33%) in the hydroformylation of styrene. Although the modular 
nature of ligands 101 allows in principle the combinatorial screening of different templates and ditopic 
P,N-ligands 100, an obvious limitation of this strategy seemed to be that the latter have to be identical, 
as the binding sites of the template are identical: treating 99 with a mixture of different P,N-ligands 
should result in a mixture of three supramolecular species. 
Quite surprisingly, however, this does not happen in several cases when the template 102 is used 
(Scheme 1.55): some combinations of P,N-ditopic ligands were reported to form the corresponding 
heterobidentate complexes with high selectivity, as demonstrated by 31P-NMR studies.137 b-c The 
authors tentatively ascribe this unexpected selectivity for the heterocomplexes to steric factors.137 bIn 
the hydroformylation of styrene the heterocomplexes showed a level of stereoselectivity much higher 
(up to 72% e.e.) than those observed both with the corresponding ligands in the absence of a template 
and with the above-discussed homocomplex 101 
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Scheme 1.54 Transition metal catalyst [HRh(101)(100)2)(CO)2] formed by selfassembly of 
pyridyldiphenylphosphine 100 on dimeric zinc(II) porphyrin 99 and in the presence of a rhodium precursor 
 
Homoleptic Rh-complexes obtained using template 102 gave poor results in the asymmetric 
hydrogenation of benchmark substrates.137c In the previous examples bis-porphyrins were used as 
templates to form bidentate ligands. 
 
 
Scheme 1.55 Formation of the templeted heterobidentate complex 
 
Alternatively, ditopic nitrogen ligands such as DABCO (diaza-[2.2.2]-bicyclooctane) can be used as 
templates to form 2: 1 assemblies with zinc(II) porphyrins. If these porphyrins are functionalised with 
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ligands, i.e. phosphines or phosphites, this self-assembly process can also lead to chelating bidentate 
ligands. Reek et al. realized this kind of self-assembly utilizing a phosphite bearing three zinc-
porphyrin moieties (104), in order to increase the rigidity of the complex (Scheme 1.56).138 
 
 
Scheme 1.56 Representation of the formation of a multicomponent assembly from ligand 83, template (dabco), 
and a transition-metal catalyst M. P = monodentate phosphorus ligand 
 
The rhodium-complex 105 was used as a catalyst in the hydroformylation of 1-octene giving a l / b 
ratio ten times higher than that obtained with ligand 104 in the absence of template. 
 
1.4.3.2 Two-component systems of ligands with complementary coordinating properties 
 
In this section examples of bidentate ligands assembled via direct interactions between 
monomeric ligand building blocks rather than via a template are discussed. 
In 2004 Reek, van Leeuwen and co-workers reported a supramolecular strategy to make 
bidentate ligands based on metal–ligand interactions that involves simply mixing monomeric ligand 
building blocks.139 They prepared phosphite functionalised porphyrins that would combine with 
nitrogen-containing phosphorus ligands for the self-assembly of bidentate ligands. Importantly, this 
approach leads to the formation of bidentate ligands with two different donor atoms (Scheme 1.57). 
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Scheme 1.57 The formation of a bidentate ligand and its transition-metal complex by selfassembly 
 
The coordination behaviour of the supramolecular ligands was investigated performing UV–Vis 
titrations and NMR experiments: it turned out that the pyridyl moiety selectively coordinates to the 
zinc(II) porphyrin 106, with a binding constant in the expected range (K = 3.8 × 103 M−1). The 
formation of a bidentate chelating system occurs with a chelate energy of 7 kJ mol−1. 48 
supramolecular systems of the 108 type were prepared from small 106 and 107 libraries (14 members 
overall) and screened in Pd-catalyzed Tsuji-Trost allylic alkylations (Scheme 1.58).140 
 
 
Scheme 1.58 Pd-catalyzed Tsuji-Trost allylic alkylations 
 
The self-assembled systems proved significantly more active than the corresponding monodentate 
ligands, yet their enantioselectivity (up to 70% e.e.) was in some cases slightly inferior (a ligand of the 
series 106 gave 97% e.e. alone).139a,b,d,fThe systems 108 were screened also in the Rh-catalyzed 
hydroformylation of styrene 139b,d and in the Rh-catalyzed hydrogenation of the challenging substrate 
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N-(3,4-dihydro-2-naphthalenyl)acetamide (Scheme 1.33, up to 94% e.e.)139c and of benchmark 
substrates.139d 
Recently Reek and co-workers developed also an analogous self-assembled ligand based on 
tin(IV) rather than zinc(II) porphyrines,139e which did not show better catalytic properties (for the 
hydroformylation reaction) compared to the parent system based on zinc. 
 
1.4.3.3 Two-component systems of ligands with complementary stereochemistry 
 
In 2004 Takacs et al.141 reported a different strategy to prepare chiral bidentate bis-phosphite 
ligands which is probably the most elegant among the self-assembly methods based on coordinative 
bond appeared so far: a modular assembly around a structural metal is used to selectively form a 
heteroleptic complex (an example is shown in Scheme 1.59). 
 
 
 
Scheme 1.59 Preparation of (box)2Zn complex and its transition-metal complex 106 
 
The selectivity of this strategy relies on the fact that the bis-oxazoline (BOX) moieties 
contained in their subunits are able to form stable tetrahedral zinc(II) complexes only if they have 
opposite configurations.142 The bifunctional subunits have a second set of ligating groups (TADDOL-
based phosphites) that are suitably disposed for binding a second metal that acts as the catalytically 
active centre. Two series of subunits having BOX residues with opposite configuration were 
synthesized, from which a ligand library of 50 self-assembled ligands (mostly differing in the tether 
portion) was constructed. In a first catalytic screening on the palladium-catalyzed asymmetric allylic 
amination (Scheme 1.60 A), enantioselectivities between 20% and 97% were reported, compared to 
48% e.e. for the bis-monodentate TADDOL phenylphosphine analogues. Nine ligand combinations 
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gave products with e.e.’s above 90%, indicating that the bidentate ligands clearly outperformed the 
monodentates. 
 
 
Scheme 1.60 (a) The palladium-catalyzed asymmetric allylic amination and (b) Rh-catalyzed asymmetric 
hydroboration of olefins 
 
The same library was later screened in the Rh-catalyzed asymmetric hydroboration of olefins (Scheme 
1.60 B):141c,143 good levels of regioselectivity for the chiral Markovnikov product were generally 
achieved. Also the level of enantioselectivity was outstanding for several heterocombinations. A 
library of similar supramolecular ligands having chiral biphenyl (BIPHEP)-derived instead of 
TADDOL-derived phosphite residues was screened in the hydrogenation of methyl 2-
acetamidoacrylate, giving up to 82% e.e.’s.141b 
 
1.4.3.4 Two-component homoleptic systems 
 
In 2007 van Leeuwen and co-workers reported a new family of homoleptic achiral 
supramolecular ligands formed by self-assembly of identical subunits.144 Each subunit contains both a 
phosphorus atom, necessary for coordinating the catalytic transition metal, and two hard donor atoms 
able to complex a second metal such as titanium(IV) or zinc(II). Some of these supramolecular 
systems are shown in Scheme 1.61. 
The new self-assembled ligands were screened in the Rh-catalyzed hydroformylation of 1-octene, 
giving in several cases better levels of regioselectivity (yet not outstanding in general terms) compared 
to the corresponding subunits: in particular, with ligands 112 and 110 l / b ratios of 13 and 21 
respectively were obtained. X-ray diffraction studies were performed on the best performing ligand 
113, for which a natural bite angle of 110° was also calculated by molecular mechanics. 
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Scheme 1.61 The new supramolecular diphosphine ligands 
 
1.4.4 Self-assembly through ionic and van der Waals interactions 
 
In recent years, some research groups have been trying to exploit also other kinds of non-
covalent interactions for achieving the self-assembly of supramolecular bidentate ligands.  
To this end, ionic interactions appeared particularly promising thanks to their intrinsic 
complementarity: given two sets of ligands bearing negative and positive charges respectively, the 
Coulombic charge attraction should obviously favour only the interaction between cations and anions, 
while the compounds having the same charge should repulse each other. For this reason, in principle 
this self-assembly strategy should allow the highly selective formation of supramolecular 
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heterocomplexes. In 2007, van Leeuwen and co-workers published the results of the first attempt to 
put this principle in practice.145 A library of meta-substituted phosphanes (Scheme 1.62) was 
synthesized, some of which possess functional groups able, in principle, to form ion pairs either by ion 
exchange or by direct acid-base reaction. Binary mixtures of ligands were combined in the presence of 
Pt-sources, and the formation of the complexes was monitored by 31P-NMR. 
 
  
Scheme 1.62 Ionic interactions for the formation of heterocomplexes. 
 
Only the combination 114a / 114b gave preferential formation of the heteroleptic square-planar Pt-
complex (upon removal of the by-product NaCl by precipitation), the ratio between hetero- and 
homocomplexes varying from 77:23 to 97:3 depending on the experimental conditions. The other 
ligand combinations led to statistical mixtures of complexes. Both NMR and X-ray diffraction data 
clearly showed that in the heterocomplex the ligands have a trans arrangement: the crucial role played 
by the ionic interaction in the heterocomplex can be seen form X-ray structure of complex trans-
[Pd(114a)(114b)(CH3)Cl], whose charged functional groups are in close proximity. No catalytic 
application of the heteroleptic complex was reported so far by the authors. 
Also our research group recently developed a self-assembly strategy relying on ionic 
interactions, according to which the ion-pairs were expected to form by direct interaction between 
ligands bearing an acidic and a basic functional group, respectively. 146 A small library of chiral 
BINOL-derived monodentate phosphites containing either a carboxylic acid (-COOH) or a tertiary 
amine (-NMe2) was synthesized. The ligand combinations were screened in the enantioselective 
rhodium-catalyzed hydrogenation of methyl 2-acetamidoacrylate. Some heterocombinations of basic 
and an acidic phosphite displayed a higher activity and a slightly better enantioselectivity compared to 
the corresponding homocombinations [up to 90% e.e. using (R)-115a/(R)-116b, shown in Scheme 
1.63]. 
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Scheme 1.63 Acidic and basic phosphite ligands and their application in Rh-catalyzed asymmetric 
hydrogenation. 
 
The nature and extent of the interaction between the acidic and basic ligands in the rhodium 
complexes were studied by spectroscopic methods. The formation of an intramolecular salt between 
the carboxylic acid and the tertiary amine could be observed from the IR spectra of acid/base mixtures 
in the presence of a rhodium source. However, only moderate  heterocomplex/homocomplexes ratios 
(up to 70:30) could be determined by 31P NMR. Despite this low level of selectivity in the 
heterocomplex formation, this remains so far the only example of ionic interaction-based self-
assembly strategy of some catalytic utility. The attractive interactions between aromatic rings with 
opposite electronic distribution  can be viewed as a possible candidate for promoting the self-assembly 
of supramolecular bidentate ligands. Our research group recently tried to develop a novel self-
assembly strategy relying on the pi-pi interaction between an electron-poor and electron-rich arene. 147 
With this goal, a library of chiral ligands was prepared, whose members are BINOL-derived 
phosphites each containing an electronrich or an electronpoor aromatic ring (Scheme 1.64). 
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Scheme 1.64 Library of chiral phosphites endowed with electron-rich and electron-poor arene rings: 
two representatives. 
 
Unfortunately, 31P NMR studies carried out on electon-rich/electron-poor phosphite mixtures in the 
presence of a rhodium source showed no selectivity, statistic heterocomplex/homocomplexes mixtures 
(2:1:1) being detected in all cases. We thus concluded that, in solution, arene-arene interactions are too 
weak for driving the selective formation of heterocomplexes. 
Schulz and co-workers also made an attempt to take advantage of electon-rich/electron poor 
arene-arene interactions for forming supramolecular ligands: 148 chiral oxazolines functionalised with 
anthracene (119) and trinitrofluorenone groups (120) were prepared and combined in the presence of a 
copper(II) source. The obtained complexes were screened in the Diels-Alder reaction between 
cyclopentadiene and an oxazolidinone-derivative, but no improvement in catalytic activity and 
stereoselectivity derived from using ligand mixtures rather than homocombinations (Scheme 1.65). 
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Scheme 1.65 Chiral oxazolines functionalised with electron-rich (119) and electron-poor (120) 
aromatic stsyems, and their application in Cu(II)-catalyzed Diels-Alder reaction. 
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Although it is very difficult to investigate what happens in solution [paramagnetic copper(II) complex 
cannot be analysed by NMR], on the base of the catalytic results the authors concluded that also in this 
case the arene-arene interactions are unable to promote the selective formation of the heterocomplex, a 
mixture of complexes being present. 
The formation of an inclusion compound was exploited by Monflier et al. to form a water-
soluble, supramolecular bidentate P,N-ligand whose Pt-complex was studied by NMR spectroscopy. 
149
 A cyclodextrine functionalized with an amino group was used as the host and the phosphine  as the 
guest (Scheme 1.66). 
 
  
Scheme 1.60 Formation of the supramolecular bidentate ligand (123) from 6’-amino-6’-
deoxycyclomaltoheptaose (121) and disodium bis(3-sulfonatophenyl)(4-tert-butylphenyl)phosphane 
(122)  
 
1.4.5  Other self-assembled ligands 
 
P-ligands are probably the class of ligand on which the concept of self-assembly has been 
most intensely studied in recent years. There are at least three reasons for this fact: 
 
1) they coordinate very well transition metals such as Pd, Rh, Ir, Ru, Ni, that play a central role in 
some of the most important organometallic reactions; 
2) their coordination properties can be easily studied by 31P-NMR spectroscopy; 
3) historically they have been the testing ground on which the groups involved in the development of 
new self-assembled systems have been competing. 
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Nevertheless, the concept of self-assembly has been applied also to other ligands than those in which 
the phosphorus atoms are employed for complexing the catalytic metal. For example, the role of the 
phosphorus atoms can be to coordinate the soft “structural” metal, while a harder metal will be the 
catalytic species (Scheme 1.67 A).150a,b In another example two rhodium P,S-complexes have been 
used as switchable linkers between two subunits each bearing a complex of the catalytic metal 
(Scheme 1.67 B).151 Finally, there are obviously also examples of self-assembled system completely 
devoid of phosphorus atoms.150c-e 
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Scheme 1.67 Synthesis of (a) phosphinooxazoline ligands and (b) the allosteric tweezer complexes150, 151 
 
These ligands, however, go far outside the scope of this short summary, and therefore they are not 
discussed here. 
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1.4.6 Transition-state stabilization by a secondary substrate-ligand 
interaction 
 
The effectiveness of enzymes, still unrivalled by any artificial catalytic system, is due to their 
ability of stabilising the transition state of a specific transformation by multiple interactions.152 The 
action of several well-placed functional groups allows to achieve catalysis with very high substrate 
selectivity, reaction selectivity and stereoselectivity. On the contrary, man-made catalysts rarely 
exploit this approach, predominantly utilising just one centre for interacting with one or more 
reactants. However, in the 1970s chemists started to take inspiration from Nature’s catalysts, and 
terms such as “artificial enzymes” and “biomimetic chemistry” appeared in the literature. A number of 
supramolecular catalytic systems were reported, which were capable of non-covalently binding the 
reaction substrate and precisely positioning it relative to the catalytic site, thus allowing a high level of 
activity and/or selectivity.153 These include both transition metal and metal-free catalysts, but only the 
former (Scheme 1.68) will be discussed in the present review. 
 
Do
M
Substrate
= donor atom = catalytic metalDo M
Non-covalent interaction
Bifunctional ligand
 
Scheme 1.68 Schematic representation of a supramolecular catalyst coordinating the reaction substrate. 
 
Most of the examples of metalloenzyme mimics appeared so far in the literature have been developed 
for reactions, such as hydrolysis of esters and phosphates and redox reactions, of limited interest from 
the synthetic point of view. Surprisingly, for a long time the world of biomimetic catalysis and the vast 
area of traditional transition metal catalysis (i.e. involving metals such as Pd, Ni, Pt, Rh or Ru and 
important organic transformations such as hydrogenation, hydroformylation, carbonylation, 
hydrocyanation or arylation) have lived sort of ‘parallel lives’, and only seldom met.154 For several 
research groups active in the latter area, the recent rediscovery of monodentate ligands and the 
subsequent effort to build supramolecular bidentate ligands by means of non-covalent interactions  
have been the occasion to approach concepts belonging to supramolecular and biomimetic catalysis. 
As a consequence, bifunctional ligands have started being employed also for creating metalloenzyme-
like, substrate-coordinating catalysts for synthetically relevant reactions, some of which are reviewed 
below. 
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In the 2001-2005 period, three papers by Grotjahn and co-workers appeared reporting the 
development of a highly efficient bifunctional ruthenium catalyst (125) for the anti-Markovnikov 
hydration of alkynes (Scheme 1.69).155 
 
Scheme 1.69 A highly efficient bifunctional organometallic catalyst for the anti-Markovnikov hydration of 
alkynes. 
 
Although the reaction mechanism has not been fully clarified yet,156  the vinylidene-ruthenium 
intermediate 126 is likely to be involved in the catalytic cycle. The basic nitrogen atoms present in the 
pyridine rings were demonstrated to be indispensable for a high catalytic activity: catalysts lacking 
these atoms are much less active than 125. These atoms may help catalysis in two key steps: (i) the 
formation of the vinylidene complex 126 from a terminal alkyne; (ii) the subsequent addition of water 
to C1 of the vinylidene (Scheme 1.69).  
In 2006 Crabtree, Brudvig and co-workers reported the bifunctional ligand 127, whose 
dinuclear manganese complex 128 catalyzes the regioselective oxidation of C-H groups of 
suitable carboxylic acids.157 The carboxylic acid recognition unit present in the catalyst is able to 
bind the COOH group of the substrate, which is positioned in such a way that one of its oxidisable 
C-H groups reacts selectively. The 128-catalyzed oxidation of Ibuprofen 129a (Scheme 1.70) 
occurred with high selectivity in favour of compound 129b (129b/129c = 98.5/1.5), while no 
selectivity between the two products (129b and 129c) could be realised with a related catalyst 
lacking the COOH groups. In the oxidation of a mixture of trans- and cis-(4-methylcyclohexyl) 
acetic acid (130a and 130b), just the former substrate (130a) reacted, yielding product 130c as a 
single diastereomer. Indeed, only in the 130a-catalyst adduct an oxidisable CH is present at the 
right distance and with the right orientation relative to the catalytic centre. 
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Breit and co-workers recently developed several interesting examples of bifunctional 
transition metal catalysts capable of non-covalently binding and activating the reaction substrate. 
In 2008, homo- and heterocombinations of achiral ligands 70a (Scheme 1.38), 70e-g (Scheme 
1.71), 70b, 70c and 70c (Scheme 1.37) were employed for developing a novel Pd-catalyzed 
allylation of indoles and pyrroles with allylic alcohols (Scheme 1.71).  
 
 
Scheme 1.71 Pd-catalyzed allylation of indoles and pyrroles with allylic alcohols promoted by homo- and 
heterocombinations of ligands 70a-g. 
  
Apparently, here the hydrogen bonding network goes beyond its structural role (i.e., holding the 
two ligands together) and assists the hydroxy group to become a better leaving group during the 
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allylic substitution process. This effect was rationalised by the authors with a tentative catalytic 
cycle which is shown in Scheme 1.72. In this novel reaction, the self-complementary, electron-
poor ligands 70g provided the most active catalysts and were thus used for exploring the reaction 
scope, which includes a large number of allylic alcohols besides several indole and pyrrole 
derivatives. This piece of work clearly shows how bifunctional, metalloenzyme-like catalytic 
systems not only improve the catalytic performance (activity and selectivity), but can also 
disclose new kinds of reactivity, not accessible with traditional monofunctional catalysts. 
 
 
Scheme 1.72 Proposed catalytic cycle for the Pd-catalyzed allylation of indoles and pyrroles with allylic 
alcohols promoted by homo- and heterocombinations of ligands 70a-g. 
 
In the same year, Breit and co-workers reported the new phosphine ligand 131 (Scheme 
1.73), endowed with an acylguanidine recognition unit capable of a two-point interaction with 
hydrogen bond-acceptor groups.158 In particular, the acylguanidine group can strongly bind the 
COOH group, and this directing effect was exploited for achieving the regioselective 
hydroformylation of unsaturated carboxylic acids (Scheme 1.73). The Rh complex of ligand 131 
catalyzed the γ-selective hydroformylation of α,β-unsaturated acids (Scheme 1.74 A) with high 
selectivity and improved activity (l/b ratio = 23, TOF = 250 h-1) compared to simple monodentate 
ligands such as PPh3 (l/b ratio = 1.3, TOF = 30 h-1).158a In a subsequent contribution,158d the same 
authors showed how activity and selectivity could be further improved by a fine-tuning of the 
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electronic properties of the ligand. Moreover, the substrate scope was further investigated, and a 
deeper understanding of mechanistic details of the reaction could be gained by a series of control 
experiments. In another paper published in 2008, Breit and co-workers reported the use of the Rh 
complex of ligand 131 as a catalyst for the decarboxylative hydroformylation of α,β-unsaturated 
acids (Scheme 1.73 B):158b in the presence of this kind of substrate, the acylguanidine group 
directs the reaction at the α-carbon of the acid. The formed α-carboxyaldehyde, which cannot be 
isolated, readily undergoes decarboxylation, thus forming a saturated aldehyde where the formyl 
group has replaced the carboxylic group. This kind of mechanism, outlined in Scheme 1.73 B, is 
supported by the observation that the reaction of [1-13C]-oct-2-enoic acid gives rise to the 
exclusive formation of unlabeled 1-octanal. The substrate scope of this reaction was investigated 
with a number of α,β-unsaturated acid substrates. In 2009 the same authors reported the use of 
other, related phosphine ligands (132 and 133) in the Rh-catalyzed chemoselective reduction of 
aldehydes and in the tandem hydroformylation-hydrogenation of olefins.158c 
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The last substrate-orientation effect that is discussed in tihis section was observed by Reek 
and co-workers in the enantioselective hydrogenation of 2-hydroxymethylacrylate promoted by 
the supramolecular Rh complex discussed in Section 1.4.2.6 (see Scheme 1.52).136a On the base of 
DFT calculations, the authors proposed an intermediate where substrate 29a is hydrogen-bonded 
to the ester group of ligand (Scheme 1.74). This substrate-orientation effect is suggested also by 
the drop of enantioselectivity observed (i) when using ligand 133 (still capable of forming the 
supramolecular bidentate ligand, but devoid of any hydrogen bond-acceptor group) or (ii) when 
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the OH group of the substrate is protected. 
 
Scheme 1.74 DFT-calculated structure of an intermediate of the hydrogenation of substrate catalyzed by the 
supramolecular complex. 
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Combination of a Binaphthol-derived Phosphite and a C1-
Symmetric Phosphinamine Generates Heteroleptic Catalysts in 
Rh- and Pd-mediated Reactions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
In this Chapter the synthesis of several enantiomerically pure phosphites and phosphinamines is described. 
DFT calculations showed that the phophite-phosphinamine rhodium heterocomplex is more stable than two 
homocomplexes by 11.29 kcal/mol. 31P NMR complexation studies, using Rh(acac)(C2H4) as the rhodium 
source, showed the preferential formation of phosphite/C1-symmetric aminophosphine heterocomplex with 
selectivities ranging from moderate (70%) to excellent (100%). The homo- and heterocombinations of 
phosphites and of the C1-symmetric phosphinamines were then screened in the Rh- and Ir-catalyzed 
hydrogenation of olefins and in the Pd-catalyzed asymmetric allylic substitution of rac-1,3-diphenyl-3-
acetoxyprop-1-ene with dimethyl malonate. Remarkably, the 1:1 combination of a binol-derived phosphite 
and a phosphinamine induced reversal of the enantioselectivity and, in the case of the palladium-catalyzed 
asymmetric allylic substitution, also a modest increase of the enantioselectivity.1 
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2.1 GENERAL INTRODUCTION  
 
In recent years, monodentate phosphorus ligands (e.g. phosphites, phosphonites, 
phosphoramidites and phosphinamines) have held the stage in asymmetric catalysis. In addition to 
their outstanding activity and selectivity, comparable or even superior to those of bidentate ligands, the 
convenient, fast and practical preparation from commercially available materials underlines their 
potential for industrial applications. Furthermore, the modular nature of all these ligands allows the 
synthesis of a wide variety of representatives, thereby making a combinatorial approach possible.  
In 2002–3, an important breakthrough in this area was made independently by the groups of Reetz and 
Feringa, who used a binary mixture of chiral monodentate P-ligands in several asymmetric rhodium 
catalyzed reactions. By mixing two ligands (La and Lb) in the presence of Rh, three species can be 
formed: RhLaLa, RhLbLb
 
(homocomplexes), and RhLaLb (heterocomplex) (see paragraph 1.1.2.2). The 
heterocombination is often more reactive and more (regio-, diastereo- and enantio-) selective than 
either of the two homocombinations. Moreover, under thermodynamic control (fast and reversible 
ligand exchange) the heterocomplex : homocomplexes ratios usually exceed the statistical value (2 : 1 
: 1). In these cases the preferential formation of heteroleptic catalysts from two monodentate ligands is 
probably favoured by weak interactions, such as van der Waals, pi-stacking or dipole–dipole 
interactions. The ideal case would constitute an equilibrium completely in favour of the heterocomplex 
[RhLaLb] because then only a single well-defined catalyst would exist in the reaction, and the 
undesired competition of the less selective homocomplexes would be avoided.  
We were intrigued by the remarkable selectivities reported for the mixtures of chiral ligands (binol-
derived phosphites, phosphonites and phosphoramidites) with achiral phosphines. In particular, the 1 : 
1 mixture of a chiral phosphite with an achiral phosphine was reported to induce reversal of the 
enantioselectivity in the Rh-catalyzed hydrogenation of N-acetamido acrylate (compared to the chiral 
phosphite alone). The only possible explanation for this peculiar behaviour is the selective formation 
of the phosphite–phosphine Rh-heterocomplex, favoured by electronically matching one σ-donor 
ligand (phosphine) and one pi-acceptor ligand (phosphite).  
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2.2 RESULTS AND DISCUSSION 
 
2.2.1 Thermodynamic approach to the selective formation of heteroleptic 
complexes 
 
In the frame of our studies directed to the selective formation of heterocomplexes resulting 
from the combination of different ligands, we considered the exploitation of the intrinsic 
thermodynamic preference of heterocomplexes Vs homocomplexes. In other words, we wondered if 
ligands having complementary electronic properties could favourably interact through a metal centre 
with the effect of increasing the thermodynamic stability of the heterocomplex over the 
homocomplexes. The obvious advantage of such an approach consists in using simple monodentate 
ligands instead of the sophisticated bifunctional ligands necessary for supramolecular interactions to 
take place. 
The fact that mixtures of monodentate ligands La and Lb, in the presence of a metal source M, 
can lead to distributions of complexes LaMLb : LaMLa : LbMLb significantly different from the 
statistical (2 : 1 : 1) had been previously reported in the literature and generally attributed to steric 
effects: the heterocomplex LaMLb were found the more favoured the more La and Lb differ in terms of 
steric bulk. For example, Feringa and Minnaard reported that up to 91% of the heterocomplex is 
formed by mixing Rh(acac)(C2H4)2 with two different monodentate phosphoramidites.2 Alternatively, 
the observed preference for the heterocomplex can be due by weak interactions, such as van der 
Waals, pi-stacking or dipole–dipole interactions. Moreover, the peculiar catalytic results often 
observed when a chiral (BINOL-derived phosphites, phosphonites and phosphoramidites) and an 
achiral monodentate ligand (phosphine) are combined clearly demonstrate that in these cases the 
heterocomplex LaMLb plays a central role in determining the stereochemical outcome of the reaction. 
In most cases a decrease of enantioselectivity was observed, which may not be surprising. However, in 
several instances the enantioselectivity increased or even reversed upon using an achiral ligand as one 
of the components.3,4 In a first example (shown in Scheme 2.1) the e.e. value climbs to 88 % when the 
tert-butylphosphonite used as the chiral ligand in combination with achiral triphenylphosphite (1:1 
mixture), while the homocombination of the phosphonite leads to an e.e. of only 45 %.3  
A second example shown in Scheme 2.2, where it can be seen that the heterocombination of 
1:1 mixture of a methylphosphonite with an achiral phosphine induced reversal of the 
enantioselectivity in Rh(I)-catalyzed hydrogenation of  methyl 2-acetamido acrylate.4  
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Scheme 2.1 Rh(I)-catalyzed hydrogenation of  β-N-acylamino acrylate using 1:1 mixture of a chiral and an 
achiral ligand: increase of  enentioselectivity3 
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Scheme 2.2 Rh(I)-catalyzed hydrogenation of methyl 2-acetamidoacrylate using 1:1 mixture of a chiral and an 
achiral ligand: inverse sense of  enantioselectivity4 
 
To the best of our knowledge, basically no attempt has been reported to verify whether the key-role 
played by the heterocomplex is due to its selective formation (i.e.: no or very little LaMLa and LbMLb 
to compete with) or to its higher activity compared to the corresponding homocomplexes. 
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Intrigued by these results, obtained combining a strongly σ-donor ligand (an achiral phosphine) with a 
pi-acceptor one (a BINOL-derived phosphite, phosphonite or phosphoramidite), we set to verify if the 
selective formation of the heterocomplexes could be obtained by combination of electronically 
complementary ligands. 
 
2.2.1.1 Selective formation of phosphite/phosphine heterocomplex 
 
It was initially decided to verify the ability of triphenylphosphine 1 to selectively form a 
heteroleptic complex when combined with the known chiral phosphite (S)-2a in the presence of a 
source of rhodium(I) [Scheme 2.3]. 
 
Scheme 2.3 Possible complexes of 1:1 mixture of triphenylphosphine 1 with phenyl phosphite (R)-2a 
 
According to our expectations, when the single phosphite ligands (homocombinations) were treated 
with Rh(acac)(C2H4)2, one or two doublet signals were visible depending on Rh / L ratio: the upfield 
signal corresponds to the mono-complex, while the downfield one is due to the homocomplex. As 
typically observed with phosphite ligands, the value of the 1JP,Rh coupling constant was typically about 
303 Hz for both the mono- and homocomplex. 
Triphenylphosphine 1 showed a more complex behaviour, with either a broad signal or sharp doublets 
at 49.2 and 31.9 ppm (1JP,Rh = 175 Hz and 134 Hz, respectively) being visible depending on the 
stoichiometry. 
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When the mixture of 1 and (R)-2a (1 equiv each) and Rh(acac)(C2H4)2 was dissolved in CD2Cl2, a 
quite clean heterocomplex was formed with cis disposition of the two P-ligands and heterocomplex / 
homocomplexes ratio = 94 : 6 (Scheme 2.4, 2JP,P = 85 Hz; 1JRh,phosphite = 318 Hz; 1JRh,phosphine = 182 Hz). 
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Scheme 2.4 31P NMR spectra of 1 : 1 mixture of triphenylphosphine 1 and phenyl phosphite (R)-2a with 
Rh(acac)(eth)2 as Rh source.  
 
The high observed amount of heterocomplex is in agreement with our initial hypothesis about 
a possible favourable interaction between the σ-donor phosphine and the pi-acceptor phosphite through 
the metal. We thus felt encouraged to further develop this new approach to the selective formation of 
heterocomplexes, as described below. 
 
2.2.1.2 DFT calculations on a phosphite-phosphine and phosphite- phosphinamine Rh 
heterocomplex 
 
Thanks to collaboration with the research group of prof. Tvaroška of the Slovak Academy of 
Sciences, DFT calculations at the B3LYP/SDD level of theory5 were performed in order to confirm 
that the phosphite-phosphine heterocomplexes are thermodynamically favoured over the 
corresponding homocomplexes. The calculation carried out on the isodesmic reaction shown in 
Scheme 2.5 shows that the heterocomplex is more stable than the two homocomplexes by 5.11 kcal 
mol-1. 
This result confirmed the validity of our approach, and we decided to prepare two ligand libraries with 
complementary electronic properties to combine in new NMR and catalytic experiments. However, 
while chiral BINOL-derived phosphites are a well-known and easy-to-prepare class of ligands, 
enantiomerically pure chiral phosphines are generally difficult to synthesize. A long and time-
consuming synthetic procedure would have been in contrast with our general goal of dealing with 
Chapter 2 
 82 
cheap and easy-to-prepare monodentate ligands, and thus only achiral phosphine would have been to 
be considered. As a consequence, the explorable combinatorial space would have been seriously 
limited, together with the probability of discovering efficient catalytic systems. 
 
 
Scheme 2.5 DFT calculations at the B3LYP/SDD level of theory on the isodesmic reaction of phosphite-
phosphine heterocomplex 
 
In view of these considerations, we wondered if the phosphine ligand could be substituted by another 
σ-donor phosphorus ligand, still retaining the thermodynamic preference for the formation of the Rh-
heterocomplex. We turned our attention to chiral phosphinamines,6 which are easy to prepare 
enantiomerically pure, and have 31P-NMR spectral properties fairly similar to those of phosphines, 
thus reflecting a similar electronic situation. 
Preliminary DFT calculations, carried out on a phosphite/phosphinamine combination (Scheme 2.6) at 
the B3LYP/SDD level of theory,5 showed that the phosphite-phosphinamine rhodium heterocomplex 
is more stable than the two homocomplexes by as much as 11.29 kcal mol-1. 
 
 
Scheme 2.6 DFT calculations at the B3LYP/SDD level of theory on the isodesmic reaction of phosphite-
phosphinamine heterocomplex 
 
We thus set to prepare a library of phosphite and one of phosphinamines as described in the following 
Paragraph, section 2.2.2. 
 
2.2.2 Synthesis of the ligand libraries 
 
We opted for chiral ligands based on BINOL derived phophites, and on C2- or C1-symmetric 
phosphinamines because these modular structures allow an easy tuning of the catalytic properties of 
ligands. The proposed ligand structures are shown in Scheme 2.7. 
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Scheme 2.7 Attractive σ-donor – pi-acceptor interactions between ligands with complementary electronic 
properties 
 
2.2.2.1 Synthesis of the chiral phosphite library 
 
A library of BINOL-derived phosphites was prepared reproducing, with little modifications, 
synthetic protocols reported in the literature. Commercially available (R)- and (S)-1,1’-bi-(2-naphthol) 
(BINOL) were the starting material for the synthesis. 
The phosphite ligands were easily prepared by condensation of appropriate phosphorochloridites with 
alcohols or phenols in the presence of an excess of triethylamine (Scheme 2.8): 2a,7 2b8 and 2c9, 2e,10 
2f11 are known products. 
 
 
 
Scheme 2.8 Synthesis of BINOL-derived phosphites  
 
The phosphite ligands proved stable when kept at low temperature under nitrogen, but they slowly 
degraded when stored at room temperature. 
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2.2.2.2 Synthesis of the chiral phosphinamine library 
 
The phosphinamine ligands were prepared by condensation of dihenylphosphinic chloride 
(Ph2PCl) with various amines, most of which commercially available, in the presence of triethylamine 
for C1 symmetric or BuLi for C2-symmetric phosphinamines (Scheme 2.9). 
 
 
Scheme 2.9 Synthesis of chiral phosphinamine library 
 
2.2.2.2.1 Preparation of non commercially available chiral amines 
 
Prolinamides 4a and 4b were prepared from N-Boc-L-proline according to the simple two-step 
sequence shown in Scheme 2.10. 
 
 
Scheme 2.10 Synthesis of prolinamides 4a and 4b 
 
As shown in Scheme 2.11, for preparing amine 4c it was necessary to react dicyclohexylamine with 
the N-Cbz-L-proline acyl chloride 5 (prepared as described in the literature12), because this sterically 
encumbered amine had proven unreactive to the condensing reagents utilised for preparing 3a and 3b. 
 
 
Scheme 211 Synthesis of prolinamide 4c  
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2.2.2.2.2 Synthesis of the C2-symmetric phosphinamines (SimplePhos ligands) 
 
The SimplePhos ligand 6a, developed by Alexakis et al., was prepared (in both the 
enantiomeric forms) following the original procedure6 with some variations, as shown in Scheme 2.12. 
In particular, we found unnecessary to protect the ligand as BH3-complex (as described in the original 
paper), and we were able to isolate it –yet in moderate yield– directly from the reaction crude. The 
obtained yield is hovewer somehow lower than the overall yield obtained with the original 
condensation-protection-deprotection sequence (31 % vs. 55%). 
 
 
 
Scheme 2.12 Preparation of the C2-symmetric phosphinamines (R,R)- and (S,S)-6a 
 
Remarkably, (R,R)- and (S,S)-6a could not be prepared under the experimental conditions described 
below for C1-symmetric phosphinamines, because sterically encumbered bis(1-phenylethyl)amine did 
not react in the presence of a weak base such as TEA. 
 
2.2.2.2.3 Synthesis of the C1-symmetric phosphinamines 
 
All of the C1-symmetric phosphinamines were prepared by reacting the corresponding amines 
with commercially available diphenylphosphinic chloride (Ph2PCl) in the presence of an excess of 
TEA, according to a modification of a known procedure13 (Scheme 2.13). The latter experimental 
protocol, indeed, proved more simple and practical than the one reported by Alexakis et al. for the 
synthesis of SimplePhos ligands. 
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Scheme 2.13 Synthesis of C1-symmetric phosphinamines 6b-6l 
 
All of the C1-symmetric phosphinamines 6b-6l (Scheme 2.13) turned out to be very sensitive to acids: 
they undergo rapid degradation on silica and could be chromatographed only on alumina using an 
eluent containing TEA (~ 5%, see the Experimental Section). In solution the ligands proved also 
moderately prone to undergo oxidation by atmospheric oxygen, while they are fairly stable in the solid 
state. The instability of these ligands to both hydrolysis and oxidation is inversely proportional to the 
steric bulk of the amine moiety, 6a being the most stable of all the prepared phosphinamines. 
The phosphinamine ligands are stable in the solid state if kept at low temperature under a nitrogen 
atmosphere. 
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2.2.3 NMR studies on the phosphite/phosphinamine metal complexes 
 
Several phosphite/phosphinamine combinations were treated with a metal source, and the 
obtained complexes were studied by 1H- and 31P-NMR spectroscopy, in order to confirm if the 
corresponding heteroleptic complex would be selectively formed as predicted by the DFT calculations 
presented above. 
2.2.3.1 Complexation experiments with rhodium (I) 
 
A number of homo- and heterocombinations of phosphites 2a-2d and phosphinamines 6b-6e 
were screened in complexation experiments in the presence of Rh(acac)(C2H4)2. 
The phosphite mono- and homocomplexes gave the expected doublet signals. Similarly, also the 
phosphinamine homocombinations gave one or two doublet signals depending on Rh / L ratio, where 
the upfield signal corresponds to the mono-complex and the downfield one is due to the 
homocomplex. Chemical shifts and coupling constants of several mono- and homocomplexes are 
listed in Table 2.1. 
 
Table 2.1 Chemical shifts and coupling constants  
Entry Ligand 
Monocomplex Homocomplex 
δ (ppm) 1JP,Rh (Hz) δ (ppm) 1JP,Rh (Hz) 
1 (S)- 2a 141.4 303.0 150.4 303.1 
2 (R)- or (S)- 2b 147.1 292.3 157.6 295.1 
3 (R)- 2c 146.6 293.4 158.9 295.8 
4 (R)- 2d 141.2 293.8 151.8 299.8 
5 (R)- or (S)-6b 101.3 193.0 104.8 203.6 
6 (R)-6c 105.5 193.0 107.2 205.4 
7 (R)-6d 79.2 187.6 83.6 199.1 
8 (S)-6e 77.9 187.2 81.9 198.7 
 
The possible combinations between phosphites 2a-2d and phosphinamines 6b-6e form a 4 × 4 matrix 
which would require 32 experiments to be covered, considering that two diastereoisomeric 
combinations are to be examined for each couple of ligands. In order to limit the number of 
complexation experiments, we opted for a positional scanning covering one line and one column of the 
matrix (14 experiments in total): all the possible diastereoisomeric combinations of the phosphinamine 
ligands with phosphites (R)- and (S)- 2b were analyzed first, then the aminophosphine giving the 
highest hetero/homocomplexes ratio (6b) was combined with all of the phosphites. The results of these 
experiments are listed in Table 2.2 in terms of percent of heterocomplex formed calculated from the 
31P-NMR integrals of all the observed complexes (i.e. heterocomplex + homocomplexes and mono-
complexes, when detected). All of the 31P-NMR spectra of these complexation experiments are printed 
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in the Experimental Section. It can be noted that the heterocomplexes were formed with selectivity 
ranging from moderate (70%) to excellent (> 99%). 
 
Table 2.2 Preference for the formation of heterocomplex between phosphites and phosphinamines 
 
Phosphites 
Phosphinamines 
(R)-6b (S)-6b (S)-6c (R)-6d (S)-6e 
(S)- 2a 83% > 99%    
(R)- 2b 99% 96% 81% 74% 70% 
(S)- 2b  
 81% 81% 84% 
(R)- 2c 94% 81%    
(R)- 2d 96% > 90%    
 
From the values of the observed coupling constants of the heterocomplexes, listed in Table 
2.3, it can be also deduced that in all of them the ligands are in a cis arrangement:14 this means that the 
labile ethylene ligands of the rhodium source have been displaced by the phosphite and the 
phosphinamine as expected, while the chelating acetylacetonate (acac) ligand remained in place. 
 
Table 2.3 Posphosrus coupling constants of the Rh(I) heterocomplexes of phosphite and phosphinamine 
 
Entry Heterocomplex 
Phosphite Phosphinamine 2JP,P (Hz) δ 
(ppm) 
1JP,Rh 
(Hz) 
δ 
(ppm) 
1JP,Rh 
(Hz) 
1 (R)-2b/(R)-6b 157.1 309.8 103.8 193.2 83.5 
2 (R)-2b/(S)-6b 155.4 310.1 103.9 192.5 84.7 
3 (R)-2b/(R)-6c 156.4 310.0 107.5 199.1 80.4 
4 (S)-2b/(R)-6c 156.1 310.8 104.2 194.6 84.3 
5 (R)-2b/(R)-6d 157.1 314.6 77.7 183.1 87.3 
6 (S)-2b/(R)-6d 156.9 314.7 78.4 182.9 87.6 
7 (R)-2b/(S)-6e 156.9 316.0 76.1 183.0 87.0 
8 (S)-2b/(S)-6e 157.1 316.1 76.0 182.4 87.1 
9 (S)-2a/(R)-6b 147.0 324.8 102.8 187.6 86.3 
10 (S)-2a/(S)-6b 147.4 324.6 103.3 189.6 85.3 
11 (R)-2c/(R)-6b 157.1 310.2 103.9 193.5 83.6 
12 (R)-2c/(S)-6b 155.5 309.8 104.1 193.0 85.1 
13 (R)-2d/(R)-6b 154.7 310.2 106.8 196.8 82.9 
14 (R)-2d/(S)-6b 152.0 311.4 105.8 195.9 83.6 
 
From a more careful look on Table 2.2 the following general observations can be drawn: 
• phosphinamine 6b generally leads to the highest level of selectivity for the heterocomplex (from 
81% up to 99%, depending on which phosphite it is combined with), while phosphinamines 6c-e, 
combined with phosphite 2b, all give similar levels of selectivity (from 70 up to 84%); 
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• A comparison between the selectivities observed with diastereoisomeric ligand combinations [for 
example (S)-2a/(R)-6b and (S)-2a/(S)-6b] denotes the presence of a moderate yet definite 
matched/mismatched effect, except for the combinations involving phosphite 6c; 
• The level of selectivity observed in all experiments is high enough to support the hypothesis of a 
thermodynamic bias in favour of the phosphite/phosphinamine heterocomplex. 
 
When the C2-symmetric SimplePhos ligand 6a was combined with phosphite ligands, no selective 
formation of the heterocomplex was observed. On the contrary, an under-statistical quantity of 
heterocomplex (about 2 : 8 heterocomplex/homocomplexes) formed, using the hetrocombination 
(R,R)-6a/(R)-2b (Scheme 2.14). Taken together with the observation that 6a, in the presence of 
Rh(acac)(C2H4)2, forms exclusively its mono-complex, the lack of selectivity observed in this case can 
be ascribed to steric factors: bulky 6a does not allow (or hardly does) other ligands to occupy the 
adjacent cis position around the rhodium atom. 
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Scheme 2.14 31P-NMR spectra of the rhodium complexes resulting from the combination of Rh(acac)(C2H4)2 
with ligands (R,R)-6a and (R)-2b, where (■) = [Rh(acac)2b2]+ homocomplex; (•) = [Rh(acac)(C2H4) 6a]+ 
homocomplex; (*) = [Rh(acac)(2b)(6a)]+ heterocomplex 
 
The complexation experiment on the combination (R)-2b/(R)-6b (Scheme 2.15 A), which had given 
the highest level of selectivity for the heterocomplex, was repeated using a different rhodium source 
(Scheme 2.15 B): Rh(cod)2BF4 was chosen in order to reproduce more precisely the actual conditions 
of catalytic hydrogenations, where this complex is widely used. 
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Scheme 2.15 31P-NMR spectra of the rhodium complexes resulting from the combination of ligands (R)-2b/(R)-
6b with: A) Rh(acac)(C2H4)2 and B) Rh(cod)2BF4 
 
As it can be seen from Scheme 2.15 B, also in the presence of Rh(cod)2BF4 the heteroleptic complex 
forms almost quantitatively. The following coupling constants are observed: 1JRh-phosphite = 264.6 Hz; 
1JRh-phosphinamine = 153.0 Hz; 2JP-P = 34.7 Hz. Such values, yet smaller than those observed in the 
presence of Rh(acac)(C2H4)2, are still consistent with a cis disposition of the ligands, one of the two 
cod ligand having been displaced. This experiment demonstrates that the new thermodynamic 
approach is compatible with the conditions required for the catalysis of asymmetric hydrogenations 
and we were stimulated to start a catalytic screening (see Paragraph 2.2.4). 
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2.2.3.2 Complexation experiments with palladium (II) 
 
Since the new strategy for self-assembly we are presenting relies on favourable electronic in-
teractions between the ligands through the metal, the nature of the metal does obviously play a 
primary role in making it successful. As a consequence, a general extension of the method based on 
phosphite/phosphinamine combinations to any transition metal is not possible, and every metal has to 
be studied separately. On the other hand, it is perfectly possible that other ‘complementary’ classes of 
ligands give good results with metals where phosphites and phosphinamines fail. 
We made a preliminary attempt to extend the use of phosphite/phosphinamine combinations to 
palladium (II), a metal having important applications in many catalytic reactions. Thus we treated 
Pd(CH3CN)2Cl2 with the ligand combination (R)-2b/(R)-6b and studied, as above, the formed 
complexes by 31P-NMR. The obtained spectrum is shown in Scheme 2.16. 
 
Scheme 2.16 31P NMR spectrum of ligand combination (R)-2b and (R)-6b with Pd(CH3CN)2Cl 
 
 
Since phosphorus and palladium nuclei do not couple, only the phosphorus-phosphorus cou-
pling through palladium is visible, provided that the phosphorus atoms are diastereotopic. Thus, the 
mono- and homocomplexes give rise to singlet signals (the chemical shifts of the homocomplexes are: 
112.0 ppm for the phosphite; 71.3 ppm for the phosphinamine), and the heterocomplex gives two 
doublets from which the coupling constant 2JP-P can be calculated. 
As it can be seen in Scheme 2.16, a basically statistical distribution of hetero- and homocomplexes 
was obtained, with heterocomplex / homocomplexes ratio = 56 : 44 and 2JP-P = 36.9 Hz. The chemical 
shifts of the two doublets are 104.1 and 78.3 ppm. 
If confirmed by a screening of several heterocombinations, this preliminary result seems to indicate 
that there is no thermodynamic preference for the phosphite/phosphinamine palladium 
heterocomplexes, unlike what happens with rhodium. 
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2.2.4 Catalytic screening of the phosphite/phosphinamine complexes 
 
With a new method for selectively generation heteroleptic rhodium complexes in hands, we 
have begun to study their catalytic properties starting from the reaction on which we are most 
experienced, i.e. the enantioselective hydrogenation of pro-chiral olefins. The ligands that performed 
best in hydrogenations were subsequently screened also in palladium-catalyzed allylic alkylation 
reactions. 
 
2.2.4.1 Rhodium(I)-catalyzed enantioselective hydrogenation of olefins 
 
So far our libraries have been screened on several substrates: methyl 2-acetamidoacrylate 7, N-
(1-phenylvinyl)acetamide 8, methyl 2-acetamidocinnamate 9,  methyl (Z)-3-acetamidocrotonate 10, 
methyl 3-N-acetylamino-2-phenyl-2-propenoate  11. This work of screening has been also carried out 
in collaboration with prof. De Vries (DSM-The Netherlands) and the results, which are not concluded 
yet, are summarised below. 
 
2.2.4.1.1 Enantioselective hydrogenation of methyl 2-acetamidoacrylate 7 
 
The asymmetric hydrogenation of methyl 2-acetamidoacrylate 7 to give the methyl N-acetyl 
alanine methyl ester 12 was initially carried out in DCM at room temperature under atmospheric 
pressure. Rh(cod)2BF4 was used as the rhodium source with a 1 mol% loading. The pure ligands 
(“homocombinations”) were used in a 2.2 mol% amount, while for the heterocombinations 1.1 mol% 
of each ligand was employed. The results of this screening are reported in Table 2.4. 
All of the ligands employed in the catalytic screening described below are shown in Scheme 2.17. 
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Scheme 2.17 Ligands employed in the Rh (I) catalyzed hydrogenation of pro-chiral olefins 
Chapter 2 
 94 
Table 2.4 Rh(I)-catalyzed hydrogenations of methyl 2-acetamidoacrylte 
 
Entry Ligands 
After 16 h (1 bar H2) 
Conv. [%] e.e. [%] (abs. conf.) 
Homocombinations 
1 (S)-2a 100 80 (R) 
2 (R)-2b 100 96 (S) 
3 (S)-2b 100 96 (R) 
4 (R)-2c 100 97 (S) 
5 (R)-2d 100 42 (S) 
6 (R)-2e 100 95 (S) 
7 (R)-2f 100 74 (S) 
8 (R,R)-6a 0 - 
9 (R)-6b 52 12 (S) 
10 (S)-6b 57 12 (R) 
11 (R)-6c 3 10 (R) 
12 (R)-6d 100 6 (R) 
13 (S)-6e 100 6 (R) 
14 (S)-6f 0 - 
15 6g 100 rac. 
16 (R)-6h 74 6 (R) 
17 (S)-6i 100 55 (R) 
18 (S)-6j 15 28 (S) 
19 (S)-6l 100 11 (S) 
Heterocombinations 
20 (R,R)-6a/(R)-2b 78 91 (S) 
21 (R,R)-6a/(R)-2c 100 95 (S) 
22 (S,S)-6a/(R)-2c 96 92 (S) 
23 (R)-6b/(S)-2a 9 4 (R) 
24 (R)-6b/(R)-2b 87 60 (R) 
25 (R)-6b/(R)-2c 85 46 (R) 
26 (R)-6b/(R)-2d 34 13 (R) 
27 (R)-6b/(R)-2e 70 20 (R) 
28 (R)-6b/(R)-2f 45 32 (R) 
29 (S)-6b/(S)-2a 13 6 (S) 
30 (S)-6b/(R)-2b 48 40 (R) 
31 (S)-6b/(R)-2c 42 56 (R) 
32 (S)-6b/(R)-2d 13 16 (R) 
33 (S)-6b/(R)-2e 67 12 (R) 
34 (S)-6b/(R)-2f 44 20 (R) 
35 (R)-6c/(S)-2a 5 14 (R) 
36 (R)-6c/(R)-2b 11 55 (S) 
37 (R)-6c/(S)-2b 25 57 (R) 
38 (R)-6c/(R)-2c 73 78 (S) 
39 (R)-6c/(R)-2d 9 12 (S) 
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40 (R)-6c/(R)-2e 55 58 (S) 
41 (R)-6c/(S)-2e 83 80 (R) 
42 (R)-6c/(R)-2f 14 37 (S) 
43 (R)-6d/(S)-2a 100 44 (R) 
44 (R)-6d/(R)-2b 100 rac. 
45 (R)-6d/(S)-2b 100 6 (R) 
46 (R)-6d/(R)-2c 100 9 (S) 
47 (R)-6d/(R)-2d 100 23 (R) 
48 (R)-6d/(R)-2e 100 20 (S) 
49 (R)-6d/(S)-2e 100 42 (R) 
50 (R)-6d/(R)-2f 100 13 (R) 
51 (S)-6e/(S)-2a 100 22 (R) 
52 (S)-6e/(R)-2b 100 6 (R) 
53 (S)-6e/(S)-2b 100 40 (S) 
54 (S)-6e/(R)-2c 100 9 (S) 
55 (S)-6e/(R)-2d 100 20 (R)  
56 (S)-6e/(R)-2e 100 25 (S) 
57 (S)-6e/(S)-2e 100 19 (S) 
58 (S)-6e/(R)-2f 100 3 (R) 
59 (S)-6f/(S)-2a 5 12 (R) 
60  (S)-6f/(R)-2b 8 60 (S) 
61 (S)-6f/(S)-2b 100 93 (R) 
62 (S)-6f/(R)-2c 100 93 (S) 
63 (S)-6f/(R)-2d 6 12 (S) 
64 (S)-6f/(R)-2e 92 65 (S) 
65 (S)-6f/(S)-2e 85 77 (R) 
66 (S)-6f/(R)-2f 4 n.d. 
67 6g(R)-2e 100 14 (R) 
68 6g/(R)-2c 100 10 (S) 
69 (R)-6h/(R)-2b 100 12 (R) 
70 (R)-6h/(S)-2b 100 50 (S) 
71 (R)-6h/(R)-2c 100 8 (S) 
72 (R)-6h/(R)-2e 100 10 (R) 
73 (R)-6h/(R)-2f 96 15 (S) 
74 (S)-6i/(R)-2b 100 32 (R) 
75 (S)-6i/(S)-2b 100 78 (S) 
76 (S)-6i/(R)-2c 100 54 (R) 
77 (S)-6i/(R)-2e 100 28(R) 
78 (S)-6i/(R)-2f 100 16 (S) 
79 (S)-6j/(R)-2b 97 77 (S) 
80 (S)-6j/(R)-2c 94 79 (S) 
81 (S)-6j/(R)-2d 96 31 (S) 
82 (S)-6j/(R)-2e 100 84 (S) 
83 (S)-6j/(R)-2f 100 60 (S) 
84 (S)-6k/(S)-2b 100 82 (R) 
85 (S)-6l/(R)-2b 100 91 (S) 
86 (S)-6l/(S)-2b 80 70 (R) 
87 (S)-6l/(R)-2c 10 11(S)  
88 (S)-6l/(R)-2e 71 50 (S) 
89 (S)-6l/(R)-2f 7 8 (R) 
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Unlike the phosphites, well known for their good catalytic properties in the hydrogenation 
processes,10b,15 the phosphinamines behaved quite poorly in this reaction, providing N-acetyl alanine 
methyl ester with moderate to good conversions and with low enantiomeric excesses (see entries 8-
20). SimplePhos ligand 6a, possibly due to its considerable steric bulk, showed no activity at all. Its 
combinations with phosphites 2b and 2c showed a slightly decreased level of stereoselectivity 
compared to phosphite homocombinations, thus indicating that in this case the phosphite 
homocomplex is the basically only species capable of catalytic activity. This result is consistent with 
the observations made on the heterocombinations involving 6a during the NMR studies (see Paragraph 
2.2.3). 
Much more interesting results could be obtained when C1-symmetric phosphinamines were combined 
with phosphites: in several cases (entries 24-29, 33-34, 53-54, 70, 75 and 89, data in bold font) the 1:1 
combination of BINOL-derived phosphite 2 and phosphinamine 6 induced reversal of the 
enantioselectivity in the hydrogenation of metyl 2-acetamidoacrylate, compared to both the phosphite 
and the phosphinamine alone. The typical example is shown in Scheme 2.18, where the combination 
(R)-6b/(R)-2b gave 60% e.e. for the enantiomer R of product 14 (Table 2.4, entry 24), while the 
homocomplexes of both ligand (R)-6b and (R)-2b are S-selective (Table 2.4, entry 9 and entry 2, 
respectively). This is clearly the sign that a heteroleptic catalyst is active in the hydrogenation 
reaction. 
-8 0
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Scheme 2.18 Rh(I) catalyzed hydrogenation of methyl 2-acetamidoacrylate with ligands (R)-6b and (R)-2b: 
heteroleptic catalyst is active in the hydrogenation reaction 
 
Similarly, the reversal of enantioselectivity observed when mixing chiral phosphite (R)-2e with achiral 
phosphinamine 6g (Table 2.4, entry 67) can be determined by nothing but the heteroleptic complex 
which is formed around the rhodium centre. 
In several other cases the heterocombinations showed opposite stereochemical preference compared to 
one of the ligands: this kind of result can be considered indicative of a catalytic role played by 
σ-donor and pi-acceptor interactions  
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heterocomplex when the stereochemical preference of the more active ligand is reversed (entries 31, 
32, 47, 50, 52, 55, 58, 69, 72, 74, 76, 77), which excludes that a mere competition between the two 
homocomplexes is taking place. For example, the combination (S)-6b/(R)-2c gave 56% e.e. for 
enantiomer R (Table 2.4, entry 31), thus reversing the stereochemical preference of the more active 
and selective ligand (R)-2c (which gave 97% e.e. for enantiomer S, 100% conversion, entry 4) and 
retaining that of phosphinamine (S)-6b (12% e.e. for enantiomer R, 57% conversion, entry 10): the 
fact that the stereochemical preference of the ‘slower’ ligand [(S)-6b] is retained indicates that a 
heteroleptic complex is determining the stereochemistry of the product in this case. 
It should be noted that the above-discussed tendency to give this phenomenon of ‘inversion’ of the 
stereochemical preference is not the same for all phosphinamine ligands: it appears to be strong for 
ligands 6b and 6e, less marked for 6h, 6i and 6d, absent in the heterocombinations involving 6f and 6j. 
This does not mean necessarily that the latter ligands do not form the heteroleptic complexes with 
phosphites. It might simply indicate that their heterocomplexes have the same stereochemical 
preference of the homocomplexes or are poorly active. 
 
2.2.4.1.2 Enantioselective hydrogenation of N-(1-phenylvinyl)acetamide 8 
 
Asymmetric hydrogenation of enamides gives access to enantioenriched acylated amines that can be 
hydrolyzed to the free chiral amines.16 We thus synthesized N-(1-phenylvinyl)acetamide from the 
acetophenone oxime 13, which was acylated and then converted into the amide by a radical reaction in 
the presence of iron.17 A small amount of trimethylsilyl chloride was added for activating the iron 
powder (Scheme 2.19). 
 
 
Scheme 2.19 Synthesis of enamides from the corresponding ketone via the oxime 
 
The ligand screening in the enantioselective hydrogenation of N-(1-phenylvinyl)acetamide 8 was 
carried out in DCM under 5 bar of hydrogen pressure. Rh(cod)2BF4 was used as the rhodium source 
with a 1 mol% loading. The pure ligands (“homocombinations”) were used in a 2.2 mol% amount, 
while for the heterocombinations 1.1 mol% of each ligand was employed. The results of the screening 
are summarised above in Table 2.5. The ligands are shown in Scheme 2.17. 
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Table 2.5 Rh(I)-catalyzed hydrogenations of N-(1-phenylvinyl)acetamide 
 
Entry Ligands 
After 16 h (5 bar H2) 
Conv. [%] e.e. [%] (abs. conf.) 
Homocombinations 
1 (S)-2a 100 86 (R) 
2 (R)-2b 100 92 (S) 
3 (S)-2b 100 92 (R) 
4 (R)-2c 100 90 (S) 
5 (R)-2d 100 6 (S) 
6 (R)-2e 100 79 (S) 
7 (R)-2f 100 77 (S) 
8 (R,R)-6a 30 29 (R) 
9 (R)-6b 83 7 (R) 
10 (S)-6b 74 7 (S) 
11 (R)-6c 53 4 (S) 
12 (R)-6d 100 12 (R) 
13 (S)-6e 100 4 (R) 
14 (S)-6f 38 10 (S) 
15 6g 100 rac. 
16 (R)-6h 100 26 (S) 
17 (S)-6i 100 70 (S) 
18 (S)-6j 30 12 (S) 
19 (S)-6k 30 12 (S) 
20 (S)-6l 40 rac. 
Heterocombinations 
21 (R,R)-6a/(R)-2e 99 89 (S) 
22 (R)-6b/(S)-2a 15 rac. 
23 (R)-6b/(R)-2b 99 57 (R) 
24 (R)-6b/(R)-2c 80 56 (R) 
25 (R)-6b/(R)-2d 95 29 (R) 
26 (R)-6b/(R)-2e 99 61 (S) 
27 (R)-6b/(R)-2f 100 51 (R) 
28 (S)-6b/(S)-2a 49 17 (S) 
29 (S)-6b/(R)-2b 96 38 (R) 
30 (S)-6b/(R)-2c 92 31 (R) 
31 (S)-6b/(S)-2b 98 40 (S) 
32 (R)-6c/(S)-2a 78 9 (S) 
33 (R)-6c/(R)-2b 60 6 (S) 
34 (R)-6c/(R)-2c 70 12 (R) 
35 (R)-6c/(R)-2e 77 12 (S) 
36 (R)-6c/(R)-2f 44 20 (S)  
37 (R)-6c/(S)-2b 99 44 (R) 
38 (R)-6d/(S)-2a 60 8 (R) 
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39 (R)-6d/(R)-2b 100 60 (S) 
40 (R)-6d/(R)-2c 100 rac. 
41 (R)-6d/(R)-2e 100 22 (S) 
42 (R)-6d/(R)-2f 100 rac. 
43 (R)-6d/(S)-2b 100 4 (R) 
44 (S)-6e/(S)-2a 100 36 (S) 
45 (S)-6e/(R)-2b 100 6 (S) 
46 (S)-6e/(R)-2c 100 rac. 
47 (S)-6e/(R)-2e 100 18 (S) 
48 (S)-6e/(R)-2f 100 17 (R) 
49 (S)-6e/(S)-2b 100 43  (S) 
50 (S)-6e/(S)-2e 100 27 (R) 
51 (S)-6f/(S)-2a 30 rac. 
52 (S)-6f/(R)-2b 35 16 (S) 
53 (S)-6f/(R)-2c 39 11 (R) 
54 (S)-6f/(R)-2e 79 22 (S) 
55 (S)-6f/(R)-2f 30 rac. 
56 (S)-6f/(S)-2b 75 9 (S) 
57 (S)-6f/(S)-2c n.a. n.a. 
58 (R)-6h/(R)-2b 100 58 (R) 
59 (R)-6h/(R)-2c 100 60 (R) 
60 (R)-6h/(R)-2e 100 10 (S) 
61 (R)-6h/(R)-2f 100 40 (R) 
62 (R)-6h/(S)-2b 100 72 (S) 
63 (S)-6i/(S)-2b 100 60 (S)  
64 (S)-6i/(R)-2c 100 54 (R) 
65 (S)-6i/(R)-2d 100 24 (R) 
66 (S)-6i/(R)-2e 100 20 (S) 
67 (S)-6i/(R)-2f 100 44 (R) 
68 (S)-6i/(R)-2b 100 53 (R) 
69 (S)-6j/(R)-2b 100 84 (S) 
70 (S)-6j/(R)-2c 100 83 (S) 
71 (S)-6j/(R)-2d 100 6 (S) 
72 (S)-6j/(R)-2e 100 73 (S) 
73 (S)-6j/(R)-2f n.a. n.a. 
74 (S)-6k/(R)-2b 100 82 (S) 
75 (S)-6k/(R)-2c 100 80 (S) 
76 (S)-6k/(R)-2e 98 70 (S) 
77 (S)-6k/(R)-2f 100 56 (S) 
78 (S)-6k/(S)-2b 100 84 (R) 
79 (S)-6l/(R)-2b 99 64 (S) 
80 (S)-6l/(S)-2b 100 86 (R) 
 
Similarly to what observed for methyl 2-acetamidoacrylate 7, phosphinamines appear to be quite poor 
ligands for the hydrogenation of N-(1-phenylvinyl)acetamide 8, especially in terms of 
enantioselectivity (e.e. from 4 to 70%, entries 8-20), whereas the phosphite ligands allow to obtain 
good levels of conversion and stereoselectivity (entries 1-4) with the exception of 3,3’-methyl 
substituted  BINOL-derived phosphite (R)-2d (entry 5). 
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Also with substrate 8 we could observe in many cases (entries 29, 30, 32, 34, 44, 49, 53, 58, 59, 61, 
64, 65, 67-69, data in bold font) that the phosphite/phosphinamine heterocombination have 
stereochemical preference opposite to that of both ligands, which indicates that the heterocomplex 
plays a major role in determining the reaction outcome. As in the hydrogenation of methyl 2-
acetamidoacrylate, also here some phosphinamines (6b, 6e, 6h, 6i, 6j) showed a more marked 
tendency than others (6f, 6k, 6l) to give the inversion of the stereochemical preference. Unfortunately, 
the maximum level of enantioselectivity that could be obtained with these combinations is only 
moderate [60% e.e. for enantiomer R obtained with the combination (R)-6h/(R)-2c], Table 2.7, entry 
59], significantly lower than that of the phosphite homocombination [(R)-2c gave 90% e.e. for 
enantiomer S]. 
Several other heterocombinations gave stereochemical preference opposite to that of one of the ligands 
(entries 21, 25, 26, 31, 37, 39, 41, 45, 47, 48, 62, 63, 78), which can be attributed to the 
heterocomplex, when it is the preference of the more active ligand to be reversed. 
 
2.2.4.1.3 Enantioselective hydrogenation of methyl 2-acetamidocinnamate 9 
 
The asymmetric hydrogenation of methyl 2-acetamidocinnamate 9 to give the N-
acetylphenylalanine methyl ester 15 was investigated also. The library screening including phosphites, 
phosphinamines and phosphoramidites (Scheme 2.17) was performed with a Premex A-96 
multireactor or with the Argonaut Endeavor multireactor autoclave. Hydrogenation reactions were 
performed in parallel at room temperature in dichloromethane with 25 bar hydrogen pressure. 
Rh(cod)2BF4  was used as the rhodium source with a 1 mol% loading. The pure ligands 
(“homocombinations”) were used in a 2.2 mol% amount, while for the heterocombinations 1.1 mol% 
of each ligand was employed. The selected screening results are shown in Table 2.6. 
 
Table 2.6 Rh(I)-catalyzed hydrogenations of methyl 2-acetamidocinnamate with selected ligands 
 
 
Entry Ligands 
After 16 h (25 bar H2) 
Conv. [%] e.e. [%]a 
Homocombinations 
1 (R)-2a n.a. n.a. 
2 (S)-2b 100 89 
3 (R)-2b 100 -89 
4 (R)-L2 100 -92 
σ-donor and pi-acceptor interactions  
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5 (R)-6b 4b -3 
6 (R)-6e 100 -24 
7 (R)-6h 100 4 
8 (S)-6i 100 -14 
9 (S)-6j 73 -27 
Heterocombinations 
10 (R)-6b/(S)-2b 93 -23 
11 (R)-6b/(R)-2b 7 43 
12 (R)-6e/(S)-L2 100 -89 
13 (R)-6h/(S)-2b 100 -55 
14 (R)-6h/(R)-2b 100 17 
15 (S)-6i/(S)-2b 100 -81 
16 (S)-6i/(R)-2b 100 36 
17 (S)-6i/(S)-L2 100 -79 
18 (S)-6j/(S)-2b 100 86 
a
 Absolute configurations were not determined; b e.e. value could not be determined accurately due to low 
conversion.  
 
A similar trend was observed in the Rh(I)-catalyzed asymmetric hydrogenation of methyl 2-
acetamidocinnamate 9 with selected ligands (Table 2.6). Phosphinamines appear to be quite poor 
ligands for the hydrogenation of  9, especially in terms of enantioselectivity (e.e. from 3 to 27%, Table 
5.7, entries 4-8), whereas the phosphite and phosphoramidite ligands allow to obtain good levels of 
conversion and stereoselectivity (entries 1-3). 
Also in the case of methyl 2-acetamidocinnamate we could observe that the phosphite/phosphinamine 
heterocombinations gave inversion of stereochemical preference to that of both ligands (Table 2.6, 
entries 11, 13, and 16, data in bold font), which indicates that the heterocomplex plays a major role in 
determining the reaction outcome. 
In few cases the heterocombination showed opposite stereochemical preference compared to the more 
active ligand, which excludes that a mere competition between the two homocomplexes is taking place 
(Table 2.6, entries 10 and 15). For example, the combination (S)-6i/(S)-2b gave -81% e.e. (Table 2.6, 
entry 15), thus reversing the stereochemical preference of the more active and selective ligand (S)-2b 
(which gave 89 % e.e. entry 2) and retaining that of phosphinamine (S)-6i (-14% e.e., entry 8): the fact 
that the stereochemical preference of the ‘slower’ ligand [(S)-6i] is retained indicates that a 
heteroleptic complex is determining the stereochemistry of the product in this case. 
The combinations of the phosphinamines with phosphoramidite ligands give a slightly decreased level 
of stereoselectivity compared to its homocombination without any inversion of stereocontrol. 
 
2.2.4.1.4 Enantioselective hydrogenation of methyl (Z)-3-acetamidocrotonate 10 
 
Another important class of compounds used in the development of drugs is β-amino acids. 
These can be made by hydrogenation of the corresponding dehydro β-amino acids. There is a large 
Chapter 2 
 102
difference in behaviour of E- and Z-enamides in the hydrogenation.18 The Z-isomer is generally more 
difficult to hydrogenate than E-izomer and usually gives the product with lower enantioselectivity. 
This could be explained by an intramolecular hydrogen bond between the NH of the amide and 
carbonyl of the ester, which makes the coordination of the substrate to the rhodium more difficult 
leading to lower reaction rates and enantioselectivities. 
The enantioselective hydrogenation of β-acylamino acrylates19 gives access to chiral β-amino acid 
derivatives which are important pharmaceutical building blocks.20 For this reason, the selected ligand 
library was screened in the hydrogenation of methyl (Z)-3-acetamidocrotonate 10 to give methyl-3-
acetamidobutanoate 16. The substrate was prepared in excellent yield in a one-step condensation and 
dehydration reaction of methyl 3-oxobutanoate with acetamide (Scheme 2.20).21  
 
 
Scheme 2.20 Synthesis of methyl (Z)-3-acetamidocrotonate 
 
The hydrogenation of methyl (Z)-3-acetamidocrotonate 10 with selective ligands was performed by 
using Premex A-96 multireactor. Hydrogenation reactions were performed in parallel at room 
temperature in dichloromethane with 25 bar hydrogen pressure. Rh(cod)2BF4  was used as the rhodium 
source with a 1 mol% loading. The pure ligands (“homocombinations”) were used in a 2.2 mol% 
amount, while for the heterocombinations 1.1 mol% of each ligand was employed. The results are 
reported in Table 2.7. 
 
Table 2.7 Rh(I)-catalyzed hydrogenations of (Z)-3-acetamidocrotonate with selected ligands 
 
 
Entry Ligands 
After 16 h (25 bar H2) 
Conv. [%] e.e. [%]a 
Homocombinations 
1 (R)-6b 0 - 
2 (R)-6e 90 19 
3 (R)-6h 8 rac. 
4 (S)-6i 39 31 
5 (S)-6j 0 - 
Heterocombinations 
6 (R)-6b/(R)-2a 0 - 
7 (R)-6b/(S)-2b 0 - 
8 (R)-6b/(S)-L1 3 20 
σ-donor and pi-acceptor interactions  
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9 (R)-6b/(S)-L2 0 - 
10 (R)-6e/(R)-2a 83 -18 
11 (R)-6e/(S)-2b 97 22 
12 (R)-6e/(S)-L1 96 26 
13 (R)-6e/(S)-L2 74 5 
14 (R)-6h/(R)-2a 76 2 
15 (R)-6h/(S)-2b 97 32 
15 (R)-6h/(S)-L1 59 22 
17 (R)-6h/(S)-L2 9 10 
18 (S)-6i/(R)-2a 82 38 
19 (S)-6i/(S)-2b 98 17 
20 (S)-6i/(S)-L1 58 28 
21 (S)-6i/(S)-L2 44 36 
22 (S)-6j/(R)-2a 2b -10 
23 (S)-6j/(S)-2b 7 24 
24 (S)-6j/(S)-L1 1b 6 
25 (S)-6j/(S)-L2 2b 11 
a
 Absolute configurations were not determined; b e.e. value could not be determined accurately due to low 
conversion.  
 
Unfortunately, as it can be seen from the results (Table 2.7), all tested phosphinamine combinations 
either with phosphite (2a or 2b) or with phosphoramidite (L1 or L2) behaved very poorly showing 
low activity and selectivity. We did not try to use more polar or protic solvents in order to break 
intramolecular hydrogen bond in the substrate or to use another isomer (E)-3-acetamidocrotonate. 
2.2.4.1.5 Enantioselective hydrogenation of methyl 3-N-acetylamino-2-phenyl-2-propenoate 
11   
 
The hydrogenation of α-substituted β-amidoacrylates gives β2-amino acid derivatives,  which 
have a potential for two stereogenic centres at C2 in their backbone. These compounds are building 
blocks for the synthesis of β-peptides and thus are the object of a wide interest. 
An isomeric mixture of the substrates Z-11 and E-11 was readily prepared from commercially 
available methyl phenylacetate by formylation and condensation of the resulting formyl esters X with 
acetamide (Scheme 2.21).22 
 
Scheme 2.21 Synthesis of methyl 3-N-acetylamino-2-phenyl-2-propenoate  
 
Intramolecular hydrogen bonding between the β-amide hydrogen and ester carbonyl group in the (Z)-
isomer was evident in the 1H NMR spectra, where a significant downfield shift of the β-amide proton 
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(δ 10–11) was observed.  The (E)- and (Z)-isomers could be readily separated by conventional column 
chromatography. 
The hydrogenation of methyl 3-N-acetylamino-2-phenyl-2-propenoate 11 with selective ligands was 
performed by using Premex A-96 multireactor. Hydrogenation reactions were performed in parallel at 
room temperature in dichloromethane with 25 bar hydrogen pressure. Rh(cod)2BF4was used as the 
rhodium source with a 1 mol% loading. The pure ligands (“homocombinations”) were used in a 2.2 
mol% amount, while for the heterocombinations 1.1 mol% of each ligand was employed (Scheme 
2.22). 
 
 
Scheme 2.22 Rh(I)-catalyzed hydrogenation of methyl 3-N-acetylamino-2-phenyl-2-propenoate   
 
Unfortunately, hydrogenation reactions employing combinations of phosphinamines ((R)-6b, (R)-6e, 
(R)-6h, (S)-6i, (S)-6j) with phosphites [(R)-2a and (S)-2b] or phosphoramidites (L1 or L2) in DCM 
led to product with only poor conversions (up to 18% for E-10 and up to 5% for Z-10). Therefore, 
enantiomeric accesses were determined.  
 
2.2.4.2 Iridium-catalyzed enantioselective hydrogenation of imines 
 
Literature precedents have shown that iridium is the metal of choice in the hydrogenation of 
imines.23 We were interested in investigating whether iridium complexes of our chiral monodentate 
phosphinamines with phosphites or phosphoramidites could also act as efficient enantioselective 
hydrogenation catalysts. Our initial studies were aimed at the preparation of cationic iridium 
complexes containing a phosphinamine ligand La, and either the same phosphinamine, a phosphite, or 
phosphoramidite as the secondary ligand Lb. Two equivalents of ligand (in case of homocombinations) 
or one equivalent of each ligand were treated with [Ir(cod)Cl]2 to the corresponding pre-catalysts 
(presumably of formula [Ir(cod)L2]+ and [Ir(cod)LaLb]+ respectively). We briefly investigated the 
scope of the catalyst with two imine substrates. 
 
2.2.4.2.1 Enantioselective hydrogenation of N-(2-Methoxy-phenyl)-(1-phenyl-ethylidene)-
amine 
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Asymmetric hydrogenation of N-(2-Methoxy-phenyl)-(1-phenyl-ethylidene)-amine 18 was 
chosen as a model reaction.  The substrate synthesis is very simple and product was obtained in 
quantitative yield in one step from acetophenone and o-anisidine (Scheme 2.23). 
 
 
Scheme 2.23 Synthesis of  N-(2-Methoxy-phenyl)-(1-phenyl-ethylidene)-amine 18 
 
The hydrogenation reactions employing phosphinamine combinations [(R)-6b, (R)-6e, (R)-6h, (S)-6i, 
(S)-6j] with phosphites [(R)-2a and (S)-2b] or phosphoramidites (L1 or L2) were performed by using 
Premex A-96 multireactor. Hydrogenation experiments were performed in parallel at room 
temperature in dichloromethane with 25 bar hydrogen pressure. [Ir(cod)Cl]2 was used as the iridium 
source with a 1 mol% loading. The pure ligands (“homocombinations”) were used in a 2.2 mol% 
amount, while for the heterocombinations 1.1 mol% of each ligand was employed. The results are 
reported in Table 2.8. 
 
Table 2.8 Ir-catalyzed hydrogenation of N-(2-Methoxy-phenyl)-(1-phenyl-ethylidene)-amine 
 
 
Entry Ligands 
After 16 h (25 bar H2) 
Conv. [%] e.e. [%]a 
Homocombinations 
1 (R)-6b 1 n.a. 
2 (R)-6e 32 n.a. 
3 (R)-6h 2 n.a. 
4 (S)-6i 0 n.a. 
Heterocombinations 
6 (R)-6b/(R)-2a 94 0 
7 (R)-6b/(S)-2b 100 0 
8 (R)-6b/(S)-L1 9 n.a. 
9 (R)-6b/(S)-L2 12 n.a. 
10 (R)-6e/(R)-2a 20 9 
11 (R)-6e/(S)-2b 31 30 
12 (R)-6e/(S)-L1 7 n.a. 
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13 (R)-6e/(S)-L2 4 n.a. 
14 (R)-6h/(R)-2a 65 -1 
15 (R)-6h/(S)-2b 88 0 
15 (R)-6h/(S)-L1 8 n.a. 
17 (R)-6h/(S)-L2 15 n.a. 
18 (S)-6i/(R)-2a 100 -5 
19 (S)-6i/(S)-2b 100 -6 
20 (S)-6i/(S)-L1 14 n.a. 
21 (S)-6i/(S)-L2 14 n.a. 
a
 Absolute configurations were not determined; n.a. – not analyzed.  
 
As it can be seen in Table 2.8, phosphinamines are poorly active ligands also in the Ir-catalyzed 
hydrogenation. The highest conversion (32 %) was observed with ligand (R)-6e (entry 2). However, 
the ligand heterocombinations led to notably high activities. In particular, in the case of combinations 
(R)-6b/(S)-2b, (S)-6i/(R)-2a, and (S)-6i/(S)-2b (Table 2.8, entries 7, 18 and 19), full conversions were 
obtained. Unfortunately, we observed low levels of enantioselectivity (up to 30 % e.e.; samples with 
conversion lower than 20 % were not analyzed by chiral HPLC). 
 
2.2.4.2.2 Enantioselective hydrogenation of 6,7-dimethoxy-1-methyl-3,4-
dihydroxyisoquinoline 20 
 
We next studied the hydrogenation of isoquinoline 20, which led to the formation of 1,2,3,4-
tetrahydro-6,7-dimethoxy-1-methyl-isoquinoline 21. For the initial screening phosphinamines [(R)-6b, 
(R)-6e, (R)-6h, (S)-6i, (S)-6j)], phosphites [(R)-2a and (S)-2b)] or phosphoramidites (L1 or L2) were 
employed. The reactions were performed in a Premex A-96 multireactor. Hydrogenation reactions 
were performed in parallel at room temperature in dichloromethane under 25 bar hydrogen pressure. 
[Ir(cod)Cl]2 was used as the iridium source with a 1 mol% loading. The pure ligands 
(“homocombinations”) were used in a 2.2 mol% amount, while for the heterocombinations 1.1 mol% 
of each ligand was employed. The results are reported in Table 2.10. 
 
Table 2.9 Ir-catalyzed hydrogenation of 6,7-dimethoxy-1-methyl-3,4-dihydroxyisoquinoline in a Premex A-96 
multireactor 
 
20
N
O
O NH
O
O
L1, L2 [Ir(COD)Cl]2
H2 (25 bar), Toluene
21
 
Entry Ligands 
After 16 h (25 bar H2) 
Conv. [%] e.e. [%]a  
Homocombinations 
1 (R)-6b 1 n.a. 
2 (R)-6e 24 n.a. 
3 (R)-6h 0 - 
4 (S)-6i 0 - 
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Heterocombinations 
6 (R)-6b/(R)-2a 29 n.a. 
7 (R)-6b/(S)-2b 41 43 
8 (R)-6b/(S)-L1 37 -3 
9 (R)-6b/(S)-L2 56 -58 
10 (R)-6e/(R)-2a 89 17 
11 (R)-6e/(S)-2b 91 63 
12 (R)-6e/(S)-L1 39 4 
13 (R)-6e/(S)-L2 68 4 
14 (R)-6h/(R)-2a 52 1 
15 (R)-6h/(S)-2b 32 44 
15 (R)-6h/(S)-L1 62 11 
17 (R)-6h/(S)-L2 57 -49 
18 (S)-6i/(R)-2a 76 13 
19 (S)-6i/(S)-2b 44 47 
20 (S)-6i/(S)-L1 8 n.a. 
21 (S)-6i/(S)-L2 42 n.a. 
a
 Absolute configurations were not determined; n.a. – not analyzed.  
 
Similarly to what observed for N-(2-Methoxy-phenyl)-(1-phenyl-ethylidene)-amine 18, 
phosphinamines appear to be quite poor ligands for the hydrogenation of 20, and gave almost no 
reaction. Again, the highest conversion (up to 24%) was observed with ligand (R)-6e (Table 2.9, entry 
2), while other phosphinamines showed no activity. Also in this case the enantiomeric access was not 
analysed. 
Also with substrate 20, we could observe in many cases that the phosphinamine/phosphite or 
phosphinamine/phosphoramidite heterocombination lead to increased conversions. The combination 
(R)-6e/(S)-2b gave the most interesting result, furnishing product 21 with 63% e.e. and almost 
complete conversion. Thus, we decided to investigate these results more in detail: we took four ligands 
our library [(R)-6b, (R)-6e, (S)-2b and L2] and compared the results of the Premex A-96 (96 high-
pressure reactors) screening with those obtained with the Endeavor multireactor (8 autoclaves) (Table 
2.10). 
 
Table 2.10 Ir-catalyzed hydrogenation of 6,7-dimethoxy-1-methyl-3,4-dihydroxyisoquinoline in the Endeavor 
multireactor 
 
Entry Ligands 
After 16 h (25 bar H2) 
Conv.[%]a e.e. [%]b 
homocombinations 
1 (R)-6b n.d. 13 
2 (R)-6e 39 13 
3 (S)-2b 55 55 
4 (R)-L2 39 -46 
heterocombinations 
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5 (R)-6b/(R)-L2 40 -40 
6 (R)-6e/(S)-2b 89 52 
a
 conversions were estimated from the chiral HPLC % areas using the calibration straight line obtained, in the 
Premex-96 experiment, by plotting the conversions determined by achiral GC against the chiral HPLC % areas; 
a
 Absolute configurations were not determined; n.d. = not determined.  
 
Unfortunately, every further attempt to reproduce the best result obtained with combination (R)-6e/(S)-
2b failed, although the effect of every single parameter on the reaction outcome was investigated. It 
was thus decided to end up the experiments on iridium catalyzed hydrogenations. 
 
2.2.4.3 Palladium-catalyzed enantioselective allylic alkylation 
 
In the attempt to extend the use of phosphite/phosphinamine combinations to palladium(II), 
we also performed a screening of our phosphite and phosphinamine libraries (Scheme 2.11) in the 
enantioselective allylic alkylation of rac-1,3-diphenyl-3-acetoxyprop-1-ene 22 with dimethyl malonate 
23. The reactions were carried out in DCM in the presence of [Pd(η3C3H5)Cl]2 (1.5 mol%) and N,O-
bis(trimethylsilyl)-acetamide (BSA). The pure ligands (“homocombinations”) were used in a 6 mol% 
amount, while for the heterocombinations 3 mol% of each ligand was employed. The results obtained 
so far are shown in Table 2.11. 
 
Table 2.11 Palladium-catalyzed asymmetric allylic substitution of rac-1,3-diphenyl-3-acetoxyprop-1-ene with 
dimethyl malonate 
 
[Pd(h3C3H5)Cl]2(1.5 mol%)
L (6 mol%) or La, Lb (3 mol% each)
BSA / cat. AcOK
DCM, RT
OAc MeOOC COOMe
*
22 24
+
COOMe
COOMe
23
 
 
Entry Ligands 
After 1 h, RT 
Conv. [%] e.e. [%] (abs. conf.) 
Homocombinations 
1 (S)-2a 41 25 (S) 
2 (R)-2b 100 58 (S) 
3 (R)-2c 100 40 (S) 
4 (R)-2d 60 73 (R) 
5 (R)-2e 100 45 (S) 
6 (R,R)-6a 96 72 (R) 
7 (R)-6b 100 68 (R) 
8 (S)-6b  100 68 (S) 
9 (R)-6c 100 rac. 
10 (R)-6d 94 7 (S) 
11 (S)-6e 100 15 (R) 
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12 (S)-6f 100 64 (S) 
13 (S)-6j 100 rac. 
14 (S)-6l 86 35 (S) 
Heterocombinations 
15 (R,R)-6a/(R)-2b 100 74 (R) 
16 (R)-6b/(S)-2a 100 20 (S) 
17 (R)-6b/(R)-2b 100 69 (S) 
18 (R)-6b/(R)-2c 100 16 (S) 
19 (R)-6b/(R)-2d 100 56 (R) 
20 (R)-6b/(R)-2e 100 36 (S) 
21 (S)-6b/(S)-2a 100 60 (S) 
22 (S)-6b/(R)-2b 100 69 (S) 
23 (S)-6b/(R)-2c 100 39 (S) 
24 (S)-6b/(R)-2d 100 31 (R) 
25 (S)-6b/(R)-2e 100 46 (S) 
26 (R)-6c/(R)-2b 76 44 (S) 
27 (R)-6c/(S)-2b 100 31 (R) 
28 (R)-6d/(R)-2b 100 14 (S) 
29 (R)-6d/(S)-2b 100 18 (R) 
30 (S)-6e/(R)-2b 100 rac. 
31 (S)-6e/(S)-2b 100 6 (R) 
32 (S)-6f/(R)-2b 100 47 (S) 
33 (S)-6f/(S)-2b 100 20 (R) 
34 (S)-6j/(R)-2b 83 65 (S) 
35 (S)-6l/(R)-2b 90 44 (S) 
 
From the data shown above it can be seen that in this reaction the effect of mixing ligands on the 
stereoselectivity is less evident than in Rh-catalyzed hydrogenations, which is in agreement with the 
lack of selectivity in the Pd heterocomplex formation that was observed in the first NMR studies. 
There are no heterocombinations showing stereochemical preference opposite to that of both the 
ligands, although the selectivity of one of the ligands is reversed in several cases (entries 15-18, 20, 
24, 29, 33). 
However, a peculiar stereochemical outcome was observed for the diastereoisomeric combinations 
(R)-6b/(R)-2b and (S)-6b/(R)-2b (entry 17 and 22, respectively), which both led to the S enantiomer of 
product 24 with the same enantiomeric excess (69%). Therefore, surprisingly both combinations retain 
the stereochemical preference of phosphite (R)-2b (58% e.e., S, entry 2) with an improved selectivity, 
whatever is the configuration of phosphinamine 6b (whose enantiomer R gives the with 68% e.e. with 
preference for R, entry 7). Whereas the result obtained with combination (S)-6b/(R)-2b can be 
attributed to (S)-6b homocomplex, the S-selectivity of combination (R)-6b/(R)-2b, higher than that of 
(R)-2b homocomplex, must be due to the presence of a heteroleptic complex with higher activity than 
the homocomplexes. 
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In conclusion, although the palladium heterocomplexes are not formed in a selective fashion, their 
presence influences the stereochemical outcome, just as observed for several other literature examples 
of ligand mixtures. 
 
2.3 CONCLUSIONS 
 
In this Chapter the development of a novel strategy for the selective formation of heteroleptic 
transition metal complexes has been started, whose main advantage consists in involving simple and 
easy-to-prepare monodentate ligands without need of supramolecular interactions. 
DFT calculations have shown that combinations of phosphites and phosphinamines should be able to 
selectively form the heteroleptic rhodium complexes thanks to their complementary electronic 
properties. For this reason, two small libraries of chiral phosphites and phosphinamines have been 
synthesized. Complexation experiments monitored by 31P-NMR spectroscopy have shown that indeed 
combinations of monodentate phosphite and phosphinamine ligands form the corresponding 
heteroleptic rhodium(I) complexes with a selectivity ranging from moderate to very high. An 
extension of the use of phosphite/phosphinamine combinations to palladium(II) complexes has been 
attempted, but in this case a statistical heterocomplex / homocomplexes ratio has been detected. 
Phosphite/phosphinamine combinations have been screened in Rh- and Ir-catalyzed hydrogenations 
and Pd-catalyzed allylic alkylations. Especially in the Rh-catalyzed hydrogenation case, typical 
phenomena due to the presence of heteroleptic complexes (e.g. reversed sense of stereoselection of the 
combinations compared to the ligands alone) have been observed. Unfortunately, the 
heterocombinations screened so far never reached a level of enantioselectivity high enough to justify a 
synthetic interest. 
 
2.4 EXPERIMENTAL SECTION 
 
2.4.1 General remarks 
 
All reactions were carried out in flame-dried glassware with magnetic stirring under nitrogen 
atmosphere, unless otherwise stated. All commercially available reagents were used as received. The 
solvents were dried by distillation over the following drying agents and were transferred under 
nitrogen: CH2Cl2 (CaH2), MeOH (CaH2), THF (Na), benzene (Na), toluene (Na), hexane (Na), Et3N 
(CaH2). Dry Et2O and CHCl3 (over molecular sieves in bottles with crown cap) were purchased from 
Fluka and stored under nitrogen. The reactions were monitored by analytical thin-layer 
chromatography (TLC) using silica gel 60 F254 pre-coated glass plates (0.25 mm thickness) or 
aluminum oxide 60 Å F254 on glass plates (0.25 mm thickness). Visualization was accomplished by 
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irradiation with a UV lamp and/or staining with potassium permanganate, ninhydrin or anisaldehyde 
solution. Flash column chromatography was performed using either neutral alumina (50-200 µm) or 
silica gel (60 Å, particle size 40-64 µm), following the procedure by Still and co-workers. Proton 
NMR spectra were recorded on a spectrometer operating at 400.13 MHz. Proton chemical shifts are 
reported in ppm (δ) with the solvent reference relative to tetramethylsilane (Me4Si) employed as the 
internal standard (CDCl3 δ = 7.26 ppm; CD2Cl2 = 5.32 ppm; d6-DMSO = 2.50 ppm). The following 
abbreviations are used to describe spin multiplicity: s = singlet, d = doublet, t = triplet, q = quartet, m 
= multiplet, br = broad signal, dd = doublet-doublet, dq = doublet-quartet. 13C-NMR spectra were 
recorded on a 400 MHz spectrometer operating at 100.56 MHz, with complete proton decoupling. 
Carbon chemical shifts are reported in ppm (δ) relative to TMS with the respective solvent resonance 
as the internal standard (CDCl3, δ = 77.23 ppm; CD2Cl2 = 54.00 ppm; d6-DMSO = 39.51 ppm). 31P 
NMR spectra were recorded on a 400 MHz spectrometer operating at 162 MHz, with complete proton 
decoupling. 31P NMR chemical shifts are reported in ppm (δ) relative to external 85% H3PO4 at 0 ppm 
(positive values downfield). The coupling constant values are given in Hz. Infrared spectra were 
recorded on a standard FT/IR; peaks are reported in cm–1. Optical rotation values were measured on an 
automatic polarimeter with a 1 dm cell at the sodium D line. Gas chromatography was performed on a 
GC instrument equipped with a flame ionization detector, using a chiral capillary column. Mass 
spectra (MS) were performed on a hybrid quadrupole time of flight mass spectrometer equipped with 
an ESI ion source. High resolution mass spectra (HRMS) were performed on a Fourier Transform Ion 
Cyclotron Resonance (FT-ICR) Mass Spectrometer APEX II & Xmass software (Bruker Daltonics) – 
4.7 T Magnet (Magnex) equipped with ESI source. 
 
2.4.2 Materials 
 
The commercially available reagents were used as received. While (R)- and (S)-1,1’-bi-(2-naphthol) 
(BINOL) is commercially available, 3,3’- methyl substituted BINOL derivative (3,3’-Me BINOL) and 
the corresponding phosphorochloridites (BINOL-PCl and 3,3’-Me BINOL-PCl) could be prepared 
from BINOL according to literature procedures which have been already described in Experimental 
Section of Chapter 4.   
Amines (+)-bis[(R)-1-phenylethyl]amine, (-)-bis[(S)-1-phenylethyl]amine, (R) or (S)-N-methyl-1-
phenylethanamine, (R)-N-benzyl-1-phenylethanamine, (R)-1-phenylethanamine, (S)-1-
cyclohexylethanamine, (S)-N-methyl-1-(naphthalen-1-yl)ethanamine, pyrrolidine, (R)-2-
methylpyrrolidine, (R)-2-methylpyrrolidine, (S)-2-(pyrrolidinecarbonyl)pyrrolidine are commercially 
available.  
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2.4.3 Hydrogenation experiments  
 
Note! Rh(cod)2BF4 is a very hygroscopic solid that in contact with the moisture of the air tends to 
become deliquescent and insoluble in organic solvents (and thus unsuitable for experiments of 
catalysis). For this reason it should be stored under nitrogen in a Schlenk tube (possibly at low 
temperature) and handled with care for limiting the contact with moisture as much as possible. 
 
General procedure for the hydrogenations at atmosphere pressure 
The reactions were performed using standard Schlenk techniques. Seven oven-dried glass test tubes 
with stirring bars were employed: in each one the ligand (0.022 equiv, 0.00922 mmol) or the mixture 
of ligands (0.011 equiv, 0.00461 mmol each) was weighted, and then the test tubes were placed in a 
Schlenk and subjected to three vacuum/nitrogen cycles. A 1.048 mM CH2Cl2 stock solution of 
[Rh(cod)2BF4] (4 mL, 0.01 equiv, 0.00419 mmol) was added and the mixtures were stirred for 30 min 
under nitrogen. A solution of the substrate (0.419 mmol) in CH2Cl2 (4 mL) was finally added. The 
reaction mixtures were subjected to three vacuum/hydrogen cycles and then left stirring overnight at 
room temperature under ambient H2 pressure. Samples were taken for chiral GC analysis. 
 
General procedure for hydrogenations at 25 bar hydrogen pressure in Parr multireactor 
with a computer-controlled FKVTM machine 
A Parr multireactor with a computer-controlled FKVTM machine allows six reactions in parallel under 
hydrogen pressure. La (0.011 equiv, 0.00407 mmol) and Lb (0.011 equiv, 0.00407 mmol) [or, 
alternatively, 0.022 mmol, 0.00814 mmol of a single ligand] were weighted in special glass vessels. 
The vessels were purged with nitrogen and a 0.462 mM CH2Cl2 stock solution of [Rh(cod)2BF4] (8 
mL, 0.01 equiv, 0.00370 mmol) was added in each one. After 30 min substrate (60 mg, 0.370 mmol, 1 
equiv) was added and the vessels were placed in the respective autoclaves and purged one time with 
argon and three times with H2 (5 bar). The reactions were stirred overnight under pressure of hydrogen 
and then analysed by chiral GC for conversion and e.e. determination. 
 
General procedure for the hydrogenations at 25 bar hydrogen pressure in the Premex A-96 
multireactor. 
Stock solutions of the ligands (0.05 M) were prepared in dry dichloromethane, and stored in a 
glovebox. A solution of [Rh(cod)2OTf] or [Ir(COD)Cl]2 in dry dichloromethane was prepared prior to 
use (0.025 M); the substrate was dissolved in the appropriate solvent (0.052 M). In a glovebox, 0.1 mL 
(5 × 10-3 mmol) of each of the stock solutions of ligands La and Lb were dispensed (using a Zinnser 
Lizzy robot) in the reaction vessels (96 vessels, in a 12 × 8 plate). After shaking for some 5 min, 0.09 
mL (2.25 × 10-3 mmol) of the stock solution of rhodium or iridium source were added. After shaking 
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for some 5 min, the solution of the substrate 2.3 mL (0.12 mmol) was added. The reactions were 
capped and hydrogenated overnight at the hydrogen pressure required. After completion, the reactors 
were opened and samples were analysed by chiral GC for conversion and e.e. determination. 
 
General procedure for the hydrogenations in the Argonaut Endeavor multireactor 
autoclave. 
 
The autoclave allowed eight hydrogenation reactions in parallel in glass vessels. La (0.011 mmol) and 
Lb (0.011 mmol) [or alternatively, 0.022 mmol of a single ligand], [Rh(cod)2OTf] (0.01 mmol, 4.06 
mg) or [Ir(COD)Cl]2 (5.1 × 10-3 mmol, 3.4 mg) were weighed in the reaction vessels. DCM (0.1 mL) 
was added and the resulting mixture is manually shaken until a solution is obtained (about 5-15 sec). 
The substrate stock solution in the appropriate solvent (5 mL, 0.4 mmol) was finally added. The 
vessels were placed in the reactor and the appropriate solvent was added (5 mL). The reaction vessels 
were then semi-automatically purged repeatedly with N2 and H2, before applying a hydrogen pressure 
and stirring. After completion of the reaction, the reactors were opened and samples were analysed by 
chiral GC for conversion and e.e. determination. 
 
Enantioselective hydrogenation of methyl 2-acetamidoacrylate 7 
The hydrogenation experiments were performed using standard Schlenk techniques at atmosphere 
pressure. GC conditions: capillary column: MEGADEX DACTBSβ, diacetyl-tert-butylsilyl-β-
cyclodextrin, 0.25 µm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; flow: 1 mL/min; oven 
temperature: 140 °C for 6 min, then a 8 °C/min gradient is applied): tsubstrate = 3.7 min; tR = 4.6 min; tS 
= 5.2 min. 
The retention times of the products (tR and tS) were matched to the corresponding enantiomers (R and 
S) on the basis of the results obtained with ligand (S)-2b, which has been reported to be highly R-
selective in the Rh-catalyzed hydrogenation of methyl 2-acetamidoacrylate.24 
 
Enantioselective hydrogenation of N-(1-phenylvinyl)acetamide 8 
The hydrogenation experiments were run in hydrogenations in Parr multireactor with a computer-
controlled FKVTM machine at 25 bar hydrogen pressure. GC conditions: capillary column: 
MEGADEX DACTBSβ, diacetyl-tert-butylsilyl-β-cyclodextrin, 0.25 µm; diameter = 0.25 mm; length 
= 25 m; carrier: hydrogen; flow: 1.3 mL/min; oven temperature: 160 °C for 8 min, then a 8 °C/min 
gradient is applied; tR = 6.7 min; tS = 6.9 min; tsubstrate = 8.6 min.  
The retention times of the products (tR and tS) were matched to the corresponding enantiomers (R and 
S) on the basis of the stereochemical preference of ligand (S)-2b, which has been reported to be highly 
R-selective in the Rh-catalyzed hydrogenation of N-(1-phenylvinyl)acetamide.25 
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Enantioselective hydrogenation of methyl 2-acetamidocinnamate 9 
The hydrogenation experiments were run in hydrogenations in the 96-Multireactor or in the Argonaut 
Endeavor multireactor autoclave at 25 bar hydrogen pressure. GC conditions: capillary column: CP-
Chirasil-l-Val, 0.25 µm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; flow: 1.3 mL/min; 
oven temperature: 160 °C for 8 min, then a 8 °C/min gradient is applied; tE1 = 7.82 min; tE2 = 8.27 
min; tsubstrate = 12.91 min.  
 
Enantioselective hydrogenation of methyl (Z)-3-acetamidocrotonate 10 
The hydrogenation experiments were run in hydrogenations in the 96-Multireactor at 25 bar hydrogen 
pressure. GC conditions: capillary column: CP-Chirasil-Dex-CB, 0.25 µm; diameter = 0.25 mm; 
length = 25 m; carrier: N2; flow: 1.0 mL/min; oven temperature: 160 °C isothermal; tE1 = 11.08 min; 
tE2 = 11.27 min. 
 
Enantioselective hydrogenation of methyl 3-N-acetylamino-2-phenyl-2-propenoate 11 
The hydrogenation experiments were run in hydrogenations in the 96-Multireactor at 25 bar hydrogen 
pressure. Enantiomeric access was not analysed due to low conversions.  
 
Enantioselective hydrogenation of 6,7-dimethoxy-1-methyl-3,4-dihydroxyisoquinoline 20 
The hydrogenation experiments were run in hydrogenations in the 96-Multireactor at 25 bar hydrogen 
pressure. The enantiomers were analyzed by HPLC using a chiral column: CHIRALCEL OD-H, 250 
mm × 4.6 mm, ID 5 µm; eluent: n-heptane/2-propanol/DEA, 95:5:0.05; flow 1.5 mL/min; temperature 
45 oC; Vinj = 5 µL, λ =  254 nm; Run time 20 min; tsubstrate = 6.3 min; tE1 = 8.78 min; tE2 = 10.45 min. 
 
2.4.4 Palladium-catalyzed allylic alkylation 
 
[Pd(η3C3H5)Cl]2 (2.81 mg, 0.0077 mmol) and the ligand (0.0311 mmol) or mixture of ligands (0.0155 
mmol each) were dissolved under nitrogen in degassed CH2Cl2 (1.0 mL). The resulting clear solution 
was stirred for 20 min at RT, then a solution of rac-1,3-diphenyl-3-acetoxyprop-1-ene (129 mg, 0.51 
mmol) in degassed CH2Cl2 (1.0 mL), dimethyl malonate (170 µL, 1.5 mmol), N,O-bis(trimethylsilyl)-
acetamide (BSA, 370 µL, 1.5 mmol), and a pinch of AcOK were added. The reaction mixture was 
stirred at room temperature. After 1h the solution was diluted with Et2O (5 mL) and saturated aqueous 
NH4Cl (25 mL) was added. The phases were separated and the aqueous phase was extracted with Et2O 
(2 × 5 mL). The combined organic phases were dried over Na2SO4 and the solvent was removed under 
reduced pressure. Conversion was determined by 1H NMR analysis of the crude reaction mixture. An 
aliquot of the crude was passed through a pad of silica using 5:1 hexane/EtOAc as the eluent. The 
solvents were removed under vacuum and the residue was directly analyzed by HPLC for the 
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determination of the enantiomeric excess. HPLC conditions: column: CHIRALCEL OD-H; eluent: 
99:1 hexane/isopropanol; flow: 0.3 mL/min; λ = 250 nm; tR = 24 min, tS = 26 min. 
 
2.4.5 Synthesis of hydrogenating substrates 
 
Acetophenone oxime 
 
A mixture of acetophenone (11.7 mL, 100 mmol), hydroxylamine hydrochloride (14.8 
g, 213 mmol), and pyridine (15 mL) in ethanol (abs. 150 mL) was refluxed for 3 h and 
subsequently the ethanol was removed under vacuum. While stirring vigorously in an 
ice-bath, ice water (150 mL) was added upon which the oxime crystallized from the solution. These 
crystals were filtrated, washed with ice water (50 mL) and dried. The product was quantitatively 
isolated as a white solid, and was used in the next step without further purification. 1H NMR (400 
MHz, CDCl3) ppm δ 9.84 (s, 1H), 7.69 (dd, J = 6.6 Hz, J = 3.0 Hz, 2H), 7.44 (dd, J = 5.0 Hz, J = 1.8 
Hz, 3H), 2.38 (s, 3H). 13C NMR (100 MHz, APT, CDCl3) ppm δ 156.8 (Cq), 137.2 (Cq), 130.0 (CH), 
129.3 (2×CH), 126.8 (2×CH), 13.2 (CH3). 
 
N-(1-Phenylvinyl)acetamide (8) 
 
To toluene (45 mL) was added acetophenone oxime (21, 4.06 g, 30 mmol), acetic 
anhydride (8.5 mL, 90 mmol), acetic acid (5.1 mL, 90 mmol) and iron powder -325 
mesh (3.36 g, 60 mmol). This mixture was stirred at 70 °C for 4 hours, then allowed to 
cool down to room temperature and filtered over Celite and subsequently washed with 
toluene (2 × 30 mL). The filtrate was washed with 2N NaOH (2 × 45 mL), dried over MgSO4 and 
evaporated in vacuo. The product was purified by column chromatography on silica using 
EtOAc:hexane 2:1 as the eluent. The product was obtained as a slightly yellow solid (3.1 g, 64 %). 1H 
NMR (400 MHz, CD3CN) ppm δ 7.89 (bs, 1H), 7.54 – 7.47 (m, 2H), 7.46 – 7.36 (m, 3H), 5.68 (s, 
1H), 5.05 (s, 1H), 2.05 (s, 3H). 13C NMR (101 MHz, APT, CD3CN) ppm δ 170.1 (Cq), 142.5 (Cq), 
138.9 (Cq), 129.1 (2×CH), 126.89 (CH), 118.01 (Cq), 102.33 (Cq), 23.93 (CH3). 
 
Methyl (Z)-3-acetamidocrotonate (10) 
 
To a solution of methylacetoacetate (5.6 mL, 51.67 mmol) in dry benzene (52 mL) 
were added acetamide (6.1 g, 103.34 mmol) and para-toluensulfonic acid (30.5 mg, 
0.16 mmol), and the mixture was refluxed using Dean Stark condenser for 36 h. The raction mixture 
was then filtered, concentrated in vacuo, diluted with water (150 mL) and extrected  into ether (3×150 
mL). After extraction solvent was evaporated and the crude mixture was purified by column 
chromatography on silica using EtOAc:hexane 4:1 as the eluent. The product was obtained as a whith 
N
OH
HN O
O
NH OAc
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solid (3.72 g, 46 %). 1H NMR (400 MHz, CDCl3) ppm δ 11.11 (bs, 1H), 4.92 (d, J = 0.9 Hz, 1H), 3.71 
(s, 3H), 2.39 (d, J = 0.9 Hz, 3H), 2.16 (s, 3H). MS (ESI +): calcd. for C7H11NO3: 157.07, found: 
158.38 [M+H]+
.
 
 
Methyl 3-oxo-2-phenylpropanoate 
 
A NaH 60% suspention (2 mol) was added over a period of 45 min at RT with 
stirring and under a dry N2 stream to a solution of the methylphenylacetate (7.2 
mL, 0.5 mol) in methyl formate (80 mL, 9.9 mol). The reaction mixture was stirred 
at RT for 4 hours and then added to 0.1 M HCl (310 mL) solution. After extraction with Et2O (2 × 150 
mL), the organic layer was anhydrified with Na2SO4, and then the solvent was removed under reduced 
pressure. The crude product was purificated by distillation (2-3 mbar pressure, 135 oC) and 
quantitatively obtained as yellowish oil. 1H NMR (400 MHz, CDCl3) showed a 1:5 mixture of aldol–
enol tautomers. Aldo tautomer: ppm δ 9.81 (d, J = 2.8 Hz, 1H), 7.45 – 7.28 (m, 5H), 4.53 (d, J = 2.8 
Hz, 1H), 3.82 (s, 3H); Enol tautomer: ppm δ 12.05 (d, J = 12.7 Hz, 1H), 7.38 – 7.27 (m, 6H), 3.82 (s, 
3H). 
 
Methyl 3-N-acetylamino-2-phenyl-2-propenoate [Z-11 and E-11) 
 
A mixture of formyl ester reported above (9.15 g, 51.4 
mmol), acetamide (6.08 g, 102.8 mmol) and a catalytic 
amount of para-toluenesulfonic acid in toluene (100 mL) 
was heated at reflux with a Dean–Stark apparatus under a nitrogen atmosphere for 3.5 h. At the end of 
the reaction period, the reaction mixture was allowed to cool to room temperature and the excess 
acetamide filtered and thoroughly washed with toluene. The filtrate was evaporated under reduced 
pressure to give an isomeric mixture of the enamide 11. Purification by flash chromatography on silica 
using EtOAc : hexane 1:4 as the eluent 1) first gave the (Z)-enamide Z-11 a as a white solid (2.32 g, 
19%). 1H NMR (400 MHz, CDCl3) ppm δ 10.72 (br d, J = 9.6 Hz, 1H), 7.64 (d, J = 11.4 Hz, 1H), 7.4 
– 7.28 (m, 5H), 3.80 (s, 3H), 2.23 (s, 3H). 13C NMR (101 MHz, APT, CDCl3) ppm δ 169.6 (Cq), 168.8 
(Cq), 138.2 (CH), 136.4 (Cq), 129.9 (2×CH), 128.5 (2×CH), 127.7 (CH), 111.4 (Cq), 52.2 (CH3), 24.2 
(CH3). The (E)-isomer E-11 was then eluted and isolated as a white solid (4 g, 31%). 1H NMR (400 
MHz, CDCl3) ppm δ 8.29 (d, J = 12.2 Hz, 1H), 7.48 (t, J = 7.4 Hz, 3H), 7.40 (t, J = 7.4 Hz, 1H), 7.31-
726 (m, 2H), 3.78 (s, 3H), 2.04 (s, 3H). MS (ESI +): calcd. for C12H13NO3: 219.09, found: 220.28 
[M+H]+. 
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2.4.6 General procedure for the preparation of BINOL-derived phosphite 
ligands 
 
Phenol and menthol were used as received. The other alcohols (liquid at RT) were anhydrified over 3 
Å molecular sieve beads. 
To a solution of the corresponding alcohols or phenol (1.1 equiv) and triethylamine (3 equiv) in THF 
(8 mL/mmol of BINOL-PCl or 3,3’-Me BINOL-PCl) BINOL-PCl or 3,3’-Me BINOL-PCl (1 equiv) 
was added as a solid at RT. The reaction was stirred overnight and then filtered through a pad of celite. 
The solvent was evaporated under reduced pressure to afford a white foam. The crude was purified by 
column chromatography on silica gel (typical eluent: neat DCM). The phosphites are less polar than 
the impurities, thus were eluted as the first fraction. 
 
(R)- and (S)-4-phenoxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine [(R)-2a and (S)-
2a] 
 
The product was prepared according to the General Procedure using (S)- 
BINOL-PCl (400 mg, 1.14 mmol), phenol (118 mg, 1.25 mmol), and 
triethylamine (0.47 mL, 3.42 mmol). It was purified by column 
chromatography on silica gel (eluent: DCM) to afford a white solid. Yield = 
91%. 1H-NMR (400 MHz, CDCl3) ppm δ 8.03 (d, J = 8.8 Hz, 1H), 7.95 (d, J = 8.3 Hz, 1H), 7.85 (d, J 
= 8.8 Hz, 1H), 7.66 (d, J = 8.8 Hz, 1H,), 7.59 (d, J = 8.7 Hz, 1H,), 7.48- 7.38 (m, 6H), 7.31- 7.23 (m, 
4H), 7.17 (d, J = 7.53 Hz, 1H), 6.70 (d, J = 8.6 Hz, 1H). 13C-NMR (100 MHz, CDCl3) ppm δ 150.4, 
149.0, 139.3, 133.2, 132.4, 131.8, 131.1, 130.7, 129.8, 128.8, 128.5, 127.3, 126.6, 125.3, 122.7, 121.9. 
31P-NMR (162 MHz, CDCl3) ppm δ 185.0. [α]24D = for S enantiomer: +221.6 (CH2Cl2, c = 1). FT-IR 
(film): ν = 3054, 1587, 1228, 948, 819, 743 cm-1. MS (ESI +): calcd. for C26H17O3P: 408.09, found: 
409.23 [M+H]+. MP = 164-166°C. 
 
(R)- and (S)-4-isopropoxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine [(R)-2b and 
(S)-2b] 
The product was prepared according to the General Procedure using (R)- or 
(S)-BINOL-PCl (400 mg, 1.14 mmol), iso-propanol (95 µL, 1.25 mmol), and 
triethylamine (0.47 mL, 3.42 mmol). It was purified by column 
chromatography on silica gel (eluent: DCM) to afford a white solid. Yield = 
91%. 1H-NMR (400 MHz, CD2Cl2) ppm δ 7.97-7.89 (m, 4H), 7.51 (d, J = 8.6 Hz, 1H), 7.44-7.34 (m, 
5H), 7.24 (t, J = 7.6 Hz, 2H), 4.58-4.47 (m, 1H), 1.31 (dd, J = 6.2 Hz, 12.8 Hz, 6H). 13C-NMR (100 
MHz, CD2Cl2) ppm δ 148.72, 148.10, 133.19, 131.69, 130.42, 128.72, 127.45, 126.56, 125.31, 122.26, 
69.96, 25.01. 31P-NMR (162 MHz, CD2Cl2) ppm δ 147.3. [α]25D = for R enantiomer: -254.7 (CH2Cl2 c 
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= 0.1). FT-IR (film): ν = 3054, 2967, 1588, 1212, 938, 746 cm-1. HRMS: calcd for C23H19O3P: 
374.1145, found: 375.1179 [M+H]+. MP = 80-82°C. 
 
(R)-4-(cyclohexyloxy)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine [(R)-2c] 
 
The product was prepared according to the General Procedure using (R)-
BINOL-PCl  (400 mg, 1.14 mmol), cyclohexanol (130 µL, 1.25 mmol), and 
triethylamine (0.47 mL, 3.42 mmol). It was purified by column 
chromatography on silica gel (eluent: DCM) to afford a white solid. Yield = 
90%. 1H-NMR (400 MHz, CD2Cl2) ppm δ 8.04 (d, J = 8.9 Hz, 1H,), 8.01-7.98 (m, 3H,), 7.56 (d, J = 
8.8 Hz, 1H), 7.50-7.44 (m, 3H), 7.40-7.36 (m, 2H), 7.33-7.29 (m, 2H), 4.28 (m, 1H), 2.05-1.94 (m, 
2H), 1.82-1.73 (m, 2H), 1.64-1.50 (m, 3H), 1.38-1.20 (m, 3H). 13C-NMR (100 MHz, CD2Cl2) ppm δ 
149.0, 148.3, 132.2, 131.7, 131.0, 130.4, 129.0, 128.9, 127.4, 127.3, 126.9, 126.8, 125.7, 125.5, 123.4, 
122.7, 122.5, 122.4, 75.4 (d, JC,P = 13 Hz), 35.3, 35.0, 25.8, 24.5. 31P-NMR (162 MHz, CDCl3) ppm δ 
149.4. [α]25D = -303 (CH2Cl2, c = 1). FT-IR (film): ν = 3057.6, 2934.2, 2858.0, 1618.9, 1508.1, 
1462.7, 1231.3, 944.9, 866.8 cm-1. MS (ESI +): calcd. for C26H23O3P : 414.15, found: 415.31 [M+H]+. 
MP = 78-80°C. 
 
(R)-4-isopropoxy-2,6-dimethyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine [(R)-2d] 
 
The product was prepared according to the General Procedure using (R)-3,3’-
Me BINOL-PCl (240 mg, 0.63 mmol), iso-propanol (55 µL, 0.70 mmol), and 
triethylamine (0.26 mL, 1.88 mmol). It was purified by column 
chromatography on silica gel (eluent: DCM) to afford a white solid. Yield = 
83%. 1H-NMR (400 MHz, CD2Cl2) ppm δ 7.92-7.89 (m, 3H), 7.87 (s, 1 H), 7.44 (m, 2 H), 7.29-7.20 
(m, 4 H), 4.59 (m, 1 H), 2.66 (d, J = 0.6 Hz, 3 H), 2.62 (d, J = 0.6 Hz, 3 H), 1.38 (d, J = 6.1 Hz, 3 H), 
1.33 (d, J = 6.2 Hz, 3 H). 13C-NMR (100 MHz, CD2Cl2) ppm δ 148.8, 147.7, 132.3, 132.1, 131.7, 
131.0, 130.4, 130.1, 128.3, 128.2, 127.4, 127.3, 125.9, 125.8, 125.6, 125.5, 124.9, 124.9, 123.4, 79.9 
(d, JC,P = 14.4 Hz), 25.2, 25.0, 18.3, 17.8. 31P-NMR (162 MHz, CD2Cl2) ppm δ 148.2. [α]22D = -547.6 
(CHCl3, c = 1). FT-IR (KBr): ν = 3057.6, 3025.8, 2967.0, 2924.5, 1492.6, 1454.1, 1433.8, 1091.5, 
1071.3, 1026.0, 914.1, 883.2 cm-1. HRMS (ESI +): calcd. for C25H23O3P: 402.12770, found: 
425.12718 [M + Na]+. MP = 65°C. (dec). 
 
(R)-4-tert-butoxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine [(R)-2e] 
 
 
The product was prepared according to the General Procedure using (S)-
BINOL-PCl (400 mg, 1.14 mmol), tert-butanol (120 µL, 1.25 mmol), and 
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triethylamine (0.47 mL, 3.42 mmol). It was purified by column chromatography on silica gel (eluent: 
DCM) to afford a white solid. Yield = 83%. 1H-NMR (400 MHz, CD2Cl2) ppm δ 8.03 (d, J = 8.7 Hz, 
1H), 8.01-7.98 (m, 3H), 7.55 (d, J = 8.9 Hz, 1H), 7.50-7.45 (m, 2H), 7.42 (d, J = 8.7 Hz, 1H), 7.40-
7.36 (m, 2H), 7.33-7.28 (m, 2H), 1.57 (br s, 9H). 13C-NMR (100 MHz, CD2Cl2) ppm δ 148.7, 148.1, 
133.5, 133.3, 132.2, 131.8, 130.9, 130.3, 129.1, 129.0, 127.5, 127.4, 126.9, 126.8, 125.7, 125.5, 125.0 
(d, JC,P = 5.3 Hz), 123.8 (d, JC,P = 3.7 Hz), 123.1, 122.6, 79.5 (d, JC,P = 10.0 Hz), 31.7 (d, JC,P = 8.3 
Hz). 31P-NMR (162 MHz, CD2Cl2) ppm δ 154.8. [α]22D = -332 (CH2Cl2, c = 1). FT-IR (film): ν = 
3050.3, 2975.6, 1589.1, 1463.7, 1369.2, 1202.0, 1172.5, 932.4, 826.3 cm-1. HRMS (ESI +): calcd. for 
C24H21O3P: 488.11205, found: 411.11248 [M+Na]+. MP = 125-126°C. 
 
(R)-4-((1S,2R,5S)-2-isopropyl-5-methylcyclohexyloxy)dinaphtho[2,1-d:1',2'f][1,3,2] 
dioxaphosphepine [(R)-2f] 
 
The product was prepared according to the General Procedure using (R)-
BINOL-PCl (400 mg, 1.14 mmol), (+)-menthol (178 mg, 1.25 mmol), and 
triethylamine (0.47 mL, 3.42 mmol). It was purified by column 
chromatography on silica gel (eluent: DCM) to afford a white solid. Yield 
= 92%. 1H-NMR (400 MHz, CD2Cl2) ppm δ 8.05 (d, J = 8.8 Hz), 8.03-
7.99 (3H, m), 7.68 (1H, d, J = 8.8 Hz), 7.58 (1H, d, J = 8.8 Hz, 1H) -7.51-7.47 (m, 2H), 7.45 (d, J = 
8.8 Hz, 1H,), 7.39 (m, 2H), 7.33-7.29 (m, 2H), 4.19 (ddt, J = 4.8 Hz, J = 8.7 Hz, J = 10.7 Hz, 1H), 
2.40 (m, 1H), 2.17 (m, 1H), 1.77-1.69 (m, 2H), 1.54-1.39 (m, 2H), 1.24 (m, 1H), 1.10 (dt, J = 3.3 Hz, J 
=12.5 Hz, 1H), 1.04 (d, J = 7.0 Hz, 3H), 0.98 (d, J = 6.5 Hz, 3H), 0.96 (d, J = 6.8 Hz, 3H), 0.90 (m, 
1H). 13C-NMR (100 MHz, CD2Cl2) ppm δ 148.9, 148.4, 133.5, 133.2, 130.9, 130.3, 129.1, 129.0, 
127.4, 126.9, 126.8, 125.7, 125.6, 123.5, 122.7, 122.5, 77.7 (d, JC,P = 16.2 Hz), 49.3, 44.8, 34.7, 32.4, 
26.1, 23.5, 22.4, 21.5, 16.2. 31P-NMR (162 MHz, CDCl3) ppm δ 154.1. [α]25D = -347 (CH2Cl2, c = 1). 
FT-IR (film): ν = 3056.6, 2955.4, 2923.6, 2868.6, 1618.9, 1590.0, 1508.1, 1462.7, 1201.4, 945.9, 
824.4 cm-1. HRMS (ESI +): calcd. for C30H31O3P: 470.20836, found: 471.20855 [M+H]+. MP = from 
188°C with dec. 
2.4.7 Synthesis of phosphinamine ligands 
 
1,1-diphenyl-N,N-bis((R)-1-phenylethyl)phosphinamine and 1,1-diphenyl-N,N-bis((S)-1-
phenylethyl)phosphinamine [(R,R)-6a or (S,S)-6a] 
 
To a stirred solution of (+)-bis[(R)-1-phenylethyl]amine or (-)-bis[(S)-1-
phenylethyl]amine (0.220 mL, 0.96 mmol, 1 equiv) in THF (5 mL) at -78°C, a 1.6 
M solution of n-BuLi in hexanes (0.60 mL, 0,96 mmol, 1 equiv) was added. The 
reaction mixture was stirred at -78°C for 10 min, then allowed to warm to RT. 
After stirring for 2 h, the mixture was cooled back to -78°C and a solution of 
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chlorodiphenylphosphine (0.170 mL, 0,96 mmol) in THF (3 mL) was slowly added dropwise. The 
reaction mixture was allowed to warm to RT and it was stirred overnight. After reaction the solvent 
was evaporated and the crude product was purified by column chromatography on silica gel to afford a 
white solid in 31% yield (eluent: 9:1 hexane / DCM). CAS for (R,R) 1176789-48-2, for (S,S) 959680-
39-8. 1H-NMR (400 MHz, C6D6) ppm δ 7.88-7.84 (m, 2H), 7.38-7.34 (m, 2H), 7.29-7.23 (m, 3H), 
7.17-7.08 (m, 13H), 4.63 (sext, J = 7.0 Hz, 2H), 1.51 (d, J = 6.8 Hz, 6H). 13C-NMR (100 MHz, C6D6) 
ppm δ 144.8, 140.5, 140.4, 140, 134.3, 134.1, 132.7, 132.6, 129.1, 128.7, 128.6, 128.57, 128.55, 
128.3, 128.2, 128.1, 127.9, 127, 56.8, 56.7, 21.9, 21.8. 31P-NMR (162 MHz, C6D6) ppm δ 42.4. [α]25D 
= for the S,S enantiomer: -233 (CHCl3, c = 1). FT-IR (film): ν = 3057.2, 2967.5, 2928.5, 1585, 1494, 
1435.1, 1275.7, 1200.6, 1118.3, 1089.3, 742.9, 697.2 cm-1. HRMS (ESI +): calcd  = 410.2037, found = 
410.2028. MP = 56-57°C. 
 
2.4.7.1 Synthesis of non-commercial chiral amines 
 
(S)-N-boc-2-(pyrrolidinecarbonyl)pyrrolidine (3a) 
 
To a stirred solution of N-Boc-L-proline (500 mg, 2.32 mmol, 1 equiv) in CHCl3 (20 
mL) at 0°C, EDC (490 mg, 2.55 mmol, 1.1 equiv) and HOBT·H2O (400 mg, 2.55 
mmol, 1.1 equiv) were added in the order. After 5 min pyrrolidine (0.214 mL, 2.55 
mmol, 1.1 equiv) was added and the mixture was stirred for 10 min at 0°C and then overnight at RT. 
The solution was washed with 1 M HCl aqueous solution (2 × 20 mL) and then with NaHCO3 
saturated aqueous solution (2 × 20 mL). The organic layer was anhydrified with Na2SO4, and then the 
solvent was removed under reduced pressure to afford pale yellow oil. The product was used in the 
next step without further purification. Yield = 96%. 1H-NMR (400 MHz, CDCl3): mix of rotamers, 
ppm δ 4.5 (dd, J = 2.3 Hz, J = 7.3 Hz, 0.5H), 4.37 (dd, J = 5.2 Hz, J = 7.7 Hz, 0.5H), 3.75 (m, 0.5 H), 
3.66-3.41 (m, 5.5H), 2.27-1.73 (m, 8H), 1.48 (s, 4.5H), 1.42 (s, 4.5H). 
 
(S)-N-boc-2-(diethylaminocarbonyl)pyrrolidine (3b) 
 
To a stirred solution of N-Boc-L-proline (500 mg, 2.32 mmol, 1 equiv) in CHCl3 (20 
mL) at 0°C EDC (490 mg, 2.55 mmol, 1.1 equiv) and HOBT·H2O (400 mg, 2.55 
mmol, 1.1 equiv) were added in the order. After 5 min diethylamine (0.266 mL, 2.55 
mmol, 1.1 equiv) was added dropwise and the mixture was stirred at 0°C for 10 min and then 
overnight at RT. The solution was washed with 1 M HCl aqueous solution (2 × 20 mL) and then with 
NaHCO3 saturated aqueous solution (2 × 20 mL). The organic layer was anhydrified with Na2SO4, 
filtered and the solvent was removed under reduced pressure to afford a colourless solid which was 
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used in the next step without further purification. Yield = 76%. 1H-NMR (400 MHz, CDCl3): mixture 
of rotamers, ppm δ 4.61 (br d, J = 5.6 Hz, 0.4H), 4.47 (dd, J = 3.2 Hz, J = 8.0, 0.6H), 3.67-3.41 (m, 
6H), 2.23-2.02 (m, 2H), 1.91-1.81 (m, 2H), 1.47 (s, 4.5H), 1.43 (s, 4.5H), 1.25 (m, 3H), 1.13 (m, 3H). 
 
(S)-N-Cbz-2-(diciclohexylaminocarbonyl)pyrrolidine (3c) 
 
To a solution of N-Cbz-L-prolinyl chloride 5 (470 mg, 1.76 mmol, 1 equiv) and 
DMAP (a crystal) in THF (10 mL) a solution of dicyclohexylamine (0.37 mL, 
1.86 mmol, 1.05 equiv) and TEA (1 mL, 7.08 mmol, 4 equiv) in THF (10 mL) 
was added. The resulting mixture was refluxed overnight. THF was removed and 
the residue was redissolved in DCM, and then washed with water and anhydrified before removing the 
solvent. The crude was purified by flash chromatography (eluent DCM/AcOEt from 95:5 to 70:30) to 
afford the desired product as a white solid. Yield = 88%. 1H-NMR (300 MHz, CDCl3): mix of 
rotamers, ppm δ 7.3 (m, 5H), 5.1 (m, 2H), 4.7 (m, 0.5H), 4.5 (m, 0.5H,), 3.7-3.4 (m, 4H), 2.2-0.9 (m, 
24H). 
 
(S)-2-(pyrrolidinecarbonyl)pyrrolidine (4a) 
 
At 0°C, TFA (3mL, 39 mmol, 18 equiv) was added to a solution of N-boc-
prolinamide (S)-N-boc-2-(pyrrolidinecarbonyl)pyrrolidine 3a (590 mg, 2.2 mmol, 1 
equiv) in DCM (5 mL). The mixture was stirred for 3 h at RT, then the volatiles were 
removed to afford a yellow oil. The crude was dissolved in DCM (5 mL), Amberlyst A21 resin was 
added and the mixture was stirred overnight, then filtered. The solvent was evaporated to afford 
brown-yellow oil in quantitative yield. CAS 41721-00-0.  1H-NMR (400 MHz, CDCl3) ppm δ 7.11 (br 
s, 1H), 4.77 (m, 1H), 3.65-3.36 (m, 6H), 2.54 (m, 1H), 2.17 (m,1H), 2.11-1.95 (m, 6H). 
 
(S)-2-(diethylaminocarbonyl)pyrrolidine (4b) 
 
TFA (3mL, 39 mmol, 22 equiv) was added to a solution of N-boc-diethyl-
prolinamide 3b (480 mg, 1.8 mmol, 1 equiv) in DCM (5 mL) kept at 0°C. The 
mixture was stirred for 3 h at RT, and then the volatiles were removed to afford a 
yellow oil. The crude oil was dissolved in DCM (5 mL), Amberlyst A21 resin was added and the 
mixture was stirred overnight, then filtered and the solvent was evaporated to afford a pale-yellow oil 
in quantitative yield. CAS 41721-01-1. 1H-NMR (300 MHz, CDCl3) ppm δ 4.81 (m, 1H), 3.69-3.31 
(m, 6H), 2.52 (m, 1H), 2.28-1.90 (m, 3H), 2.11-1.95 (m, 6H). 
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(S)-2-(diciclohexylaminocarbonyl)pyrrolidine (4c) 
 
5% Pd/C (320 mg, 0.15 mmol) was added to a solution of (S)-N-Cbz-2-
(dicyclohexylaminocarbonyl)pyrrolidine 3c (620 mg, 1.50 mmol) in MeOH (15 
mL). The resulting suspension was subjected to three vacuum/hydrogen cycles 
and then reacted overnight under 1 bar of hydrogen pressure. The catalyst was 
filtered off through a celite pad and the solvent was evaporated to afford a clean oil in quanitative 
yield, which was used in the next step without purification. 1H-NMR (300 MHz, CDCl3): mixture of 
rotamers, ppm δ 4.2 (m, 0.5H), 4.1 (m, 0.5H), 3.7-3.4 (m, 4H), 2.2-0.9 (m, 24H). 
 
N-Cbz-L-prolinyl chloride (5) 
 
Oxalyl chloride (0.265 mL, 3.03 mmol, 1.71 equiv) was slowly added dropwise to a 
stirred solution of N-Cbz-L-proline (446 mg, 1.77 mmol, 1 equiv) and DMF (2 drops) 
in DCM (6 mL), kept at 0°C. The mixture was allowed to reach RT and stirred for 5 h, 
and then the volatiles were removed at rotavapor and under high vacuum to afford N-Cbz-L-prolinyl 
chloride 5. CAS 61350-60-5. The product was used in the next step without purification. 
 
2.4.7.2 Preparation of C1-symmetric dipheylphosphinamines 
 
General procedure 
Chlorodiphenylphosphine (0.7 mL, 830 mg, 3.76 mmol, 1 equiv) was added dropwise to a stirred 
solution of the selected primary or secondary amine (4.70 mmol, 1.25 equiv) and Et3N (0.68 mL, 4.89 
mmol, 1.3 equiv) in benzene (10 mL). The mixture was stirred overnight and then dry hexane (10 mL) 
was added for favouring the precipitation of the ammonium salt. The obtained suspension was filtered 
under nitrogen through a short pad of celite. The filtrate was concentrated at rotavapor to give the 
crude product, which was purified by column chromatography using short pads of neutral alumina as 
the stationary phase. Eluent mixtures containing 2-5% Et3N had to be used in order to prevent product 
degradation in the column. Similarly, for preventing product degradation on the alumina plates (and 
thus unreliability of the TLC analysis), they had to be pre-eluted with eluent mixtures containing Et3N 
(1-2%). 
The phosphinamine ligands showed a moderate tendency to undergo oxidation by atmospheric oxygen 
when in solution. They proved fairly stable in the solid state. 
 
(R)-and (S)-N-methyl-1,1-diphenyl-N-(1-phenylethyl)phosphinamine [(R)-6b and (S)-6b] 
 
The product was prepared according to the General Procedure  using (R) or (S)-
N-methyl-1-phenylethanamine (700 µL, 4.70 mmol), chlorodiphenylphosphine 
(0.7 mL, 3.76 mmol) and triethylamine (0.68 mL, 4.89 mmol). It was purified 
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by column chromatography on neutral alumina (eluent: hexane / CH2Cl2 / TEA 9:1:0.3) to afford a 
white solid. CAS for enantiomer S 52364-43-9, for enantiomer R 76152-62-0. Yield = 84%. 1H-NMR 
(400 MHz, CD2Cl2) ppm δ 7.46-7.26 (m, 15H), 4.67 (qd, JH,P = 10.7 Hz, JH,H = 7.0 Hz, 1H), 2.27 (d, 
JH,P = 2.9 Hz, 3H), 1.63 (d, JH,H = 7.0Hz, 3H). 13C-NMR (100 MHz, CD2Cl2) ppm δ 144.6 (d, JC,P = 
6.0 Hz), 140.4, 140.3, 133.1, 132.9, 132.5, 132.3, 129.0, 128.7, 128.1, 127.4, 64.2 (d, JC,P = 38.7 Hz), 
32.3 (d, JC,P = 9.7 Hz), 19.6 (d, JC,P = 9.8 Hz). 31P-NMR (162 MHz, CD2Cl2) ppm δ 61.0. [α]25D = for 
the S enantiomer: +88.0 (CH2Cl2, c = 1). FT-IR (film): ν = 3067.2, 2969.8, 2872.5, 1952.6, 1585.2, 
1432.8, 1200.4, 1155.2, 919.8 cm-1. MS (ESI +): calcd. for C21H22NP: 319.17, found: 320.38 [M+H]+. 
MP = 42-43 °C. 
 
(R)-N-benzyl-1,1-diphenyl-N-(1-phenylethyl)phosphinamine [(R)-6c] 
 
The product was prepared according to the General Procedure using (R)-N-
benzyl-1-phenylethanamine (980 µl, 4.70 mmol), chlorodiphenylphosphine (0.7 
mL, 3.76 mmol) and triethylamine (0.68 mL, 4.89 mmol). It was purified by 
column chromatography on neutral alumina (eluent: hexane / CH2Cl2 / TEA 
9:1:0.3) to afford a colourless oil which crystallized on standing givinig a white solid. Yield = 52%. 
CAS 1176789-49-3. 1H-NMR (400 MHz, CD2Cl2) ppm δ 7.58 (m, 2 H), 7.42-7.22 (m, 14 H), 7.12 (m, 
2 H), 6.97 (dd, J = 2.1 Hz, J = 7.7 Hz, 2 H,), 4.20 (d, JAB = 15.1 Hz, 1 H), 4.15 (dq, JH,H = 7.1 Hz, JH,P 
= 18.0 Hz, 1H), 4.06 (d, JAB = 15.1 Hz, 1 H), 1.71 (d, J = 7.1 Hz, 3 H). 13C-NMR (100 MHz, CD2Cl2) 
ppm δ 141.3, 141.1, 140.3, 133.8, 133.5, 132.7, 132.5, 129.3, 129.0, 128.9, 128.8, 128.7, 128.5, 128.5, 
128.3, 128.3, 127.7, 127.5, 58.0 (d, JC,P = 25.4 Hz), 54.1 (d, JC,P = 9.2 Hz), 21.7 (d, JC,P = 18.4 Hz). 
31P-NMR (162 MHz, CDCl3) ppm δ 44.8 . [α]22D = +88.6 (CH2Cl2, c = 1). FT-IR (film): ν = 3051.8, 
2974.7, 2925.5, 1240.0, 973.9, 879.4 cm-1. HRMS (ESI +): calcd. for C27H26NP 395.18756, found: 
396.18804 [M+H]+. MP = 62-63°C. 
 
(R)-1,1-diphenyl-N-(1-phenylethyl)phosphinamine [(R)-6d] 
 
The product was prepared according to the General Procedure using (R)-1-
phenylethanamine (600 µL, 4.70 mmol), chlorodiphenylphosphine (0.7 mL, 
3.76 mmol) and triethylamine (0.68 mL, 4.89 mmol). It was purified by column 
chromatography on neutral alumina (eluent: hexane / CH2Cl2 / TEA 9:1:0.3) to 
afford a clean oil. Yield = 87%. CAS 66067-96-7. 1H-NMR (400 MHz, CD2Cl2) ppm δ 7.85-7.19 (m, 
15H), 4.40 (m, 1H), 2.45 (br s, 1H), 1.56 (d, JH,H = 6.9 Hz, 3H). 13C-NMR (100 MHz, CD2Cl2) ppm δ 
147.6 (d, JC,P = 4.6 Hz), 143.4 (d, JC,P = 14.4 Hz), 143.2 (d, JC,P = 12.0 Hz), 131.83, 131.78, 131.64, 
131.60, 129.09, 129.02, 128.96, 128.90, 128.84, 127.4, 127.0, 57.3 (d, JC,P = 23.5 Hz), 26.5 (d, JC,P = 
7.3 Hz). 31P-NMR (162 MHz, CD2Cl2) ppm δ 36.0. [α]25D = +6.5 (CH2Cl2, c = 0.8). FT-IR (film): ν = 
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3362.3, 3289.0, 3065.3, 2966.9, 2866.7, 1952.6, 1585.2, 1433.8, 1369.2, 1203.6, 1026.9, 943.9, 
828.3.740.5 cm-1. MS (ESI +): calcd. for C20H20NP: 305.14, found: 306.18 [M+H]+.  
 
(S)-N-(1-cyclohexylethyl)-1,1-diphenylphosphinamine [(S)-6e] 
 
The product was prepared according to the General Procedure using (S)-1-
cyclohexylethanamine (720 µ, 4.70 mmol), chlorodiphenylphosphine (0.7 mL, 
3.76 mmol) and triethylamine (0.68 mL, 4.89 mmol). It was purified by column 
chromatography on neutral alumina (eluent: hexane / CH2Cl2 / TEA 9:1:0.3) to 
afford a clean oil. Yield = 75%. CAS 1176789-50-6. 1H-NMR (400 MHz, 
CD2Cl2) ppm δ 7.45-7.31 (m, 10H), 3.05 (m, 1H), 1.92-0.97 (m, 15H). 13C-NMR (100 MHz, CD2Cl2) 
ppm δ 144.8 (d, JC,P = 12.8 Hz), 144.2 (d, JC,P = 11.1 Hz), 131.6, 131.5, 131.4, 131.3, 128.85, 128.81, 
128.79, 128.75, 59.0 (d, JC,P = 24.9 Hz), 46.3 (d, JC,P = 6.3 Hz), 30.1, 29.4, 27.4, 27.2, 27.1, 21.3 (d, 
JC,P = 5.9 Hz). 31P-NMR (162 MHz, CD2Cl2) ppm δ 37.5. [α]25D = +18.0 (CH2Cl2, c = 1). FT-IR 
(film): ν = 3369.0, 3290.9, 3067.3, 2923.6, 2850.7, 1585.2, 1432.9, 1153.2, 1094.9, 960.0, 739.6, 
699.1 cm-1. MS (ESI +): calcd. for C20H26NP: 311.19, found: 312.41  [M+H]+. 
 
(S)-N-methyl-N-(1-(naphthalen-1-yl)ethyl)-1,1-diphenylphosphinamine [(S)-6e] 
 
The product was prepared according to the General Procedure using (S)-N-methyl-
1-(naphthalen-1-yl)ethanamine (840 µL, 4.70 mmol), chlorodiphenylphosphine 
(0.7 mL, 3.76 mmol) and triethylamine (0.68 mL, 4.89 mmol). It was purified by 
column chromatography on neutral alumina (eluent: hexane / CH2Cl2 / TEA 
9:1:0.3) to afford a white solid. Yield = 81%. 1H-NMR (400 MHz, CD2Cl2) ppm δ 8.42 (m, 1H), 7.94 
(m, 1H), 7.86 (d, J = 7.9 Hz, 1H), 7.57-7.50 (m, 6H), 7.44-7.42 (m, 3H), 7.27-7.21 (m, 5H), 5.51 (dq, 
JH,H = 6.9 Hz, JH,P = 9.8 Hz, 1H), 2.27 (d, JH,P = 2.9 Hz, 3H), 1.73 (JH,H = 6.9 Hz, 1H). 13C-NMR (100 
MHz, CD2Cl2) ppm δ 140.3 (d, JC,P = 8.0 Hz), 140.2, 139.4 (d, JC,P = 9.6 Hz), 140.4, 140.3, 140.1, 
139.5, 139.4, 134.9, 133.9, 133.8, 132.7, 132.2, 132.0, 130.2, 129.4, 129.2, 128.8, 128.7, 128.6, 128.5, 
128.4, 126.5, 126.2, 125.7, 125.5, 125.4, 124.9, 59.9 (d, JC,P = 40.0 Hz), 31.4 (d, JC,P = 10.4 Hz), 18.8 
(d, JC,P = 6.0 Hz). 31P-NMR (162 MHz, CD2Cl2) ppm δ 61.9. [α]22D = +321.1 (CH2Cl2, c = 1). FT-IR 
(film): ν = 3047.9, 2970.8, 2932.2, 2865.7, 1589.0, 1430.9, 1308.5, 1151.3, 979.7, 908.3,  837.9 cm-1. 
HRMS (ESI +): calcd. for C30H31O3P: 392.15386, found: 369.15341 [M+Na]+. MP = 114-115°C. 
 
1-(diphenylphosphino)pyrrolidine (6g) 
 
The product was prepared according to the General Procedure using pyrrolidine (1.5 
mL, 18 mmol), chlorodiphenylphosphine (0.7 mL, 3.76 mmol). It was purified by 
column chromatography on neutral alumina (eluent: hexane / CH2Cl2 / TEA 9:1:0.3) 
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to afford a white solid. Yield = 85%. CAS 22859-55-8. 1H-NMR (400 MHz, CD2Cl2) ppm δ 7.48-7.36 
(m, 10H), 3.10 (dt, J
 
= 3.8 Hz, J
 
= 6.5 Hz, 4H), 1.82 (m, 4H). 13C-NMR (100 MHz, CD2Cl2) ppm δ 
140.1 (d, JC,P = 13.2 Hz), 132.8, 132.6, 128.9, 128.8, 128.7, 50.3 (d, JC,P = 12.9 Hz), 27.1 (d, JC,P = 5.2 
Hz). 31P-NMR (162 MHz, CD2Cl2) ppm δ 48.2. MS (ESI +): calcd. for C16H18NP: 255.11, found: 
278.15  [M+Na]+.
 
 
(R)-1-(diphenylphosphino)-2-methylpyrrolidine [(R)-6h] 
 
The product was prepared according to the General Procedure using (R)-2-
methylpyrrolidine (0.490 mL, 4.70 mmol), chlorodiphenylphosphine (0.7 mL, 3.76 
mmol) and triethylamine (0.68 mL, 4.89 mmol). It was purified by column 
chromatography on neutral alumina (eluent: hexane / CH2Cl2 / TEA 9:1:0.3) to afford 
a clean oil. Yield = 77%. 1H-NMR (400 MHz, CD2Cl2) ppm δ 7.51-7.35 (m, 10H), 
3.67 (m, 1H), 3.03 (m, 1H), 2.76 (m, 1H,), 2.04 (dq, J = 7.2 Hz, J =12.0 Hz, 1H), 1.87 (m, 1H), 1.70 
(m, 1H), 1.56 (m, 1H), 1.33 (d, J = 6.0 Hz, 3H). 13C-NMR (100 MHz, CD2Cl2) ppm δ 140.8 (d, JC,P = 
8.5 Hz), 139.9 (d, JC,P = 17.1 Hz), 133.3, 133.1, 132.3, 132.1, 129.0, 128.7, 128.7, 128.5, 59.1 (d, JC,P 
= 30.5 Hz) , 47.4 (d, JC,P = 9.3 Hz) , 35.1 (d, JC,P = 6.1 HZ), 25.8, 23.3 (d, JC,P = 8.0 Hz). 31P-NMR 
(162 MHz, CD2Cl2) ppm δ 42.6. [α]25D = -29.0 (CH2Cl2, c = 1). FT-IR (film): ν = 3066.3, 2959.2, 
2864.7, 1585.2, 1478.2, 1432.9, 1370.8, 1063.5, 743.4, 698.1 cm-1. MS (ESI +): calcd. for C17H20NP: 
269.12, found: 292.33  [M+Na]+.  
 
(S)-1-(diphenylphosphino)-2-(trifluoromethyl)pyrrolidine [(R)-6i] 
The product was prepared according to the General Procedure using (R)-2-
methylpyrrolidine (650 mg, 4.70 mmol), chlorodiphenylphosphine (0.7 mL, 3.76 
mmol) and triethylamine (0.68 mL, 4.89 mmol). It was purified by column 
chromatography on neutral alumina (eluent: hexane / CH2Cl2 / TEA 9:1:0.3) to 
afford a white solid. Yield = 86%. 1H-NMR (400 MHz, CD2Cl2) ppm δ 7.50-7.37 
(m, 10H), 4.16 (m, 1H), 3.11 (m, 1H), 2.79 (m, 1H), 2.14-1.79 (m, 3H), 1.65 (m, 1H). 13C-NMR (100 
MHz, CD2Cl2) ppm δ 139.4 (d, JC,P = 7.3 Hz), 138.5 (d, JC,P = 16.2 Hz), 133.7, 133.5, 131.8, 131.6, 
129.8, 128.9, 128.8, 128.7, 65.8 (dq, JC,P = 34.6 Hz, JC,F = 28.8 Hz) , 47.9 (d, JC,P = 9.7 Hz), 27.6 (d, 
JC,P = 3.6 Hz), 26.0. 31P-NMR (162 MHz, CD2Cl2) ppm δ 57.4 (1P, q, JP,F = 16.5 Hz). [α]25D =:+16.7 
(CH2Cl2, c = 1). FT-IR (film): ν = 3069.2, 2982.4, 2916.8, 1959.3, 1887.0, 1586.2, 1480.0, 
1433.3,1285.3, 745.4 cm-1. MS (ESI +): calcd. for C17H17F3NP: 323.11, found: 324.75 [M+H]+. MP = 
79-81°C. 
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(S)-1-(diphenylphosphino)-2-(pyrrolidine-1-carbonyl)pyrrolidine [(S)-6j] 
 
The product was prepared according to the General Procedure using (S)-2-
(pyrrolidinecarbonyl)pyrrolidine 4a (395 mg, 2.35 mmol), 
chlorodiphenylphosphine (0.35 mL, 1.88 mmol) and triethylamine (0.34 mL, 
2.44 mmol). It was purified by column chromatography on neutral alumina 
(eluent: hexane / CH2Cl2 / TEA 9:1:0.3) to afford a white solid. Yield = 36%. 
1H-NMR (400 MHz, CD2Cl2) ppm δ 7.58-7.54 (m, 2H), 7.44-7.32 (m, 8H), 4.36 (m, 1H), 3.65 (m, 
1H), 3.48-3.39 (m, 3H), 3.17 (m, 1H), 2.90 (m, 1H), 2.10 (m, 1H), 2.00-1.71 (m, 7H). 13C-NMR (100 
MHz, CD2Cl2) ppm δ 172.7, 139.2 (d, JC,P = 7.6 Hz), 138.1 (d, JC,P = 9.2 Hz), 132.4, 132.3, 132.1, 
131.9, 128.4, 128.1, 128.0, 127.9, 127.8, 127.7, 63.8 (dq, JC,P = 38.3 Hz), 47.6 (d, JC,P = 4.7 Hz), 46.2, 
46.0, 31.0 (d, JC,P = 6.3 Hz), 26.3, 25.9, 24.1. 31P-NMR (162 MHz, CD2Cl2) ppm δ 48.7. MS (ESI +): 
calcd. for C21H25N2OP: 352.16, found: 375.43 [M+Na]+. 
 
(S)-1-(diphenylphosphino)-2-(N,N-diethylaminocarbonyl)pyrrolidine [(S)-6k] 
 
The product was prepared according to the General Procedure using (S)-2-
(diethylaminocarbonyl)pyrrolidine 4b (400 mg, 2.35 mmol), 
chlorodiphenylphosphine (0.35 mL, 1.88 mmol) and triethylamine (0.34 mL, 
2.44 mmol). It was purified by column chromatography on neutral alumina 
(eluent: hexane / CH2Cl2 / TEA 9:1:0.3) to afford a white solid. Yield = 38%. 1H-NMR (400 MHz, 
CD2Cl2) ppm δ 7.57-7.53 (m, 2H), 7.44-7.32 (m, 8H), 4.46 (m, 1H), 3.68-3.30 (m, 4H), 3.18 (m, 1H), 
2.92 (m, 1H), 2.10-1.86 (m, 3H), 1.72 (m, 1H), 1.25-1.10 (m, 6H). 13C-NMR (100 MHz, CD2Cl2) ppm 
δ 173.1, 139.2 (d, JC,P = 7.0 Hz), 138.7 (d, JC,P = 14.1 Hz), 132.4, 132.2, 132.0, 128.2, 128.0, 127.8, 
127.7, 63.9 (d, JC,P = 32.2 Hz) , 48.1 (d, JC,P = 3.6 Hz), 30.1 (d, JC,P = 11.6 Hz), 26.7, 26.1, 25.7, 25.6, 
25.3. 31P-NMR (162 MHz, CD2Cl2) ppm δ 48.7. MS (ESI +): calcd. for C21H27N2OP: 377.18, found: 
377.03 [M+Na]+. 
 
(S)-N,N-dicyclohexyl-1-(diphenylphosphino)pyrrolidine-2-carboxamide [(S)-6l] 
 
The product was prepared according to the General Procedure using (S)-2-
(dicyclohexylaminocarbonyl)pyrrolidine 4c (165 mg, 0.59 mmol), 
chlorodiphenylphosphine (90 µL, 0.48 mmol) and triethylamine (0.90 mL, 
0.62 mmol). It was purified by column chromatography on neutral alumina 
(eluent: hexane / CH2Cl2 / TEA 9:1:0.3) to afford a white solid. Yield = 42%. 
[α]25D =: -35.5 (CH2Cl2, c = 1). 1H-NMR (400 MHz, CD2Cl2) ppm δ 7.58-7.55 (m, 2H), 7.44-7.34 (m, 
8H), 4.42 (m, 1H), 3.17 (m, 1H), 2.98 (m, 1H), 2.05 (m, 1H), 2.08-1.10 (m, 25H). 13C-NMR (100 
MHz, CD2Cl2) ppm δ 173.2, 140.0 (d, JC,P = 14.0 Hz), 139.4 (d, JC,P = 10.9 Hz), 132.5, 132.2, 132.0, 
P
N
O
N
P
N
O
N
P
N
O
N
σ-donor and pi-acceptor interactions  
127 
 
128.4, 128.0, 127.9, 127.8, 61.9 (d, JC,P = 31.9 Hz) , 47.7, 41.7, 40.5, 31.8, 25.9, 14.7, 12.8. 31P-NMR 
(162 MHz, CD2Cl2) ppm δ 50.0. FT-IR (film): ν = 3050.8, 2929.3, 2853.7, 1646.9, 1433.8, 1363.4, 
1156.1, 893.8 cm-1. MS (ESI +): calcd. for C29H39N2OP: 462.27, found: 485.40 [M+Na]+. MP = 120-
121°C. 
 
2.4.8 Complexation experiments 
 
General procedure 
Note! Most of the phosphite ligands use to degrade in CDCl3 even after solvent filtration trough 
alumina. 
The complexation experiments were run in NMR tubes under nitrogen atmosphere and monitored by 
1H and 31P NMR spectroscopy. The typical scale of the experiments was 0.0134 mmol of metal source 
in 0.75 mL of deuterated solvent (0.018 M concentration) and up to 0.0268 mmol of ligand or ligands 
(0.0134 mmol each). In all of the experiments CD2Cl2 was used as the solvent. 
Experiments with one ligand: CD2Cl2 was added to a 1:1 mixture of the selected metal source and the 
ligand, then 1H and 31P-NMR spectra were recorded. The mono-ligated species was usually dominant 
at this stage; more ligand was added (always monitoring the experiment by NMR) until the doublet 
signal of the homocomplex appeared. 
Ligand combinations: CD2Cl2 was added to a 1:1:1 mixture of ligand A, ligand B and the selected 
metal source then 1H and 31P NMR spectra were recorded. It is important to remark that the formation 
of the heterocomplexes proved kinetically quite slow, and an equilibration time of the order of 1-2 h 
was necessary for observing the hetero/homocomplexes ratios reported into Table 5.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
 128
(R)-2b/(R)-6b: Heterocomplex/6b Homocomplex  = 99 : 1 
102.5103.0103.5104.0104.5105.0105.5106.0155.5156.0156.5157.0157.5158.0158.5
 
(R)-2b/(S)-6b: Heterocomplex/6b Homocomplex = 96 : 4 
 
102.0103.0104.0105.0153.0154.0155.0156.0157.0158.0159.0160.0
 
 
 
(R)-2b/(R)-6c: Heterocomplex/2b Homocomplex /6c Monocomplex  = 81 : 14 : 5 
σ-donor and pi-acceptor interactions  
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104.5105.5106.5107.5108.5109.5154.5155.5156.5157.5158.5159.5
 
 
S)-2b/(R)-6c: Heterocomplex/6b Homocomplex / = 81 : 19 
102.5103.5104.5105.5153.5154.5155.5156.5157.5158.5159.5160.5161.5
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(R)-2b/(R)-6d: Heterocomplex/2b Homocomplex /2b Monocomplex /6d Monocomplex = 74 : 
18 : 3 :5 
767778798081145146147148149150151152153154155156157158159
 
(S)-2b/(R)-6d: Heterocomplex/6d Homocomplex = 81 : 19 
77.077.578.078.579.079.580.080.5154.5155.5156.5157.5158.5159.5
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(R)-2b/(S)-6e: Heterocomplex /2b Homocomplex /2b Monocomplex /6e Monocomplex = 70 : 
21 : 4 :5 
 
747576777879146147148149150151152153154155156157158159
 
(S)-2b/(S)-6e: Heterocomplex/2b Homocomplex = 84 : 16 
74.074.575.075.576.076.577.077.578.0155.0156.0157.0158.0159.0
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(S)-2a/(R)-6b: Heterocomplex/2a Homocomplex /6b Monocomplex = 83 : 7 : 10  
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(S)-102a/(S)-112b: Heterocomplex/112b Homocomplex > 99 : 1 
 
101.5102.5103.5104.5105.5145.0146.0147.0148.0149.0150.0
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(R)-2c/(R)-6b: Heterocomplex/2c Homocomplex /6b Homocomplex = 94 : 5 :1 
102.5103.5104.5105.5155.0156.0157.0158.0159.0160.0161.0
 
 
(R)-2c/(S)-6b: Heterocomplex/2c Homocomplex = 81 : 19 
 
103.5104.5105.5154.0155.0156.0157.0158.0159.0160.0
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(R)-2d/(R)-6b: Heterocomplex/2d Homocomplex = 96 : 4 
 
105.5106.5107.5108.5151.0152.0153.0154.0155.0156.0157.0
 
 
(R)-2d/(S)-6b: Heterocomplex/2d Homocomplex > 9 :1 (an exact assessment was not possible 
in this case) 
104.5105.0105.5106.0106.5107.0107.5149.5150.0150.5151.0151.5152.0152.5153.0153.5
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2.4.9 Computational calculations 
 
Methods 
The structures of the ligands were pre-optimised using the semi-empirical PM6 Hamiltonian,26 within 
the Mopac2009 programme.27 Rhodium was considered as a +1 cation in square planar geometry, 
bearing the anionic acac ligand, (CH3COCHCOCH3)-, and bound in a bidentate fashion through the 
oxygen atoms. The whole complex is a closed-shell neutral molecule. After pre-optimisation using 
PM6,27 calculations were performed at the B3LYP/SDD level of theory28 in the Gaussian03 
programme suite.29 The employed basis set consists of SDD effective core potential30 for rhodium and 
Dunning-Hay valence double-ζ basis D95V set for the remaining atoms. All degrees of freedom were 
free to optimise with default convergence criteria. The nature of the obtained stationary points was 
confirmed by frequency calculation within the same level of theory. Free energies of isodesmic 
reactions were calculated in order to minimise the error resulting from inadequate treatment of 
electron correlation. 
 
Results 
In the Scheme 2.5 (see section 2.2.1.2), the hypothetical reaction could be described as ligand 
exchange between two homocomplexes, [Rh(P[OPh]3)2(acac)] and [Rh(PPh3)2(acac)], forming the 
heterocomplex  [Rh(PPh3)(P[OPh]3)(acac)]. Calculated energies in kcal/mol, at temperature T = 298 
K, are shown in Table 2.13. From the results it can be concluded that the heterocomplex formation is 
favoured. The calculated quantities are as following: E = electronic energy, G = Gibbs free energy, H 
= enthalpy, TS = temperature (298 K) times entropy. 
 
Table 2.12 Calculated energies for phosphite-phosphine heterocomplex at T = 298 K temperature 
 
 E G H TS 
phosphite -1869661.80 -1869289.38 -1869196.66 92.67 
phosphine -1586441.70 -1586074.30 -1585994.36 79.90 
heterocomplex -1728055.28 -1727684.39 -1727599.01 85.34 
     
reaction -7.06 -5.11 -7.00 -1.89 
 
In the Scheme 2.6 (see section 2.2.1.2), the hypothetical reaction could be described as ligand exchange between 
two homocomplexes, [Rh(P[OPh]3)2(acac)] and [Rh(PPh2NMe2)2(acac)], forming the heterocomplex 
[Rh(PPh2NMe2)(P[OPh]3)(acac)]). Calculated energies in kcal/mol, at temperature T = 298 K, are shown in 
Table 2.14. Again, the heterocomplex formation is significantly favoured. 
 
Table 2.13 Calculated energies for phosphite-phosphinamine heterocomplex at T = 298 K temperature 
 
 E G H TS 
phosphite -1869661.80 -1869289.38 -1869196.66 92.67 
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phosphinamine -1464618.28 -1464258.05 -1464181.99 76.02 
heterocomplex -1667143.61 -1666779.35 -1666692.96 86.35 
     
reaction -7.15 -11.29 -7.27 4.02 
 
Optimized geometries as XYZ coordinates for all 5 structures (two phosphite complexes are identical), 
distances in Ångstroms: 
 
Rh(P[OPh]3)2(acac)] 
  89 
scf: -2979.497982 
Rh    -0.275792    -1.234429     0.098781 
 H    -3.287161    -5.167736    -1.419462 
 C    -3.251852    -4.076613    -1.352398 
 C    -1.930415    -3.586031    -0.797230 
 H    -4.072873    -3.720629    -0.719070 
 H    -3.413584    -3.652023    -2.351877 
 O    -1.863385    -2.287251    -0.617288 
 C    -0.887744    -4.497791    -0.523886 
 C     0.391057    -4.162024    -0.019281 
 H    -1.081734    -5.545582    -0.720786 
 C     1.424062    -5.242992     0.225777 
 O     0.792563    -2.951846     0.274500 
 H     1.670685    -5.278076     1.294943 
 H     1.070644    -6.228127    -0.091784 
 H     2.347785    -4.994602    -0.310568 
 O     3.116909    -0.921044     0.716179 
 P     1.587478    -0.101742     0.746580 
 O     1.908411     1.298481    -0.179944 
 O     1.833479     0.543219     2.331051 
 O    -2.035624     1.293014    -1.577465 
 P    -1.594314     0.609197    -0.031340 
 O    -3.206026     0.580127     0.591228 
 O    -1.067080     1.962001     0.861707 
 C     1.207603     0.030862     3.496484 
 C     1.838551    -0.999326     4.213931 
 C     0.015724     0.624161     3.944815 
 C     1.258276    -1.442690     5.416985 
 H     2.759647    -1.429850     3.831958 
 C    -0.552012     0.172067     5.150631 
 H    -0.442221     1.412728     3.355461 
 C     0.065004    -0.858594     5.888262 
 H     1.737362    -2.237826     5.983321 
 H    -1.473013     0.624266     5.510483 
 H    -0.378402    -1.202313     6.819603 
 C     3.022616     2.172082    -0.193603 
 C     3.208502     2.874808    -1.397950 
 C     3.867316     2.372247     0.913247 
 C     4.265855     3.796429    -1.496789 
 H     2.531535     2.689405    -2.226694 
 C     4.924461     3.294341     0.793413 
 H     3.695258     1.829566     1.835245 
 C     5.129490     4.008491    -0.403058 
 H     4.415447     4.342223    -2.425359 
 H     5.584982     3.454355     1.642292 
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 H     5.948608     4.718663    -0.482739 
 C     3.647872    -1.659489    -0.359887 
 C     4.628547    -2.608905    -0.022592 
 C     3.274396    -1.444503    -1.699905 
 C     5.242223    -3.357584    -1.041836 
 H     4.894447    -2.741268     1.021635 
 C     3.892070    -2.207015    -2.708865 
 H     2.525464    -0.701187    -1.956401 
 C     4.874727    -3.163595    -2.389551 
 H     6.005940    -4.087731    -0.783977 
 H     3.606086    -2.044612    -3.745444 
 H     5.351338    -3.742977    -3.176136 
 C    -1.499334     3.311595     0.782029 
 C    -2.831570     3.674466     1.047356 
 C    -0.510945     4.271253     0.505282 
 C    -3.174552     5.039671     1.024499 
 H    -3.566169     2.905372     1.258459 
 C    -0.868848     5.632133     0.495170 
 H     0.506626     3.944989     0.314689 
 C    -2.199851     6.019957     0.750963 
 H    -4.201847     5.334357     1.225146 
 H    -0.110300     6.383514     0.289737 
 H    -2.472665     7.072300     0.741104 
 C    -1.228089     1.252506    -2.738801 
 C    -0.782376     2.476148    -3.266985 
 C    -0.954239     0.031535    -3.381560 
 C    -0.050822     2.476041    -4.469089 
 H    -1.016831     3.397755    -2.742373 
 C    -0.215342     0.045639    -4.579361 
 H    -1.315367    -0.898154    -2.952797 
 C     0.237046     1.262608    -5.127023 
 H     0.289361     3.419293    -4.889980 
 H     0.000748    -0.893061    -5.084182 
 H     0.802571     1.266495    -6.055494 
 C    -4.299621    -0.210189     0.169056 
 C    -4.834807    -1.119936     1.096889 
 C    -4.890990    -0.012667    -1.091897 
 C    -5.988916    -1.847799     0.754217 
 H    -4.350646    -1.239561     2.061643 
 C    -6.039709    -0.754625    -1.424806 
 H    -4.455642     0.703581    -1.780754 
 C    -6.593230    -1.670449    -0.507455 
 H    -6.414972    -2.546631     1.470279 
 H    -6.505888    -0.608301    -2.396405 
 H    -7.486856    -2.232100    -0.768437 
 
[Rh(PPh3)2(acac)] 
   83 
 scf: -2528.15767805 
 C    -1.211722    -2.967171     0.825890 
 C    -1.605488    -2.121621    -0.234652 
 C    -1.826766    -2.684850    -1.508237 
 C    -1.681759    -4.069808    -1.712532 
 C    -1.307495    -4.909573    -0.647310 
 C    -1.068470    -4.351240     0.623283 
 P    -1.777973    -0.262661     0.047480 
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Rh     0.039795     1.254192     0.055591 
 O     1.448004     2.743843     0.018458 
 C     1.230785     4.030910    -0.036338 
 C    -0.042321     4.651988    -0.044223 
 C    -1.285882     3.982940     0.010443 
 C    -2.578800     4.779524     0.000319 
 C    -3.015954     0.211357    -1.301484 
 C    -4.373969    -0.165150    -1.259318 
 C    -5.245190     0.193938    -2.305119 
 C    -4.765198     0.930685    -3.405871 
 C    -3.410652     1.312708    -3.449468 
 C    -2.542384     0.958744    -2.399708 
 C    -2.807361    -0.214161     1.635868 
 C    -2.656101     0.894351     2.496616 
 C    -3.413355     0.986349     3.679607 
 C    -4.329107    -0.028344     4.017923 
 C    -4.482353    -1.138222     3.164422 
 C    -3.727727    -1.229196     1.979872 
 O    -1.443163     2.684787     0.071720 
 P     1.814032    -0.281003     0.001417 
 C     3.531859     0.482140    -0.228918 
 C     4.303043     0.298166    -1.392287 
 C     5.575867     0.894227    -1.506630 
 C     6.087727     1.679518    -0.458357 
 C     5.315667     1.870518     0.705946 
 C     4.045213     1.281363     0.816414 
 C     1.751178    -1.526343    -1.412343 
 C     1.391792    -1.014919    -2.680359 
 C     1.363551    -1.853223    -3.808427 
 C     1.678627    -3.220732    -3.679146 
 C     2.010468    -3.739564    -2.414268 
 C     2.048504    -2.896478    -1.286277 
 C     2.135886    -1.272027     1.576015 
 C     3.283018    -2.080851     1.735251 
 C     3.511915    -2.760600     2.945419 
 C     2.603009    -2.627947     4.014933 
 C     1.471478    -1.803425     3.869420 
 C     1.241481    -1.128245     2.655176 
 C     2.484609     4.885868    -0.102870 
 H    -3.032633     1.890801    -4.289812 
 H    -1.502398     1.275179    -2.413180 
 H    -5.439201     1.207901    -4.213496 
 H    -6.291811    -0.098470    -2.258269 
 H    -4.764788    -0.725133    -0.415271 
 H    -2.121165    -2.052923    -2.340843 
 H    -1.031113    -2.557640     1.815049 
 H    -1.952992     1.678081     2.233361 
 H    -3.843968    -2.102935     1.344329 
 H    -1.858474    -4.485912    -2.701561 
 H    -0.772980    -4.986613     1.455006 
 H    -3.285472     1.846300     4.333251 
 H    -5.183688    -1.930041     3.417911 
 H    -1.202091    -5.980729    -0.804472 
 H    -4.911852     0.041935     4.933744 
 H     0.776624    -1.676559     4.696455 
 H     0.385544    -0.466461     2.547615 
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 H     2.784397    -3.148423     4.952717 
 H     4.399051    -3.379842     3.057094 
 H     4.013080    -2.156513     0.933413 
 H     1.127124     0.036191    -2.774813 
 H     2.290182    -3.319859    -0.316982 
 H     3.931235    -0.312377    -2.209342 
 H     3.451398     1.448228     1.710824 
 H     1.091565    -1.443286    -4.778437 
 H     2.234301    -4.797672    -2.299565 
 H     6.161421     0.738590    -2.410065 
 H     5.700061     2.478264     1.522140 
 H     1.654769    -3.872674    -4.549542 
 H     7.071514     2.135687    -0.544693 
 H    -0.063853     5.734989    -0.094201 
 H    -3.154136     4.565082     0.910390 
 H    -2.397788     5.856791    -0.062939 
 H    -3.196425     4.466010    -0.850939 
 H     3.132986     4.659946     0.752735 
 H     3.052569     4.636481    -1.008473 
 H     2.252862     5.955269    -0.107668 
 
[Rh(PPh3)(P[OPh]3)(acac)] 
   86 
scf: -2753.833454 
Rh    -0.317372    -1.246075     0.027370 
 H     2.021742    -5.823282     0.839647 
 C     2.219137    -4.751075     0.748928 
 C     0.946022    -3.954077     0.540279 
 H     2.901382    -4.575076    -0.091737 
 H     2.731253    -4.402955     1.655505 
 O     1.125813    -2.666187     0.388584 
 C    -0.309610    -4.603635     0.527108 
 C    -1.562009    -3.972467     0.345120 
 H    -0.313468    -5.677654     0.673766 
 C    -2.833967    -4.799921     0.362708 
 O    -1.748651    -2.691622     0.146685 
 H    -3.301670    -4.776425    -0.630542 
 H    -2.642806    -5.840891     0.639338 
 H    -3.550156    -4.358705     1.065850 
 P    -2.063043     0.334376    -0.241731 
 O     2.635436     0.467320     0.915708 
 P     1.377292     0.195313    -0.279724 
 O     2.503963    -0.142564    -1.564440 
 O     1.001779     1.790916    -0.776769 
 C     1.857675     2.907498    -0.935558 
 C     2.916450     2.901889    -1.862216 
 C     1.546507     4.053832    -0.183352 
 C     3.678893     4.073926    -2.025556 
 H     3.131257     1.999896    -2.423616 
 C     2.313515     5.219638    -0.363509 
 H     0.713860     4.020979     0.512477 
 C     3.382988     5.233562    -1.281673 
 H     4.501590     4.078764    -2.736800 
 H     2.075209     6.112106     0.210529 
 H     3.974866     6.135436    -1.417445 
 C     2.440619     0.507189     2.312134 
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 C     2.797264     1.691452     2.982094 
 C     1.982980    -0.622323     3.016909 
 C     2.696197     1.744301     4.384392 
 H     3.150296     2.540083     2.403469 
 C     1.876135    -0.551154     4.418725 
 H     1.727488    -1.525962     2.472953 
 C     2.231500     0.626142     5.107232 
 H     2.980461     2.653860     4.908573 
 H     1.521400    -1.418617     4.970694 
 H     2.154698     0.669417     6.190928 
 C     3.369774    -1.253598    -1.662543 
 C     3.086823    -2.231544    -2.632060 
 C     4.532638    -1.321056    -0.873247 
 C     3.988287    -3.296018    -2.816638 
 H     2.178903    -2.147479    -3.222289 
 C     5.423636    -2.393136    -1.064335 
 H     4.715908    -0.551085    -0.131285 
 C     5.157910    -3.381593    -2.034027 
 H     3.778280    -4.052607    -3.569199 
 H     6.325753    -2.452168    -0.459744 
 H     5.854638    -4.203198    -2.181974 
 C    -1.901582     1.860589     0.848462 
 C    -2.390724     3.127859     0.475080 
 C    -1.273382     1.703192     2.102799 
 C    -2.262483     4.223500     1.350537 
 H    -2.850250     3.275301    -0.497160 
 C    -1.147984     2.796664     2.979550 
 H    -0.869752     0.733650     2.385593 
 C    -1.645840     4.060498     2.606681 
 H    -2.639253     5.198208     1.049351 
 H    -0.654308     2.660116     3.938268 
 H    -1.548242     4.907637     3.281831 
 C    -2.415055     0.990347    -1.970708 
 C    -3.670285     1.545770    -2.305933 
 C    -1.405865     0.926832    -2.952537 
 C    -3.909042     2.034044    -3.603560 
 H    -4.467617     1.578892    -1.568196 
 C    -1.643997     1.417571    -4.249896 
 H    -0.440313     0.497270    -2.707969 
 C    -2.894307     1.974062    -4.579119 
 H    -4.880597     2.455955    -3.850054 
 H    -0.855337     1.364347    -4.996348 
 H    -3.078382     2.351413    -5.582438 
 C    -3.746928    -0.347251     0.261293 
 C    -4.391861    -1.270434    -0.590441 
 C    -4.354408     0.000397     1.483773 
 C    -5.634933    -1.819804    -0.233517 
 H    -3.923225    -1.564355    -1.525450 
 C    -5.597520    -0.556082     1.845560 
 H    -3.875086     0.707420     2.154295 
 C    -6.243443    -1.464866     0.987582 
 H    -6.123983    -2.524129    -0.902661 
 H    -6.056103    -0.274876     2.790752 
 H    -7.205508    -1.890481     1.264015 
 
[Rh(PPh2NMe2)2(acac)] 
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   79 
scf: -2334.019559 
Rh    -0.141441    -1.117071     0.094583 
 H     2.476463    -4.368992     2.218472 
 C     2.013393    -4.753826     1.300240 
 C     0.835000    -3.877041     0.913408 
 H     1.716098    -5.794250     1.461968 
 H     2.776792    -4.714121     0.513092 
 O     1.140078    -2.630913     0.655840 
 C    -0.466054    -4.425275     0.862366 
 C    -1.641010    -3.719891     0.509418 
 H    -0.574168    -5.473627     1.117061 
 C    -2.978874    -4.440192     0.509934 
 O    -1.694937    -2.461082     0.162370 
 H    -3.389019    -4.465934    -0.508344 
 H    -2.892587    -5.465414     0.882448 
 H    -3.694367    -3.887253     1.130777 
 P    -1.692795     0.557982    -0.442597 
 N    -1.504067     1.359845    -2.030333 
 C    -2.545174     2.292280    -2.504573 
 C    -0.935523     0.542924    -3.119659 
 H    -2.921577     2.908538    -1.683228 
 H    -2.109726     2.961838    -3.259908 
 H    -3.404058     1.769251    -2.961245 
 H    -0.430931     1.196058    -3.847482 
 H    -0.209247    -0.166899    -2.709323 
 H    -1.708043    -0.031504    -3.663924 
 H     2.312911    -1.694597     2.872047 
 C     3.043057    -0.915702     2.596631 
 H     3.763683    -1.354437     1.903078 
 H     3.580348    -0.599835     3.502527 
 N     2.401233     0.276825     2.000928 
 P     1.827932     0.179386     0.286393 
 C     1.391388     0.857139     2.920077 
 H     1.887226     1.122747     3.863745 
 H     0.952422     1.765500     2.496371 
 H     0.570145     0.152459     3.136639 
 C    -3.524338     0.061133    -0.508719 
 C    -4.560468     0.825942     0.066041 
 C    -3.861992    -1.066289    -1.291860 
 C    -5.909049     0.464911    -0.124165 
 H    -4.329528     1.706208     0.658338 
 C    -5.208114    -1.420725    -1.491792 
 H    -3.073400    -1.675615    -1.720182 
 C    -6.237947    -0.658564    -0.905058 
 H    -6.695170     1.064297     0.329721 
 H    -5.451616    -2.291325    -2.096930 
 H    -7.279134    -0.935532    -1.055341 
 C    -1.695135     2.004187     0.756421 
 C    -1.186939     3.270149     0.407246 
 C    -2.137768     1.778465     2.079532 
 C    -1.141969     4.305635     1.361291 
 H    -0.810278     3.438475    -0.595999 
 C    -2.095717     2.812176     3.031222 
 H    -2.502403     0.795731     2.370402 
 C    -1.600417     4.083139     2.673117 
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 H    -0.739885     5.275694     1.079107 
 H    -2.442444     2.625840     4.045066 
 H    -1.565531     4.883412     3.408891 
 C     2.101214     1.984934    -0.214576 
 C     1.709769     2.406083    -1.501094 
 C     2.774512     2.889047     0.631047 
 C     1.983439     3.716062    -1.935908 
 H     1.193668     1.722909    -2.165123 
 C     3.036398     4.204163     0.202918 
 H     3.104089     2.550361     1.608548 
 C     2.643147     4.622654    -1.082957 
 H     1.685067     4.024970    -2.935337 
 H     3.553789     4.893496     0.866702 
 H     2.854162     5.635851    -1.418431 
 C     3.323587    -0.573983    -0.579810 
 C     4.622003    -0.070592    -0.350113 
 C     3.133836    -1.604787    -1.520028 
 C     5.721467    -0.603768    -1.046399 
 H     4.774216     0.730192     0.368860 
 C     4.233358    -2.130455    -2.226213 
 H     2.134230    -1.995876    -1.685830 
 C     5.529086    -1.633795    -1.990023 
 H     6.719522    -0.213148    -0.860992 
 H     4.077080    -2.924624    -2.952947 
 H     6.378696    -2.040747    -2.534117 
 
[Rh(PPh2NMe2)(P[OPh]3)(acac)] 
   84 
scf: -2656.766044 
Rh    -0.510204    -1.114235    -0.033342 
 H    -3.625475    -4.322460    -1.346402 
 C    -3.289632    -4.477116    -0.312421 
 C    -1.972514    -3.757260    -0.092962 
 H    -3.208319    -5.551373    -0.123453 
 H    -4.057111    -4.048042     0.343147 
 O    -2.042709    -2.452703    -0.201555 
 C    -0.802646    -4.492523     0.196296 
 C     0.481504    -3.943391     0.426966 
 H    -0.896057    -5.571010     0.249814 
 C     1.652972    -4.856866     0.732653 
 O     0.770541    -2.668422     0.401674 
 H     1.360283    -5.910746     0.741906 
 H     2.439015    -4.705513    -0.017629 
 H     2.082962    -4.596424     1.708465 
 H    -2.520691    -1.457180    -3.016276 
 C    -3.237397    -0.632659    -2.859200 
 H    -4.029086    -0.991226    -2.197368 
 H    -3.684654    -0.369121    -3.827060 
 N    -2.591860     0.579177    -2.298907 
 P    -2.145342     0.496839    -0.555857 
 C    -1.514262     1.070032    -3.192857 
 H    -1.962009     1.367779    -4.150224 
 H    -1.009207     1.936149    -2.758916 
 H    -0.750338     0.297520    -3.391076 
 O     2.838937    -0.455969    -0.286733 
 P     1.272480     0.246602     0.035171 
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 O     1.259695     1.615275    -0.991664 
 O     1.831291     1.094406     1.439357 
 C     3.162303    -1.394177    -1.281342 
 C     4.277658    -2.210265    -1.017771 
 C     2.466946    -1.489589    -2.501658 
 C     4.702086    -3.133324    -1.989465 
 H     4.790510    -2.105592    -0.066298 
 C     2.897420    -2.424147    -3.461866 
 H     1.611530    -0.850689    -2.699352 
 C     4.012705    -3.247613    -3.214587 
 H     5.569011    -3.759359    -1.790763 
 H     2.361411    -2.502352    -4.404952 
 H     4.342792    -3.961994    -3.964445 
 C     2.148694     2.718707    -1.050090 
 C     1.561814     3.955791    -1.365378 
 C     3.538537     2.589370    -0.873266 
 C     2.385129     5.086080    -1.517946 
 H     0.484158     4.018321    -1.477377 
 C     4.347051     3.731635    -1.022098 
 H     3.969140     1.628019    -0.617711 
 C     3.779837     4.979561    -1.347317 
 H     1.935966     6.045478    -1.763760 
 H     5.422160     3.641404    -0.885504 
 H     4.413901     5.854913    -1.464145 
 C     2.183026     0.550488     2.688479 
 C     2.533229     1.491288     3.674377 
 C     2.195337    -0.831072     2.960953 
 C     2.899577     1.042633     4.955191 
 H     2.519156     2.546982     3.420943 
 C     2.561974    -1.261879     4.250228 
 H     1.932763    -1.552442     2.193114 
 C     2.914528    -0.335874     5.250509 
 H     3.173311     1.767762     5.718075 
 H     2.571837    -2.327331     4.469041 
 H     3.197746    -0.680742     6.241685 
 C    -1.968008     2.323901    -0.142642 
 C    -1.272318     2.692699     1.024798 
 C    -2.600623     3.314223    -0.921456 
 C    -1.208044     4.043730     1.412741 
 H    -0.778398     1.939436     1.632421 
 C    -2.527135     4.666088    -0.538279 
 H    -3.144539     3.024503    -1.816187 
 C    -1.833905     5.034257     0.632220 
 H    -0.665537     4.318166     2.313696 
 H    -3.014874     5.425550    -1.145238 
 H    -1.780986     6.078825     0.930532 
 C    -3.814015     0.156390     0.244734 
 C    -4.998630     0.702828    -0.290996 
 C    -3.862142    -0.572874     1.448245 
 C    -6.226151     0.507762     0.367511 
 H    -4.960271     1.269151    -1.217859 
 C    -5.089232    -0.756055     2.113462 
 H    -2.949977    -0.999172     1.855798 
 C    -6.273913    -0.219309     1.573985 
 H    -7.137112     0.927383    -0.053123 
 H    -5.118294    -1.316019     3.045335 
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 H    -7.222191    -0.363369     2.087067 
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5 Chapter 3 
 
 
 
 
 
 
 
 
 
 
Chiral (salen)Co(III)(N-benzyl-L-serine)-derived phosphites: 
monodentate P-ligands for enantioselective catalytic applications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
In this Chapter the screening of a series of salen-bearing monodentate P-ligands was studied in several 
enantioselective catalytic applications, showing good activity and moderate enantioselectivity in several 
palladium-catalyzed asymmetric reactions.  
A small library of ligands was synthesized reacting the (S,S)-salen-cobalt(III)-N-benzyl-L-serine complex 
with four diol-derived chlorophosphites affording phosphites 7a–7d in moderate yields (37–72%). 
Structural studies of these monodentate phosphite ligands and of their Rh-complexes were performed in 
solution by 1H and 31P NMR spectroscopy.1   
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3.1 GENERAL INTRODUCTION 
 
We widely discussed, in the chapter 1, supramolecular interactions and , more specifically, 
coordinative bonds have been used to induce higher stereoselectivity in catalytically active complexes. 
Both chiral and achiral scaffolds, such as porphyrins or bisoxazolines binding chiral Schiff-bases 
functionalities constituted a privileged class of ligands for enantioselective transition-metal catalytic 
applications. Among these chiral (salen)cobalt(III) and cobalt (II) complexes were successfully 
employed in several asymmetric transformations.  
Recently, our group has reported a novel approach to the resolution of racemic N-benzyl α-
amino acids (N-Bn-AA) by liquid-liquid extraction, using the lipophilic chiral (salen)cobalt(III) 
complex (R,R)-N,N’-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclo-hexanediaminocobalt(III) acetate, in 
excellent yield and enantioselectivity.2a As a result of the thermodynamic-controlled resolution by 
extraction, one enantiomer of the N-benzyl amino acid predominates in the aqueous phase, while the 
other enantiomer is driven into the organic phase by complexation to the cobalt center (Scheme 3.1).  
N N
O Ot-Bu
t -Bu t-Bu
t-Bu
Co
OAc
O
OHHN
R
Ph
DCM/H2O
10°C
N N
O Ot-Bu
t -Bu t-Bu
t -Bu
Co
NH
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O
RPh
organic phase
up to 0.98 equiv extracted, 90-99% ee
H
N
O
OH
RPh
aqueous phase
1 2 (racemic) 3 2-(S)
Scheme 3.1 Resolution of a racemic mixture of N-benzyl amino acids by liquid-liquid extraction using 
(salen)cobalt(III) complexes. 
 
This methodology has shown the optimal results when temperature is controlled at 10°C and the salen-
complex is reacted in presence of an excess of racemic amino acids mixture in a typical ratio 1 : 2. The 
complexed amino acid can be then released by a reductive (CoIII /CoII) counter-extraction into an 
aqueous phase in presence of Na2S2O4 or ascorbic acid as reductive agents. The original chiral CoIII 
complex can be regenerated and reused with essentially no loss of selectivity. 
Spectroscopic and molecular modelling investigations revealed a cis-β-folded arrangement around the 
octahedral cobalt ion of the (R,R)-salen ligand in the (N-Bn-AA)Co(salen) complex, with the 
remaining two cis coordination sites being occupied by the N-benzylamino acid. 2c The amino acid 
coordination takes place in such a way that a meridional arrangement of the three oxygen and three 
nitrogen atoms is obtained (meridional N3O3 structure). Using the (R,R)-salen ligand, the favored 
diastereomeric complex contains the (R)-enantiomer of the N-benzylamino acid, while the absolute 
configuration of the additional stereogenic elements (the octahedral cobalt and the tetrasubstituted 
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nitrogen of the N-benzylamino acid) was assigned as D and (S), respectively. As a consequence, the N-
benzylamino acid is nicely accommodated in the binding pocket of the chiral cobalt complex.  
The keen interest towards the design and the synthesis of new P-ligand architectures, together with the 
renaissance of monodentate P–ligands since 2000 (see chapter 1, paragraph 1.1), 3 prompted us to take 
advantage of well-defined salen4-cobalt(III)-N-Bn-AA coordination geometry and to develop a salen-
cobalt(III)-N-benzyl-serine complex as a chiral platform for the preparation of new families of both 
monodentate and supramolecular bidentate P-ligands (Scheme 3.2). L-serine was initially chosen 
because of its free hydroxylic group which can be functionalized to afford phosphites. Working with 
natural amino acids, (S,S)-N,N'-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclo-hexanediaminocobalt(II) 
complex was used as starting material. 
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Scheme 3.2 (A) Monodentate (salen)cobalt(III)(N-Bn-Ser) phosphites, (B) Bidentate hybrid P-ligands suitable 
for the formation of transition metal-catalysts by the supramolecular approach. 
 
3.2 RESULTS AND DISCUSSION 
3.2.1 Synthesis of salen-based monodentate P-ligands 
 
The chiral (salen)cobalt(III) acetate complex 5 was prepared following well estabilished-
oxidative procedures in presence of air/AcOH,5 starting from commercially available (S,S)-salen 
ligand 4 and cobalt(II)acetate (Scheme 3.3).  
Scheme 3.3 Synthesis of chiral(salen)cobalt(III) acetate 5.5 
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(S,S)-salen-cobalt(III)-acetate 5 was reacted with an excess (2.0 equiv.) L-serine in a DCM/H2O 
1:1 mixture at RT for 24 h. As this process is not a resolution, the control of temperature is not a 
determining variable (Scheme 3.4). This reaction was also performed on a multigram scale and 
complex 6 was obtained in excellent yield (96%) after chromatographic purification over silica gel, 
thus confirming the excellent stability of these complexes. 
N N
O Ot-Bu
t -Bu t-Bu
t-Bu
Co
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DCM/H2O
RT, 24 h
96%
N N
O Ot-Bu
t-Bu t -Bu
t-Bu
Co
N
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OBn
5 6
HO COOH
HN
Bn
OH
Scheme 3.4 Synthesis of the (S,S)-salen-cobalt(III)-N-benzyl-L-serine complex 6. 
 
The amino acid complexation procedure could be realized by three different methods:  
A) biphasic water/dichloromethane extraction; 
B) biphasic water/dichloromethane treatment and recovery of the uncomplexed amino acid by 
filtration; 
C) stirring a suspension of the racemic N-Bn amino acid with dichloromethane solution of 
[Co(III)(OAc)] complex and recovery of the uncomplexed amino acid by filtration.2a,b 
 
All these methods could be independently used without no substantially loss of conversions and 
stereoselectivities even if method A is preferred to method C for more hydrophilic amino acid (such as 
serine and threonine). This is probably due to the limited solubility of these amino acids in 
dichloromethane and the complexation becomes extremely slow.  
Another important point is the nitrogen substitution. Tipically, during the resolution of a racemic 
mixture of amino acids, N-unsubstituted and N-monosubstituted amino acids with a small substituent 
(e.g. methyl), reacted with the chiral selector to form the complex, hovewer, the small substituent does 
not provide sufficient steric interactions for a chiral discrimination. On the contrary, N,N-disubstituted 
amino acids are too bulky and this prevents the formation of the complex. Apparently, benzyl is the 
most suitable N-substituent to be accommodated in the chiral environment of the metal complex. 2a,b In 
our case, even if the enantiodiscrimination is not a fundamental step, N-benzyl amino acids were used 
as well and no attempts aimed at the use of N-unsubstituted amino acids was investigated. 
1H NOESY studies were then performed on complex 6 to demonstrate a similar configuration of the 
octahedral cobalt ion and arrangement of the substituents with respect to the well-known “matched” 
complex (R,R)salen-cobalt(III)-N-Bn-D-alanine.2c The NOESY spectrum of (S,S)salen-cobalt(III)-N-
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Bn-L-serine revealed that the two benzylic protons HA and HB strongly interact through space with the 
tert-butyl groups of the ligand. In particular, proton HA gives a cross-peak with t-Bu5’, and proton HB 
with t-Bu3. A NOE contact is also clearly visible between the protons in the ortho positions of the N-
Bn moiety and the t-Bu5’. Additional NOE contacts are observed between the NH of N-Bn-(S)-serine 
and the ligand backbone. On the other hand, the C-H stereocenter of the N-Bn-serine is in NOE 
contact with HA and the proton H6’ but not with the N-H. This suggest that the N-H pointed out in the 
opposite direction with respect to the C-H stereocenter of serine. Therefore, being the nitrogen atom 
locked in the coordination to cobalt, its absolute configuration can be determined as R. The NOESY 
spectrum also revealed that the –OH proton of serine does not give any significant NOE contact 
because it probably points out with respect to the plane of the complex. (Scheme 3.5 and experimental 
section).  
This spectroscopic study suggests that the amino acid is well-accommodated in the “binding pocket” 
of the chiral cobalt complex and the hydroxyl group can be easily functionalized notwithstanding the 
hindrance architecture of the whole complex. 
 
Scheme 3.5 NOE contacts in “matched” complex (S,S)salen-cobalt(III)-N-Bn-L-serine. 
 
The corresponding phosphite ligands 7a-7d were then synthesized by reaction of complex 6 with four 
(tropos and atropos) diol derived clorophosphites.6 The chlorophosphites were added at low 
temperature and the reaction mixtures were then warmed to room temperature and stirred for 20 min. 
After purification by flash chromatography, phosphites 7a-7d were obtained in moderate yields (37-
72%, Scheme 3.6).  
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Scheme 3.6 Synthesis of the (S,S)-salen-cobalt(III)-N-benzyl-L-serine derived phosphites 7a-7d. 
 
Most importantly, the reaction time was optimized to preserve the integrity of the complexes. We 
found that longer reaction times were not beneficial to the yields and causing decomposition of the 
product. In the synthesis of 7a, a decomposition product 8 was  isolated and tentatively characterized 
as a cobalt(III) complex containing the chiral salen moiety, a biphenyl phosphorous acid diester 
ligand, and no trace of the N-benzylamino acid (Scheme 3.7).  
N N
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Scheme 3.7 by-product obtained from a hypothetic Arbuzov’s type rearrangement. 
 
The structure of this specific was supported by the 31P NMR spectrum where a singlet at δ 37.5 ppm 
was detected. Chiral phosphorous diesters, which exist in a tautomeric equilibrium between a (RO)2P-
OH and a (RO)2P=O form, have been recently reported by Reetz to perform as active and 
enantioselective ligands in the Ir-catalised hydrogenation of imines. 7 From a mechanistic point of 
view, it can be assumed that, once formed, phosphite 7 activates the OH group of serine towards an 
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elimination reaction (Arbuzov’s type rearrangement),8 which is promoted by the base (TEA) present in 
the reaction medium. The biphenyl phosphorous acid diester 9 which is thus formed, exists in a 
tautomeric equilibrium between 9A and 9B. Although such equilibrium generally favors 9A,7 some X-
ray crystallography evidences showed that 9B-like derivatives are able to coordinate a transition metal 
center affording very stable complexes.9 For this reason, it is plausible that phosphorous acid diester 
9B is able to coordinate the cobalt center displacing the amino acid derivative (Scheme 3.8). Even if 
we have not X-ray crystallographic evidences, we can hypothesize that the cobalt(III) center forms a 
square pyramidal phosphonate complex where the Co(III) is directly linket to P and the salen moiety 
binds in an equatorial fashion while the P is axial.10 
Scheme 3.8 Hypothetic mechanism pathway of decomposition of (S,S)-salen-cobalt(III)-N-benzyl-L-
serine/threonine derived phosphites in basic conditions.  
 
An indirect proof of the existence of 8 was related to the absence of the formation of a P-Rh bond 
when 31P NMR complexation studies were performed in the presence of a Rh source. Indeed, the 
recorded 31P spectra showed the characteristic singlet of 8 at δ 37.5 ppm when both 8 was added in 
ratio 1 : 1 and in ratio 2 : 1 to the Rh source. 
An analogous synthetic pathway was attempted using N-benzyl-L-threonine instead of serine to study 
the effect of an additional stereogenic center closed to the P-atom. The chiral (S,S)-salen-cobalt(III)-N-
benzyl-L-threonine complex was prepared and isolated, after flash chromatography, in good yield 
(83%). Unfortunately, all attempts to proceed further with the formation of the phosphite met with no 
success and only the decomposition complex described above was isolated (Scheme 3.9). 
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Scheme 3.9 Synthesis of the (S,S)-salen-cobalt(III)-N-benzyl-L-threonine complex 10. 
 
3.2.2 Structural and complexation studies of salen-based monodentate P-
ligands 
 
NMR investigations of the ligands were then undertaken. The experiments were conducted in 
CDCl3, which was degassed and passed over a short pad of neutral alumina. 31P NMR spectra of the 
phosphites displayed in all cases a singlet at similar chemical shifts as reported in Table 3.1. 
 
Table 3.1 Chemical shifts of ligands 7a-d. 
Entry Ligand δ (ppm) 
1 7a 144.6 
2 7b 147.1 
3 7c 146.6 
4 7d 141.2 
 
 
The complexation of ligand 7a, which was chosen as representative of the ligand library, with 
[Rh(acac)(C2H4)2] was then studied (Scheme 3.10). A doublet at δ 148.6 ppm (JP-Rh = 312.2 Hz) and a 
doublet at δ 138.0 ppm (JP-Rh = 302.2 Hz) were observed in ratio 3:1 upon addition of 1.0 equiv. of 7a 
with respect to the rhodium source. In this case, the downfield doublet (138 ppm) was attributed to the 
complex in which only one ethylene molecule has been substituted by P ligand (monocomplex 
Rh(acac)(7a)(ethylene)), while the upfield doublet was assigned to the complex containing two 
ligands units coordinated to the rhodium center (homocomplex: Rh(acac)(7a)2). When the ratio 7a/Rh 
was increased to 2.1:1, the spectrum displayed only a doublet at δ 148.6 ppm plus a small singlet at δ 
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144.6 ppm (JP-Rh = 312.2 Hz) corresponding to excess ligand. Interestingly, two ligands can be 
accommodated around the rhodium atom notwithstanding their steric hindrance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.10 31P NMR spectra of the rhodium complexes resulting from the combination of ligand 7a with 
Rh(acac)(C2H4)2 in a) 1 : 1 ratio and b) 2.1 : 1 ratio. 
 
 
3.2.3 Catalytic screening of salen-derived monodentate P-ligands  
 
The ligands were then screened for several enantioselective catalytic applications. 
Unfortunately, in the rhodium catalyzed enantioselective hydrogenation of functionalized olefins and 
in the rhodium catalyzed asymmetric conjugate addition of arylboronic acids to enones, reduction of 
cobalt(III) to cobalt(II) was observed, as a rapid change in colour of the reactions mixtures from green 
to brown (typical for salen-Co(II) derivative), with consequent loss of the (salen)Co(N-Bn-Ser) 
phosphite ligand integrity. The brown species was isolated and characterization by NMR spectroscopy 
was tried but all attempts to record the NMR-spectra failed probably due to the paramagnetic character 
of Co(II) metal center. On the contrary, when the Pd-catalyzed allylic substitution of rac-1,3-diphenyl-
3-acetoxyprop-1-ene 11 (Scheme 3.11)11 with dimethyl malonate was tested, the ligands proved 
perfectly stable and gave excellent conversions, albeit with low enantiomeric excess (up to 35% e.e. 
using ligand 7a).  
OAc
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L 6.1 mol%
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CH(COOMe)2
11 12
 
Scheme 3.11 Pd-catalyzed enantioselective allylic substitution of rac-1,3-diphenyl-3-acetoxyprop-1-ene. 
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Quite surprisingly, the use of bulkier 3,3’,5,5’-tetramethyl-2,2’-biphenol derivative 7b gave the 
opposite enantiomer, while the use of axially chiral BINOL derivatives 7c and 7d led to racemic 
products (Table 3.2) . As a proof of the positive effect of our ligands on this kind of transformation, 
the reaction was run only in presence of the Pd source leading to poor conversion after 24 h (entry 1, 
Table 3.2). An attempt to improve enantioselectivity was done reducing the reaction temperature from 
RT to -10°C. Unfortunately, a drastic decrease in conversion was obtained (entry 4, Table 3.2). 
 
Table 3.2 Screening of ligands 7a-7d in the Pd-catalyzed allylic alkylation of rac-1,3-diphenyl-3-acetoxyprop-1-
ene. 
Entry Ligand Reaction Time 
(h) 
Temperature 
(°C) 
Conv. (%) ee (%)  
1 none 24 25 11 - 
2 7a 5 25 100 12 
3 7b 5 25 100 -35 
4 7b 5 -10 <5% - 
5 7c 5 25 100 3 
6 7d 5 25 100 8 
 
Ligands 7a-7d were then screened in the Pd-catalyzed desymmetrization of meso-cyclopenten-
2-ene-1,4-diol biscarbamate 13 (Scheme 3.12).12 This intramolecular allylic substitution reaction was 
developed by Trost and co- workers and has proven a very powerful method in several synthetic 
approaches to biologically relevant targets. 13 The ligands used in the original examples are chiral 
bidentate phosphines and give the product with excellent enantioselectivity (ee up to 99 %)14 while, to 
our knowledge, no monodentate phosphite ligands have ever been reported for this reaction. 
 
TsNCO
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Scheme 3.12 Pd-catalyzed enantioselective desymmetrization of meso- cyclopenten-2-ene-1,4-diol biscarbamate 
13. 
 
The reaction was performed using 10 mol% of palladium (5% of the dimer Pd2dba3) and 20 mol% of 
ligands 7a-7d. In several cases, a stoichiometric amount of triethylamine (TEA), which has been 
reported to increase the enantioselectivity of the reaction,14 was added to the mixture. The results are 
summarized in Table 3.3. 
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Table 3.3 Screening of ligands 7a-7d in the Pd-catalyzed desymmetrization of meso- cyclopenten-2-ene-1,4-diol 
biscarbamate 13. 
 
Entry Ligand Temperature 
(°C) 
TEA Conv. (%) 16 (S,R):(R,S)  
1 None 25 No - - 
2 7a 25 No 96 50:50 
3 7a 25 Yes 100 15:85 
4 7a 0 Yes 85 18:82 
5 7b 25 Yes 90 48:52 
6 7b 0 Yes 90 28:72 
7 7c 25 No 100 90:10 
8 7c 25 Yes 99 80:20 
9 7d 25 No 100 35:65 
10 7d 25 Yes 93 32:68 
 
 
Reaction conversions were always good, in many cases quantitative, with all four ligands (7a-
7d). Addition of TEA to the reaction with ligand 7a was fundamental to achieve higher levels of 
enantioselectivity14 while, in the case of ligand 7c, TEA had a negative effect. (At the moment, we are 
not able to give a plausible explanation to this behavior.) Remarkably, the use of complex 7a, 
containing a tropos biphenol moiety (entries 3, 4), afforded enantiomeric ratios comparable (yet 
opposite) to 7c, containing an atropos (Sa)-1,1’-binaphthyl moiety (entries 7, 8). All these observations 
confirm that the chiral and well organized structure of the salen-cobalt(III)-N-benzyl-L-serine complex 
is relevant in determining the stereochemical outcome of the reaction. 
 
3.2.4 Synthesis of salen-based supramolecular bidentate P-ligands 
 
Coordination complexes have been recently used for the preparation of supramolecular 
bidentate P-ligands.15 In this approach, two monodentate P-ligands self-assemble around a transition 
metal (Rh, Pd) by virtue of an additional coordinative bonding of nitrogen to a transition metal such as 
zinc. Key-players in this research field are Reek, 16 Takacs17.The advantage of these supramolecular 
approaches is the expectation that degrees of freedom in the respective transition metal coordination 
complex are reduced, resulting in the simulation of a preorganised bidentate system with predictable 
geometric properties, as in conventional bidentate ligands. 
Having in hand the stable salen-cobalt(III)-N-Bn-L-serine-monodentate phosphites, we were 
intrigued by the possibility to introduce a secondary additional phosphorous functionality in the salen 
moiety to realize a new class of supramolecular bidentate P-ligands (Scheme 3.13). 
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Scheme 3.13 Generic.structures of (S,S)-salen-cobalt(III)-N-Bn-L-serine monodentate P-ligands (17A) and 
supramolecular bidentate ligands (17B). 
 
The synthesis of the supramolecular bidentate P-ligands 17B required the preparation of 
unsymmetrical salen18 containing a –CH2OH group (blue pointed out in Scheme 3.4) by sequential 
condensation of (S,S)-1,2 diaminocyclohexane with 3,5-di-tert-butylsalicylaldehyde and 3-tert-butyl-
5-hydroxymethylsalicylaldehyde 23,19 following the one-pot protocol by Weck and co-workers 
(Scheme 3.14).20  
Scheme 3.14 Synthesis of unsymmetrical (S,S)-salen backbone 24. 
 
This methodology has the advantage of avoiding the isolation step of the monoamine intermediate that 
is prone to the undesired disproponation reaction.21 
The preparation of nonracemic unsymmetrical salen ligand 24 started with monoprotection of one 
amine moiety of (S,S)-1,2 diaminocyclohexane 18 as monoammonium chloridrate salt by reaction with 
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2.0 M hydrogen chloride in ether. The first condensation between the monoammonium salt 19 and 3,5-
di-tert-butylsalicylaldehyde was carried out in a1:1 (v/v) mixture of anhydrous methanol at room 
temperature. The presence of activated molecular sieves has a crucial role to remove the water that is 
formed during the reaction thus reducing the reaction time. After the first condensation was complete, 
a solution of the 3-tert-butyl-5-hydroxymethylsalicylaldehyde 23 in dichloromethane was added to the 
reaction system, followed by the slow addition of an excess of anhydrous triethylamine as a 
deprotective base. The target unsymmetrical salen ligand 24 was isolated in good yield (75%). 
The salen-cobalt(III)-acetate complex was then synthesized in good yield (75%) (as a 1:1 mixture of 
two inseparable diastereoisomers (25 and 26)) by an oxidative reaction in presence of air/AcOH 
(Scheme 3.15).5  
 
Scheme 3.15 Synthesis of unsymmetrical (S,S)-salen-cobalt(III)(OAc) complex. 
 
Addition of (N)-Bn-L-Ser to the mixture of 25 and 26 (1:1), following the well-known liquid-liquid 
extraction procedure,2 led to the formation of the different diastereomeric complexes for which a 
perfect isolation and a complete characterization was not possible. In principle, several stereoisomers 
can be obtained, due to the presence of different stereogenic elements and namely: (a) the 
stereocenters at the amino acid (S) and the diamine (S,S), the stereocenter at N; (b) the helicity of the 
octahedral Co complex (Λ), (c) the disposition of the three oxygen and the three nitrogen of the salen 
and amino acid ligand (mer) and finally (d) the position of the –CH2OH bound to the salicylaldehyde 
unit. To the best of our knowledge the mer arrangement is apparently typical for this kind of 
complexes and the helicity is fixed by the configuration of the diamine.2c Starting from an inseparable 
mixture of 25 and 26, a mixture of four diastereomers differing from the position of the -CH2OH and 
the stereochemistry of the N-amino acid atom can be obtained (Scheme 3.16). 
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Scheme 3.16 Possible diastereomers can be formed by liquid-liquid extraction of mixture of 25 and 26 (1:1) with 
N-Bn-L-serine.  
 
As explorative test, the mixture of diastereomers (27-30) was reacted with biphenol-PCl but only the 
decomposition of the cobalt architecture was detected. 
Further studies are being aimed at the development of a procedure to obtain the unsymmetrical (S,S)-
salen-ligand and the corresponding unsymmetrical (S,S)-salen-cobalt(III)-N-Bn-L-serine bidentate P-
ligand in a pure diastereoisomeric fashion. 
 
3.3 CONCLUSIONS 
 
In this Chapter, we have investigated the use of an octahedral (S,S)-(salen)cobalt(III)-N-
benzyl-L-serine complex for the formation of monodentate phosphites, to be used as chiral ligands in 
enantioselective catalytic applications. The ligands were obtained in moderate yields by reaction of 
(S,S)-(salen)cobalt(III)-N-benzyl-L-serine with diol-derived chlorophosphites. These phosphites 
showed a remarkable air and moisture stability. 
31P-NMR complexation studies of ligand 7a, chosen as representative of the ligand library, were 
performed in presence of [Rh(acac)(C2H4)2] as Rh(I) source. Upon addition of 2.1 equiv. of salen-
based P-ligand with respect to the Rh source, a stable Rh-homocomplex with two ligand units 
coordinated to the metal center was detected. Interestingly the formation of this complex has been took 
place in spite of the steric hindrance of the salen backbone. 
The small ligand library was then screened for several asymmetric catalytic applications, showing 
good activity and moderate enantioselectivity in the palladium catalyzed desymmetrization of meso-
cyclopenten-2-ene-1,4-diol biscarbamate. 
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Further studies were aimed at the desymmetrization of the salen unit to introduce a secondary 
additional phosphorous functionality in the salen moiety to realize a new class of supramolecular 
bidentate P-ligands. these preliminary attempts led to the formation of inseparable mixtures of 
diastereomers and the reaction with biphenol-PCl led to the decomposition of the whole complex 
structure. Next aims are being focused on synthetic pathways able to afford the unsymmetrical (S,S)-
salen-ligand and the corresponding unsymmetrical (S,S)-salen-cobalt(III)-N-Bn-L-serine bidentate P-
ligand in a pure diastereoisomeric fashion. 
 
3.4 EXPERIMENTAL SECTION 
 
3.4.1 General remarks 
 
All reactions were carried out in flame-dried glassware with magnetic stirring under nitrogen 
atmosphere, unless otherwise stated. Commercially available dry solvents (over molecular sieves in 
bottles with crown cap) were stored under nitrogen and used without further distillation. TEA was 
distilled over CaH2 under nitrogen. Reactions were monitorated by analytical thin-layer 
chromatography (TLC) using silica gel 60 F254 precoated glass plates (0,25 mm thickness). 
Visualization was accomplished by irradiation with a UV lamp and/or staining with a permanganate 
alkaline solution. Flash chromatography was performed using silica gel 60Ả, particle size 40-64µm, 
following the procedure by Still and co-workers.22 1H NMR spectra were recorded on a spectrometer 
operating at 400.13 MHz. Proton chemical shift are reported in ppm (δ) with the solvent reference 
relative to tetramethylsilane (TMS) employed as the internal standard (CDCl3 7.28 ppm). The 
following abbreviations are used to describe spin multiplicity: s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet, br = broad signal, dd = doublet of doublet.1H COSY and 1H NOESY spectra of 
6 were recorded using a 20 mM solution of complex in CDCl3. 13C NMR spectra were recorded on a 
400 MHz spectrometer operating at 100.56 MHz, with complete proton decoupling. Carbon chemical 
shifts are reported in ppm (δ) relative to TMS with the respective solvent resonance as internal 
standard (CDCl3, 77.0 ppm). 31P-NMR spectra were recorded on a 400 MHz spectrometer operating at 
162 MHz, with complete proton decoupling. 31P-NMR chemical shifts are reported in ppm (δ) relative 
to external 85% H3PO4 at 0 ppm (positive value downfield). Infrared spectra were recorded on a 
standard FT/IR spectrometer; bands are reported in cm-1. Optical rotation values were measured on a 
automatic polarimeter with a 1 dm cell at the sodium D line (λ = 589 nm). HPLC analyses were 
performed with a chiral stationary phase column CHIRALCEL OD-H (eluent hexane/isopropanol 
90:10, flow 0,6 mL/min, tr = 35 min (first enantiomer) 44 min (second enantiomer), λ = 254 nm. High 
resolution mass spectra (HRMS) were performed on Fourier Transform Ion Ciclotron Resonance (FT-
ICR) Mass Spectrometer APEX II & Xmass software (Bruker Daltonics) - 4.7 T Magnet (Magnex). 
Chiral (salen)Cobalt(III)(N-benzyl-L-serine)-derived phosphites 
163 
 
Commercially available reagents were used as received. (S,S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-
1,2-cyclo-hexanediaminocobalt(III) acetate 5,5 N-benzyl-L-serine,23  and diol derived 
monochlorophosphites were synthesized as reported in the literature.24 
 
3.4.2 General procedure for the Pd-catalyzed allylic alkylation of rac-1,3-
diphenyl-3-acetoxyprop-1-ene.11 
 
[Pd(η3C3H5)Cl]2 (2.81 mg, 0.0077 mmol) and the ligand (0.0311 mmol) were dissolved under 
nitrogen in degassed CH2Cl2 (1.0 mL). The resulting clear solution was stirred for 20 min at RT, then a 
solution of rac-1,3-diphenyl-3-acetoxyprop-1-ene (129 mg, 0.51 mmol) in degassed CH2Cl2 (1.0 mL), 
dimethyl malonate (170 µL, 1.5 mmol), N,O-bis(trimethylsilyl)-acetamide (BSA, 370 µL, 1.5 mmol), 
and a pinch of AcOK were added. The reaction mixture was stirred at room temperature. After 1h the 
solution was diluted with Et2O (5 mL) and saturated aqueous NH4Cl (25 mL) was added. The phases 
were separated and the aqueous phase was extracted with Et2O (2 × 5 mL). The combined organic 
phases were dried over Na2SO4 and the solvent was removed under reduced pressure. Conversion was 
determined by 1H NMR analysis of the crude reaction mixture. An aliquot of the crude was passed 
through a pad of silica using 5:1 hexane/EtOAc as the eluent. The solvents were removed under 
vacuum and the residue was directly analyzed by HPLC for the determination of the enantiomeric 
excess. HPLC conditions: column: CHIRALCEL OD-H; eluent: 99:1 hexane/isopropanol; flow: 0.3 
mL/min; λ = 250 nm; tR = 24 min, tS = 26 min. 
 
3.4.3 General procedure for the Pd-catalised desymmetrization of meso-
cyclopenten-2-ene1,4 diol biscarbamate.14 
 
To a solution of the meso-cyclopenten-2-ene-1,4-diol (10 mg, 0.099 mmol) in 0.5 mL of THF, 
tosyl isocyanate (35 µL, 0.232 mmol, 2.35 equiv) was added. The mixture was stirred at rt for 15 min 
to give a colorless solution then heated to 55 °C for 1 h. The reaction was cooled back to rt, and 
triethylamine (14.0 µL, 0.099 mmol, 1.0 equiv) was added as additive in specific cases. The resulting 
white slurry was brought to the chosen temperature conditions and a solution of tris(dibenzylidine 
acetone)dipalladium(0) chloroform complex (5.1 mg, 4.94 µmol) and ligand (20.25 µmol) in 0.5 mL 
of THF was added (the solution of the Pd-source and the ligand was prepared under nitrogen and 
stirred for 40 min at rt, 10 min at 55°C and finally cooled back to rt). The reaction solution was stirred 
for 30 min. The solvent was removed in vacuo and purified by flash chromatography on a short pad of 
silica gel (10 cm, hexane/AcOEt 80:20) gave the desired products as a slightly brown solid. 
Conversions were determined by NMR analysis of the crude reaction mixture. Enantiomeric excesses 
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were determined by chiral HPLC (column Chiralcel OD-H, n-hexane/2-propanol 90:10, flow 0,6 
ml/min). 
 
3.4.4 Synthesis of (S,S) salen-cobalt(III)-N-Bn-L-serine complex 6. 
 
To a solution of the cobalt complex (S,S)-(salen)Co(III)(OAc) (5) (1.65 g, 2.38 mmol) in 
dichloromethane (300 mL) at rt in a 1 L round-bottom flask, a solution of N-Bn-L-serine (464 mg, 1.0 
equiv, 2.38 mmol) in H2O (100 mL) was added. The biphasic mixture was stirred vigorously overnight 
at RT, then transferred to a separating funnel. The organic phase was removed and the aqueous phase 
washed twice with dicholoromethane (40 mL). The combined organic phases were washed once with 
H2O (40 mL), dried over Na2SO4 and the solvent removed under reduced pressure. The crude was 
purified by flash chromatography (dicholoromethane/methanol 95:5) to afford the product as a green 
powder (1.82 g, yield 96%). Mp decomposition at 160 °C. [α]22D=  1671.1 (c = 0.027, CHCl3); IR 
(nujol) νmax 3346, 3215, 2730, 1638, 1644, 1615, 1524, 1377, 1256, 1168, 1015, 930, 781 cm-1. 1H 
NMR (CDCl3) δ 7.92 (s, 1H), 7.44 (d, 1H, J=2.4 Hz), 7.39 (s, 1H), 7.30 (d, 1H, J=2.4 Hz), 7.26-7.19 
(m, 4H),7.13 (d, 1H, J=2.3), 6.62 (d, 2H, J=7.0 Hz), 5.35 (m, 1H) 4.63(m, 2H), 4.02 (d, 1H, J=13.6 
Hz), 3.43-3.25 (m, 3H), 2.94 (m, 1H), 2.80 (m, 1H), 2.29 (m, 1H), 2.18 (m, 1H), 1.73-1.61 (m, 3H), 
1.54 (s, 9H), 1.38 (s, 19 H), 1.18 (s, 9H), 1.0-0.94 (m, 2H) ppm. 13C NMR (CDCl3) δ 163.7, 163.3, 
162.6, 160.1, 144.3, 141.1, 137.3, 136.9, 134.4, 129.8, 129.2, 128.9, 128.2, 125.7, 122.6, 117.4, 75.2, 
70.8, 62.7, 55.4, 35.8, 34.0, 33.8, 31.5, 31.4, 31.0, 29.7, 29.6, 25.1, 22.6 ppm. HRMS (ESI+) m/z calcd 
for [C46H64CoNaN3O5]+: 820.40702 [M+Na]+; found: 820.40507. 
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Section of 1H-COSY spectrum of (S,S)salen-cobalt(III)-N-Bn-L-serine with cross-peaks corresponding to the 
interactions of the hydrogen atoms of the L-N-Bn-Ser portion. 
 
 
Section of 1H-NOESY spectrum of (S,S)-salen-cobalt(III)-N-Bn-L-serine showing spatial interactions between 
protons of the L-serine backbone and the chiral salen ligand. 
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Section of 1H-NOESY spectrum of (S,S)-salen-cobalt(III)-N-Bn-L-serine showing spatial interactions between 
protons HA and HB of the benzyl group of (S)-N-Bn-Ser and t-butyl groups of the chiral salen ligand. 
 
3.4.5 Synthesis of (S,S) salen-cobalt(III)-N-Bn-L-threonine complex 10. 
 
(S,S) salen-cobalt(III)-N-Bn-L threonine complex 10 was synthesized following 
the same procedure reported above for compound 6 (Yield: 83%). 
IR (nujol): υmax 3367, 2918, 2723, 1655, 1631, 1574, 1544, 1526, 1406, 1270, 
1256, 1208, 1168, 1128, 1098, 1056, 1024, 987, 932, 915 cm-1. 1H NMR (400 
MHz, CDCl3): δ = 7.91 (s, 1H), 7.53 (s, 1H), 7.46 (s, 1H), 7.32-7.16 (m, 5H), 
7.14 (s, 1H), 6.60 (s, 1H), 6.58 (s, 1H), 4.81-4.60 (m, 2H), 4.33-4.18 (m, 2H), 3.40-3.34 (m, 2H), 3.15-
3.03 (m, 2H), 2.86 (d, J = 8.4 Hz, 1H), 2.45-2.35 (m, 1H), 2.00-1.81 (m, 3H), 1.60-1.52 (m, 3H), 1.55 
(s, 9H), 1.42 (s, 9H), 1.37 (s, 9H), 1.19 (s, 9H), 0.72 ppm (d, J = 4.4 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ = 182.7, 165.4, 163.7, 163.6, 161.0, 145.4, 141.7, 138.5, 137.3, 135.6, 130.9, 130.4, 130.2, 
129.8, 129.2, 126.1, 122.9, 118.0, 76.0, 71.3, 68.8, 67.8, 57.1, 36.5, 36.4, 32.1, 31.5, 30.5, 30.3, 29.8, 
25.3, 24.5, 20.0 ppm. HRMS (ESI+) m/z calcd for [C47H66N3O5CoNa]+: 834.4227 [M+Na]+; found: 
834.4259. Elemental analysis calcd (%) for C47H66N3O5Co (MW = 811.99): C 69.52, H 8.19, N 5.17; 
found: C 69.21, H 8.21, N 4.87. 
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3.4.6 General procedure for the synthesis of the .(S,S)-salen-Co(III)-N-Bn-
L-serine complex phosphites 7a-7d. 
 
The (S,S)-Salen-Co(III)-N-Bn-L-Serine complex 6 (120 mg, 0.15 mmol) was dissolved in THF 
(1.0 mL) in a schlenk under nitrogen atmosphere. Freshly distilled TEA (42 µL, 0.3 mmol, 2 equiv) 
was added to the green solution at RT and the whole mixture was cooled to -78 °C. A solution of the 
diol derived monochlorophosphite (0.18 mmol, 1.2 equiv) in THF (1.0 mL) was added dropwise and 
the reaction mixture was allowed to warm to rt. After 20 min the solvent was removed under reduced 
pressure and the crude was quickly purified by flash chromatography to afford the product as a green 
fine powder. 
 
(S,S)-salen-Co(III)-N-Bn-L-serine-biphenyl phosphite 7a. 
 
(hexane/AcOEt 3:2 Rf = 0.50) (76 mg, yield 50%). [α]23D= -681.8 (c = 
0.094, CHCl3). IR (nujol) νmax 3231, 2705, 1672, 1643, 1615, 1529, 1377, 
1321, 1250, 1207, 1168, 1096, 1015, 897, 739 cm-1. 1H-NMR (CDCl3) δ 
7.84 (s, 1H), 7.44-7.43 (m, 4H), 7.36-7.12 (m, 12H), 6.65 (d, 2H, J=7.3 
Hz), 5.16 (m, 1H), 4.66(dd, 1H, J = 13.6 Hz, J = 3.8 Hz), 4.12 (dd, 1H, J = 
5.9 Hz, J = 3.8 Hz), 4.02 (m, 2H), 3.46 (m, 1H), 2.98 (m, 1H), 2.82 (m, 
1H), 2.71 (m, 1H), 1.96-1.55 (m, 4H), 1.55 (s, 10H), 1.42 (s, 9H), 1.36 (s, 
10H), 1.17 (s, 10H) ppm. 13C-NMR (CDCl3) δ 179.8, 164.9, 163.5, 163.4, 160.7, 150.1, 149.3, 144.9, 
141.2, 137.7, 137.0, 135.2, 131.8, 130.4, 130.3, 130.1, 129.8, 129.7, 129.6, 129.4, 129.1, 128.8, 126.0, 
125.7, 125.6, 122.8, 122.5, 122.4, 120.9, 118.1, 117.9, 75.9, 70.6, 65.5, 65.3, 64.89, 64.8, 55.9, 36.2, 
34.5, 34.2, 32.0, 31.9, 31.1, 30.3, 29.9, 29.3, 25.0, 24.3 ppm. 31P-NMR (CDCl3) δ 164.6 ppm. HRMS 
(ESI+) m/z calcd for [C58H71CoNaN3O7P]+: 1034.42538 [M+Na]+; found: 1034.42271. 
Decomposition by-product 8: 1H-NMR (CDCl3) δ 8.30 (bs, 1H), 8.01 (bs, 1H), 
7.51 (d, 1H, J=2.4 Hz), 7.44 (d, 1H, J=2.4 Hz), 7.32 (dd, 1H, J = 7.4 Hz, J = 1.3 
Hz), 7.26 (d, 1H, J = 7.2 Hz), 7.21 (d, 1H, J=2.4 Hz), 7.17 (d, 1H, J=2.4 Hz), 
7.13-7.04 (m, 2H), 6.99-6.95 (m, 1H), 6.68-6.64 (m, 1H), 6.14 (d, 1H, J=7.7 
Hz), 5.47 (d, 1H, J=8.2 Hz), 4.25-4.18 (m, 1H), 3.73-3-67 (m, 1H), 2.91 (d, 1H, 
J=10.5 Hz), 2.78 (d, 1H, J=9.7 Hz), 2.09-2.05 (m, 2H), 1.96-1.87 (m, 1H), 1.78-
1.68 (m, 1H), 1.63-1.49 (m, 2H), 1.48 (s, 9H), 1.43 (s, 9H), 1.40 (s, 9H), 1.22 (s, 
9H) ppm. 31P-NMR (CDCl3) δ 37.5 ppm. 
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(S,S)-salen-Co(III)-N-Bn-L-serine-3,3’,5,5’biphenyl phosphite 7b. 
 
(hexane/AcOEt 3:1 Rf = 0.40) (115 mg, yield 72%). [α]23D= -1050.8 (c = 
0.077, CHCl3); IR (nujol) νmax 3251, 3232, 2726, 1680, 1645, 1618, 1535, 
1380, 1320, 1257, 1212, 1168, 1093, 1015, 860, 739 cm-1. 1H-NMR 
(CDCl3) δ 7.81 (s, 1H), 7.42 (d, 1H, J = 2.5 Hz), 7.38-7.28 (m, 4H), 7.27 
(d, 1H, J = 2.4 Hz), 7.18 (s, 1H), 7.12-7.11 (m, 2H), 7.06 (s, 1H), 7.00 (d, 
1H, J = 2.3 Hz), 6.75 (m, 2H), 6.51 (s, 1H), 5.04 (m, 1H), 4.68 (m, 1H), 
4.34 (m, 1H), 4.15 (dd, 1H, J = 14.3 Hz, J = 7.13 Hz), 4.01-3.92 (m, 2H), 
3.52 (m, 1H), 2.89-2.78 (m, 2H), 2.62-2.58 (m, 1H), 2.46 (s, 3H), 2.37 (s, 6H), 2.30 (s, 3H), 1.83-1.70 
(m, 3H), 1.57 (s, 9H), 1.50 (s, 9H), 1.36 (s, 10H), 1.23-1.17 (m, 11H) ppm. 13C-NMR (CDCl3) δ 
179.3, 164.8, 163.5, 147.4, 145.0, 144.8, 141.2, 137.6, 135.6, 135.1, 134.8, 133.9, 132.1, 131.9, 131.3, 
131.2, 130.7, 130.4, 130.2, 129.6, 129.5, 129.0, 128.4, 127.7, 126.0, 122.8, 118.2, 75.9, 71.0, 66.3, 
66.1, 65.9, 60.8, 55.9, 36.1, 34.6, 34.1, 32.2, 31.9, 31.3, 30.3, 29.9, 29.5, 25.0, 23.9, 21.3, 17.4, 16.9, 
14.6 ppm. 31P-NMR (CDCl3) δ 150.7 ppm. HRMS (ESI+) m/z calcd for [C62H79CoNaN3O7P]+: 
1090.48798 [M+Na]+; found: 1090.48576. 
 
(S,S)-salen-Co(III)-N-Bn-L-serine-(Sa)-binaphthyl-phosphite phosphite 7c. 
 
 (hexane/AcOEt 2:1 Rf = 0.40) (62 mg, yield 37%). [α]22D= -775.2 (c = 0.078, 
CHCl3); IR (nujol) νmax 3159, 2722, 1660, 1634, 1615, 1526, 1365, 1321, 1255, 
1230, 1168, 945, 828, 730 cm-1. 1H-NMR (CDCl3) δ 8.06 (d, 1H, J = 8.8 Hz), 
7.97 (d, 1H, J = 8.3 Hz), 7.87 (d, 1H, J = 8.5 Hz), 7.82 (d, 1H, J = 8.8 Hz), 7.77 
(m, 1H), 7.62 (d, 1H, J = 8.7 Hz), 7.50-7.33 (m, 9H), 7.31-7.26 (m, 3H), 7.13 (d, 
1H, J = 8.7 Hz), 7.08-7.06 (m, 2H), 6.73 (m, 2H), 5.32 (m, 1H), 4.67 (m, 1H), 
4.16-4.04 (m, 3H), 3.59 (m, 1H), 3.46 (m, 1H), 2.80 (m, 1H), 2.73-2.68 (m, 2H), 
1.77-1.63 (m, 3H), 1.54 (s, 9H), 1.42 (s, 9H), 1.41-1.35 (m, 2H), 1.33 (s, 9H), 1.19-1.12 (m, 10H) 
ppm. 13C-NMR (CDCl3) δ 179.2, 164.4, 163.1, 162.9, 160.7, 152.0, 147.7, 146.8, 144.5, 140.8, 137.3, 
136.9, 134.8, 132.9, 132.1, 131.7, 131.0, 130.7, 130.5, 130.4, 130.2, 129.9, 129.8, 129.3, 128.6, 128.5, 
128.4, 127.2, 127.0, 126.6, 126.5, 126.2, 125.7, 125.4, 124.9, 122.1, 122.0, 121.6, 119.3, 118.0, 117.7, 
75.5, 69.7, 64.6, 64.5, 63.6, 63.5, 55.4, 35.8, 34.1, 33.7, 31.6, 31.4, 30.4, 30.1, 29.8, 29.5, 29.1, 28.5, 
24.4, 23.6 ppm. 31P-NMR (CDCl3) δ 146.6 ppm. HRMS (ESI+) m/z calcd for [C66H75CoNaN3O7P]+: 
1134.45668 [M+Na]+; found: 1134.45474. 
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(S,S)-salen-Co(III)-N-Bn-L-serine-(Ra)-binaphthyl-phosphite phosphite 7d. 
 
(hexane/AcOEt 2:1 Rf = 0.40) (75 mg, yield 45%). [α]23D= -1227.3 (c = 0.055, 
CHCl3); IR (nujol) νmax 3221, 2725, 1670, 1652, 1634, 1521, 1377, 1314, 1256, 
1168, 1095, 1023, 945; 823, 744 cm-1. 1H-NMR (CDCl3) δ 8.06-7.59 (m, 3H), 
7.80 (s, 1H), 7.59 (d, 1H, J=8.7 Hz), 7.51-7.45 (m, 2H), 7.42-7.27 (m, 7H), 7.20 
(d, 1H, J=2.4 Hz), 7.09-6.96 (m, 5H), 6.59-6.57 (m, 3H), 4.85 (m, 1H), 4.59 (m, 
1H), 4.17-4.09 (m, 2H), 3.91 (m, 1H), 3.42 (m, 1H), 2.88-2.75 (m, 2H), 2.61 (m, 
1H), 1.99-1.85 (m, 3H), 1.56-1.41 (m, 19H), 1.36-1.34 (m, 10H), 1.28-1.25 (m, 
1H), 1.22-1.12 (m, 11H) ppm. 13C-NMR (CDCl3) δ 179.2, 164.4, 162.9, 161.2, 159.6, 148.3, 147.0, 
144.4, 140.8, 137.1, 136.4, 134.8, 132.7, 132.3, 131.6, 130.8, 130.6, 129.9, 129.8, 129.3, 129.1, 129.0, 
128.8, 128.4, 128.3, 126.9, 126.8, 126.4, 126.3, 126.0, 125.6, 125.2, 125.1, 124.5, 123.9, 123.5, 122.6, 
75.5, 70.4, 66.3, 66.1, 65.1, 55.5, 35.7, 34.1, 33.7, 31.7, 31.4, 30.6, 29.8, 29.4, 29.0, 24.5, 23.7 ppm. 
31P-NMR (CDCl3) δ 144.2 ppm. HRMS (ESI+) m/z calcd for [C66H75CoNaN3O7P]+: 1134.45668 
[M+Na]+; found: 1134.45423. 
 
3.4.7 Complexation Experiments 
 
General procedure 
All experiments were conducted using CDCl3 pre-emptively passed over a short plug of neutral 
alumina. 
The complexation experiments were run in NMR tubes under nitrogen atmosphere and monitored by 
1H and 31P NMR spectroscopy. The typical scale of the experiments was 6.51 µmol of metal source 
([Rh(acac)(C2H4)2]) in 500 µL of deuterated solvent (0.013 M concentration). The clear yellow 
solution was titrated by addition of defined aliquots (150 µL each) of ligand 7a, chosen as 
representative of the ligand library, in such a way the ratio Rh : L was 1 : 1. At this stage two specie 
was obtained namely homocomplex (Rh(acac)(7a)2) and monocomplex (Rh(acac)(7a)(ethylene)) in a 
3 : 1 ratio. Upon addition of a second aliquot of ligand, the exclusive formation of the homocomplex 
appeared, showing the good coordinative features of our P-ligands notwithstanding their steric 
hindrance.  
31P NMR spectra have been reported on paragraph 3.1.2. 
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PhthalaPhos: Chiral Supramolecular Ligands for Enantioselective 
Rhodium-Catalyzed Hydrogenation Reactions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
In this chapter the synthesis of a library of novel chiral supramolecular ligands containing a phthalamide moiety 
capable of hydrogen bonding interactions is reported. The new ligands, named PhthalaPhos, are easy to prepare from 
inexpensive starting materials, and displayed an excellent level of enantioselectivity in the hydrogenation of 
benchmark olefins (methyl 2-acetamidoacrylate and acetamidostyrene) as well as of more challenging, industrially 
relevant substrates. In two reported cases, namely the cyclic enamide N-(3,4-dihydronaphthalen-1-yl)acetamide and 
β2-dehydro aminoester (E)-methyl 2-(acetamidomethyl)-3-phenylacrylate, our ligands rival or even outperform the best 
results obtained with known ligands. The pre-catalytic Rh complex of one of these ligands was fully characterized by 
NMR, IR and MS spectroscopy. These studies show that a supramolecular bidentate ligand is formed in the Rh 
complex by ligand self-association through a pair of interligand hydrogen bonds.1   
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4.1 GENERAL INTRODUCTION 
 
Chemists have largely taken inspiration from Nature in the development of new approaches to 
synthetic challenges. Combinatorial chemistry stems from the concept of evolution, where random 
mutation of a chemical structure gives rise to libraries of compounds, from which an optimal lead can 
be found with high probability. On the other hand, Nature makes wide use of noncovalent interactions 
to build its complex supramolecular architectures and to achieve efficient and selective 
transformations. In recent years, combinatorial and supramolecular approaches to the development of 
new ligands for asymmetric catalysis gained momentum.2,6b The term 'supramolecular ligand' 
encompasses all the ligands possessing, besides the atom(s) coordinating the catalytic metal, an 
additional functionality capable of non-covalent interactions (mainly hydrogen3 or coordinative 
bonds4, as widely reported in chapter 1) which can play the following role: (i) self-assemble two 
monodentate ligands to form a so-called 'supramolecular bidentate ligand';5 (ii) bind the substrate(s) in 
proximity to the catalytic metal center6 in analogy to metalloenzymes.7 Among the different kinds of 
non-covalent interactions that have been used so far for developing supramolecular ligands,5 hydrogen 
bonds are arguably the most practical and efficient3,6 for several reasons: (i) functional groups capable 
of hydrogen bonding (e.g. amides, ureas, guanidines) are stable and relatively easy-to-introduce; (ii) 
H-bonds are created dynamically and reversibly in the reaction medium (where catalysis is to take 
place), being able to self-repair when broken, and often coexist with other interactions in a 
'noninvasive' manner.  
In this chapter, as a result of our continued interest in developing supramolecular ligands,8 we 
report the design and synthesis of a novel class of chiral monodentate phosphite ligands, named 
PhthalaPhos, which contain a phthalic acid primary diamide moiety (Scheme 4.1). Such phthalamidic 
group displays both donor and acceptor hydrogen bonding properties that, in principle, can give rise to 
supramolecular interactions both between the ligands and with the reaction substrate. The modular 
nature of the PhthalaPhos ligands allows to tune their properties by simply varying structural elements 
such as the linker, the BINOL moiety and the ancillary amide group (i.e. the amide not connected to 
the phosphite group), thus allowing a parallel-combinatorial ligand optimization.2a,c 
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Scheme 4.1 General structure of Phthalaphos ligands 
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4.2 SYNTHESIS OF PHTHALAPHOS LIBRARY 
 
The Phthalaphos ligands were easily prepared in four steps as reported in Scheme 4.2. Phthalic 
anhydride was treated with a primary amine to give in good yield the corresponding phthalic acid 
monoamides 1.9 Dehydration of the latter in presence of trifluoroacetic anhydride gave 
phthalisoimides 2 in high yields, whose reaction with a chosen amino alcohol led to phthalic acid 
diamides 3.10 To give PhthalaPhos ligands 4. 
 
Scheme 4.2 PhthalaPhos synthetic protocol  
 
This protocol allows the synthesis of PhthalaPhos ligands starting from cheap and available materials 
and in relatively short time (2-3 days). Indeed, as reported in Experimental Section, monoacids 1 and 
isoimides 2 can be obtained by a simple precipitation and only diamide mono-alcohols and final 
ligands necessitate a chromatographic purification. All PhthalaPhos ligands are solids and have also 
been demonstrated good stability and an easy-handiness.  
Our library was composed of 19 members on the whole (Scheme 4.3). Terms of variation of the 
PhthalaPhos backbone were substantially three:  
(i) the ancillary amine (all ligands were synthesized from 4-nBu-aniline except for ligands 4h and 
4i for which 3,5-bis-trifluoromethyl aniline was used as starting material and for ligand 4m 
which was obtained from nBu-amine. This exceptions were dictated to investigate whether the 
different acidities of NH- amide groups had a positive effect on the self-assembly via hydrogen-
bonding)  
the linker (various amino alcohols were used to investigate the role of geometry properties on the self-
assembly and on the stereoselective processes: ligands 4a-k, 4m, 4o-4q and 4s were obtained starting 
from aromatic amino alcohols varying the position of the substituents on the ring and the length of 
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amino alcohol side-chains. Whenever the amino aclcohol linkers were not commercially available, 
their synthesis could be obtained through a limited number of synthetic steps following previously 
published procedures (see Experimental Section). Moreover, a more constrained ligand 4r was 
synthesized starting from the 2,2-dimethyl-3-amino propan-1-ol (Thorpe-Ingold effect). Finally, 
ligands 4l and 4n were built from a naphthalene unit as linker.  
(ii) 
 
Scheme 4.3 PhthalaPhos library and reference phosphite 5. 
 
(iii) the binaphthol unit (all ligands were obtained from (S)-binaphthol except for ligands 4p-q for 
which two methyl groups were introduced on the binaphthol backbone in 3-3’ position). 
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4.3 CATALYTIC APPLICATIONS: RHODIUM-CATALYZED 
ASYMMETRIC HYDROGENATIONS 
 
We assessed the catalytic properties of the new ligands in the hydrogenation of classical 
benchmark substrates, namely, methyl 2-acetoamidoacrylate (S1) (Table 4.1) and N-(1-phenyl-
vinyl)acetamide (S2) (Table 4.2), taking the known phosphite 5 as touchstone.11,12 
 

Entry Ligand 
Phydrogen = 1 bar, S1/L/Rh = 100/2.2/1, 
 reaction time = 20 h 
Conv. (%) ee (%), abs. conf. 
1 4a 100 94, R 
2 4b 100 98, R 
3 4c 100 92, R 
4 4d 99 94, R 
5 4e 100 99, R 
6 4f 100 98, R 
7 4g 98 95, R 
8 4h 100 89, R 
9 4i 100 98, R 
10 4j 100 86, R 
11 4k 100 77, R 
12 4l 100 94, R 
13 4m 100 83, R 
14 4n 100 78, R 
15 4o 100 94, R 
16 4p - - 
17 4q - - 
18 4r 100 98, R 
19 4s 100 > 99, R 
20 5 100 84, R 
 
Table 4.1. Screening of the Phthalaphos ligands in the hydrogenation of methyl 2-acetamidoacrylate S1. 
 
The results of this preliminary screening turned out to be very encouraging: four ligands gave ee 
values higher than 97% with substrate S1 (Table 4.1, entries 2, 5, 6 and 9), and six reached the same 
level of performance with S2 (Table 4.2, entries 1-2, 5-8). Remarkably, the reference ligand 5, 
featuring the same binol phosphite moiety as 4a–i, gave only 84%ee with S1 and 90% ee with S2 
(Table 4.1 and Table 4.2, entries 20), which suggests that the phthalamide residue significantly 
influences the catalytic properties of these ligands. Further support to this conclusion came from the 
effect on the enantioselectivity displayed by the linker, particularly evident in the case of ligands 4h 
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and 4i, for which a subtle variation of the linker length resulted in remarkably different ee values (S1, 
4h: 89%ee, 4i: 98%ee; S2, 4h: 97% ee, 4i: 83% ee). Indeed, if the phthalamide residue were a simple 
bystander and 4a–i behaved as “normal” monodentate phosphites, only negligible differences in 
enantioselectivity should be expected for the ligands. Another interesting observation is that not 
always the best ee values with S1 and S2 were obtained with the same ligands, which underlines the 
advantage of the combinatorial approach followed in the ligand design. 
 

Entry Ligand 
Phydrogen = 5 bar, S2/L/Rh = 100/2.2/1, 
 reaction time = 20 h 
Conv. (%) ee (%), abs. conf. 
1 4a 100 98, R 
2 4b 100 98, R 
3 4c 100 93, R 
4 4d 100 96, R 
5 4e 100 97, R 
6 4f 100 98, R 
7 4g 100 99, R 
8 4h 100 97, R 
9 4i 100 83, R 
10 4j 100 86, R 
11 4k 100 79, R 
12 4l 100 72, R 
13 4m 100 77, R 
14 4n 100 89, R 
15 4o 100 92, R 
16 4p 99 10, R 
17 4q 100 37, S 
18 4r 100 96, R 
19 4s 100 96, R 
20 5 100 90, R 

Table 4.2. Screening of the Phthalaphos ligands in the hydrogenation of N-(1-phenylvinyl)acetamide S2. 
 
To explore the scope of the PhthalaPhos ligands, we decided to investigate the Rh-catalyzed 
hydrogenation of more challenging substrates such as cyclic enamide S3 [N- (3,4-dihydronaphthalen-
1-yl)acetamide] and β2-dehydro amino ester S4 [(E)-methyl 2-(acetamidomethyl)-3-phenylacrylate], 
both of which are industrially relevant compounds.3p  
Initially studies of S3 were carried out to optimize the hydrogenation pressure using ligand 4a 
as representatives of the whole library. As reported in Table 4.3, the best conversion and 
enantioselectivity were reached under 20 bar of hydrogen pressure (entry 4) but a only slightly lower 
result, in terms of conversion, was obtained with a lower pressure of 12 bar, which was therefore 
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chosen to screen the library. A short series of tests (Table 4.3, entries 5-7) showed as the ratio Rh/L 
has to be fixed to 1:2 to obtain the highest conversions and stereoselectivities. 
 

Entry Rh/4a 
S3/Rh = 100/1, reaction time = 20 h 
Phydrogen 
(bar) 
Conv. 
(%) ee (%), abs. conf. 
1 1:2.2 1 77 91, R 
2 1:2.2 5 83 86, R 
3 1:2:2 12 98 96, R 
4 1:2.2 20 99 96, R 
5 1:1 12 77 90, R 
6 1:3.3 12 99 96, R 
7 2:1 12 86 74, R 
 
Table 4.3. Study of the effect of hydrogen pressure and Rh/L ratio in the hydrogenation of N-(3,4-
dihydronaphthalen-1-yl)acetamide S3 carried out with ligand 4a. 
 
Having in hand the optimized conditions we hydrogenated S3 and all results are reported in Table 
4.4.13 The results of this screening were quite variegated both in terms of activity and 
enantioselectivity, and excellent conversion and ee value were attained with ligand 4a (Table 4.4, 
entry 1). The conversions followed more or less the same trend as the ee values, the most 
stereoselective ligands being also the most active. Poor results were obtained with reference ligand 5 
(Table 4.4, entry 20). 
 
 

Entry Ligand 
Phydrogen = 12 bar, S3/L/Rh = 100/2.2/1, 
reaction time = 20 h 
Conv. (%) ee (%), abs. 
conf. 
1 4a 99 96, R 
2 4b 90 93, R 
3 4c 9 60, R 
4 4d 98 92, R 
5 4e 6 24, R 
6 4f 46 86, R 
7 4g 5 48, R 
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8 4h 22 73, R 
9 4i 9 28, R 
10 4j 29 11, R 
11 4k 15 0 
12 4l 12 12, R 
13 4m 10 2, R 
14 4n 18 3, R 
15 4o 7 21, R 
16 4p 2 - 
17 4q 4 - 
18 4r 3 - 
19 4s 45 23, R 
20 5 30 53, R 

Table 4.4. Screening of the Phthalaphos ligands in the hydrogenation of N-(3,4-dihydronaphthalen-1-
yl)acetamide S3. 
 
Additionally, the fact that the enantioselectivity strongly decreased increasing the polarity of the 
solvent (Table 4.5, entry 2) and dropped dramatically in the presence of isopropanol which can act as a 
H-bond donor (Table 4.5, entry 3) confirms that hydrogen-bonding interactions between the 
phthalamide groups play a crucial role in the activity and selectivity of the catalyst. To the best of our 
knowledge, the 96% ee obtained with ligand 4a is the highest ever obtained for this substrate with 
phosphite ligands, and rivals the best literature precedents, obtained with a monodentate 
phosphoramidite (84% ee at rt, 98% ee at -20°C)14 and a bisphosphine (98% ee at rt).15 
 

Entry Reaction 
solvent 
Phydrogen = 12 bar, S3/L/Rh = 100/2.2/1, 
reaction time = 20 h 
Conv. (%) ee (%), abs. 
conf. 
1 DCM 99 96, R 
2 THF / DCM 7:1 70 57, R 
3 i-PrOH / DCM 7:1 77 21, R 
4 toluene / DCM 7:1 82 87, R 
5 AcOEt / DCM 7:1 94 67, R 
Table 4.5. Solvent screening in the hydrogenation of N-(3,4-dihydronaphthalen-1-yl)acetamide S3 carried out 
with ligand 4a.[a] The pre-catalytic complex was prepared in DCM (0.9 mL) see General Procedure ( 
Experimental Section). To the complex solution the selected solvent (7.1 mL) was added, followed by substrate 
S3 as a solid. The obtained mixture was then hydrogenated as described in the General Procedure. 
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The screening of the ligand library on S4 required a hydrogen pressure of 50 bar (as reported in table 
4.6) due to the lower reactivity of this substrate (Table 4.7). Also in this screening the 
enantioselectivity varied quite widely and appeared to be linked to the catalytic activity.  

Entry Ligand Phydrogen (bar) T (°C) 
S4/L/Rh = 100/2.2/1, 
reaction time = 20 h 
Conv. (%) ee, [α]D sign 
1 4a 1 20 13 30, (+) 
2 4a 5 20 40 64, (+) 
3 4a 5 40 79 50, (+) 
4 4a 12 20 83 68, (+) 
5 4a 25 20 82 64, (+) 
6 4a 50 20 96 64, (+) 
7 4b 1 20 9 28, (+) 
8 4b 5 20 36 42, (+) 
9 4b 5 40 59 30, (+) 
10 4b 12 20 77 64, (+) 
11 4b 25 20 89 52, (+) 
12 4b 50 20 98 62, (+) 
Table 4.6. Study of the effect of hydrogen pressure and temperature in the hydrogenation of (E)-methyl 2-
(acetamidomethyl)-3-phenylacrylate S4 carried out with ligand 4a and ligand 4b. 
 
Ligands 4c and 4i (Table 4.7, entries 3 and 9) gave very high ee values and good conversions, while 
the other ligands displayed moderate to fair enantioselectivity. Again, the reference phosphite 5 gave 
only very low conversion and ee with this substrate (Table 4.7, entry 19). 
 

Entry Ligand 
Phydrogen = 50 bar, T = 20 °C, S4/L/Rh = 
100/2.2/1, 
reaction time = 20 h 
Conv. (%) ee, [α]D sign 
1 4a 96 64, (+) 
2 4b 98 62, (+) 
3 4c 75 91, (+) 
4 4d 96 54, (+) 
5 4e 8 31, (+) 
6 4f 27 67, (+) 
7 4g 73 74, (+) 
8 4h 23 43, (+) 
9 4i 87 98, (+) 
10 4j 27 4, (+) 
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11 4k 57 28, (–) 
12 4l 79 14, (–) 
13 4n 35 0 
14 4o 41 0 
15 4p 27 6, (+) 
16 4q 11 12, (–) 
17 4r 30 0 
18 4s 50 14, (–) 
19 5 6 32, (+) 
Table 4.7. Screening of the Phthalaphos ligands in the hydrogenation of (E)-methyl 2-(acetamidomethyl)-3-
phenylacrylate S4. 
 
Most importantly, 98% is the highest ee ever obtained with substrate S4, and only one highly 
stereoselective ligand having been reported so far.3p 
 
4.4 SPECTROSCOPIC STUDIES 
 
Encouraged by these results, we decided to investigate the role of hydrogen bonding in the catalytic 
properties of the PhthalaPhos ligands. The precatalyst obtained by treating a representative ligand (4a, 
2 equiv) with [Rh(cod)2]BF4 (cod=1,5-cyclooctadiene, 1 equiv) in CH2Cl2 or CD2Cl2 was studied by 
spectroscopic methods. 
 
4.4.1 NMR-, HRMS- and IR- studies 
Initially, we studied the complexation properties of ligand 4a by titration of a standard solution of 
Rh(cod)2BF4 chosen as Rh(I) source. When the ratio Rh/L was 1:2 the 31P NMR spectrum of the Rh 
complex displayed a clean doublet at 122.0 ppm with JRh,P = 257.7 Hz (Figure 4.1) which matched 
with the 1H NMR spectrum (see Experimental Section) and the result of HRMS analysis (m/z 
1643.49193, Figure 4.2) and indicated the formation of the cationic species [Rh(4a)2(cod)]+, where the 
phosphite groups occupy two adjacent cis positions.  
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Figure 4.1. Complex [Rh(cod)(4a)2BF4] (10 mM solution in CD2Cl2): 31P NMR spectrum (162 MHz). 
 
Figure 4.2. HRMS spectrum of complex [Rh(4a)2(cod)BF4] in DCM solution. 
 
Only one set of signals could be detected in the NMR spectra of the Rh complex, and the two 
coordinated molecules of 4a could not be distinguished.  
The hydrogen bonding state of the NH protons (NHA and NHB, Scheme 4.4) for both the free ligand 
and the Rh complex was then investigated by 1H NMR spectroscopy, and in particular the following 
data were collected: 1) temperature coefficient (∆δ/DT) of each NH proton; 2) kinetics of H/D 
exchange of the amide protons upon addition of excess CD3OD; 3) downfield shift of the NH protons 
in the presence of excess CD3OD. These experiments, which are commonly used to differentiate 
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between random-coil peptides and peptides in hydrogen-bonded conformations,16,17 were conducted in 
dilute (1.2 mM) solutions in CD2Cl2. This concentration was chosen since aggregation, at least of the 
Rh complex, is not significant at 1.2 mM, as determined by studying the dependence of the NH 
chemical shifts on the concentration in the 20.0–0.3 mM range. 
 
 
Scheme 4.4. Ligand 4a used as representatives of the ligand library for spectroscopic studies 
From the experimental results, which are outlined in Table 4.8 and reported in detail in the 
Experimental Section, the following conclusions can be drawn: on the one hand, no evidence of 
intramolecular hydrogen bonding could be found for the free ligand 4a, which, moreover, shows a 
strong tendency to intermolecular aggregation even at high dilution. On the other hand, proton NHA in 
the Rh complex is definitely involved in an intramolecular hydrogen bond, as confirmed by its 
downfield chemical shift (δ=9.6 ppm), its reduced rate of exchange with CD3OD (t1/2=47 min), and 
limited shift when CD3OD is added (∆δ=0.27 ppm). Proton NHB, conversely, appears to be in a non-
bonded state.  
 
 
 
Free ligand 4a [Rh(4a)2(cod)]BF4 
 
NHAb NHBb NHAb NHBb 
δ (ppm) 8.692 8.342 9.604 8.506 
∆δ/∆T (ppb K-1) n.dc n.dc -12.94 1.73 
H/D exchange: t1/2 (min) 12.2 14.9 47.1 28.5 
∆δ in presence of excess CD3OD 0.654 0.742 0.274 0.558 
 
Table 4.8: Results of 1H NMR studies on NH protons of ligand 4a and its Rh complex.[a] 
[a] c=1.2 mm in CD2Cl2. [b] Assignment of HA and HB was based on the NOESY and COSY spectra. [c] Not 
determined: no linear dependence observed. 
 
Consistent with these observations, two distinct NH stretching bands (ν=3409.5 and 3268.8 cm-1) were 
detected in the IR spectrum of the Rh complex (1.2 mM solution in CH2Cl2), while only one band 
could be found for the free ligand (ν = 3408.6 cm-1)as reported in Figure 4.3.  
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Figure 4.3. N-H stretching IR bands of (a) free ligand 4a and (b) complex [Rh(4a)2(cod)BF4] (1.2 mM DCM 
solutions). 
 
Also, detection of the C=O stretching band of the Rh complex at a lower wavenumber than that of the 
free ligand (ν =1661.4 vs. 1676.8 cm-1) confirmed the presence of an intramolecular hydrogen bond 
(Figure 4.4). 
 
Figure 4.4. C=O stretching IR bands of (a) free ligand 4a and (b) complex [Rh(4a)2(cod)BF4] (1.2 mM DCM 
solutions). 
 
 
4.4.2 DFT CALCULATIONS 
 
We ran a Monte Carlo conformational search18,19, of the precatalyst [Rh(4a)2(cod)]+ using AMBER* 
force field20 for the phthalamide region and a frozen core for the Rh(cod) phosphite complex, which 
was previously optimized with DFT calculations at the B3LYP/LACVP level of theory.21 A number of 
low-energy conformers were identified which, in agreement with the spectroscopic data, are 
characterized by interligand hydrogen bonding involving proton NHA. These low-energy conformers 
were used as starting geometries for DFT optimization21 of the entire precatalyst [Rh(4a)2(cod)]+, 
which showed that the double hydrogen-bond array displayed in Figure 4.5 is highly favored over 
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other arrangements involving a single hydrogen-bonding interaction (see the Experimental Section for 
details). In the DFT calculated structure shown in Figure 4.5, the ligands are held together by two 
hydrogen bonds between proton NHA of each ligand and the carbonyl group of the ancillary amide, 
bearing NHB, of the other ligand. Therefore, the two molecules of 4a behave as a supramolecular 
bidentate ligand with a reduced degree of conformational freedom compared to two simple 
monodentate phosphites coordinated to a rhodium center.22 This may explain the superior 
stereoselectivity displayed by PhthalaPhos ligands compared to simple monodentate phosphites, 
although substrate orientation in the catalytic cycle through hydrogen bonding with the ligand could 
also play a crucial role.3o 
  
Figure 4.5. Supramolecular bidentate precatalyst [Rh(4a)2(cod)]+ and DFT calculated structure. Heteroatoms (N, 
O, P, Rh) are shown in black, carbon atoms in gray, and amide hydrogen atoms in light gray. For clarity, all 
hydrogen atoms bound to carbon are omitted. 
 
4.5 CONCLUSIONS 
In conclusion, a library of novel chiral supramolecular ligands containing a phthalamide moiety 
capable of hydrogen- bonding interactions has been prepared. The new ligands, named PhthalaPhos, 
are easily prepared from inexpensive starting materials and show excellent enantioselectivity in the 
hydrogenation of both benchmark olefins and challenging substrates of potential industrial interest. 
The precatalytic Rh complex of one of these ligands was fully characterized and studied by NMR, IR, 
and mass spectroscopy, which confirmed the presence of hydrogen bonds between the coordinated 
ligands, and thus formation of a supramolecular bidentate ligand. Further work is underway to expand 
the scope of PhthalaPhos ligands to other substrates and different transition metal catalyzed processes. 
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4.6 EXPERIMENTAL SECTION 
 
4.6.1  General Remarks 
 
All reactions were carried out in flame-dried glassware with magnetic stirring under nitrogen 
atmosphere, unless otherwise stated. The solvents for reactions were distilled over the following 
drying agents and transferred under nitrogen: CH2Cl2 (CaH2), MeOH (CaH2), THF (Na), dioxane (Na), 
Et3N (CaH2). Dry Et2O and CHCl3 (over molecular sieves in bottles with crown cap) were purchased 
from Fluka and stored under nitrogen. The reactions were monitored by analytical thin-layer 
chromatography (TLC) using silica gel 60 F254 pre-coated glass plates (0.25 mm thickness). 
Visualization was accomplished by irradiation with a UV lamp and/or staining with a potassium 
permanganate alkaline solution. Flash column chromatography was performed using silica gel (60 Å, 
particle size 40-64 µm) as stationary phase, following the procedure by Still and co-workers.23 Proton 
NMR spectra were recorded on a spectrometer operating at 400.13 MHz. Proton chemical shifts are 
reported in ppm (δ) with the solvent reference relative to tetramethylsilane (TMS) employed as the 
internal standard (CDCl3 δ = 7.26 ppm; CD2Cl2, δ = 5.32 ppm; [D]6DMSO, δ = 2.50 ppm; CD3OD, δ 
= 3.33 ppm). The following abbreviations are used to describe spin multiplicity: s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, br = broad signal, dd = doublet-doublet, td = triplet-
doublet. 13C-NMR spectra were recorded on a 400 MHz spectrometer operating at 100.56 MHz, with 
complete proton decoupling. Carbon chemical shifts are reported in ppm (δ) relative to TMS with the 
respective solvent resonance as the internal standard (CDCl3, δ = 77.23 ppm; CD2Cl2, δ = 54.00 ppm; 
[D]6DMSO, δ = 39.51 ppm; CD3OD, δ = 49.05 ppm). 31P NMR spectra were recorded on a 400 MHz 
spectrometer operating at 162 MHz, with complete proton decoupling. 31P NMR chemical shifts are 
reported in ppm (δ) relative to external 85% H3PO4 at 0 ppm (positive values downfield). 19F NMR 
were recorded on a 300 MHz spectrometer operating at 282 MHz. 19F NMR chemical shifts are 
reported in ppm (δ) relative to external CFCl3 at 0 ppm (positive values downfield). The coupling 
constant values are given in Hz. Infrared spectra were recorded on a standard FT/IR spectrometer. 
Optical rotation values were measured on an automatic polarimeter with a 1 dm cell at the sodium D 
line (λ = 589 nm). Gas chromatography was performed on a GC instrument equipped with a flame 
ionization detector, using a chiral capillary column. High resolution mass spectra (HRMS) were 
performed on a Fourier Transform Ion Cyclotron Resonance (FT-ICR) Mass Spectrometer APEX II & 
Xmass software (Bruker Daltonics) – 4.7 T Magnet (Magnex) equipped with ESI source, available at 
CIGA (Centro Interdipartimentale Grandi Apparecchiature) c/o Università degli Studi di Milano. Low 
resolution mass spectra (MS) were acquired either on a Thermo-Finnigan LCQ Advantage mass 
spectrometer (ESI ion source) or on a VG Autospec M246 spectrometer (FAB ion source). Elemental 
analyses were performed on a Perkin Elmer Series II CHNS/O Analyzer 2000. 
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4.6.2 Materials 
Phthalic anhydride sometimes contains large amounts of phthalic acid. In such cases, the mixture 
could be easily re-converted into the pure anhydride by melting it into an open flask and strongly 
heating for 10 minutes. On cooling down to R.T., pure phthalic anhydride crystallized as a white solid. 
Phthalic anhydride was stored in a desiccator. The other commercially available starting materials [(3-
aminophenyl)methanol, (4-aminophenyl)methanol, 3-cyanobenzoic acid, methyl 4-cyanobenzoate, 2-
cyanobenzaldehyde, methyl 3-(bromomethyl)benzoate, methyl 4-(bromomethyl)benzoate and (S)-2,2’-
dihydroxy-1,1’-binaphthalene (BINOL)] were used as received. Chlorophosphite BINOL-PCl was 
prepared from (S)-2,2’-dihydroxy-1,1’-binaphthalene on gram scale according to a literature 
procedure.24 Non-commercially available substrates for catalysis experiments [N-(1-
phenylvinyl)acetamide, N-(3,4-dihydronaphthalen-1-yl)acetamide and (E)-methyl 2-
(acetamidomethyl)-3-phenylacrylate] were prepared according to literature procedures.25 Ligand 5 has 
been previously described:26 its physical and spectroscopic data are superimposable with those 
reported in the literature. 
 
4.6.3 Synthesis of PhthalaPhos ligands 
 
Experimental procedures and full characterization of ligands 4a-i are reported below. The whole 
PhthalaPhos library is displayed in Figure 4.3 (see page 186). 
 
4.6.3.1 Preparation of non-commercially available starting aminoalcohols. 
Non-commercially available aminoalcohols were prepared by slight modification of known 
procedures. The spectroscopic properties of compounds 6-15 comply with those reported in the 
literature. Compounds 10 and 13, which we prepared as described below, are also commercially 
available. 
 
 
(3-(Aminomethyl)phenyl)methanol 7. A solution 3-cyanobenzoic acid (2 g, 13.59 mmol, 1 eq) and 
96% H2SO4 (0.68 mL, 12.23 mmol, 0.9 eq) in dry MeOH (27 mL) was refluxed for 3h. MeOH was 
partially evaporated and the residue was poured in water (20 mL) and extracted with AcOEt (4 × 30 
mL). The combined organic phases were washed with sat. aq. NaHCO3 (3 × 20 mL) and dried on 
Na2SO4. Evaporation of the organic solvent gave pure methyl 3-cyanobenzoate 6 as a colorless oil 
which slowly crystallized in the cold (2.124 g, 13.18 mmol, 97% yield).27 Compound 6 (2.113 g, 13.11 
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mmol, 1 eq) was dissolved in THF (10 mL) and added dropwise to a stirred suspension of LiAlH4 
(1.49 g, 39.33 mmol, 3 eq) in THF (70 mL) kept at 0 °C. The mixture was heated to reflux and stirred 
overnight. The reaction was cooled to 0 °C and slowly quenched with H2O (1.5 mL) / 15% NaOH (1.5 
mL) / H2O (4.5 mL). After stirring for 15 min at R.T., the obtained suspension was filtered on a pad of 
celite (washing with AcOEt). The filtrate was evaporated giving (3-(aminomethyl)phenyl)methanol 
7S28 as a white solid (1.74 g, 97% yield), which was pure enough for being used in the next step. 
 
 
(4-(Aminomethyl)phenyl)methanol 8. LiAlH4 (2.01 g, 52.92 mmol, 4 eq) was added in three 
portions to a stirred suspension of commercially available 4-(aminomethyl)benzoic acid (2 g, 13.23 
mmol, 1 eq) in THF (20 mL) kept at 0 °C. The mixture was heated to reflux and stirred overnight 
before cooling down again to 0 °C and quenching with H2O (2 mL) / 15% NaOH (2 mL) / H2O (6  
mL). After stirring for 10 min at R.T. the mixture was filtered on a pad of celite (washing with 
AcOEt). Evaporation of the filtrate gave (4-(aminomethyl)phenyl)methanol 8S29 as a white solid 
(1.179 g, 65% yield), which was used without purification. 
 
 
 
 
(2-(Aminomethyl)phenyl)methanol 9. A solution of commercially available 2-cyanobenzaldehyde 
(0.5 g, 3.81 mmol, 1 eq) in THF (6 mL) was added dropwise to a stirred suspension of LiAlH4 (0.434 
g, 11.439 mmol, 3 eq) in THF (15 mL) kept at 0 °C. The resulting dark mixture was stirred at R.T. for 
5 h before quenching at 0 °C with H2O (0.43 mL) / 15% NaOH (0.43 mL) / H2O (1.29 mL). After 
stirring for 10 min at R.T. the mixture was filtered on celite (washing with AcOEt). Evaporation of the 
filtrate gave product 9S30 as a brown oil which slowly crystallized (0.418 g, 80% yield) and was clean 
enough for being used in the next step. 
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(3-(2-Aminoethyl)phenyl)methanol 12. Commercially available methyl 3-toluate (2 g, 13.32 mmol, 1 
eq) was dissolved in CCl4 (15 mL) and treated with freshly crystallized NBS (2.37 g, 13.32 mmol, 1 
eq) and benzoyl peroxide (32 mg, 0.133 mmol, 0.01 eq). The stirred mixture was heated to reflux and 
irradiated with visible light for 3 h. After cooling down to R.T., succinimide was filtered off (washing 
the filter with CCl4), and the filtrate was evaporated giving a colorless liquid containing product 10S31  
in mixture with a minor amount of starting material and bis-bromination product. The crude product 
10 was dissolved in a mixture of MeOH (20 mL) and H2O (4.5 mL), and KCN (1.04 g, 15.98 mmol, 
1.2 eq) was added. The mixture was heated to reflux and stirred for 5 h, then it was poured in H2O (40 
mL) and extracted with AcOEt (3 × 50 mL). The combined organic phases were dried with Na2SO4 
and evaporated. Purification by flash chromatography (9:1 and 8:2 hexane/AcOEt) gave nitrile 11S31 as 
an oil (1 g, 58% yield over two steps). A solution of 11 (0.764 g, 4.36 mmol, 1 eq) in Et2O (9 mL) was 
added dropwise to a stirred suspension of AlCl3 / LiAlH4 in THF [just prepared by adding a solution of 
AlCl3 (1.28 g, 9.6 mmol, 2.2 eq) in 15 mL of THF to a suspension of LiAlH4 (0.364 g, 9.6 mmol, 2.2 
mL) in 10 mL of THF]. The resulting suspension was stirred overnight at R.T. and then quenched with 
H2O (6.5 mL) and 3 M H2SO4 (13 mL). The resulting mixture was extracted with Et2O (3 × 20 mL). 
The aqueous phase was brought to pH ~ 12 by adding solid KOH, then it was diluted with H2O (30 
mL) and extracted with AcOEt (5 × 30 mL). The combined organic phases were dried over Na2SO4 
and evaporated to give aminoalcohol 12S32 (0.548 g, 83% yield) as a colorless oil, which was used 
without further purification. 
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(4-(2-Aminoethyl)phenyl)methanol 15. Compound 15 was prepared by a procedure identical to that 
described above for aminoalcohol 12: commercial methyl 4-toluate was converted into nitrile 14S33 via 
bromide 13S33 (53% yield over two steps). Compound 14 was reduced with AlCl3 / LiAlH4 in 78% 
yield to give aminoalcohol 15.S34 
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4.6.3.2 Preparation of the phthalic acid mono-amides 1a-b. 
 
General Procedure. The chosen amine (1 eq) was added to a stirred 1.44 M solution of phthalic 
anhydride (1 eq, typical scale: 15 g) in CHCl3: a white precipitate soon began to form. The mixture 
was heated to reflux and stirred for 3 h, then it was cooled down with an ice bath. The precipitate was 
collected on a Buchner funnel and washed on the filter with 6:1 CHCl3 / hexane until the red 
impurities had disappeared. The product was dried under high vacuum. 
 
 
2-(4-Butylphenylcarbamoyl)benzoic acid 1a. The product, a white solid, was prepared according to 
the General Procedure starting from 15 g of phthalic anhydride and 15.58 g of 97% 4-butylaniline. 
Yield: 28.2 g (94%); m.p. = 163-166 °C; 1H NMR (400 MHz, [D6]DMSO): δ = 12.98 (s, 1H), 10.24 
(s, 1H), 7.88 (dd, 3J(H,H) = 6.8 Hz, 4J(H,H) = 1.0 Hz, 1H), 7.68-7.53 (m, 5H), 7.15 (d, 3J(H,H) = 8.4 
Hz, 2H), 2.55 (t, 3J(H,H) = 7.6 Hz, 2H), 1.55 (m, 2H), 1.32 (m, 2H), 0.91 (t, J(H,H) = 7.3 Hz, 3H); 13C 
NMR (100 MHz, [D6]DMSO): δ = 167.5, 167.1, 139.0, 137.3, 131.6, 130.0, 129.5, 129.3, 128.3, 
127.8, 119.5, 34.3, 33.3, 21.7, 13.8; IR (KBr): ν = 3325.6, 2922.6, 1723.1, 1636.3, 1577.5, 1245.8, 
645.1 cm-1; MS (ESI+): m/z 320.1 [M + Na]+ (calcd. for C18H19NO3Na: 320.1); elemental analysis 
(%): C 73.06, H 6.37, N 4.69 (calcd. for C18H19NO3: C 72.71, H 6.44, N 4.71). 
 
 
2-(3,5-Bis(trifluoromethyl)phenylcarbamoyl)benzoic acid 1b. The product, a white solid, was 
prepared according to the General Procedure starting from 3.14 g of phthalic anhydride and 5 g of 3,5-
bis(trifluoromethyl)aniline. Yield: 7.82 g (98%); m.p. = 190-192 °C; 1H NMR (400 MHz, 
[D6]DMSO): δ = 13.17 (br s, 1H), 10.98 (s, 1H), 8.37 (s, 2H), 7.94 (dd, 3J(H,H) = 7.5 Hz, 4J(H,H) = 
1.7 Hz, 1H), 7.78 (s, 1H), 7.70 (td, 3J(H,H) = 7.5 Hz, 4J(H,H) = 1.3 Hz, 1H), 7.65-7.61 (m, 2H); 13C 
NMR (100 MHz, [D6]DMSO): δ = 168.3, 167.1, 141.2, 137.9, 131.9, 130.8 (q, 2J(C,F) = 32.9 Hz), 
129.9, 129.7, 129.7, 127.7, 123.2 (q, 1J(C,F) = 272.6 Hz), 119.0 (d, 3J(C,F) = 3.5 Hz), 116.0 (m); 19F 
NMR (282 MHz, [D6]DMSO): δ = -57.7 (s); IR (KBr): ν = 3286.1, 3114.5, 1702.8, 1671.0, 1278.6, 
703.9 cm-1; MS (FAB+): m/z 378.0 [M + H]+ (calcd. for C16H10F6NO3: 378.1) and 400.0 [M + Na]+ 
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(calcd. for C16H9F6NO3Na: 400.0); elemental analysis (%): C 50.93, H 2.28, N 3.70 (calcd. for 
C16H9F6NO3: C 50.94, H 2.40, N 3.71. 
 
4.6.3.3 Preparation of the phthalisoimides 2a-b. 
 
3-(4-Butylphenylimino)isobenzofuran-1(3H)-one 2a. A literature procedure for preparing this class 
of compounds was followed:S35 trifluoroacetic anhydride (2.1 mL, 15.13 mmol, 1.5 eq) was added 
dropwise to a stirred solution of acid 1a (3 g, 10.09 mmol, 1 eq) and TEA (4.2 mL, 30.27 mmol, 3 eq) 
in dioxane (45 mL) kept at 0 °C with an ice bath. After 5 min the yellow solution was allowed to reach 
R.T. and stirred for 15 min, then it was poured in cold H2O (120 mL). A pale yellow, light precipitate 
formed, which was filtered on Buchner and washed with some H2O. The product was dried for 20 min 
on the filter and then for one night under high vacuum. A pale yellow solid was obtained. Yield: 2.72 
g (97%); m.p. = 58-61 °C; 1H NMR (400 MHz, CD2Cl2): δ = 8.11 (d, 3J(H,H) = 7.6 Hz, 1H), δ 8.00 (d, 
3J(H,H) = 7.6 Hz, 1H), δ 7.90 (t, 3J(H,H) = 7.6 Hz, 1H), 7.80 (t, 3J(H,H) = 7.6 Hz, 1H), 7.41 (d, 
3J(H,H) = 8.2 Hz, 2H), 7.28 (d, 3J(H,H) = 8.2 Hz, 2H), 2.69 (t, 3J(H,H) = 7.8 Hz, 2H), 1.68 (m, 2H), 
1.43 (m, 2H), 1.00 (t, J(H,H) = 7.4 Hz, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 165.5, 147.2, 142.2, 
142.1, 137.8, 136.0, 133.6, 129.5, 128.2, 125.7, 125.1, 124.0, 35.8, 34.2, 22.9, 14.3; IR (KBr): ν = 
2956.3, 2855.1, 1791.6, 1689.3, 915.1,  cm-1; MS (ESI+): m/z 280.3 [M + H]+ (calcd. for C18H18NO2: 
280.1); elemental analysis (%):  C 77.33, H 6.32, N 4.97 (calcd. for C18H17NO2: C 77.40, H 6.13, N 
5.01). 
 
3-(3,5-Bis(trifluoromethyl)phenylimino)isobenzofuran-1(3H)-one 2b. Trifluoroacetic anhydride 
(0.276 mL, 1.988 mmol, 1.5 eq) was added dropwise to a stirred solution of acid 1b (0.5 g, 1.325 
mmol, 1 eq) and TEA (0.185 mL, 1.325 mmol, 1 eq) in THF (6 mL) kept at 0 °C with an ice bath. 
After 5 min the solution was allowed to reach R.T. and stirred for 10 min. A second portion of TEA 
(0.37 mL, 3.976 mmol, 2 eq) was added dropwise, and the solution was stirred for 20 min at R.T.. The 
volatiles were removed at rotavapor and the product was purified by flash chromatography through a 
short pad of silica (1:1 hexane/DCM). Compound 2b was obtained as a white solid. Yield: 471 mg 
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(99%); m.p. = 127-129 °C; 1H NMR (400 MHz, CDCl3): δ = 8.15 (d, 3J(H,H) = 7.6 Hz, 1H), 8.06 (d, 
3J(H,H) = 7.6 Hz, 1H), 7.97 (td, 3J(H,H) = 7.6 Hz, 4J(H,H) = 0.9 Hz, 1H), 7.90 (td, 3J(H,H) = 7.6 Hz, 
4J(H,H) = 0.7 Hz, 1H), 7.82 (s, 2H), 7.80 (s, 1H); 13C NMR (100 MHz, CDCl3): δ = 164.4, 150.7, 
146.5, 136.7, 136.5, 134.7, 132.7 (q, 2J(C,F) = 33.5 Hz), 128.3, 126.2, 124.5, 124.5, 123.9 (q, 1J(C,F) 
= 272.2 Hz), 119.9 (m); 19F NMR (282 MHz, CDCl3): δ = -62.2; IR (film): ν = 3083.6, 3042.2, 
1827.2, 1796.4, 1700.9, 1279.5, 1118.5 cm-1; MS (FAB+): m/z 360.0 [M + H]+ (calcd. for 
C16H8F6NO2: 360.0); elemental analysis (%): C 53.35, H 1.88, N 3.90 (calcd. for C16H7F6NO2: C 
53.50, H 1.96, N 3.90). 
 
4.6.3.4 Preparation of the alcohols 3a-i 
 
General Procedure. Phthalisoimide 2a or 2b (1 eq) was added to the stirred 0.11 M solution of the 
chosen aminoalcohol (1.2 eq) in THF. The mixture was stirred overnight at R.T.. Two alternative 
workup procedures were followed depending on whether the product precipitated or not. Workup 1 
(soluble product): the mixture was diluted with AcOEt (triple volume with respect to THF) and 
washed three times with 1 M HCl. The organic phase was dried with Na2SO4 and evaporated. The 
product was purified by column chromatography. Workup 2 (insoluble product): the precipitated 
product was collected by filtration on a Buchner funnel and washed on the filter with little amounts of 
1:1 Et2O / hexane until the yellow impurities had disappeared. The product obtained with this workup 
procedure did not need a chromatographic purification. 
 
 
N1-(4-Butylphenyl)-N2-(3-(hydroxymethyl)phenyl)phthalamide 3a. The product was prepared 
according to the General Procedure – Workup 1 starting from 2 g of phthalisoimide 2a and 1.09 g of 
97% 3-aminobenzyl alcohol. Purification by flash chromatography (8:2 and then 7:3 DCM/AcOEt) 
gave the product as a white solid. Yield: 1.9 g (66%); m.p. = 110-115 °C; 1H NMR (400 MHz, 
CD3OD): δ = 7.74-7.71 (m, 2H), δ 7.67 (s, 1H), 7.64-7.61 (m, 2H), 7.52-7.53 (m, 3H), 7.31 (t, 3J(H,H) 
= 7.8 Hz, 1H), 7.15 (m, 3H), 4.59 (s, 2H), 2.60 (t, 3J(H,H) = 7.7 Hz, 2H), 1.60 (m, 2H), 1.37 (m, 2H), 
0.95 (t, 3J(H,H) = 7.4 Hz, 3H); 13C NMR (100 MHz, CD3OD): δ = 169.6, 169.5, 143.6, 140.4, 139.9, 
137.6, 137.5, 137.4, 131.4, 131.4, 129.8, 129.7, 129.1, 124.1, 122.1, 120.8, 120.5, 65.1, 36.1, 34.9, 
23.3, 14.3; IR (KBr): ν = 3247.5, 2926.5, 2856.1, 1646.9, 1541.8, 1325.8, 828.3 cm-1; MS (ESI+): m/z 
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425.4 [M + Na]+ (calcd. for C25H26N2O3Na: 425.2); elemental analysis (%): C 75.04, H 6.47, N 6.94 
(calcd. for C25H26N2O3: C 74.60, H 6.51, N 6.96). 
 
 
 
 
N1-(4-Butylphenyl)-N2-(3-(hydroxymethyl)benzyl)phthalamide 3b. The product, a white solid, was 
prepared according to the General Procedure – Workup 2 starting from 0.5 g of phthalisoimide 2a and 
0.3 g of aminoalcohol 7. Yield: 0.61 g (82%); m.p. = 150-154 °C; 1H NMR (400 MHz, [D6]DMSO): δ 
= 10.27 (s, 1H), 8.92 (t, 3J(H,H) = 5.9 Hz, 1H), 7.62-7.54 (m, 4H), 7.61 (d, 3J(H,H) = 8.3 Hz, 2H), 
7.31 (s, 1H), 7.26-7.18 (m, 3H), 7.14 (d, 3J(H,H) = 8.3 Hz, 2H), 5.15 (t, 3J(H,H) = 5.7 Hz, 1H), 4.49 
(d, 3J(H,H) = 5.7 Hz, 2H), 4.42 (d, 3J(H,H) = 5.9 Hz, 2H), 2.55 (t, 3J(H,H) = 7.4 Hz, 2H), 1.55 (m, 
2H), 1.31 (m, 2H), 0.90 (t, 3J(H,H) = 7.3 Hz, 3H); 13C NMR (100 MHz, [D6]DMSO): δ = 167.7, 
166.8, 142.4, 139.1, 137.2, 137.1, 137.1, 135.8, 129.5, 129.3, 128.2, 127.8, 127.7, 127.5, 125.4, 125.2, 
124.7, 119.5, 62.8, 42.5, 34.2, 33.2, 21.6, 13.7; IR (KBr): ν = 3451.0, 3280.3, 2925.5, 1646.9, 1543.7, 
1330.6, 830.2 cm-1; MS (ESI+): m/z 439.4 [M + Na]+ (calcd. for C26H28N2O3Na: 439.2); elemental 
analysis (%): C 74.77, H 6.61, N 6.63 (calcd. for C26H28N2O3: C 74.97, H 6.78, N 6.73). 
 
 
N1-(4-Butylphenyl)-N2-(4-(hydroxymethyl)phenyl)phthalamide 3c. The product was prepared 
according to the General Procedure – Workup 1 starting from 0.246 g of phthalisoimide 2a and 0.130 
g of 4-aminobenzyl alcohol. Purification by flash chromatography (8:2 and then 6:4 DCM/AcOEt) 
gave the product as a white solid. Yield: 0.254 g (75%); m.p. = 88-93 °C; 1H NMR (400 MHz, 
[D6]DMSO): δ = 10.38 (s, 1H), 10.33 (s, 1H), 7.68-7.58 (m, 8H), 7.26 (d, 3J(H,H) = 8.4 Hz, 2H), 7.13 
(d, 3J(H,H) = 8.4 Hz, 2H), 5.11 (t, 3J(H,H) = 5.7 Hz, 1H), 4.45 (d, 3J(H,H) = 5.7 Hz, 2H), 2.54 (t, 
3J(H,H) = 7.5 Hz, 2H), 1.54 (m, 2H), 1.30 (m, 2H), 0.90 (t, 3J(H,H) = 7.3 Hz, 3H); 13C NMR (100 
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MHz, [D6]DMSO): δ = 166.6, 166.6, 138.0, 137.6, 137.4, 137.1, 136.8, 136.8, 129.6, 128.3, 127.8, 
127.7, 119.6, 119.3, 62.6, 34.3, 33.2, 21.6, 13.8; IR (KBr): ν = 3368.1, 3245.6, 2926.5, 1646.9, 
1603.5, 1540.8, 1514.8, 1326.8, 827.3 cm-1; MS (ESI+): m/z 425.3 [M + Na]+ (calcd. for 
C25H26N2O3Na: 425.2); elemental analysis (%):C 74.30, H 6.42, N 6.89 (calcd. for C25H26N2O3: C 
74.60, H 6.51, N 6.96). 
 
 
N1-(4-Butylphenyl)-N2-(4-(hydroxymethyl)benzyl)phthalamide 3d. The product, a white solid, was 
prepared according to the General Procedure – Workup 1 starting from 0.613 g of phthalisoimide 2a 
and 0.301 g of aminoalcohol 8. Purification by flash chromatography (98:2, then 96:4 and 95:5 
DCM/MeOH) gave the product as a white solid. Yield: 0.816 g (89%); m.p. = 163-167 °C; 1H NMR 
(400 MHz, [D6]DMSO): δ = 10.24 (s, 1H), 8.86 (t, 3J(H,H) = 6.0 Hz, 1H), 7.61-7.53 (m, 6H), 7.30 (d, 
3J(H,H) = 8.1 Hz, 2H), 7.22 (d, 3J(H,H) = 8.1 Hz, 2H), 7.15 (d, 3J(H,H) = 8.4 Hz, 2H), 5.11 (t, 3J(H,H) 
= 5.7 Hz, 1H), 4.46 (d, 3J(H,H) = 5.7 Hz, 2H), 4.41 (d, 3J(H,H) = 6.0 Hz, 2H), 2.56 (t, 3J(H,H) = 7.5 
Hz, 2H), 1.55 (m, 2H), 1.31 (m, 2H), 0.91 (t, 3J(H,H) = 7.3 Hz, 3H); 13C NMR (100 MHz, 
[D6]DMSO): δ = 167.8, 166.9, 140.9, 137.7, 137.2, 137.2, 135.9, 129.6, 129.4, 128.3, 127.7, 127.6, 
126.9, 126.3, 119.5, 62.7, 42.3, 34.3, 33.3, 21.7, 13.8; IR (KBr): ν = 3490.5, 3229.2, 2927.4, 1629.6, 
1541.8, 1321.9, 724.1 cm-1; MS (ESI+): m/z 439.3 [M + Na]+ (calcd. for C26H28N2O3Na: 439.2); 
elemental analysis (%): C 74.72, H 6.62, N 6.44 (calcd. for C26H28N2O3: C 74.97, H 6.78, N 6.73). 
 
 
N1-(4-Butylphenyl)-N2-(2-(hydroxymethyl)benzyl)phthalamide 3e. The product, a white solid, was 
prepared according to the General Procedure – Workup 2 starting from 1.06 g of phthalisoimide 2a 
and 1.28 g of aminoalcohol 9. Yield: 1.27 g (80%); m.p. = 145-147 °C; 1H NMR (400 MHz, 
[D6]DMSO): δ = 10.25 (s, 1H), 8.77 (t, 3J(H,H) = 5.6 Hz, 1H), 7.62-7.54 (m, 6H), 7.38 (m, 2H), 7.21 
(td, 3J(H,H) = 7.4 Hz, 4J(H,H) = 1.2 Hz, 1H),  7.15 (td, 3J(H,H) = 7.4 Hz, 4J(H,H) = 1.4 Hz, 1H), 7.14 
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(d, 3J(H,H) = 8.4 Hz, 2H), 5.13 (t, 3J(H,H) = 5.4 Hz, 1H), 4.59 (d, 3J(H,H) = 5.4 Hz, 2H), 4.47 (d, 
3J(H,H) = 5.6 Hz, 2H), 2.55 (t, 3J(H,H) = 7.5 Hz, 2H), 1.55 (m, 2H), 1.31 (m, 2H), 0.90 (t, 3J(H,H) = 
7.3 Hz, 3H); 13C NMR (100 MHz, [D6]DMSO): δ = 167.7, 166.9, 139.4, 137.2, 137.2, 137.1, 136.4, 
135.9, 129.6, 129.4, 128.3, 127.7, 127.6, 127.2, 127.1, 126.7, 126.4, 119.6, 60.7, 39.6, 34.3, 33.3, 
21.6, 13.8; IR (KBr): ν = 3433.6, 3244.6, 2927.4, 1645.9, 1605.5, 1542.8, 1326.8, 825.4 cm-1; MS 
(ESI+): m/z 439.3 [M + Na]+ (calcd. for C26H28N2O3Na: 439.2); elemental analysis (%): C 75.23, H 
6.50, N 6.69 (calcd. for C26H28N2O3: C 74.97, H 6.78, N 6.73). 
 
3f
NH
O
O
N
H
OH
 
N1-(4-Butylphenyl)-N2-(3-(hydroxymethyl)phenethyl)phthalamide 3f. The product, a white solid, 
was prepared according to the General Procedure – Workup 1 starting from 1.012 g of phthalisoimide 
2a and 0.548 g of aminoalcohol 12. Purification by flash chromatography (6:4, then 1:1 and 4:6 
DCM/AcOEt) gave the product as a white solid. Yield: 1.28 g (82%); m.p. = 146 °C; 1H NMR (400 
MHz, CD3OD): δ = 7.67 (dd, 3J(H,H) = 6.8 Hz, 4J(H,H) = 1.6 Hz, 1H), 7.60-7.50 (m, 3H), 7.57 (d, 
3J(H,H) = 8.4 Hz, 2H), 7.27-7.24 (m, 2H), 7.21-7.15 (m, 2H), 7.18 (d, 3J(H,H) = 8.4 Hz, 2H), 4.59 (s, 
2H), 3.57 (t, 3J(H,H) = 7.6 Hz, 2H), 2.89 (t, 3J(H,H) = 7.6 Hz, 2H), 2.62 (t, 3J(H,H) = 7.6 Hz, 2H), 
1.62 (m, 2H), 1.37 (m, 2H), 0.96 (t, 3J(H,H) = 7.6 Hz, 3H); 13C NMR (100 MHz, CD3OD): δ = 171.4, 
169.7, 142.9, 140.7, 140.4, 137.7, 137.6, 137.0, 131.3, 131.3, 129.7, 129.6, 129.1, 128.9, 128.9, 128.6, 
126.1, 121.9, 65.3, 42.7, 36.4, 36.1, 35.1, 23.3, 14.3; IR (KBr): ν = 3448.1, 3250.4, 2928.4, 1647.8, 
1623.8, 1546.6, 1332.6, 821.5 cm-1; MS (ESI+): m/z 453.4 [M + Na]+ (calcd. for C27H30N2O3Na: 
453.2); elemental analysis (%): C 75.32, H 6.86, N 6.37 (calcd. for C27H30N2O3: C 75.32, H 7.02, N 
6.51). 
 
 
PhthalaPhos : Chiral Supramolecular Ligands for Rh-catalized hydrogenations 
199 
 
N1-(4-Butylphenyl)-N2-(4-(hydroxymethyl)phenethyl)phthalamide 3g. The product, a white solid, 
was prepared according to the General Procedure – Workup 1 starting from 1.524 g of phthalisoimide 
2a and 0.825 g of aminoalcohol 15. Purification by flash chromatography (6:4 and then 1:1 
DCM/AcOEt) gave the product as a white solid. Yield: 1.79 g (76%); m.p. = 120-130 °C; 1H NMR 
(400 MHz, CDCl3): δ = 9.18 (s, 1H), 7.74 (d, 3J(H,H) = 7.5 Hz, 1H), 7.56 (d, 3J(H,H) = 8.3 Hz, 2H), 
7.48-7.38 (m, 3H), 7.20 (d, 3J(H,H) = 8.0 Hz, 2H), 7.16 (d, 3J(H,H) = 8.3 Hz, 2H), 7.11 (d, 3J(H,H) = 
8.0 Hz, 2H), 6.57 (br s, 1H), 4.57 (s, 2H), 3.63 (q, 3J(H,H) = 7.0 Hz, 2H), 2.82 (t, 3J(H,H) = 7.0 Hz, 
2H), 2.59 (t, 3J(H,H) = 7.7 Hz, 2H), 1.59 (m, 2H), 1.35 (m, 2H), 0.92 (t, 3J(H,H) = 7.3 Hz, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 170.1, 166.9, 139.4, 139.4, 138.0, 136.0, 134.9, 134.7, 130.5, 130.3, 
129.3, 129.0, 129.0, 127.9, 127.4, 120.4, 65.0, 41.5, 35.3, 35.2, 33.9, 22.5, 14.1; IR (KBr): ν = 3264.9, 
2926.5, 1637.3, 1594.8, 1513.8, 1326.9, 829.4 cm-1; MS (ESI+): m/z 453.4 [M + Na]+ (calcd. for 
C27H30N2O3Na: 453.2); elemental analysis (%): C 74.99, H 6.96, N 6.36 (calcd. for C27H30N2O3: C 
75.32, H 7.02, N 6.51). 
 
N1-(3,5-Bis(trifluoromethyl)phenyl)-N2-(3-(hydroxymethyl)phenyl)phthalamide 3h. The product 
was prepared according to the General Procedure – Workup 1 starting from 0.429 g of phthalisoimide 
2b and 0.182 g of 97% 3-aminobenzyl alcohol. Purification by flash chromatography (8:2 and then 6:4 
DCM/AcOEt) gave the product as a white solid. Yield: 0.456 g (79%); m.p. = 187-190 °C; 1H NMR 
(400 MHz, CD3OD): δ = 8.30 (s, 2H), 7.76 (m, 2H), 7.66 (m, 4H), 7.54 (d, 3J(H,H) = 7.8 Hz, 1H), 
7.31 (t, 3J(H,H) = 7.8 Hz, 1H), 7.14 (d, 3J(H,H) = 7.8 Hz, 1H), 4.59 (s, 2H); 13C NMR (100 MHz, 
CD3OD): δ = 170.1, 169.6, 143.6, 142.1, 139.8, 137.4, 136.8, 133.1 (q, 2J(C,F) = 33.2 Hz), 131.9, 
131.5, 129.8, 129.1, 129.0, 124.7 (q, 1J(C,F) = 272.0 Hz), 124.2, 120.8, 120.4, 117.8, 65.1; 19F NMR 
(282 MHz, CD3OD): δ = -62.0 (s); IR (KBr): ν = 3452.9, 3262.9, 3089.4, 1647.9, 1559.2, 1277.6, 
840.8 cm-1; MS (ESI+): m/z 505.1 [M + Na]+ (calcd. for C23H16F6N2O3Na: 505.1); elemental analysis 
(%): C 57.02, H 3.20, N 5.78 (calcd. for C23H16F6N2O3: C 57.27, H 3.34, N 5.81). 
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N1-(3,5-Bis(trifluoromethyl)phenyl)-N2-(3-(hydroxymethyl)benzyl)phthalamide 3i. The product, a 
pale yellow solid, was prepared according to the General Procedure – Workup 1 starting from 0.400 g 
of phthalisoimide 2b and 0.184 g of aminoalcohol 7. Yield: 0.495 g (90%); m.p. = 175-177 °C; 1H 
NMR (400 MHz, CD3OD): δ = 8.31 (s, 2H), 7.57 (s, 1H), 7.50-7.43 (m, 4H), 7.41 (s, 1H), 7.32-7.22 
(m, 3H), 4.59 (s, 2H), 4.54 (s, 2H); 13C NMR (100 MHz, CD3OD): δ = 171.0, 170.2, 143.0, 142.2, 
140.0, 137.0, 136.6, 133.0 (q, 2J(C,F) = 33.0 Hz), 131.7, 131.4, 129.5, 129.0, 129.0, 127.7, 127.3,  
126.9, 124.7 (q, 1J(C,F) = 270.3 Hz), 120.7, 117.7, 65.1, 44.7; 19F NMR (282 MHz, CD3OD): δ = -
62.0 (s); IR (KBr): ν = 3394.1, 3273.6, 3084.6, 1635.3, 1592.9, 1280.5, 840.8 cm-1; MS (ESI+): m/z 
519.2 [M + Na]+ (calcd. for C24H18F6N2O3Na: 519.1); elemental analysis (%): C 57.81, H 3.58, N 5.41 
(calcd. for C24H18F6N2O3: C 58.07, H 3.65, N 5.64). 
 
4.6.3.5 Synthesis of phosphites 4a-i (PhthalaPhos ligands). 
Two alternative, slightly different procedures were followed depending on whether the starting alcohol 
was soluble in THF or not. 
 
General Procedure 1. (S)-BINOL-PCl (1 eq, typical scale: 0.3 g) was added to a stirred 0.1 M 
solution of the selected alcohol (1 eq) and Et3N (3 eq) in THF. The obtained mixture was stirred 
overnight and then filtered through a pad of celite (washing with THF). The solvent was evaporated 
under reduced pressure and the crude product was purified by flash column chromatography on silica 
gel. 
 
General Procedure 2. (S)-BINOL-PCl (1 eq, typical scale: 0.3 g) was added to a stirred suspension of 
the selected alcohol (1 eq) and Et3N (3 eq) in 6:4 THF/DCM (conc. ~ 0.1 M). The obtained mixture 
was stirred overnight and then Et2O (half volume with respect to the THF/DCM mixture) was added. 
The mixture was filtered through a pad of celite (washing with THF), the solvent was evaporated 
under reduced pressure and the crude product was purified by flash column chromatography on silica 
gel. 
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N1-(4-Butylphenyl)-N2-(3-(((11bS)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-
yloxy)methyl)phenyl)phthalamide 4a. The product, a white solid, was prepared according to the 
General Procedure 1 starting from 0.314 g of (S)-BINOL-PCl and 0.36 g of alcohol 3a in the presence 
of 0.375 mL of TEA. Yield: 0.473 g (74%); m.p. = 114-121 °C; [α]19D = + 277.6 (c = 1.0 in DCM); 1H 
NMR (400 MHz, CD2Cl2): δ = 9.40 (s, 1H), 9.02 (s, 1H), 8.04 (d, 3J(H,H) = 8.8 Hz, 1H), 8.00 (d, 
3J(H,H) = 8.4 Hz, 1H), 7.93 (d, 3J(H,H) = 8.8 Hz, 1H), 7.92 (d, 3J(H,H) = 8.2 Hz, 1H), 7.59-7.56 (m, 
3H), 7.53-7.42 (m, 6H), 7.39-7.27 (m, 7H), 7.23 (t, 3J(H,H) = 8.0 Hz, 1H), 7.04 (d, 3J(H,H) = 8.4 Hz, 
2H), 7.00 (d, 3J(H,H) = 8.0 Hz, 1H), 4.92 (dd, 2J(H,H) = 12.3 Hz, 3J(H,P) = 8.0 Hz, 1H), 4.70 (dd, 
2J(H,H) = 12.3 Hz, 3J(H,P) = 8.0 Hz, 1H), 2.53 (t, 3J(H,H) = 7.8 Hz, 2H), 1.54 (m, 2H), 1.33 (m, 2H), 
0.92 (t, 3J(H,H) = 7.3 Hz, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 167.9, 149.2, 148.1, 139.8, 139.0, 
138.5, 136.3, 135.7, 135.6, 133.3, 133.1, 132.2, 131.7, 131.1, 131.0, 130.9, 129.5, 129.3, 129.1, 129.1, 
128.8, 127.4, 127.0, 126.9, 125.8, 125.6, 124.1, 123.2, 122.5, 122.3, 121.6, 120.8, 120.4, 119.8, 67.2 
(d, 2J(C,P) = 5.6 Hz), 35.6, 34.3, 23.0, 14.3; 31P NMR (162 MHz, CD2Cl2): δ = 141.3 (s). IR (film): ν 
= 3238.9, 3060.5, 2954.4, 1639.2, 1541.8, 1230.3, 823.5 cm-1; HRMS (ESI+): m/z 739.23323 [M + 
Na]+ (calcd. for C45H37N2O5PNa: 739.23469).  
 
 
N1-(4-Butylphenyl)-N2-(3-(((11bS)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-
yloxy)methyl)benzyl)phthalamide 4b. The product, a white solid, was prepared according to the 
General Procedure 2 starting from 0.337 g of (S)-BINOL-PCl and 0.40 g of alcohol 3b in the presence 
of 0.40 mL of TEA. Yield: 0.475 g (67%); m.p. = 139-145 °C; [α]23D = + 120.1 (c = 1.0 in DCM); 1H 
NMR (400 MHz, CD2Cl2): δ = 8.80 (s, 1H), 8.06 (d, 3J(H,H) = 8.8 Hz, 1H), 8.01 (d, 3J(H,H) = 8.2 Hz, 
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1H), 7.95 (d, 3J(H,H) = 9.0 Hz, 1H), 7.92 (d, 3J(H,H) = 7.8 Hz, 1H), 7.79 (d, 3J(H,H) = 7.1 Hz, 1H), 
7.62 (dd, 3J(H,H) = 7.4 Hz, 4J(H,H) = 1.5 Hz, 1H), 7.58-7.43 (m, 7H), 7.39-7.20 (m, 9H), 7.15 (d, 
3J(H,H) = 8.3 Hz, 2H), 6.89 (t, 3J(H,H) = 6.0 Hz, 1H), 4.91 (dd, 2J(H,H) = 12.3 Hz, 3J(H,P) = 8.0 Hz, 
1H), 4.71 (dd, 2J(H,H) = 12.3 Hz, 3J(H,P) = 8.2 Hz, 1H), 4.60 (d, 3J(H,H) = 6.0 Hz, 2H), 2.62 (t, 
3J(H,H) = 7.8 Hz, 2H), 1.62 (m, 2H), 1.39 (m, 2H), 0.97 (t, 3J(H,H) = 7.3 Hz, 3H); 13C NMR (100 
MHz, CD2Cl2): δ = 170.0, 167.3, 149.2, 148.1, 139.7, 139.1, 138.2, 136.6, 135.7, 135.0, 133.4, 133.1, 
132.2, 131.7, 131.0, 130.8, 130.8, 129.4, 129.1, 129.0, 128.9, 128.7, 127.3, 126.8, 126.8, 125.7, 125.5, 
124.6, 124.0, 123.1, 122.4, 122.2, 120.7, 120.3, 119.7, 67.1 (d, 2J(C,P) = 5.7 Hz), 44.3, 35.5, 34.2, 
22.9, 14.3; 31P NMR (162 MHz, CD2Cl2): δ =  141.8 (s). IR (film): ν = 3243.7, 3058.6, 2954.4, 
1635.3, 1538.9, 1230.0, 825.4 cm-1; HRMS (ESI+): m/z 753.24782 [M + Na]+ (calcd. for 
C46H39N2O5PNa: 753.24888). 
 
 
N1-(4-Butylphenyl)-N2-(4-(((11bS)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-
yloxy)methyl)phenyl)phthalamide 4c. The product, a white solid, was prepared according to the 
General Procedure 1 starting from 0.174 g of (S)-BINOL-PCl and 0.200 g of alcohol 3c in the 
presence of 0.208 mL of TEA. Yield: 0.219 g (62%); m.p. = 150-159 °C; [α]18D = + 209.1 (c = 0.8 in 
DCM); 1H NMR (400 MHz, CD2Cl2): δ = 8.96 (s, 1H), 8.53 (s, 1H), 8.06 (d, 3J(H,H) = 8.8 Hz, 1H), 
8.01, (d, 3J(H,H) = 8.2 Hz, 1H), 7.97 (d, 3J(H,H) = 8.6 Hz, 2H), 7.78 (m, 1H), 7.72 (m, 1H), 7.65 (d, 
3J(H,H) = 8.2 Hz, 2H), 7.60-7.46 (m, 7H), 7.39-7.29 (m, 7H), 7.18 (d, 3J(H,H) = 8.3 Hz, 2H), 5.00 (dd, 
2J(H,H) = 12.1 Hz, 3J(H,P) = 8.0 Hz, 1H), 4.78 (dd, 2J(H,H) = 12.1 Hz, 3J(H,P) = 8.3 Hz, 1H), 2.61 (t, 
3J(H,H) = 7.8 Hz, 2H), 1.60 (m, 2H), 1.37 (m, 2H), 0.95 (t, 3J(H,H) = 7.3 Hz, 3H); 13C NMR (100 
MHz, CD2Cl2): δ = 168.2, 168.0, 149.3, 148.2, 139.2, 136.8, 135.6, 135.5, 133.4, 133.1, 132.2, 131.7, 
131.0, 130.7, 130.3, 130.2, 129.0, 128.8, 128.5, 127.3, 126.8, 125.7, 125.5, 124.7, 124.6, 123.2, 122.4, 
122.2, 120.6, 120.5, 67.1 (d, 2J(C,P) = 4.6 Hz), 35.6, 34.2, 22.9, 14.3; 31P NMR (162 MHz, CD2Cl2): δ 
= 141.8 (s). IR (film): ν = 3240.1, 3059.1, 2954.4, 1639.2, 1541.8, 1230.0, 823.5 cm-1; HRMS (ESI+): 
m/z 739.23437 [M + Na]+ (calcd. for C45H37N2O5PNa: 739.23323). 
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N1-(4-Butylphenyl)-N2-(4-(((11bS)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-
yloxy)methyl)benzyl)phthalamide 4d. The product, a white solid, was prepared according to the 
General Procedure 1 starting from 0.278 g of (S)-BINOL-PCl and 0.30 g of alcohol 3d in the presence 
of 0.30 mL of TEA. Yield: 0.342 g (65%); m.p. = 110-130 °C; [α]18D = + 239.6 (c = 0.93 in DCM); 1H 
NMR (400 MHz, CD2Cl2): δ = 8.88 (s, 1H), 8.06 (d, 3J(H,H) = 8.8 Hz, 1H), 8.01 (d, 3J(H,H) = 8.3 Hz, 
1H), 7.97 (d, 3J(H,H) = 8.7 Hz, 2H), 7.80 (d, 3J(H,H) = 7.0 Hz, 1H), 7.62-7.46 (m, 8H), 7.39-7.30 (m, 
7H), 7.20 (d, 3J(H,H) = 7.4 Hz, 2H), 7.18 (d, 3J(H,H) = 7.4 Hz, 2H), 6.88 (t, 3J(H,H) = 5.9 Hz, 1H), 
4.97 (dd, 2J(H,H) = 12.2 Hz, 3J(H,P) = 8.0 Hz, 1H), 4.76 (dd, 2J(H,H) = 12.2 Hz, 3J(H,P) = 8.2 Hz, 
1H), 4.60 (d, 3J(H,H) = 5.9 Hz, 2H), 2.61 (t, 3J(H,H) = 7.6 Hz, 2H), 1.61 (m, 2H), 1.37 (m, 2H), 0.95 
(t, 3J(H,H) = 7.3 Hz, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 170.0, 167.4, 149.3, 148.1, 139.7, 138.7, 
137.0, 136.6, 135.7, 135.0, 133.4, 133.1, 132.2, 131.7, 131.1, 130.8, 130.7, 130.6, 129.2, 129.1, 129.0, 
129.0, 128.5, 128.4, 128.3, 127.3, 126.9, 126.9, 125.7, 125.6, 124.6, 123.2, 122.3, 122.1, 120.8, 67.0 
(d, 2J(C,P) = 5.7 Hz), 44.2, 35.6, 34.3, 22.9, 14.3; 31P NMR (162 MHz, CD2Cl2): δ =  141.6 (s). IR 
(film): ν = 3259.1, 3058.6, 2954.4, 1637.3, 1540.8, 1230.0, 824.4 cm-1; HRMS (ESI+): m/z 753.24963 
[M + Na]+ (calcd. for C46H39N2O5PNa: 753.24888). 
 
 
N1-(4-Butylphenyl)-N2-(2-(((11bS)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-
yloxy)methyl)benzyl)phthalamide 4e. The product, a white solid, was prepared according to the 
General Procedure 2 starting from 0.287 g of (S)-BINOL-PCl and 0.340 g of alcohol 3e in the 
presence of 0.342 mL of TEA. Yield: 0.412 g (69%); m.p. = 115-122 °C; [α]20D = + 313.5 (c = 0.87 in 
DCM); 1H NMR (400 MHz, CD2Cl2): δ = 8.91 (s, 1H), 8.04 (d, 3J(H,H) = 8.8 Hz, 1H), 8.00 (d, 
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3J(H,H) = 8.2 Hz, 1H), 7.89 (d, 3J(H,H) = 8.8 Hz, 1H), 7.88 (d, 3J(H,H) = 8.0 Hz, 1H), 7.70 (d, 
3J(H,H) = 7.7 Hz, 1H), 7.52-7.38 (m, 7H), 7.34-7.20 (m, 10H), 7.16 (d, 3J(H,H) = 8.3 Hz, 2H), 6.76 (t, 
3J(H,H) = 5.4 Hz, 1H), 5.13 (dd, 2J(H,H) = 12.1 Hz, 3J(H,P) = 7.8 Hz, 1H), 4.98 (dd, 2J(H,H) = 12.1 
Hz, 3J(H,P) = 8.4 Hz, 1H), 4.61 (dd, 2J(H,H) = 14.7 Hz, 3J(H,P) = 5.9 Hz, 1H), 4.53 (dd, 2J(H,H) = 
14.7 Hz, 3J(H,P) = 5.7 Hz, 1H), 2.63 (t, 3J(H,H) = 7.8 Hz, 2H), 1.64 (m, 2H), 1.40 (m, 2H), 0.98 (t, 
3J(H,H) = 7.8 Hz, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 169.6, 166.8, 148.9, 147.8, 139.7, 137.3, 
136.5, 135.7, 135.6, 134.7, 133.3, 133.0, 132.2, 131.6, 131.1, 130.8, 130.7, 130.4, 130.2, 129.7, 129.6, 
129.3, 129.0, 128.9, 128.5, 128.3, 127.3, 127.3, 126.9, 126.9, 125.8, 125.6, 124.5, 123.2, 122.2, 122.0, 
121.9, 120.6, 65.6 (d, 2J(C,P) = 9.3 Hz), 41.9, 35.6, 34.3, 22.9, 14.3; 31P NMR (162 MHz, CD2Cl2): δ 
=  144.0 (s). IR (film): ν = 3245.6, 3058.8, 2954.4, 1636.3, 1541.8, 1230.0, 824.4 cm-1; HRMS (ESI+): 
m/z 753.24983 [M + Na]+ (calcd. for C46H39N2O5PNa: 753.24888). 
 
 
N1-(4-Butylphenyl)-N2-(3-(((11bS)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-
yloxy)methyl)phenethyl)phthalamide 4f. The product, a white solid, was prepared according to the 
General Procedure 1 starting from 0.137 g of (S)-BINOL-PCl and 0.390 g of alcohol 3f in the presence 
of 0.163 mL of TEA. Yield: 0.183 g (63%); m.p. = 105-116 °C; [α]20D = + 201.7 (c = 0.8 in DCM); 1H 
NMR (400 MHz, CD2Cl2): δ = 9.21 (s, 1H), 8.06 (d, 3J(H,H) = 8.8 Hz, 1H), 8.01 (d, 3J(H,H) = 8.3 Hz, 
1H), 7.96 (d, 3J(H,H) = 8.7 Hz, 2H), 7.73 (d, 3J(H,H) = 7.4 Hz, 1H), 7.58 (d, 3J(H,H) = 8.8 Hz, 1H), 
7.57 (d, 3J(H,H) = 8.1 Hz, 2H), 7.52-7.28 (m, 11H), 7.19-7.17 (m, 5H), 6.55 (bs, 1H), 5.00 (dd, 
2J(H,H) = 12.2 Hz, 3J(H,P) = 7.9 Hz, 1H), 4.80 (dd, 2J(H,H) = 12.2 Hz, 3J(H,P) = 8.4 Hz, 1H), 3.64 
(m, 2H), 2.88 (t, 3J(H,P) = 7.1 Hz, 2H), 2.62 (t, 3J(H,P) = 7.6 Hz, 2H), 1.63 (m, 2H), 1.38 (m, 2H), 
0.96 (t, 3J(H,P) = 7.3 Hz, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 170.3, 167.1, 149.2, 148.1, 139.9, 
139.6, 138.1, 136.8, 135.6, 135.4, 133.4, 133.1, 132.2, 131.7, 131.1, 130.8, 130.4, 129.3, 129.2, 129.1, 
129.0, 128.6, 128.2, 127.3, 126.9, 126.3, 125.7, 125.6, 124.6, 123.2, 122.4, 122.1, 120.7, 67.2 (d, 
2J(C,P) = 4.6 Hz), 41.8, 35.8, 35.6, 34.3, 22.9, 14.3; 31P NMR (162 MHz, CD2Cl2): δ =  142.2 (s). IR 
(film): ν = 3240.6, 3058.5, 2954.4, 1636.3, 1541.8, 1230.0, 825.4 cm-1; HRMS (ESI+): m/z 745.28262 
[M + H]+ (calcd. for C47H42N2O5P: 745.28259) and 767.26300 [M + Na]+ (calcd. for C47H41N2O5PNa: 
767.26453). 
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N1-(4-Butylphenyl)-N2-(4-(((11bS)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-
yloxy)methyl)phenethyl)phthalamide 4g. The product, a white solid, was prepared according to the 
General Procedure 2 starting from 0.275 g of (S)-BINOL-PCl and 0.338 g of alcohol 3g in the 
presence of 0.328 mL of TEA. Yield: 0.415 g (71%); m.p. = 109-117 °C; [α]20D = + 248.8 (c = 0.8 in 
DCM); 1H NMR (400 MHz, CD2Cl2): δ = 9.22 (s, 1H), 8.06 (d, 3J(H,P) = 8.8 Hz, 1H), 8.01 (d, 3J(H,P) 
= 8.3 Hz, 1H), 7.96 (d, 3J(H,P) = 9.0 Hz, 2H), 7.74 (d, 3J(H,P) = 7.4 Hz, 1H), 7.58 (m, 3H), 7.52-7.29 
(m, 10H), 7.23 (m, 4H), 7.19 (d, 3J(H,P) = 8.5 Hz, 2H), 6.62 (t, 3J(H,P) = 5.6 Hz, 1H), 4.98 (dd, 
2J(H,H) = 12.1 Hz, 3J(H,P) = 8.0 Hz, 1H), 4.77 (dd, 2J(H,H) = 12.1 Hz, 3J(H,P) = 8.2 Hz, 1H), 3.65 (q, 
3J (H,H) = 6 Hz, 2H), 2.89 (t, 3J(H,P) = 7.1 Hz, 2H), 2.63 (t, 3J(H,P) = 7.6 Hz, 2H), 1.63 (m, 2H), 1.39 
(m, 2H), 0.97 (t, 3J(H,P) = 7.3 Hz, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 170.2, 167.5, 149.3, 148.1, 
139.8, 139.4, 137.0, 135.9, 135.7, 135.4, 133.4, 133.1, 132.2, 131.7, 131.1, 130.8, 130.5, 130.2, 129.4, 
129.1, 129.0, 129.0, 128.4, 128.1, 127.3, 126.9, 126.9, 125.7, 125.6, 124.6, 123.2, 122.4, 122.1, 120.7, 
67.2 (d, 2J(C,P) = 4.8 Hz), 41.8, 35.6, 35.5, 34.3, 22.9, 14.4; 31P NMR (162 MHz, CD2Cl2): δ = 141.9 
(s). IR (film): ν = 3252.4, 3073.0, 2954.3, 1635.3, 1540.8, 1230.0, 823.5 cm-1; HRMS (ESI+): m/z 
767.26494 [M + Na]+ (calcd. for C47H41N2O5PNa: 767.26453). 
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N1-(3,5-Bis(trifluoromethyl)phenyl)-N2-(3-(((11bS)-dinaphtho[2,1-d:1',2'-
f][1,3,2]dioxaphosphepin-4-yloxy)methyl)phenyl)phthalamide 4h. The product, a white solid, was 
prepared according to the General Procedure 1 starting from 0.168 g of (S)-BINOL-PCl and 0.230 g of 
alcohol 3h in the presence of 0.2 mL of TEA. Yield: 0.296 g (78%); m.p. = 165-176 °C; [α]21D = + 
216.7 (c = 0.75 in DCM); 1H NMR (400 MHz, CD2Cl2): δ = 10.53 (s, 1H), 9.16 (s, 1H), 8.07 (s, 2H), 
7.96 (d, 3J(H,H) = 8.8 Hz, 1H), 7.92 (d, 3J(H,H) = 8.2 Hz, 1H), 7.85 (d, 3J(H,H) = 8.7 Hz, 1H), 7.83 
(d, 3J(H,H) = 7.5 Hz, 1H), 7.63 (s, 1H), 7.45 (d, 3J(H,H) = 8.8 Hz, 1H), 7.42-7.34 (m, 4H), 7.31-7.15 
(m, 6H), 7.04 (m, 1H), 6.96 (d, 3J(H,H) = 7.7 Hz, 2H), 6.89 (m, 2H), 4.87 (dd, 2J(H,H) = 12.4 Hz, 
3J(H,P) = 8.1 Hz, 1H), 4.69 (dd, 2J(H,H) = 12.4 Hz, 3J(H,P) = 8.2 Hz, 1H); 13C NMR (100 MHz, 
CD2Cl2): δ = 168.7, 168.4, 149.1, 148.0, 140.6, 138.7, 138.5, 135.7, 134.8, 133.3, 133.1, 132.2, 132.1 
(q, 2J(C,F) = 33.3 Hz), 131.6, 131.2, 131.0, 130.8, 130.7, 129.6, 129.0, 128.9, 128.5, 128.0, 127.3, 
127.3, 126.9, 126.8, 125.7, 125.5, 124.6, 124.5, 123.7 (q, 1J(C,F) = 272.6 Hz), 123.1, 122.3, 122.0, 
120.4, 119.9, 119.4, 117.8, 66.9 (d, 2J(C,P) = 6.7 Hz); 31P NMR (162 MHz, CD2Cl2): δ =  141.0 (s); 
19F NMR (282 MHz, CD2Cl2): δ = -62.2 (s); IR (film): ν = 3220.4, 1638.2, 1380.8, 1276.0, 1230.0, 
823.5 cm-1; HRMS (ESI+): m/z 819.14729 [M + Na]+ (calcd. for C43H27F6N2O5PNa: 819.14540). 
 
 
N1-(3,5-bis(trifluoromethyl)phenyl)-N2-(3-(((11bS)-dinaphtho[2,1-d:1',2'-
f][1,3,2]dioxaphosphepin-4-yloxy)methyl)benzyl)phthalamide 4i. The product, a white solid, was 
prepared according to the General Procedure 1 starting from 0.234 g of (S)-BINOL-PCl and 0.330 g of 
alcohol 3i in the presence of 0.279 mL of TEA. Yield: 0.413 g (76%); m.p. = 138-145 °C; [α]21D = + 
229.8 (c = 0.95 in DCM); 1H NMR (400 MHz, CD2Cl2): δ = 10.81 (s, 1H), 8.16 (s, 2H), 8.02 (d, 
3J(H,H) = 8.8 Hz, 1H), 7.98 (d, 3J(H,H) = 8.2 Hz, 1H), 7.92 (d, 3J(H,H) = 8.8 Hz, 1H), 7.90 (d, 
3J(H,H) = 8.1 Hz, 1H), 7.54-7.25 (m, 12H), 7.22-7.16 (m, 2H), 6.69 (t, 3J(H,H) = 5.7 Hz, 1H), 5.03 
(dd, 2J(H,H) = 12.3 Hz, 3J(H,P) = 8.2 Hz, 1H), 4.85 (dd, 2J(H,H) = 12.3 Hz, 3J(H,P) = 8.2 Hz, 1H), 
4.65 (AB system, 2H); 13C NMR (100 MHz, CD2Cl2): δ = 170.0, 168.8, 149.2, 148.0, 141.2, 139.5, 
138.3, 135.1, 134.4, 133.3, 133.1, 132.2, 132.1 (q, 2J(C,F) = 33.2 Hz), 131.7, 131.1, 130.8, 130.3, 
129.4, 129.0, 128.9, 128.4, 128.3, 127.7, 127.6, 127.4, 127.3, 127.3, 127.0, 126.9, 125.8, 125.6, 124.6, 
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123.8 (q, 1J(C,F) = 272.7 Hz), 123.2, 122.2, 122.0, 119.6, 117.2, 67.1 (d, 2J(C,P) = 6.5 Hz), 44.3; 31P 
NMR (162 MHz, CD2Cl2): δ =  140.6 (s); 19F NMR (282 MHz, CD2Cl2): δ = -62.2 (s); IR (film): ν = 
3219.2, 1635.3, 1382.7, 1281.0, 1230.0, 823.5 cm-1; HRMS (ESI+): m/z 833.16280 [M + Na]+ (calcd. 
for C44H29F6N2O5PNa: 833.16105). 
 
4.6.4 NMR studies 
 
4.6.4.1 Concentration dependence of the chemical shift of NH protons of ligand 4a and 
complex [Rh(4a)2(cod)BF4] 
Experimental parameters: T = 298 K; solvent: CD2Cl2 (0.8 mL). 
Ligand: 
 
Complex [Rh(4a)2(cod)BF4]: prepared in situ from [Rh(cod)2BF4] (1 eq) and 4a (2.1 eq). 
 
Table 4.9. Concentration dependence of chemical shift of protons NH A and NH B in the free ligand 4a. 
 Proton NH A Proton NH B 
Conc. / mM δA / ppm 
∆δA = δA - δA 0,3125 mM / ppm 
δB / ppm 
∆δB = δB - δB 0,3125 mM / ppm 
0.3125 8.6540 0.0000 8.3080 0.0000 
0.625 8.6620 0.0080 8.3130 0.0050 
1.25 8.6740 0.0200 8.3260 0.0180 
2.5 8.7060 0.0520 8.3550 0.0470 
5 8.7590 0.1050 8.4050 0.0970 
10 8.8480 0.1940 8.4870 0.1790 
20 9.0064 0.3524 8.6363 0.3283 
 
Table 4.10 Concentration dependence of chemical shift of protons NH A and NH B in the complex 
[Rh(4a)2(cod)BF4]. 
 Proton NH A Proton NH B 
Conc. / mM δA / ppm 
∆δA = δA - δA 0,3125 mM / ppm 
δB / ppm 
∆δB = δB - δB 0,3125 mM / ppm 
0.3125 9.6270 0.0000 8.3980 0.0000 
0.625 9.6140 -0.0130 8.4450 0.0470 
1.25 9.6040 -0.0230 8.5060 0.1080 
2.5 9.5990 -0.0280 8.5840 0.1860 
5 9.6060 -0.0210 8.6870 0.2890 
10 9.6130 -0.0140 8.7890 0.3910 
20 9.6570 0.0300 8.9410 0.5430 
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Note: in all the experiments, the 31P NMR spectra invariably showed a clean doublet signal at δ = 
122.0 ppm with JRh-P = 257.7 Hz. 
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Figure 4.6 Concentration dependence of proton NH A in the free ligand 4a and in complex [Rh(4a)2(cod)BF4]. 
 
 
Figure 4.7 Concentration dependence of proton NH B in the free ligand 4a and in complex [Rh(4a)2(cod)BF4]. 
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4.6.4.2 Temperature dependence of the chemical shift of NH protons of ligand 4a and 
complex [Rh(4a)2(cod)BF4] 
 
Experimental parameters: concentration: 1.2 mM; solvent: CD2Cl2 (0.8 mL). 
Ligand: 
 
Complex [Rh(4a)2(cod)BF4]: prepared in situ from [Rh(cod)2BF4] (1 eq) and 4a (2.1 eq). 
 
Table 4.11 Temperature dependence of chemical shift of protons NH A and NH B in the free ligand 4a. 
 Proton NH A Proton NH B 
T (K) δA (ppm) ∆δA (ppm) = δA - δA 298 K δB (ppm) ∆δB (ppm) = δB - δB 298 K 
298 8.6922 0.0000 8.3423 0.0000 
288 8.7362 0.0440 8.3739 0.0316 
278 8.7902 0.0980 8.4117 0.0694 
268 8.8628 0.1706 8.4592 0.1169 
258 8.9919 0.2997 8.5459 0.2036 
248 9.2746 0.5824 8.7624 0.4201 
 
Table 4.12. Temperature dependence of chemical shift of protons NH A and NH B in complex 
[Rh(4a)2(cod)BF4]. 
 Proton NH A Proton NH B 
T (K) δA (ppm) ∆δA (ppm) = δA - δA 298 K δB (ppm) ∆δB (ppm) = δB - δB 298 K 
298 9.6060 0.0000 8.4800 0.0000 
288 9.7390 0.1330 8.4690 -0.0110 
278 9.8770 0.2710 8.4510 -0.0290 
268 10.0080 0.4020 8.4320 -0.0480 
258 10.1330 0.5270 8.4130 -0.0670 
248 10.2490 0.6430 8.3960 -0.0840 
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Figure 4.8 Temperature dependence of chemical shift of proton NH A in free ligand 4a and in complex 
[Rh(4a)2(cod)BF4]. 
 
Figure 4.9 Temperature dependence of chemical shift of proton NH B in free ligand 4a and in complex 
[Rh(4a)2(cod)BF4]. 
 
 
Note: the ∆δ/∆T values were calculated from the slope of a linear least squares fit to the δ vs. T graph 
obtained for the complex [Rh(4a)2(cod)BF4] (Tables S3 and S4), which showed a linear dependence of 
NH proton chemical shift from temperature. No ∆δ/∆T calculation was carried out for the free ligand 
4a, whose NH protons did not show a linear temperature dependence of chemical shift. 
 
Table 4.13 Determination of ∆δ/∆T values of protons NH A and NH B in complex [Rh(4a)2(cod)BF4]. 
 
Proton NH A 
 
Proton NH B 
Linear regression of Slope Intercept   Slope Intercept 
 vs. T -0.0129 13.4672   0.0017 7.9667 
Standard error = 0.0002 0.0519   0.0001 0.0171 
R2 = 0.9991 0.0079   0.9948 0.0026 
F index = 4641.4392 4.0000   771.8904 4.0000 
 0.2929 0.0003   0.0053 0.0000 
∆δ / ∆T (ppb K-1) = -12.94    1.73  
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4.6.4.3 Kinetic study of H/D exchange of NH protons of ligand 4a and complex 
[Rh(4a)2(cod)BF4] in the presence of a large excess of CD3OD 
 
Experimental parameters: T = 298 K; concentration: 1.2 mM; solvent: CD2Cl2 (0.8 mL). Excess of 
CD3OD: 513 eq (20 µL, 0.492 mmol). 
Abbreviations used in the tables: %Ht = percent of H still not exchanged (%Ht) for each NH group; 
RH,t = fraction of unexchanged H (RH,0 = 1). 
Ligand: 
 
Complex [Rh(4a)2(cod)BF4]: prepared in situ from [Rh(cod)2BF4] (1 eq) and 4a (2.1 eq). 
Note: time = 0 was marked when CD3OD was added. A distinct non-exchanging NMR signal was 
used as an internal integration reference. Rate constants k and corresponding half-lives t1/2 were 
determined from the slope of a linear least squares fit to the graph of ln(RH,t) = -kt. The part of the 
curve corresponding values of RH,t < 0.1 (i.e. %Ht < 10%) was not computed for the least square fit 
because, for such low values, the integration error becomes significant. 
Table 4.14 H/D exchange of the NH protons of ligand 4a (1.2 mM CD2Cl2 solution). 
 Proton NH A Proton NH B 
t (min) %Ht RH,t ln (RH,t) %Ht RH,t ln (RH,t) 
0.00 100.00 1.0000 0.000 100.00 1.0000 0.000 
3.12 77.17 0.7717 -0.259 79.80 0.7980 -0.226 
6.99 59.81 0.5981 -0.514 66.18 0.6618 -0.413 
10.84 47.53 0.4753 -0.744 53.96 0.5396 -0.617 
14.70 39.16 0.3916 -0.937 45.36 0.4536 -0.791 
18.55 31.56 0.3156 -1.153 39.07 0.3907 -0.940 
22.42 26.66 0.2666 -1.322 33.03 0.3303 -1.108 
26.29 21.48 0.2148 -1.538 27.34 0.2734 -1.297 
30.14 16.17 0.1617 -1.822 22.50 0.2250 -1.491 
34.00 16.86 0.1686 -1.780 20.79 0.2079 -1.571 
37.85 12.15 0.1215 -2.108 16.12 0.1612 -1.825 
41.72 10.75 0.1075 -2.230 15.96 0.1596 -1.835 
49.59 9.57 0.0957 -2.347 11.72 0.1172 -2.144 
57.44 7.14 0.0714 -2.640 8.80 0.0880 -2.431 
65.30 7.45 0.0745 -2.597 8.49 0.0849 -2.466 
73.17 6.05 0.0605 -2.805 6.73 0.0673 -2.699 
81.02 5.63 0.0563 -2.876 6.88 0.0688 -2.677 
88.89 5.66 0.0566 -2.872 6.60 0.0660 -2.718 
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96.75 4.85 0.0485 -3.026 5.27 0.0527 -2.944 
104.60 5.18 0.0518 -2.960 5.55 0.0555 -2.891 
112.47 4.96 0.0496 -3.003 4.82 0.0482 -3.033 
120.34 4.67 0.0467 -3.064 5.36 0.0536 -2.925 
133.19 4.42 0.0442 -3.120 4.30 0.0430 -3.147 
146.05 3.76 0.0376 -3.281 4.53 0.0453 -3.093 
158.92 3.63 0.0363 -3.316 3.86 0.0386 -3.254 
171.79 4.01 0.0401 -3.217 3.42 0.0342 -3.377 
184.65 4.25 0.0425 -3.158 4.98 0.0498 -2.999 
202.50 4.26 0.0426 -3.157 3.72 0.0372 -3.290 
220.37 3.82 0.0382 -3.265 4.20 0.0420 -3.169 
238.22 3.53 0.0353 -3.345 3.45 0.0345 -3.368 
256.09 3.67 0.0367 -3.306 3.87 0.0387 -3.251 
288.95 3.91 0.0391 -3.242 4.20 0.0420 -3.169 
321.80 3.58 0.0358 -3.331 3.34 0.0334 -3.400 
354.69 4.06 0.0406 -3.203 3.80 0.0380 -3.271 
 
Table 4.15 H/D exchange of the NH protons of complex [Rh(4a)2(cod)BF4] (1.2 mM CD2Cl2 solution). 
 Proton NH A Proton NH B 
t (min) %Ht RH,t ln (RH,t) %Ht RH,t 
ln 
(RH,t) 
0.00 100.00 1.0000 0.000 100.00 1.0000 0.000 
1.75 98.02 0.9802 -0.020 94.33 0.9433 -0.058 
4.22 97.70 0.9770 -0.023 89.61 0.8961 -0.110 
6.68 90.22 0.9022 -0.103 81.89 0.8189 -0.200 
9.17 85.55 0.8555 -0.156 75.32 0.7532 -0.283 
11.63 84.70 0.8470 -0.166 71.78 0.7178 -0.332 
14.10 78.01 0.7801 -0.248 65.67 0.6567 -0.421 
16.58 77.93 0.7793 -0.249 63.55 0.6355 -0.453 
19.03 77.07 0.7707 -0.260 62.34 0.6234 -0.473 
21.52 75.44 0.7544 -0.282 58.89 0.5889 -0.530 
24.00 74.28 0.7428 -0.297 56.38 0.5638 -0.573 
26.47 69.11 0.6911 -0.370 50.56 0.5056 -0.682 
32.93 63.89 0.6389 -0.448 45.30 0.4530 -0.792 
39.42 58.85 0.5885 -0.530 38.68 0.3868 -0.950 
45.88 50.06 0.5006 -0.692 30.55 0.3055 -1.186 
52.38 47.45 0.4745 -0.746 27.75 0.2775 -1.282 
58.88 44.67 0.4467 -0.806 25.62 0.2562 -1.362 
70.55 35.28 0.3528 -1.042 17.04 0.1704 -1.769 
77.03 32.18 0.3218 -1.134 15.06 0.1506 -1.893 
83.50 29.23 0.2923 -1.230 12.69 0.1269 -2.064 
89.98 25.66 0.2566 -1.360 11.07 0.1107 -2.201 
96.45 23.54 0.2354 -1.446 10.77 0.1077 -2.228 
102.92 22.00 0.2200 -1.514 8.04 0.0804 -2.521 
114.42 17.02 0.1702 -1.771 6.38 0.0638 -2.752 
125.88 14.14 0.1414 -1.956 6.03 0.0603 -2.808 
137.37 12.75 0.1275 -2.060 4.66 0.0466 -3.066 
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148.83 11.73 0.1173 -2.143 4.13 0.0413 -3.187 
160.32 10.55 0.1055 -2.249 5.12 0.0512 -2.971 
176.78 7.96 0.0796 -2.530 4.84 0.0484 -3.029 
193.27 7.33 0.0733 -2.614 4.04 0.0404 -3.208 
209.73 6.14 0.0614 -2.791 4.19 0.0419 -3.171 
237.12 4.99 0.0499 -2.997 4.78 0.0478 -3.042 
268.58 4.82 0.0482 -3.033 5.30 0.0530 -2.938 
300.08 5.37 0.0537 -2.925 4.44 0.0444 -3.114 
331.57 4.16 0.0416 -3.180 4.65 0.0465 -3.069 
363.13 3.41 0.0341 -3.379 3.88 0.0388 -3.251 
 
Figure 4.5 H/D exchange of the NH protons of ligand 4a and complex [Rh(4a)2(cod)BF4]: plot of %Ht vs. time. 
 
 
Table 4.16 H/D exchange of the NH protons of ligand 4a (1.2 mM CD2Cl2 solution): kinetic data. 
 Proton NH A 
 
 Proton NH B 
Regression  interval = 0 - 41.72 min 
 
Regression  interval = 0 - 49.59 min 
Linear regression of Slope Intercept 
 
Linear regression of Slope Intercept 
ln (RH,t) vs. t -0.0566 0.0000 
 
ln (RH,t) vs. t -0.0466 0.0000 
Standard error = 0.0012 #N/D 
 
Standard error = 0.0009 #N/D 
R2 = 0.9949 0.1035 
 
R2 = 0.9951 0.0930 
F index = 2145.6915 11.0000 
 
F index = 2418.1351 12.0000 
 22.9931 0.1179 
 
 20.9011 0.1037 
k (min-1) = 0.057  
 
k (min-1) = 0.047  
t1/2 (min) = ln(2) / k = 12.24  
 
t1/2 (min) = ln(2) / k = 14.88  
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Table 4.17 H/D exchange of the NH protons of complex [Rh(4a)2(cod)BF4] (1.2 mM CD2Cl2 solution): kinetic 
data. 
 Proton NH A   Proton NH B 
Regression  interval = 0 - 160.32 min  Regression  interval = 0 - 96.45 min 
Linear regression of Slope Intercept  Linear regression of Slope Intercept 
ln (RH,t) vs. t -0.0147 0.0000  ln (RH,t) vs. t -0.0243 0.0000 
Standard error = 0.0001 #N/D  Standard error = 0.0002 #N/D 
R2 = 0.9984 0.0445  R2 = 0.9984 0.0470 
F index = 17017.5956 27.0000  F index = 13181.3248 21.0000 
 33.6475 0.0534   29.1005 0.0464 
k (min-1) = 0.015   k (min-1) = 0.024  
t1/2 (min) = ln(2) / k = 47.10   t1/2 (min) = ln(2) / k = 28.47  
 
Table 4.18 Effect of an excess of CD3OD on the chemical shift of NH protons of ligand 4a and complex 
[Rh(4a)2(cod)BF4]. 
 
1.2 mM CD2Cl2 solution of 
Free ligand 4a [Rh(4a)2(cod)BF4] 
NH A NH B NH A NH B 
Before CD3OD addition  (ppm) = 8.683 8.333 9.619 8.508 
After addition of CD3OD (513 eq)  (ppm) = 9.337 9.075 9.893 9.066 
Chemical shift variation  (ppm) = 0.654 0.742 0.274 0.558 
 
 
4.6.5 CATALYTIC SCREENING OF THE PHTHALAPHOS LIBRARY 
 
The results of the catalytic screening of the whole PhthalaPhos library (ligands 4a-s) on substrates S1, 
S2, S3 and S4 are reported in this section. 
 
General Procedure for asymmetric hydrogenations under atmospheric pressure. Seven oven-
dried glass test tubes with stirring bars were employed: in each one the ligand (0.0042 mmol, 0.022 
eq) was weighted, then the test tubes were placed in a Schlenk and subjected to three vacuum/nitrogen 
cycles. A 2.12 mM DCM solution of [Rh(cod)2BF4] (0.9 mL, 0.001909 mmol, 0.01 eq) was added and 
the mixtures were stirred for 10 min under nitrogen. A 0.1909 M solution of the substrate in DCM (1 
mL, 0.1909 mmol, 1 eq) was finally added, followed by 2.1 mL of DCM. The reaction mixtures were 
subjected to three vacuum/hydrogen cycles and then left stirring overnight at room temperature under 
1 bar of hydrogen. Samples were taken for chiral GC analysis (for the GC conditions, see below). 
 
General Procedure for asymmetric hydrogenations under pressure higher than atmospheric. A 
Parr multireactor was employed, allowing six reactions in parallel under hydrogen pressure. The 
selected ligands (0.0042 mmol, 0.022 eq) were weighted in special glass vessels. The vessels were 
purged with nitrogen and a 2.12 mM DCM solution of [Rh(cod)2BF4] (0.9 mL, 0.001909 mmol, 0.01 
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eq) was added in each of them. After 10 min a 0.1909 M solution of the substrate in DCM (1 mL, 
0.1909 mmol, 1 eq) was added followed by 6.1 mL of DCM, and the vessels were placed in the 
respective autoclaves and purged three times with hydrogen at the selected pressure. The reactions 
were stirred overnight at R.T. under pressure of hydrogen, and then analysed by chiral GC for 
conversion and ee determination (see below). 
 
GC conditions for conversion and ee determination 
 
Methyl 2-acetamidopropanoate P1: capillary column: MEGADEX DACTBSβ, diacetyl-tert-
butylsilyl-β-cyclodextrin, 0.25 µm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; flow: 1 
mL/min; oven temperature: 140 °C for 6 min, then a 8 °C/min gradient is applied): tsubstrate = 3.7 min; tR 
= 4.7 min; tS = 5.3 min.S36 
N-(1-Phenylethyl)acetamide P2: capillary column: MEGADEX DACTBSβ, diacetyl-tert-butylsilyl-
β-cyclodextrin, 0.25 µm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; flow: 1.3 mL/min; 
oven temperature: 145 °C for 15 min, then a 8 °C/min gradient is applied; tR = 12.8 min; tS = 13.4 min; 
tsubstrate = 16.1 min.S37 
N-(1,2,3,4-Tetrahydronaphthalen-1-yl)acetamide P3: capillary column: MEGADEX DACTBSβ, 
diacetyl-tert-butylsilyl-β-cyclodextrin, 0.25 µm; diameter = 0.25 mm; length = 25 m; carrier: 
hydrogen; inlet pressure: 1.15 bar; oven temperature: 160 °C for 13 min, then a 13 °C/min gradient is 
applied; tR = 11.5 min; tS = 12.1 min; tsubstrate = 15.2 min.S38 
Methyl 3-acetamido-2-benzylpropanoate P4: capillary column: MEGADEX DACTBSβ, diacetyl-
tert-butylsilyl-β-cyclodextrin, 0.25 µm; diameter = 0.25 mm; length = 25 m; carrier: hydrogen; flow: 
1.4 mL/min; oven temperature: 170 °C for 30 min, then a 10 °C/min gradient is applied; t(+) = 22.4 
min; t(—) = 23.0 min; tsubstrate = 24.1 min.S39 
 
4.6.6 DFT AND MOLECULAR MECHANICS CALCULATIONS 
 
All calculations were run using the Schrödinger suite of programs (http://www.schrodinger.com) 
through the Maestro graphical interface. The following procedure was implemented to generate 
starting geometries of the [Rh(4a)2(cod)]+ complex for DFT optimization: 
 
4.6.6.1 DFT Rh(cod) phosphite core optimization 
 
The structure of the Rh(cod) phosphite core (Figure 4.6) was optimized at the B3LYP/LACVP level of 
theory using the Jaguar module.21 Rhodium was considered as a +1 cation in square planar geometry, 
coordinated to the cod ligand, and bound to the phosphorous atoms of simplified ligands. The core 
complex is a closed-shell molecule with a net charge of +1. Default convergence criteria have been 
employed. 
Figure 4.6 Structure of Rh(cod) phosphite core optimized by DFT calculation. 
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Optimized geometry as XYZ coordinates for Rh(cod) phospite core (distances in Ångstroms) 
Rh(COD) phospite core 
121 
energy:           -3635.39774745126 hartrees 
  O1           -1.8803856334     -5.5528705386      0.1696196923  
  P2           -3.2302291903     -6.6558832217     -0.0949629230  
  O3           -2.4471325236     -8.1879879804      0.2674333589  
  C4           -0.5384778702     -5.8345218335     -0.1956259881  
  C5            0.1489234315     -6.9111064962      0.3544239580  
  C6            0.0753431005     -4.9015774923     -1.0572669697  
  C7            1.4629009000     -7.1988485233     -0.1680993917  
  C8            1.3754130566     -5.1005422217     -1.4612257860  
  H9           -0.5010538512     -4.0423364376     -1.3711660938  
  C10           2.0810541198     -6.2759814084     -1.0808069847  
  H11           1.8612968390     -4.3841566891     -2.1140461299  
  C12          -1.6381522664     -8.3133115686      1.4370830607  
  C13          -2.1610956765     -9.1031164365      2.4868344469  
  C14          -0.4039879887     -7.6850910194      1.5018660172  
  C15          -1.4404119355     -9.2377791934      3.6524834126  
  C16           0.3174986317     -7.7501523981      2.7531526028  
  C17          -0.2054846758     -8.5499515331      3.8283750126  
  C18           2.1709377645     -8.3927092706      0.1623645788  
  C19           3.3779961821     -6.5635956073     -1.5952969354  
  C20           3.4200565479     -8.6506308185     -0.3677042601  
  C21           4.0369425991     -7.7251061512     -1.2480511737  
  H22           1.7087342817     -9.1134311598      0.8250461700  
  H23           3.9342227455     -9.5713370844     -0.1115849266  
  H24           3.8332407999     -5.8545671656     -2.2797818352  
  H25           5.0214511142     -7.9381053516     -1.6510875002  
  H26          -1.8170977870     -9.8557169647      4.4611115391  
  H27          -3.1135805638     -9.5995420762      2.3437689504  
  C28           0.5057428554     -8.6167409806      5.0608653662  
  C29           1.5123346189     -7.0072835938      2.9922218164  
  C30           1.6707915882     -7.9017804642      5.2478683633  
  C31           2.1681582951     -7.0799704370      4.2054893694  
  H32           3.0704419933     -6.4987250364      4.3646137993  
  H33           1.9033480310     -6.3664508343      2.2141235400  
  H34           0.1045708863     -9.2355329607      5.8579568646  
  H35           2.2014633511     -7.9560030728      6.1923908120  
  O36          -4.1241193608     -6.1734892706      1.2773679046  
  C37          -3.6515999757     -5.5308684731      2.5574170334  
  H38          -3.1425773003     -6.2968816576      3.1459951316  
  H39          -2.9537782014     -4.7359968615      2.2927119457  
  C40          -7.3547038365     -4.1770836461      4.2954475516  
  C41          -6.6642634818     -3.3605107254      3.3891223926  
  C42          -5.4473037181     -3.7878620843      2.8494115194  
  C43          -4.9060036151     -5.0344136633      3.2102109395  
  C44          -5.6031650703     -5.8450375834      4.1221192304  
  C45          -6.8204219964     -5.4183158479      4.6643638566  
  H46          -8.2976540263     -3.8445623836      4.7170277307  
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  H47          -7.0711322715     -2.3936451508      3.1108417207  
  H48          -4.9123605146     -3.1566279792      2.1451577473  
  H49          -5.1903248615     -6.8091187794      4.4062362437  
  O50          -3.9011301923     -4.4852108834     -4.1811731114  
  C51          -5.1307744999     -3.8774066878     -4.7465751347  
  H52          -4.7212839881     -3.0534467317     -5.3380266576  
  H53          -5.6122441338     -4.5802429174     -5.4343723203  
  C54          -7.8670265351     -2.3421494794     -1.7713859458  
  C55          -8.3568090138     -2.9142425448     -2.9520341939  
  C56          -7.4673442224     -3.4374488791     -3.8999053507  
  C57          -6.0804148558     -3.3849641677     -3.6803080448  
  C58          -5.5950217419     -2.8062428867     -2.4952991209  
  C59          -6.4842117976     -2.2913459132     -1.5456568993  
  H60          -8.5546495111     -1.9314418955     -1.0394913316  
  H61          -9.4253587986     -2.9479583397     -3.1390701788  
  H62          -7.8532091813     -3.8684595758     -4.8207515338  
  H63          -4.5245737831     -2.7544056632     -2.3267471304  
  Rh64         -5.0451830756     -7.0461596095     -1.7716026790  
  C65          -6.2803665550     -8.1852146901     -3.2507069012  
  C66          -6.3816828296     -9.6182606148     -2.7703806590  
  C67          -6.6309046305     -9.7640682869     -1.2474910135  
  C68          -5.9144131938     -8.7049984227     -0.4214183780  
  C69          -6.4637525698     -7.4886888203     -0.0205492996  
  C70          -7.8228957552     -6.9358188822     -0.3903256224  
  C71          -8.2282871080     -7.1774434894     -1.8653094930  
  C72          -7.0519758584     -7.0952699017     -2.8277286830  
  H73          -7.1715767608    -10.1414031404     -3.3336454363  
  H74          -5.4416087303    -10.1170353274     -3.0313511621  
  H75          -7.7036950243     -9.7349695389     -1.0294019994  
  H76          -6.2804278367    -10.7524243343     -0.9302525379  
  H77          -8.5868761447     -7.3510537866      0.2860935544  
  H78          -7.8026732489     -5.8574166080     -0.1977909646  
  H79          -8.7231834815     -8.1482507321     -1.9766937439  
  H80          -8.9658007071     -6.4206775826     -2.1538356494  
  H81          -7.0197950574     -6.1919305401     -3.4330175136  
  H82          -5.7445754752     -8.0710347739     -4.1878021387  
  H83          -5.9654621583     -6.9620900327      0.7897609960  
  H84          -5.0103936183     -9.0389652247      0.0851930972  
  O85          -3.6376608564     -6.9285531541     -5.1328530801  
  P86          -3.7719224790     -6.0880617261     -3.5711939237  
  O87          -2.1070666249     -6.0591150680     -3.1197749530  
  C88          -2.9734638950     -8.1929427453     -5.1221253411  
  C89          -1.6048726799     -8.2914089918     -4.8573957530  
  C90          -3.7747656289     -9.3150179683     -5.4366365343  
  C91          -1.0731577032     -9.6223522549     -4.6671534046  
  C92          -3.2344250340    -10.5793329500     -5.3889625321  
  H93          -4.7957558132     -9.1497814306     -5.7590282065  
  C94          -1.8939224866    -10.7702278544     -4.9531734169  
  H95          -3.8292252260    -11.4442094894     -5.6644589551  
  C96          -1.0865287919     -5.9509552201     -4.1127883823  
  C97          -0.4455471102     -4.6995043666     -4.2167457021  
  C98          -0.7439479403     -7.0649684643     -4.8655039423  
  C99           0.6621196743     -4.5798322981     -5.0202656817  
  C100          0.3998040455     -6.9340351050     -5.7464746150  
  C101          1.1336154142     -5.6929711612     -5.7690496648  
  C102          0.2397129831     -9.8510726932     -4.1581540430  
  C103         -1.3567342031    -12.0778687502     -4.7825948084  
  C104          0.7213529706    -11.1334645429     -3.9779349325  
  C105         -0.0745322081    -12.2602718271     -4.3078944818  
  H106          0.8572180125     -9.0013232404     -3.8951160603  
  H107          1.7181083694    -11.2810213186     -3.5755413354  
  H108         -1.9839501292    -12.9312905444     -5.0215068839  
  H109          0.3238297526    -13.2603101729     -4.1738965722  
  H110          1.1847278638     -3.6318248192     -5.1010137725  
  H111         -0.8377178923     -3.8652206508     -3.6521158768  
  C112          2.3044690906     -5.5786545199     -6.5714689761  
  C113          0.8415155972     -7.9712447011     -6.6212591313  
  C114          2.7336207001     -6.6275520073     -7.3566300930  
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  C115          1.9782350657     -7.8257703352     -7.3934978912  
  H116          2.2920431846     -8.6372583894     -8.0419672228  
  H117          0.2797933760     -8.8923940289     -6.6816194529  
  H118          2.8489586197     -4.6391049653     -6.5587566566  
  H119          3.6295298193     -6.5329586831     -7.9607886249  
  H120         -6.0988967592     -1.8398273451     -0.6371237072  
  H121         -7.3479999301     -6.0486954719      5.3727782542  
 
4.6.6.2  Molecular Mechanics calculations of [Rh(4a)2(cod)]+ complex.  
 
Monte Carlo conformational search of the [Rh(4a)2(cod)]+ complex was performed as implemented in 
the framework of Macromodel version 9.6S19 (AMBER* force field,S20 in vacuo condition with ε= 
4r). The butyl group of ligand 4a was not included in the model. The Rh(cod) phosphite core was 
frozen to the optimized DFT geometry leaving the benzyl groups free to move. For each search, at 
least 1000 starting structures for each variable torsion angle were generated and minimized until the 
gradient was less than 0.05 kJ/Å mol using the truncated Newton–Raphson algorithm.18 Duplicate 
conformations of ligands and those with an energy greater than 6 kcal/mol above the global minimum 
were discarded. A number of low energy conformers were identified which, in agreement with the 
spectroscopic data, are characterized by interligand hydrogen bonding involving proton NHA, namely: 
(i) structure-type I where the ligands are held together by two hydrogen bonds between proton NHA of 
each ligand and the carbonyl of the NHB-bearing ancillary amide of the other ligand (Figure 4.7); (ii) 
structure-type II with a single hydrogen bond between proton NHA of one ligand and the carbonyl of 
the NHB-bearing amide of the other ligand (Figure 4.8); (iii) structure-type III, where only one 
hydrogen bond connects proton NHA of one ligand with the carbonyl of the NHA-bearing amide of the 
other ligand (Figure 4.9). Obviously, III is in equilibrium with the iso-energetic structure where the 
roles of H-bond donor and acceptor of - NHACO- in the two ligands are inverted. 
 
Figure 4.7 Low energy structure-type I identified by molecular mechanics calculations. 
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Figure 4.8 Low energy structure-type II identified by molecular mechanics calculations. 
 
 
 
Figure 4.10 Low energy structure-type III identified by molecular mechanics calculations. 
 
 
 
DFT optimization of structure-types I, II and III obtained from the conformational search. 
Structure-type I, II and III identified by the above-described conformational search were fully 
optimized with DFT calculations at the B3LYP/LACVP level of theory using the Jaguar moduleSErrore. 
Il segnalibro non è definito.
 and their relative energies are reported in Table S20. The obtained stationary points 
were confirmed as minima by frequency calculation at the same level of theory. 
 
Table 4.19 Relative energies (kcal/mol) of optimized (B3LYP/LACVP) structure-type I, II and III. 
 
Structure-type ∆E (kcal/mol) 
I 0.00 
II 8.50 
III 7.45 
 
Optimized geometry as XYZ coordinates of the lowest energy minimum (structure-type I) of 
[Rh(4a)2(cod)]+ complex (distances in Ångstroms). The DFT optimized structure is shown in Figure 
4.5, see page 187). 
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Rh(4a)2(COD)  
177 
energy:      -5233.98053359893     hartrees 
  O1           -1.4114873516     -5.6097599810      0.6918941919 
  P2           -2.6852425090     -6.7611456051      0.2710151962 
  O3           -1.7250787417     -8.2517033599      0.3566885059 
  C4           -0.1010432778     -5.6766582168      0.1452629318 
  C5            0.7446761946     -6.7294934323      0.4753820426 
  C6            0.3162168903     -4.5805527098     -0.6379192177 
  C7            2.0352717822     -6.7823033246     -0.1644308930 
  C8            1.5896327832     -4.5694371240     -1.1609872386 
  H9           -0.3804566364     -3.7738990282     -0.8144569130 
  C10           2.4615530445     -5.6791291711     -0.9820477021 
  H11           1.9225335657     -3.7263469883     -1.7550038900 
  C12          -0.8118825487     -8.4541976420      1.4385979850 
  C13          -1.1852077025     -9.4120228221      2.4126465546 
  C14           0.3564614104     -7.7089817539      1.5292696037 
  C15          -0.4270325863     -9.5537931835      3.5532662836 
  C16           1.1423247976     -7.8268719678      2.7399465251 
  C17           0.7220440927     -8.7390034741      3.7706032781 
  C18           2.9114780516     -7.9004082433     -0.0290740900 
  C19           3.7439232813     -5.7248041692     -1.6017955169 
  C20           4.1454918966     -7.9162366978     -0.6491533481 
  C21           4.5722761658     -6.8163412319     -1.4377076191 
  H22           2.5930042131     -8.7519932139      0.5598697375 
  H23           4.7938675447     -8.7793723699     -0.5376705271 
  H24           4.0517852043     -4.8853493486     -2.2178563457 
  H25           5.5454710929     -6.8425752721     -1.9166893362 
  H26          -0.7112485997    -10.2748048425      4.3134001754 
  H27          -2.0772390396    -10.0043766659      2.2449637465 
  C28           1.4483299433     -8.7953700603      4.9959189855 
  C29           2.2915572346     -7.0187226911      2.9951304641 
  C30           2.5531134248     -7.9946048714      5.2055932103 
  C31           2.9777590315     -7.1031444401      4.1901637582 
  H32           3.8373410441     -6.4641201908      4.3623162198 
  H33           2.6183524665     -6.3101081356      2.2483714127 
  H34           1.1124149534     -9.4838834989      5.7657224574 
  H35           3.0953518183     -8.0434534294      6.1439867258 
  O36          -3.5486237250     -6.6357085624      1.7523639163 
  O37          -4.0187176526     -4.0829836152     -3.7467051061 
  Rh38         -4.5187775557     -6.9590414862     -1.4908912579 
  C39          -5.6511076043     -7.9464409755     -3.1325986009 
  C40          -5.6631931545     -9.4407096652     -2.8884440396 
  C41          -5.8877944381     -9.8401069718     -1.4089118553 
  C42          -5.2334248526     -8.8748380967     -0.4303853590 
  C43          -5.8698424073     -7.7792294261      0.1521838625 
  C44          -7.2828057518     -7.3073127605     -0.1277171486 
  C45          -7.6661623283     -7.2989334527     -1.6303141769 
  C46          -6.4943208204     -6.9824424037     -2.5526927636 
  H47          -6.4272564129     -9.9120326813     -3.5282963684 
  H48          -4.6987120805     -9.8341427914     -3.2280993783 
  H49          -6.9584606561     -9.9133169796     -1.1890274543 
  H50          -5.4727955852    -10.8412908840     -1.2483352126 
  H51          -7.9996480157     -7.9218066589      0.4398897615 
  H52          -7.3773203112     -6.2914083946      0.2725100017 
  H53          -8.1002737855     -8.2625102482     -1.9199358614 
  H54          -8.4525277711     -6.5530157381     -1.7899074460 
  H55          -6.5423903916     -6.0156570237     -3.0526665813 
  H56          -5.1422592395     -7.6560100789     -4.0449886855 
  H57          -5.4084071447     -7.3471566496      1.0377745781 
  H58          -4.3046396499     -9.2199324655      0.0211517919 
  O59          -3.3094786362     -6.2142260137     -4.8535817785 
  P60          -3.4478959798     -5.6066526758     -3.1980232801 
  O61          -1.7640040408     -5.4316625010     -2.8227731200 
  C62          -2.5406412034     -7.3960981432     -5.0491275374 
  C63          -1.1633446417     -7.4140546360     -4.8268538620 
  C64          -3.2528440263     -8.5193222994     -5.5306749785 
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  C65          -0.5256257942     -8.7122353877     -4.8227455665 
  C66          -2.6160257913     -9.7314836269     -5.6599349396 
  H67          -4.2859746057     -8.3873494441     -5.8291039607 
  C68          -1.2613198220     -9.8744656982     -5.2489114405 
  H69          -3.1423670332    -10.5932679406     -6.0573052147 
  C70          -0.7885714606     -5.1355750169     -3.8215218993 
  C71          -0.2158539918     -3.8464475360     -3.7766153690 
  C72          -0.4023261604     -6.1293464983     -4.7116773884 
  C73           0.8470312038     -3.5625867433     -4.6016295140 
  C74           0.6871682256     -5.8171749705     -5.6140925525 
  C75           1.3406009709     -4.5364492304     -5.5127230210 
  C76           0.8111088653     -8.8999363777     -4.3622017886 
  C77          -0.6266927177    -11.1489618732     -5.2436811450 
  C78           1.3893298234    -10.1549378544     -4.3453115758 
  C79           0.6724266130    -11.2907722235     -4.8018485362 
  H80           1.3681398974     -8.0428800016     -4.0034453458 
  H81           2.4017390612    -10.2745466142     -3.9736254838 
  H82          -1.1927510481    -12.0117497189     -5.5824473076 
  H83           1.1452032683    -12.2671466084     -4.7921701730 
  H84           1.3131653771     -2.5828315084     -4.5685878685 
  H85          -0.5987527665     -3.1076204683     -3.0837499452 
  C86           2.4558644159     -4.2465541883     -6.3499409025 
  C87           1.1439319584     -6.7093252961     -6.6305978928 
  C88           2.9028516369     -5.1591433707     -7.2818303798 
  C89           2.2238665370     -6.3936935597     -7.4323235907 
  H90           2.5508028490     -7.0963978227     -8.1919293153 
  H91           0.6363528671     -7.6516919247     -6.7804686803 
  H92           2.9417790217     -3.2809486987     -6.2448490989 
  H93           3.7552649346     -4.9295503346     -7.9125114737 
  C94          -1.8909563618     -1.2886364328      5.9163551503 
  N95          -1.9089969358     -2.3365197688      5.0358977122 
  O96          -2.7296622354     -1.1279918552      6.8406208379 
  H97          -1.2183780239     -2.3053201117      4.2826049207 
  C98           1.3920878427      1.5120387400      5.6017759089 
  C99           0.3756403370      1.5542690380      4.6462725923 
  C100         -0.7177681542      0.6719144285      4.7096670650 
  C101         -0.7689722826     -0.2895274711      5.7452658284 
  C102          0.2393038437     -0.2978768510      6.7231859770 
  C103          1.3177887030      0.5883567052      6.6516821620 
  H104          2.2207516746      2.2105669687      5.5440790976 
  H105          0.4027145227      2.2703415852      3.8337949463 
  H106          0.1790462500     -1.0170040998      7.5323358841 
  H107          2.0886190511      0.5629612011      7.4151837082 
  C108         -1.7321074348      0.7933828478      3.6102246206 
  N109         -3.0255063710      0.4592301139      3.9243136890 
  O110         -1.3822963016      1.1747828537      2.4637973019 
  H111         -3.2392893322      0.2873471037      4.8993619269 
  C112         -6.2622585959     -0.4243780454      1.3491620119 
  C113         -5.1987032721      0.3476668719      0.8708469424 
  C114         -4.1173853573      0.6776917215      1.6963095558 
  C115         -4.0983212983      0.2128890072      3.0236454702 
  C116         -5.1712323306     -0.5581384346      3.5108956050 
  C117         -6.2454592581     -0.8703906125      2.6775913261 
  H118         -7.0967226540     -0.6695482059      0.7003660355 
  H119         -5.2053140907      0.7056634700     -0.1537476557 
  H120         -3.2951796652      1.2716251176      1.3274076774 
  H121         -5.1536097118     -0.9181814304      4.5357185122 
  H122         -7.0671852791     -1.4637156122      3.0661124758 
  C123         -0.5807367159     -0.8340111320     -0.4320556357 
  N124         -1.5863994857     -1.2991353503      0.3613298959 
  O125         -0.5254059311     -1.0301414586     -1.6773575539 
  H126         -1.4527115614     -1.1487306615      1.3606528932 
  C127          2.3960045180      1.8659347201      1.1904577988 
  C128          2.1044333578      0.7087728805      1.9141671941 
  C129          1.1324735018     -0.2150323091      1.4760036464 
  C130          0.4641961549      0.0297232126      0.2435612023 
  C131          0.8094152066      1.1755230320     -0.4926960044 
  C132          1.7414579098      2.1016235325     -0.0207241289 
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  H133          3.1231943480      2.5747293418      1.5722224584 
  H134          2.5912896075      0.5519874595      2.8702991175 
  H135          0.3197549595      1.3311122677     -1.4465872000 
  H136          1.9549895523      2.9954136394     -0.5968302195 
  C137          0.8177903647     -1.3436907108      2.4118798274 
  N138          1.8685556139     -1.9413759967      3.0496362333 
  O139         -0.3699621903     -1.7025045234      2.6791335230 
  H140          2.8057000760     -1.6492912476      2.8099720928 
  C141          1.1647239525     -4.5999414205      6.2731808305 
  C142          2.0276584581     -3.5099830628      6.4374812793 
  C143          2.2898650852     -2.6491555966      5.3650345411 
  C144          1.6926220734     -2.8876749265      4.1196002297 
  C145          0.8772789388     -4.0119285447      3.9366221308 
  C146          0.6030076499     -4.8538319609      5.0182090025 
  H147          0.9434520901     -5.2522084150      7.1109717509 
  H148          2.4818320350     -3.3149834786      7.4035234555 
  H149          2.9140739751     -1.7733368714      5.5055399756 
  H150          0.4559887329     -4.2097843737      2.9591162219 
  H151         -0.0402927677     -5.7140215715      4.8793794689 
  C152         -2.9382335786     -6.7281741805      3.1297419668 
  H153         -3.2830680174     -7.6889699404      3.5161305996 
  H154         -1.8563010336     -6.7464235087      3.0196768743 
  C155         -3.8690720815     -3.5930917987      5.9322447238 
  C156         -4.6720999390     -4.7368025763      5.8619810150 
  C157         -4.4200716321     -5.7445862776      4.9258279779 
  C158         -3.3514046574     -5.6005498435      4.0254955030 
  C159         -2.5703759171     -4.4385781489      4.0637982810 
  C160         -2.8011829424     -3.4373224826      5.0237974093 
  H161         -4.0416713399     -2.8371745528      6.6837592722 
  H162         -5.4896271468     -4.8473673738      6.5669443396 
  H163         -5.0239990831     -6.6471195833      4.9131164815 
  H164         -1.7570954484     -4.3277377474      3.3572432428 
  C165         -4.8675809639     -3.1803070522     -2.9033424022 
  H166         -4.8425816681     -2.2557878986     -3.4819523285 
  H167         -5.8875097088     -3.5765313079     -2.9059310101 
  C168         -3.3519595997     -2.7408644307      1.0861325612 
  C169         -4.4891193244     -3.5079780280      0.8628827836 
  C170         -4.9928839323     -3.6453776677     -0.4366465080 
  C171         -4.3445873190     -3.0071385317     -1.5078365114 
  C172         -3.1947585946     -2.2305173695     -1.2857696689 
  C173         -2.6960953049     -2.0940358699      0.0189729376 
  H174         -2.9702762490     -2.6231333545      2.0908912016 
  H175         -4.9783917545     -3.9939374949      1.6979003660 
  H176         -5.8969545209     -4.2199796568     -0.6170551545 
  H177         -2.6931637291     -1.7355761522     -2.1064342667 
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“Combinatorial and Supramolecular Approaches to Monodentate 
Phosphorus-Ligands for Transition Metal Catalyzed Asymmetric Reactions” 
 
SUMMARY 
 
In recent years, monodentate phosphorus ligands (e.g. phosphites, phosphonites, phosphoramidites 
and phosphinamines) have held the stage in asymmetric catalysis.1 In addition to their outstanding activity 
and selectivity, comparable or even superior to those of bidentate ligands, the convenient, fast and 
practical preparation from commercially available materials underlines their potential for industrial 
applications. Furthermore, the modular nature of all these ligands allows the synthesis of a variety of 
representatives, thereby making a combinatorial approach possible.2 
My PhD research project deals with the synthesis of libraries of new chiral monodentate P-ligands 
and their screening in asymmetric transition metal-catalyzed reactions through two innovative approaches:  
 combination of binaphthol-derived phosphites and C1-symmetric phosphinamines for the 
selective generation of heteroleptic catalysts in Rh- and Pd-mediated reactions (Ligand 
Combination Approach, Research line 1);  
 supramolecular ligand-ligand interactions for highly selective transition metal catalysis 
(Supramolecular Approach, Research line 2). 
 
Research line 1 
In 2002-3, the groups of Reetz and Feringa independently used a binary mixture of chiral monodentate P-
ligands in several asymmetric rhodium-catalyzed reactions. By mixing two different ligands (La and Lb) in 
the presence of a transition metal [M], three species can be formed: [M]LaLa, [M]LbLb (homocomplexes) 
and [M]LaLb (heterocomplex). The heterocomplex is often more reactive and more (regio-, diastereo-, 
enantio-) selective than either of the two homocomplexes. Moreover, under thermodynamic control the 
heterocomplex : homocomplexes ratios usually exceed the statistical value (2 :1 :1). 
La + Lb
[M]
M
La La
+
M
Lb Lb
M
La Lb
homocomplexes heterocomplex
 
Scheme 1. The concept of using mixtures of chiral monodentate ligands 
 
The ideal case would constitute an equilibrium completely in favor of the heterocomplex [M]LaLb, 
because a single well-defined catalyst would then exist in the reaction mixture and the undesired 
competition of the less selective homocomplexes would be avoided.3  
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We were intrigued by the remarkable selectivities reported for the mixtures of chiral ligands (binol-
derived phosphites, phosphonites and phosphoramidites) with achiral phosphines.4 In particular, the 1:1 
mixture of a chiral phosphite with an achiral phosphine was reported to induce reversal of the 
enantioselectivity in the Rh-catalysed hydrogenation of N-acetamido acrylate (compared to the chiral 
phosphite alone). The only possible explanation for this peculiar behaviour is the selective formation of 
the phosphite-phosphine Rh-heterocomplex, favoured by electronically matching one σ-donor ligand 
(phosphine) and one pi-acceptor ligand (phosphite). As enantiomerically pure chiral phosphines are not 
easy to synthesize, we were wondering whether the phosphine ligands could be substituted by other σ-
donor phosphorus ligands still retaining the thermodynamic preference for the formation of the 
heterocomplex. For this reason, we turned our attention to chiral phosphinamines, which are easy to 
prepare enantiomerically pure, and have electronic properties similar to those of phosphines.5 DFT 
calculations showed that the phosphite-phosphinamine rhodium heterocomplex is more stable than the two 
homocomplexes by 11.29 kcal/mol (Scheme 2). 
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Rh
P
P
N Ph
Ph
Ph
N
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MeMe
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Me
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Rh
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PhO OPh
OPh
OPh
OPh
OPh
O
O
Rh
P
P
PhO OPh
OPh
Ph
N
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MeMe
+ 2
 
Scheme 2 DFT calculations at the B3LYP/SDD level of theory on the isodesmic reaction of phosphite-
phosphinamine heterocomplex 
 
We synthesized a library of monodentate chiral phosphites 1a-d by reacting enantiopure BINOL-PCl with 
different chiral and achiral alcohols. Monodentate chiral phosphinamines 2a-e were prepared by reaction 
of Ph2PCl with a number of C2-symmetric secondary amines and C1-symmetric secondary and primary 
amines. Complexation studies were performed by means of 31P-NMR, using Rh(acac)(C2H4)2 as the 
rhodium source. When C1-symmetric phosphinamine ligands were employed, the cis-heterocomplexes 
were formed with selectivity ranging from moderate (70%) to excellent (≥ 99%). 
The homo- and heterocombinations of phosphites and C1-symmetric phosphinamines were then screened 
in the rhodium-catalyzed hydrogenation of methyl 2-acetamidoacrylate. Remarkably, the 1:1 combination 
of a BINOL-derived phosphite and a phosphinamine induced reversal of the enantioselectivity, compared 
both to the phosphite and the phosphinamine alone. This heterocombination induced a peculiar 
stereochemical outcome also in the palladium-catalyzed asymmetric allylic substitution of rac-1,3-
diphenyl-3-acetoxyprop-1-ene with dimethyl malonate. 
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Scheme 3. Synthesis of binaphthol monodentate phosphites and C-1/C-2-symmetric monodentate aminophosphines. 
 
Research line 2 
In recent years, non-covalent interactions appeared as a clever way to achieve the exclusive formation of 
the heteroleptic complexes from mixtures of monodentate ligands.6 To this end, supramolecular ligands 
capable of complementary interactions (Scheme 3 A) are required, so that attractive interactions take place 
only between different ligands. 
 
DoDo
M
DoDo
M
DoDo
M
+
Non-covalent, complementary
interaction
2
DoDo
M
= donor atom
= catalytic metal
Do
M
Non-covalent, non complementary
interaction
Do
+
Do
+ M
, ,
= functional groups capable of non-covalent interactions
 
Scheme 3 Schematic representation of supramolecular bidentate ligands formed by complementary (A) and non-
complementary interactions (B). 
 
The heterocomplexes formed in this way are expected to have reduced degrees of freedom7 compared to 
the complexes of normal monodentate ligands, and thus supramolecular ligands somehow resemble 
traditional bidentate ligands. According to this analogy, they are often referred to as supramolecular 
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bidentate ligands or self-assembled ligands, thanks to their ability to spontaneously form bidentate 
systems in solution. These terms also apply to those supramolecular ligands that are only capable of non-
complementary interactions (Scheme 3 B):6 indeed these systems are still capable of forming rigid and 
conformationally restricted complexes, although they cannot selectively form heterocomplexes when used 
in a mixture, which quite reduces their "combinatorial appeal".  
Prompted by the studies of Prof. Reek and co-workers on the synthesis of supramolecular 
bidentate heterocomplexes through complementary interactions (e.g. coordinative bondings)8 and by the 
efficient resolution strategy of racemic N-benzyl α-amino acids (N-Bn-AA) by liquid-liquid extraction 
using a chiral salen–cobalt(III) complex as enantioselective receptor, accomplished in our laboratories,9 
we decided to use the salen-cobalt(III)-N-benzyl-L-serine complex as a chiral platform for the preparation 
of new families of supramolecular mono- and bi-dentate P-ligands (Scheme 4 A and B).10 
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Scheme 4 (A) Monodentate (salen)cobalt(III)(N-Bn-Ser) phosphites, (B) Bidentate hybrid P-ligands suitable for the 
formation of transition metal-catalysts by the supramolecular approach. 
 
The salen-cobalt(III)-N-Bn-AA complexes, in fact, possess a rigid framework with the salen ligand in a 
cis-β-folded arrangement around the octahedral cobalt ion. The remaining two cis coordination sites are 
occupied by the N-benzyl α-amino acid, which is thus accommodated in the “binding pocket” of the chiral 
cobalt complex. 9b 
Ligands 3 were synthesized in good yields starting from the symmetrical tetra-t-butyl-salen  which was 
transformed into the corresponding cobalt(III) acetate complex, and the acetate ion was exchanged with N-
benzyl-L-serine. In the case of symmetric salen backbone, the complex was obtained pure in high yield 
and the phosphite moieties were then introduced by reaction with different diol-derived chlorophosphite. 
In the case of the supramolecular bidentate ligands 4, the unsymmetrical hydroxymethyl-containing salen 
afforded the corresponding cobalt(III) acetate complex as a mixture of two inseparable diastereoisomers.  
Complexation of monodentate ligands 3 to rhodium(I) was studied by 31P-NMR spectroscopy, which 
showed the formation of the desired Rh-complexes. The reactivity of supramolecular monodentate P-
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ligands was investigated in two Pd-catalyzed-allylic alkylation on (E)-1,3-diphenylallyl acetate and Pd-
catalized desymmetrization of meso-cyclopenten-2-ene-1,4-diol biscarbamate.  
We are now exploring new synthetic pathways to obtain the unsymmetrical (S,S)-salen-ligand and the 
corresponding unsymmetrical (S,S)-salen-cobalt(III)-N-Bn-L-serine bidentate P-ligand in a pure 
diastereoisomeric fashion. 
We have also investigated the design and synthesis of a novel class of chiral monodentate 
phosphite ligands, named PhthalaPhos, which contain a phthalic acid primary diamide moiety. Such 
phthalamidic group displays both donor and acceptor hydrogen bonding properties that, in principle, can 
give rise to supramolecular interactions both between the ligands and with the reaction substrate (Scheme 
6).11  
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Scheme 5 Synthetic pathway for PhthalaPhos ligands 
 
The pre-catalytic Rh complex of one of these ligands was fully characterized and studied by NMR, IR and 
mass spectroscopy, which confirmed the presence of hydrogen bonds between the coordinated ligands, 
and the formation of a supramolecular bidentate ligand. 
The catalytic properties of these new ligands were assessed in the rhodium-catalyzed hydrogenation of 
benchmark olefins (e.g. methyl 2-acetoamidoacrylate and N-(1-phenylvinyl)acetamide), taking the known 
phosphite 9 as a touchstone. Four ligands gave e.e. values higher than 97% with methyl 2-
acetoamidoacrylate as substrate, and six reached the same level of performance with N-(1-
phenylvinyl)acetamide. Remarkably, the reference ligand 9, featuring the same BINOL phosphite moiety, 
gave only 84% and 90% e.e. respectively for the same substrates, thus suggesting that the phthalimide 
residue significantly influences the catalytic properties of these ligands. 
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Scheme 6. Supramolecular bidentate precatalyst [Rh(4a)2(cod)]+ and DFT calculated structure. Heteroatoms (N, O, 
P, Rh) are shown in black, carbon atoms in gray, and amide hydrogen atoms in light gray. For clarity, all hydrogen 
atoms bound to carbon are omitted. 
 
Evaluation of the catalytic properties of the Phthalaphos ligands were also extended to the Rh-catalyzed 
hydrogenation of more challenging substrates of potential industrial interest, such as N-(3,4-
dihydronaphthalen-1-yl)acetamide and (E)-methyl 2-(acetamidomethyl)-3-phenylacrylate. The results of 
this screening were quite variegated both in terms of activity and enantioselectivity, but the employment 
of a Phthalaphos ligand gave the highest e.e. value ever obtained on N-(3,4-dihydronaphthalen-1-
yl)acetamide with phosphite ligands and the highest e.e. value ever obtained with (E)-methyl 2-
(acetamidomethyl)-3-phenylacrylate. 
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